‫תש"ע‬/'‫ו‬
3/2010
‫רשומות‬
ISRAEL STATE RECORDS
‫כ"ג בחשון התשע"א‬
October 31 ,2010
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
Page/‫עמוד‬
Patents
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Corrections
Country codes
Indices of applications accepted
Designs
Designs registered
Desgins renewed
Designs void
Withdrawn designs
1
4
119
314
314
315
317
321
343
336
322
333
334
335
‫פטנטים‬
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקע‬
‫פטנטים שחודשו לעשרים שנה‬
‫תיקונים‬
‫קודים למדינות‬
‫מפתחות לבקשות שהתקבלו‬
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שחודשו‬
‫מדגמים שבוטלו‬
‫מדגמים שהוזנחו‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
.‫ ירושלים‬,‫ מלחה‬5 ‫ בנין‬,‫ גנים טכנולוגיים ירושלים‬,‫רשם הפטנטים והמדגמים‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬.0-24145-2
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office
together with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
2
‫זכות היוצרים בתקצירים אלה שמורה למדינת‬
‫ אין להעתיק מתקצירים אלה אלא‬,‫ישראל‬
.‫ברשות לשכת הפטנטים‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
PATENTS
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
applications complying with the provisions
of rule 32(a) of the Patent Regulations, 57281968:
Particulars of the applications are given in
the following order:
Number and date of application and the first
four symbols of the International
Classification.
Title of invention (as proposed by applicant)
Applicant
Priority right:
Convention countryNumber and date of
Foreign application
International Application Number
International Publication Number
3
‫פטנטים‬
-‫ תשכ"ז‬,‫ לחוק הפטנטים‬16 ‫הודעה לפי סעיף‬
1967
‫להלן רשימת בקשות חדשות הממלאות אחר‬
‫(א) לתקנות‬32 ‫הדרישות שנקבעו בתקנה‬
:1968-‫ תשכ"ח‬,‫הפטנטים‬
:‫פרטי הבקשות מובאים לפי סדר זה‬
‫מספר הבקשה – ותאריך הגשתה וארבעה‬
‫הסמנים הראשונים של הסיווג הבינלאומי‬
)‫שם האמצאה (כפי שהוצע ע"י המבקש‬
‫המבקש‬
– ‫מדינת האיגוד‬
:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
‫מספר בקשה בינלאומית‬
‫מספר פרסום בינלאומי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
14/06/2009
199336
SYSTEMS AND METHODS FOR
STREAMING AND ARCHIVING
VIDEO WITH GEOGRAPHIC
ANCHORING OF FRAME CONTENTS
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
23/06/2009
25/06/2009
‫מערכות ושיטות להפצה ולאירכוב של‬
‫וידאו עם תוכן מבוסס מידע גיאוגרפי‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
199514
METHOD AND SYSTEM FOR EARLY
IDENTIFICATION AND IMMEDIATE
DIAGNOSIS IN SYSTEMS THET
INCLUDES VISUAL OPTICAL OR
ELECTRO - OPTICAL MEANS
UZI EZRA HAVOSHA
US
60/902743
23/02/2007
4
A63B )2010.01(
‫שיטה ומערכת לזיהוי ואבחון מוקדם ומיידי‬
‫במערכות ראייה אופטיות או‬
‫אלקטרואופטיות‬
199559
‫פוליבודה ישי‬
F41H )2010.01(
‫מיגון גחון‬
‫פלסן סאסא בע"מ‬
BELLY ARMOR
PLASAN SASA LTD.
25/06/2009
G06T )2010.01(
199560
H01Q )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
SYSTEM AND METHOD FOR
CALIBRATION OF PHASED ARRAY
ANTENNA HAVING INTEGRAL
COLIBRATION NETWORK IN
PRESENCE OF AN INTERFERING
BODY
ELTA SYSTEMS LTD.
01/07/2009
‫מערכת ושיטה לכיול אנטנה בעלת רשת‬
‫כיול אינטגרלית בנוכחות גוף שיוצר‬
‫הפרעה‬
‫אלתא מערכות בע"מ‬
199643
‫מערכת הצתה היפרגולית לחומר הנעת‬
‫טילים ג'לי‬
HYPERGOLIC LGNITION SYSTEM
FOR GELLED ROCKET PROPELLANT
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
02/07/2009
FACE REPRESENTATION SYSTEMS
FOR PRIVACY AWARE
APPLICATIONS AND METHODS
USEFUL IN CONJUNCTION
THEREWITH
CARMEL-HAIFA UNIVERSITY
ECONOMIC CORP. LTD.
02/07/2009
ANONYMOUS TRANSACTIONS IN
COMPUTER NETWORKS
5
F42C )2010.01(
‫מוסד הטכניון למחקר ופיתוח בע"מ‬
199657
G06F )2010.01(
‫מערכות לייצוג פרצופים לאפליקציות‬
‫הרגישות לפרטיות ושיטות השימושיות‬
‫למערכות כנ"ל‬
‫החברה הכלכלית של אוניברסיטת‬-‫כרמל‬
‫חיפה בע"מ‬
199665
G06F )2010.01(
‫פעולות אנונימיות ברשתות מחשב‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
DEUTSCHE TELEKOM AG
07/07/2009
199737
VIEW DEPENDENT TEXTURE
PROJECTION MAPPING FOR URBAN
SCENES
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
23/07/2009
26/07/2009
‫רפאל מערכות לחימה מתקדמות בע"מ‬
F42B )2010.01(
‫מערכת ושיטה לטעינה מוגנת של עמדת‬
‫נשק מבוקרת מרחוק‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
200078
PROJECTILE LAUNCHING SYSTEM
INCLUDING DEVICE FOR AT LEAST
PARTLY ENCASING A PROJECTILE
ISRAEL AEROSPACE INDUSTRIES
LTD.
6
‫הטלת טסקטורה תלויה מבט עבור נוף‬
‫עירוני‬
200036
A SYSTEM AND A METHOD FOR
PROTECTED RELOADING OF A
REMOTE CONTROLLED WEAPON
STATION
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
G03B )2010.01(
F42B )2010.01(
‫מערכת להטלת קליע לרבות התקן‬
‫לעיטוף לפחות חלק מן הקליע‬
‫התעשייה האוירית לישראל בע"מ‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫(‪G08B )2010.01‬‬
‫‪201275‬‬
‫מודול אורטל למניעת התרסקות כלי טיס‬
‫מאוישים ‪ /‬לא מאוישים‬
‫יוסף שמואל‬
‫(‪G09B )2010.01‬‬
‫‪ORTAL MODULE FOR OBSTACLE‬‬
‫‪AIRPLANES CRUSH‬‬
‫‪YOSEF SHMUEL‬‬
‫‪202388‬‬
‫פרסום שומר מסך על מכשירים‬
‫סוללאריים‬
‫ידידיה יעקב‬
‫(‪B67B )2010.01‬‬
‫‪YEDIDYA YAKOV‬‬
‫‪203256‬‬
‫‪12/01/2010‬‬
‫‪LID& BASE FOR WASHCUP‬‬
‫‪COHEN YEHUDA‬‬
‫‪203268‬‬
‫שיטה לאיטום פריט בפני נוזלים באמצעות‬
‫פולימריזציה המרכיבה פלסמה‬
‫כ"ג בחשון התשע"א‪October 31, 2010-‬‬
‫‪29/11/2009‬‬
‫אאאאאאאאאאאאאאאאאאאאאאאא‬
‫מכסה בסיס לנטלן‬
‫כהן יהודה‬
‫(‪C08F )2010.01‬‬
‫‪01/10/2009‬‬
‫‪16/07/2008‬‬
‫‪METHOD FOR LIQUID PROOFING AN‬‬
‫‪ITEM BY PLASMA GRAFT‬‬
‫‪POLYMERISATION‬‬
‫‪P2I LTD‬‬
‫‪GB‬‬
‫‪0713827.4‬‬
‫‪17/07/2007‬‬
‫‪0721205.3‬‬
‫‪30/10/2007‬‬
‫‪GB‬‬
‫‪PCT/GB/2008/002416‬‬
‫‪WO/2009/010741‬‬
‫‪7‬‬
17/01/2010
203341
CATHETER WITH ISOLATION
BETWEEN ULTRASOUND
TRANSDUCER AND POSITION
SENSOR
BIOSENSE WEBSTER, INC.
US
12/358745
23/01/2009
18/07/2008
‫צנתר עם בידוד בין מתמר אולטראסאונד‬
‫וחיישן מיקום‬
203358
5-PYRIDINONE SUBSTITUTED
INDAZOLES
ALBANY MOLECULAR RESEARCH,
INC.
US
60/951201
21/07/2007
PCT/US/2008/070535
WO/2009/015037
14/07/2008
20/06/2008
8
H04Q )2010.01(
‫שיטה ומערכת לעיבוד תעבורת תקשורת‬
203360
CONTROLSYSTEM FOR INDUSTRIAL
WATER SYSTEM AND METHOD FOR
ITS USE
C07D )2010.01(
1 – ‫ – פירידין‬5 –‫אינדזולים מותמרים ב‬
203359
METHOD AND SYSTEM FOR
PROCESSING
TELECOMMUNICATION TRAFFIC
JAJAH INC
US
60/929918
18/07/2007
PCT/IL/2008/000975
WO/2009/010966
A61B )2010.01(
G05D )2010.01(
‫מערכת בקרה עבור מערכת מים‬
‫תעשייתית ושיטה לשימוש בה‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
GENERAL ELECTRIC COMPANY
US
11/833282
03/08/2007
PCT/US/2008/067680
WO/2009/020709
24/07/2008
203361
MONOAMIDE DERIVATIVES AS
OREXIN RECEPTOR ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
07113702.0 02/08/2007
PCT/EP/2008/059697
WO/2009/016087
07/08/2008
203362
PREDICTIVE MARKER FOR EGFR
INHIBITOR TREATMENT
F. HOFFMANN-LA ROCHE AG
EP
07114314.3 14/08/2007
08156516.0
20/05/2008
EP
PCT/EP/2008/006519
WO/2009/021680
29/07/2008
203363
PYRROLIDINE ARYL - ETHER AS
NK3 RECEPTOR ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
07113942.2 07/08/2007
PCT/EP/2008/059908
WO/2009/019163
18/01/2010
A CLOSED ELECTRON DRIFT
THRUSTER
9
203365
C07C )2010.01(
‫תולדות מונואמיד כאנטגוניסטים לקולטן‬
‫של אורקסין‬
C12Q )2010.01(
EGFR ‫סמן מקדים לטיפול מעכב‬
C07D )2010.01(
‫פירולידין אריל – אתר כאנטאגוניסטים‬
NK3–‫לרצפטור ל‬
H05H )2010.01(
‫מדחף סחף המבוסס על אלקטרון סגור‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
SNECMA
FR
0950486
16/08/2007
27/01/2009
203366
AQUEOUS COMPOSITION FOR
INACTIVATING SPORULATED AND
/OR NON-SPORULATED COCCIDIAN
PARASITES
ECOLAB INC.
A01N )2010.01(
‫תרכיב מימי לעיכוב פרזיטים המייצרים או‬
‫שאינם מייצרים נבגים‬
PCT/EP/2007/058530
WO/2009/021557
17/07/2008
203367
A NATURAL TASTE ENHANCING
SAVOURY BASE AND A PROCESS
FOR ITS PREPARATION
NESTEC S.A.
EP
07117260.5 26/09/2007
PCT/EP/2008/059378
WO/2009/040150
08/08/2008
10
‫שיפור טיב הטעם על בסיס שיפור התיבול‬
‫ותהליך להכנתו‬
203368
METHOD FOR SEPARATING AND
PURIFYING ?-UNSATURATED AMINE
COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
P2007JP
08/08/2007
206350
PCT/JP/2008/064293
WO/2009/020203
A23L )2010.01(
C07D )2010.01(
a ‫שיטה עבור הפרדה וטיהור תרכובת‬
‫אמין בלתי רוויה‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
16/07/2008
203369
COMPOSITIONS AND METHODS FOR
PURIFYING AND CRYSTALLIZING
MOLECULES OF INTEREST
AFFISINK BIOTECHNOLOGY LTD
US
11/826906
19/07/2007
PCT/IL/2008/000988
WO/2009/010976
17/07/2008
‫תרכובות ושיטות ל זיכוך וגיבוש מולקולות‬
203370
COMPOSITIONS - AND METHODS
FOR BLOCKING ETHYLENE
RESPONSE IN PLANTS USING 3 CYCLOPROPYL - 1 - ENYL PROPANOIC ACID SALT
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD
IL
184729
19/07/2007
PCT/IL/2008/000995
WO/2009/010981
30/07/2008
203371
PYRONE ANALOG COMPOSITIONS
AND METHODS
LIMERICK BIOPHARMA INC.
US
60/953187
31/07/2007
61/076584
27/06/2008
US
PCT/US/2008/071606
WO/2009/018350
30/07/2008
11
C07K )2010.01(
203372
‫אפיסינק ביוטכנולוגיה בע"מ‬
A01N )2010.01(
‫קומפוזיציות ושיטות לחיסום התגובה‬
‫לאתילן בצמחים באמצועת מלח של‬
– ‫ – אניל‬1 – ‫ – ציקלופרופיל‬3 ‫חומצה‬
‫פרופאנואית‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬
A01N )2010.01(
‫תכשירי אנלוג פירון ושיטות‬
A61K )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
PHOSPHORYLATED PYRONE
ANALOGS AND METHODS
LIMERICK BIOPHARMA INC.
US
60/953188
31/07/2007
61/076608
27/06/2008
US
PCT/US/2008/071588
WO/2009/018338
08/08/2008
203373
HANDOVER IN WIRELESS DATA
PACKET COMMUNICATION SYSTEM
THAT AVOID USER DATA LOSS
QUALCOMM INCORPORATED
US
60/954797
08/08/2007
12/187255
06/08/2008
US
PCT/US/2008/072705
WO/2009/021217
01/08/2008
12
C07K )2010.01(
‫ לטיפול‬NACHR 7 – ‫אגוניסטים של אלפא‬
‫או מניעת הפרעות מטבוליות‬
203375
LAYER 2 TUNNELING OF DATA
DURING HANDOVER IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
60/954779
08/08/2007
H04W )2010.01(
‫העברה במערכת תקשורת חבילות מידע‬
‫אלחוטית שמנועת איבוד מידע משתמש‬
203374
ALPHA7 NACHR AGONISTS FOR
TREATING OR PREVENTING
METABOLIC DISORDERS
TARGACEPT, INC.
US
60/953610
02/08/2007
60/953613
02/08/2007
US
60/953614
02/08/2007
US
60/971654
12/09/2007
US
2008/071893/‫וד‬PCT/
WO/2009/018511
08/08/2008
‫אנלוגי פירון מזורחנים ושיטות‬
H04W )2010.01(
‫ חפירת מנהרות למידע בזמן‬2 ‫שכבה‬
‫העברה במערכת תקשורת אלחוטית‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
12/187539
US
PCT/US/2008/072698
WO/2009/021214
28/07/2008
07/08/2008
203376
PHARMACEUTICAL COMBINATIONS
COMPRISING A TYROSINE KINASE
INHIBITOR AND AN ANTIBODY
AGAINST INTEGRIN ALPHA 1 BETA
5(CD49E)
FACET BIOTECH CORPORATION
US
60/952328
27/07/2007
PCT/US/2008/071379
WO/2009/018226
01/08/2008
18/07/2008
A61K )2010.01(
–1– )‫ – פירידיניל) מתיל‬3(( – 2( –
)‫ – איל‬3 – ‫ ] אוקט‬2.2.2 [ ‫אזאביציקלו‬
N3 ) –R 2, ,‫ – קרבוקסאמיד‬2 – ‫בנזופוראן‬
‫ וצורות מלח חדשות ושיטות לשימושן‬S
203378
TISSUE KALLIKREIN FOR THE
TREATMENT OF DISEASES
ASSOCIATED WITH AMYLOID
PROTEIN
GENESYS VENTURE INC.
US
60/950960
20/07/2007
13
‫שילובים פארמצבטיים הכוללים מעכב‬
– ‫קינאז טירוזין ונוגדן נגד אינטגרין אלפא‬
)E49CD( 5 ‫ – בטא‬21
203377
(2S,3R) - N - (2 - ((3 - PYRIDINYL)
METHYL) - 1 - AZABICYCLO [2.2.2]
OCT - 3 - YL) BENZOFURAN - 2 CARBOXAMIDE, NOVEL SALT
FORMS, AND METHODS OF USE
THEREOF
TARGACEPT, INC.
US
60/953610
02/08/2007
60/953613
02/08/2007
US
60/953614
02/08/2007
US
60971654
12/09/2007
US
PCT/US/2008/071872
WO/2009/018505
C07K )2010.01(
A61K )2010.01(
‫קליקרין רקמתי לטיפול במחלות‬
‫הקשורות בחלבון אמילואיד‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
61/023505
US
61/056411
US
61/061322
US
PCT/CA/2008/001327
WO/2009/012571
18/07/2008
25/01/2008
27/05/2008
13/06/2008
203379
DRY-POWDER MEDICAMENT
NORTON HEALTHCARE LIMITED
GB
0714134.4
19/07/2007
PCT/GB/2008/002473
WO/2009/010770
19/01/2010
203380
203381
SYSTEM FOR ACCUMULATING AND
FUNNELING GRAY WATER
AVRAHAM ROTBERG
19/01/2010
203382
PACKAGING FOR THROWING LIGHT
CARGO FROM AIR
SHABTAI AZRIEL
14
‫תרופה במצב אבקה יבשה‬
B41F )2010.01(
‫סורק מוזן נייר למחשב נייד‬
‫רפאל שיפרין‬
SCANNERS FOR LAPTOPS
REFAEL SHIFRIN
19/01/2010
A61K )2010.01(
F24H )2010.01(
‫מערכת אגירת וניתוב מים אפורים‬
‫אברהם רוטברג‬
B65D )2010.01(
‫אריזה להטלת מטענים קלים מהאוויר‬
‫שבתאי עזריאל‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
19/01/2010
203383
A WATER IMMERSION
THERMOSTAT AND METHOD FOR
USING THEREOF
ELIAHU BABI
11/06/2008
‫תרמוסטט טבול מים ושיטה לשימוש בו‬
‫יונה‬-‫אמנון חכם‬
203384
METHOD AND SYSTEM FOR
AUTOMATED INSPECTION OF WEB
MATERIALS
3M INNOVATIVE PROPERTIES
COMPANY
US
11/828369
26/07/2007
PCT/US/2008/066513
WO/2009/014818
15/07/2008
203385
FIDUCIAL MADKING FOR MULTI UNIT PROCESS SPATIAL
SYNCHRONIZATION
3M INNOVATIVE PROPERTIES
COMPANY
US
11/828376
26/07/2007
PCT/US/2008/070066
WO/2009/014939
15/07/2008
15
B65D )2010.01(
203386
G01N )2010.01(
‫שיטה ומערכת לבדיקה אוטומטית של‬
‫חומרים ברשת‬
G05B )2010.01(
‫סימון מהימן עבור תהליך סינכרוניזציה‬
‫מרחבי רב–יחידות‬
G06T )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
MULTI-UNIT PROCESS SPATIAL
SYNCHRONIZATION OF IMAGE
INSPECTION SYSTEMS
3M INNOVATIVE PROPERTIES
COMPANY
US
11/828383
26/07/2007
PCT/US/2008/070069
WO/2009/014940
22/07/2008
‫תהליך סינכרוניזציה מרחבי רב–יחידות של‬
‫מערכות לבדיקת תמונה‬
203387
ANTENNA MODULE INCLUDING
INTEGRATED RADOME
THALES
FR
07/05523
27/07/2007
PCT/EP/2008/059615
WO/2009/016071
01/08/2008
203388
STEM CELLS DERIVED FROM THE
CAROTID BODY AND USES
THEREOF
UNIVERSIDAD DE SEVILLA
ES
200702167
02/08/2007
PCT/EP/2008/060192
WO/2009/016262
27/08/2008
203389
BALLOON CANNULA SYSTEM FOR
ACCESSING AND VISUALIZING
SPINE AND RELATED METHODS
SPINE VIEW, INC.
US
60/968086
27/08/2007
61/045919
17/04/2008
US
PCT/US/2008/074405
WO/2009/029639
16
H01Q )2010.01(
‫מודול אנטנה הכולל כיפת מגן לאנטנה‬
‫באופן משולב‬
C12N )2009.01(
‫תאי גזע הנגזרים מגוף הקרוטיד ושימוש‬
‫בהם‬
A61B )2010.01(
‫מערכת צינורית לבלון לגישה וראיית‬
‫השדרה ושיטות מתאימות לכך‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
02/07/2003
203390
METHOD FOR PERFORMING
WIRELESS SWITCHING
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/394151
05/07/2002
334858
31/12/2002
US
PCT/US/2003/020823
WO/2004/006117
20/07/2008
‫שיטת מיתוג אל –חוטית‬
203391
203392
A METHOD OF PROCESSING AND
DRYING WASTE IN A CONTINUOUS
PROCESS
GEDALYAHU MANOR
US
60/961159
19/07/2007
PCT/US/2008/008842
WO/2009/014669
13/08/2008
17
B09B )2010.01(
‫שיטה לעיבוד ויבוש פסולת בתהליך רציף‬
‫גדליהו מנור‬
203393
OPTIMIZING IN-ORDER DELIVERY
OF DATA PACKETS DURING
WIRELESS COMMUNICATION
HANDOVER
QUALCOMM INCORPORATED
US
60/955607
13/08/2007
D04H )2010.01(
‫חומר אלבד‬
‫ בע"מ‬1953 ‫אבגול תעשיות‬
NON-WOVEN MATERIAL
AVGOL INDUSTRIES 1953 LTD
US
60/929950
19/07/2007
PCT/IL/2008/001006
WO/2009/010984
21/07/2008
H04W )2009.01(
H04L )2010.01(
‫ייעול משלוח לפי הסדר של חבילות מידע‬
‫בזמן העברה בתקשורת אלחוטית‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
PCT/US/2008/073073
WO/2009/023746
13/08/2008
203394
METHOD AND APPARATUS FOR
SUPPORTING BROADCAST AND
MULTICAST SERVICES IN A
WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
60/955620
13/08/2007
12/190441
12/08/2008
US
PCT/US/2008/073068
WO/2009/023741
08/08/2008
‫שיטה והתקן לתמיכת שירותי שידור‬
‫ושידור מרובב במערכת תקשורת אלחוטית‬
203395
ADAPTATION OF TRANSMIT POWER
FOR NEIGHBORING NODES
QUALCOMM INCORPORATED
US
60/955301
10/08/2007
60/957967
24/08/2007
US
12/187304
06/08/2008
US
PCT/US/2008/072690
WO/2009/023592
05/08/2008
18
H04W )2010.01(
‫התאמת כוח שידור לצמתים שכנים‬
203396
MULTIPLEXING AND
TRANSMISSION OF TRAFFIC DATA
AND CONTROL INFORMATION IN A
WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
60/954299
06/08/2007
12/185597
04/08/2008
US
PCT/US/2008/072254
WO/2009/020983
H04W )2010.01(
H04W )2010.01(
‫ריבוב ושידור של מידע נתוני ובקרת תנועה‬
‫במערכת תקשורת אלחוטית‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
30/07/2008
203397
TRANSDERMAL ADMINISTRATION
OF (2S) - (4E) - N - METHYL - 5 - (3 -(5
- ISOPROPOXYPYRIDIN) YL)- 4 PENTEN - 2 - AMINE
TARGACEPT, INC.
US
60/953062
31/07/2007
PCT/US/2008/071638
WO/2009/018373
04/08/2008
24/07/2008
19
H04L )2010.01(
‫שיטה והתקן לבחירה ורכישה יעילות של‬
‫ או‬OFDM –‫מערכות המשתמשות ב‬
FDM–SC
203400
PEPTIDES DERIVED FROM
PLASMINOGEN ACTIVATOR
INHIBITOR - 1 AND USES THEREOF
THROMBOTECH LTD
US
60/951485
24/07/2007
PCT/IL/2008/001027
WO/2009/013753
21/03/2005
– S2) – (E4) – N – (5( ‫מתן דרך העור של‬
2 – ‫ – פנטין‬4 – )‫איזופרופוקסיפירידין) איל‬
‫– אמין‬
203398
METHOD AND APPARATUS FOR
EFFICIENT SELECTION AND
ACQUISITION OF SYSTEM
UTILIZING OFDM OR SC-FDM
QUALCOMM INCORPORATED
US
60/953948
03/08/2007
12/181116
28/07/2008
US
PCT/US/2008/072139
WO/2009/020930
A61K )2010.01(
A61K )2010.01(
‫ של משפעל‬1 – ‫פפטידים שנגזרים ממעכב‬
‫פלסמינוגן ושימושים שלהם‬
203401
‫טרומבוטק בע"מ‬
C08F )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
METHODS OF PREPARATION
MONOLAYERS AND BILAYERS
COMPRISING ULTRA HIGH
MOLECULAR WEIGHT
POLYETHYLENE AND BALLISTIC
RESISTANT ARTICLES
MANUFACTURED THEREFROM
FMS ENTERPRISES MIGUN LTD.
US
60/601645
16/08/2004
60/626206
08/11/2004
US
22/01/2004
‫ דו ורב שכבתיות‬,‫שיטות להכנת יריעות חד‬
‫מחומר פוליאתילן בעל משקל מולקולרי‬
‫ וחפצים עמידי ירי המיוצרים‬,‫גבוה במיוחד‬
‫מהם‬
203402
FUSION POLYPEPTIDES, HOST
CELLS COMPRISING THE SAME AND
METHODS OF PRODUCING THE
SAME
GLY CART BIOTECHNOLOGY AG.
US
60/441307
22/01/2003
60/491254
31/07/2003
US
60/495142
15/08/2003
US
PCT/IB/2004/000844
WO/2004/065540
31/07/2008
203404
METHOD OF CONSTRUCTING
MASSES OF MYOCARDIAL CELLS
AND USE OF THE MYOCARDIAL
CELL MASS
KEIO UNIVERSITY
2007JP
31/07/2007
200246
2008-046772 27/02/2008
JP
PCT/JP/2008/064168
WO/2009/017254
20
‫ מיגון בע"מ‬.‫ס‬.‫מ‬.‫מפעלי פ‬
C12N )2010.01(
‫ תאים מארחים‬,‫פוליפפטידי איחוי‬
‫המכילים אותם ושיטות לייוצורם‬
C12N )2009.01(
‫שיטה לבניית מסת שריר הלב ושימוש‬
‫במסת שריר הלב‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
25/07/2008
203405
NOVEL COMBINATIONS OF
NERAMEXANE FOR THE
TREATMENT OF
NEURODEGENERATIVE DISORDERS
MERZ PHARMA GMBH & CO. KGaA
EP
07252976.1 27/07/2007
60/962259
27/07/2007
US
PCT/EP/2008/006162
WO/2009/015844
28/07/2008
‫קומבינציות חדשות של נרמקסאן לטיפול‬
‫במחלות ניווניות של מערכת העצבים‬
203406
NANOPARTICLES
NANOCO TECHNOLOGIES LIMITED
GB
0714865.3
31/07/2007
PCT/GB/2008/002560
WO/2009/016354
09/06/2008
203407
APPARATUS AND METHOD FOR
INCREASING THE DATA
THROUGHPUT IN RADIO NETWORKS
ROHDE & SCHWARZ GMBH & CO.
KG
10 2007 034
DE
25/07/2007
754.7
PCT/EP/2008/004587
WO/2009/012847
20/01/2010
203408
NON-CONTACT PATTERN TRANSFER
MOSHE FINAROV
21
A61K )2010.01(
C09K )2010.01(
‫ננוחלקיקים‬
H04L )2010.01(
‫התקן ושיטה להגברת קצב העברת‬
‫נתונים ברשתות רדיו‬
B23K )2010.01(
‫העברת תרשים חומר ללא מגע‬
‫משה פינרוב‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
20/01/2010
203409
AN APPARATUS FOR A SAILBOAT
AND METHOD THEREFOR
KETTER MEIR
28/03/2001
‫מתקן עבור מפרשית ושיטה עבורה‬
‫כתר מאיר‬
203410
CDMA SYSTEM WHICH USES PREROTATION BEFORE TRANSMISSION
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/192670
28/03/2000
PCT/US/2001/009968
WO/2001/073968
03/08/2006
203412
22
E04H )2010.01(
‫רובוט לניקוי בריכות מים‬
‫מיטרוניקס בע"מ‬
203413
DEGRADATION ACCELERATOR FOR
POLYMERS AND POLYER ARTICLE
COMPRISING IT
BASF SE
EP
07113692.3 02/08/2007
PCT/EP/2008/059681
WO/2009/016083
H04B )2010.01(
‫ המשתמשת בקדם–סיבוב‬CDMA ‫מערכת‬
‫לפני העברה‬
POOL CLEANING ROBOT
MAYTRONICS LTD.
US
11/196737
04/08/2005
PCT/IL/2006/000901
WO/2007/015251
24/07/2008
B63B )2010.01(
C07C )2010.01(
‫מאיץ התבלות לפולימרים ופריט פולימרי‬
‫המכיל אותו‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
24/07/2008
203414
MONOMERIC VHH DOMAIN
DERIVED FROM ANTI-VP6 CAMELID
ANTIBODIES, DIMERIC DOMAIN,
IMMUNISATION METHOD,
ROTAVIRUS DETECTION METHOD,
COMPOSITION, PREVENTION AND
TREATMENT METHODS FOR
ROTAVIRUS INFECTIONS
INSTITUTO NACIONAL DE
TECNOLOGIA AGROPECUARIA
(INTA)
AR
P070103331 27/07/2007
PCT/EP/2008/059745
WO/2009/016100
06/08/2008
11/09/2008
A61K )2010.01(
‫בופרופיון הידרוברומיד ויישומים טיפוליים‬
203416
TREATMENT OF VASOMOTOR
SYMPTOMS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
60/971605
12/09/2007
PCT/EP/2008/062011
WO/2009/034111
23
‫ מונומרי הנגזר מנוגדני קמליד‬VHH ‫אזור‬
,‫ שיטת חיסון‬,‫ אזור דימרי‬,VP6– ‫אנטי‬
‫ שיטות‬,‫ תכשיר‬,‫שיטה לגילוי רוטאוירוס‬
‫למניעה וטיפול בזיהומי רוטאוירוס‬
203415
BUPROPION HYDROBROMIDE AND
THERAPEUTIC APPLICATIONS
BIOVAIL LABORATORIES
INTERNATIONAL S.R.L.
US
11/834848
07/08/2007
PCT/EP/2008/060361
WO/2009/019294
C07K )2010.01(
A61K )2010.01(
‫טיפול בסימפטומים ואסומוטוריים‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
09/07/2008
203417
MEASUREMENT OF PROTEIN USING
INCLUSION BODY DRY WEIGHT
AMGEN INC.
US
60/947800
03/07/2007
PCT/US/2008/069529
WO/2009/006643
13/08/2008
203418
CODING AND MULTIPLEXING OF
CONTROL INFORMATION IN A
WIRELESS COMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
60/955624
13/08/2007
12/190461
12/08/2008
US
PCT/US/2008/073054
WO/2009/023730
01/08/2008
203419
PHOTOINITIATED TISSUE FILLER
THE JOHNS HOPKINS UNIVERSITY
US
60/953375
01/08/2007
PCT/US/2008/072034
WO/2009/018555
16/07/2008
203420
ELECTROGRAPHIC APPARATUS FOR
FORMING A LATENT IMAGE ON AN
IMAGING SURFACE
HEWLETT-PACKARD
DEVELOPMENT COMPANY L.P
US
11/830694
30/07/2007
PCT/US/2008/008713
WO/2009/017603
24
G01N )2010.01(
‫מדידת חלבון המשתמשת במשקל יבש‬
‫של גופיף הסגר‬
H04L )2010.01(
‫קידוד וריבוב של מידע בקרה במערכת‬
‫תקשורת אלחוטית‬
A61F )2010.01(
‫ממלא רקמה מותחלים על ידי אור‬
G03G )2010.01(
‫התקן אלקטרוגראפי לייצור דמות סמויה‬
‫במשטח הדמייה‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
25/07/2008
203421
SURGICAL SUTURING DEVICE,
METHOD AND TOOLS USED
THERWITH
ALPHA SCIENTIFIC CORPORATION
US
60/962031
26/07/2007
PCT/US/2008/009012
WO/2009/045248
28/07/2008
203422
NOVEL BENZAMIDINE
DERIVATIVES, PROCESS FOR THE
PREPARATION THEREOF AND
PHARMACEUTICAL COMPOSITION
FOR PREVENTING OR TREATING
OSTEOPOROSIS COMPRISING THE
SAME
DONG WHA PHARMACEUTICAL CO.,
LTD.
10-2007KR
27/07/2007
0075976
PCT/KR/2008/004394
WO/2009/017346
23/07/2008
ARMOR SYSTEM
FOSTER-MILLER, INC.
US
60/961810
11/999345
US
PCT/US/2008/008918
WO/2009/045243
20/07/2008
25
203423
A61B )2010.01(
‫ שיטה וכלים‬,‫התקן תפירה כירורגי‬
‫שמשתמשים בהם אתו‬
C07D )2010.01(
‫ תהליך להכנתן‬,‫נגזרות בנזמידין חדשות‬
‫ותכשיר רוקחות למניעת אוסטאופורוזיס‬
‫או לטיפול בה המכיל את אותן נגזרות‬
F41H )2010.01(
‫מערכת שריון‬
24/07/2007
05/12/2007
203424
G02C )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
A METHOD AND SYSTEM FOR
PROTECTION OF RETINA FROM
LIGHT INDUCED DAMAGE
RAPPAPORT FAMILY INSTITUTE
FOR RESEARCH IN THE MEDICAL
SCIENCES
US
60/929997
20/07/2007
PCT/IL/2008/001002
WO/2009/013737
18/07/2008
‫שיטה ומערכת להגנה על הרשתית מנזק‬
‫שמקורו באור‬
203425
INTERNAL REFORMING SOLID
OXIDE FUEL CELLS
NANO-DYNAMICS ENERGY. INC.
US
11/880105
19/07/2007
PCT/US/2008/008776
WO/2009/014645
21/01/2010
203426
A SYSTEM AND METHOD FOR
ADDING ADVERTISEMENTS TO
INFORMATION DISPLAY SYSTEMS
TRANSSPOT LTD
23/07/2008
H01M )2010.01(
)SOFC( ‫תאי דלק תחמוצת מוצקה‬
G09B )2010.01(
‫מערכת ושיטה להוספת פרסומות‬
‫למערכות להצגת מידע‬
‫טרנספוט בע"מ‬
203428
ANTIGEN - ADJUVANT
COMPOSITIONS AND METHODS
SANOFI PASTEUR LIMITED
US
60/952225
26/07/2007
PCT/CA/2008/001386
WO/2009/012601
26
‫המכון רפפורט למחקר במדעי הרפואה‬
‫ע"ש משפחת רפפורט‬
A61K )2010.01(
‫תרכובות אנטיגן – אדג'ובאנט ושיטות‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
15/08/2008
203430
INSULIN ANALOGUES WITH AN
ACYL AND ALKYLENE GLYCOL
MOIETY
NOVO NORDISK A/S
EP
07114386.1 15/08/2007
PCT/EP/2008/060768
WO/2009/022013
14/08/2008
‫אנלוגים של אינסולין עם אציל וחלק‬
‫אלקילן גליקולי‬
203431
SEED TREATMENT COMPOSITIONS
AND METHODS
BASF SE
EP
07114462.0 16/08/2007
PCT/EP/2008/060672
WO/2009/021985
01/08/2008
23/07/2008
27
A01N )2010.01(
‫תכשירים ושיטות לטיפול בזרעים‬
203432
NANOTHIN POLYMER FILMS WITH
SELECTIVE PORES AND METHOD OF
USE THEREOF
THE UNIVERSITY OF MEMPHIS
RESEARCH FOUNDATION
US
11/888739
02/08/2007
PCT/US/2008/071884
WO/2009/018508
C12N )2009.01(
A61K )2010.01(
‫שכבות פולימריות ננו–דקות עם נקבוביות‬
‫ברירתיות ושיטה לשימוש בהן‬
203433
A61K )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
PROCESS FOR THE PREPARATION OF
CONTROLLED - RELEASE SOLID
FORMULATIONS CONTAINING
OXCARBAZEPINE, AND
FORMULATIONS OBTAINABLE BY
SAID PROCESS
ARCHIMICA S.R.L.
IT
MI2007A1502 25/07/2007
PCT/IB/2008/001904
WO/2009/013594
22/07/2008
203434
PROCESS FOR PREPARING
OXAZOLIDINE AND
OXAZOLIDINONE AMINODIOLS AND
RELATED INTERMEDIATES
INTERVET INTERNATIONAL B.V.
US
60/951816
25/07/2007
PCT/US/2008/070696
WO/2009/015111
11/07/2008
‫תהליך להכנת הרכבים מוצקים לשחרור‬
‫מבוקר המכילים אוקסאקרבאזאפין‬
‫והרכבים המתקבלים מתהליך זה‬
‫תהליך להכנת אוקסאזולידין‬
‫ואוקסאזולידינון אמינודיאולים וחומרי ביניים‬
‫קשורים‬
203435
ABSORBENT ARTICLE
THE PROCTER & GAMBLE
COMPANY
US
11/880931
25/07/2007
PCT/IB/2008/052808
WO/2009/013660
11/07/2008
203436
ABSORBENT ARTICLE
THE PROCTER & GAMBLE
COMPANY
US
11/881115
25/07/2007
PCT/IB/2008/052807
WO/2009/013659
28
C07D )2010.01(
A61F )2010.01(
‫פריט סופג‬
A61F )2010.01(
‫פריט סופג‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
11/07/2008
203437
REMOVABLE DRIVE ELECTRONICS
UNIT FOR HIGH RESOLUTION PRINT
ENGINE
VIDEOJET TECHNOLOGIES INC.
US
11/781750
23/07/2007
PCT/US/2008/069828
WO/2009/014918
01/08/2008
‫יחידה אלקטרונית של כונן הניתן להסרה‬
‫עבור מנוע הדפסה ברזולוציה גבוהה‬
203438
HIGH HARDNESS, HIGH TOUGHNESS
IRON - BASE ALLOYS AND
METHODS FOR MAKING SAME
ATI PROPERTIES, INC.
US
60/953269
01/08/2007
PCT/US/2008/071931
WO/2009/018522
25/07/2008
31/07/2008
29
C22C )2010.01(
‫סגסוגות על בסיס ברזל בעלות קשיות‬
‫גבוהה וקשיחות גבוהה ושיטות להכנתן‬
203439
CONTROLLED RELEASE
INTERFERON DRUG PRODUCTS
AND TREATMENT OF HVC
INFECTION USING SAME
BIOLEX THERAPEUTICS, INC.
US
60/951879
25/07/2007
60/952140
26/07/2007
US
60/978330
08/10/2007
US
60/985526
05/11/2007
US
PCT/US/2008/071191
WO/2009/015336
B41J )2010.01(
A61K )2010.01(
‫תרופות עם שחרור מבוקר המכילות‬
‫ באמצעותן‬HCV ‫אינטרפרון וטיפול בזיהום‬
203440
G01S )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫ארכיטקטורת מכ"ם מודולרית‬
MODULAR RADAR ARCHITECTURE
THALES
FR
07/05709
03/08/2007
PCT/EP/2008/060068
WO/2009/019191
11/08/2008
203441
A MODULE AND ASSOCIATED
METHOD FOR TR - 069 OBJECT
MANAGEMENT
ALCATEL LUCENT
EP
07291009.4 14/08/2007
PCT/EP/2008/006699
WO/2009/021739
05/08/2008
31/07/2008
C04B )2010.01(
‫תערובת דלילה מוקצפת ולוח מבנה העשוי‬
‫ממנה‬
203443
METHOD FOR MANUFACTURING
LINEAR POLYETHYLENIMINE (PEI)
FOR TRANSFECTION PURPOSE AND
LINEAR PEI OBTAINED WITH SUCH
METHOD
POLYPLUS- TRANSFECTION
US
60/952993
31/07/2007
PCT/IB/2008/002339
WO/2009/016507
30
069 ‫מודול ושיטה קשורה לניהול אובייקט‬
TR –
203442
FOAMED SLURRY AND BUILDING
PANEL MADE THEREFROM
UNITED STATES GYPSUM COMPANY
US
11/893758
17/08/2007
PCT/US/2008/072217
WO/2009/025989
F21S )2010.01(
C08G )2010.01(
‫שיטה לייצור פוליאתילנאימין לינארי‬
‫למטרת העברת גנים ופוליאתילנאימין‬
‫לינארי המתקבל ע"י שיטה זו‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
22/08/2008
203444
ANTIVIRAL COMPOSITION
COMPRISING A SULFATED
POLYSACCHARIDE
MARINOMED BIOTECHNOLOGIE
GMBH
US
60/935668
24/08/2007
PCT/EP/2008/006910
WO/2009/027057
21/01/2010
‫תכשיר אנטי–ויראלי המכיל פוליסכאריד‬
‫סולפטי‬
203445
INSPECTION APPARATUS,
LITHOGRAPHIC APPARATUS,
LITHOGRAPHIC PROCESSING CELL
AND INSPECTION METHOD
ASML NETHERLANDS B.V.
US
61/151665
11/02/2009
31/07/2007
A61K )2010.01(
G01B )2010.01(
‫ תא‬,‫ מכשיר הדפסת אבן‬,‫מכשיר בדיקה‬
‫עיבוד להדפסת אבן ושיטת בדיקה‬
203446
C02F )2010.01(
‫מערכת סינון בחלחול‬
PERCOLATION FILTER SYSTEM
SELWYN CORPORATE LTD.
PCT/EP/2007/006831
WO/2009/015679
30/07/2008
203447
BENZOYL-PIPERIDINE DERIVATIVES
AS DUAL MODULATORS OF THE 5 HT2A AND D3 RECEPTORS
C07D )2010.01(
‫תולדות בנזויל – פיפרידין כמאפננים‬
– ‫ ול‬A2TH–5 – ‫כפולים של הרצפטורים ל‬
D3
F. HOFFMANN-LA ROCHE AG
EP
07114119.6 09/08/2007
PCT/EP/2008/059971
WO/2009/019174
31
October 31, 2010-‫כ"ג בחשון התשע"א‬
08/08/2008
203448
AZABIPHENYLAMINOBENZOIC
ACID DERIVATIVES AS DHODH
INHIBITORS
ALMIRALL, S.A.
ES
P200702261 10/08/2007
08382011.8
13/03/2008
EP
PCT/EP/2008/006573
WO/2009/021696
21/01/2010
‫תולדות חומצה אזאביפנילאמינובנזואית‬
DHODH ‫כמעכבי‬
203449
METHODS AND SYSTEMS FOR
MEASURING THE FREQUENCY
RESPONSE AND IMPULSE RESPONSE
OF OBJECTS AND MEDIA
ARIEL- UNIVERSITY RESEARCH
AND DEVELOPMENT COMPANY
LTD.
04/10/2004
C07D )2010.01(
‫שיטות ומערכות למדידת תגובת התדר או‬
‫תגובת האימפולס של אובייקטים ושל תווך‬
‫חברה אוניברסיטאית למחקר‬-‫אריאל‬
‫ופיתוח בע"מ‬
203450
32
C07K )2010.01(
TIM–3 ‫פוליפפטידים‬
TIM-3 POLYPEPTIDES
BRIGHAM AND WOMEN'S HOSPITAL
US
60/508319
03/10/2003
PCT/US/2004/032749
WO/2005/033144
23/07/2008
G01R )2010.01(
203451
B65H )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
NON STOP UNWINDING DEVICE WITH
LIMITED BULK FOR ROLLS OF WEBLIKE MATERIAL
OMET SRL
IT
MI2007A001497 25/07/2007
PCT/IB/2008/002019
WO/2009/013615
10/07/2008
203452
MECHANICAL PART INCLUDING AN
INSERT MADE OF A COMPOSITE
MATERIAL
SNECMA
FR
0705454
26/07/2007
PCT/FR/2008/001015
WO/2009/034264
10/07/2008
33
C22C )2010.01(
‫חלק מכני הכולל תוספת העשויה מחומר‬
‫מרוכב‬
203454
AN IMPLANTED MEDICAL DEVICE
ESPECIALLY USED IN COSMETIC
SURGERY
AESTHETICS POINT LTD
US
60/951,960
26/07/2007
PCT/IL/2008/001038
WO/2009/013758
C22C )2010.01(
‫חלק מכני הכולל תוספת העשויה מחומר‬
‫מרוכב‬
203453
MECHANICAL PART INCLUDING AN
INSERT MADE OF A COMPOSITE
MATERIAL
SNECMA
FR
0705453
26/07/2007
PCT/FR/2008/001014
WO/2009/034263
27/07/2008
‫מכשיר ריפוף ללא הפסקות עם מסה‬
‫מוגבלת לגלילים של חומר דמוי אריג‬
A61B )2010.01(
‫שתל רפואי לשימוש בניתוחים קוסמטיים‬
‫אסתטיקס פוינט בע"מ‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
21/01/2010
203455
REUSING HOUSEHOLD GRAY
WATER TO FLUSH TOILETS
NEHEMIAH KAPLAN INVESTMENTS
LTD
23/07/2008
08/08/2008
‫מערכת לניצול מים אפורים להדחת אסלה‬
‫נחמיה קפלן השקעות בע"מ‬
203456
SOLAR ENERGY SYSTEMS WITH
REFLECTING AND PHOTOVOLTAIC
CONVERSION MEANS
BRIGHTSOURCE INDUSTRIES
(ISRAEL) LTD
US
60/951241
23/07/2007
61/053035
14/05/2008
US
PCT/US/2008/070910
WO/2009/015219
HYDROPHILLIC BIODEGRADABLE
ADHESIVES
COHERA MEDICAL, INC.
34
H01L )2010.01(
‫מערכת אנרגיה סולארית עם אמצעי מראי‬
‫ופוטוולטאיק‬
‫ברייטסורס אינדוסרייס מרק ון דייק‬
203457
REUSABLE MATERIAL FOR
COLLECTING SAMPLES FOR
ANALYSIS
L-3 COMMUNICATIONS CYTERRA
CORPORATION
US
60/955,123
10/08/2007
PCT/US/2008/072652
WO/2009/023576
07/07/2008
E03B )2010.01(
G01N )2010.01(
‫חומר לשימוש חוזר עבור איסוף דוגמיות‬
‫לבדיקה‬
203458
C09J )2010.01(
‫דבקים הידרופיליים הניתנים לפירוק ביולוגי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
US
11/781539
12/123927
US
PCT/US/2008/069329
WO/2009/014886
08/08/2008
23/07/2007
20/05/2008
203459
QUATERNARY OPIOID
CARBOXAMIDES
RENSSELAER POLYTECHNIC
INSTITUTE
US
60/954960
09/08/2007
PCT/US/2008/072632
WO/2009/023567
‫קרבוקסאמידים אופיאוגדים רביעונים‬
203460
21/01/2010
APPARATUS FOR MOUNTING
AUXILIARY EQUIPMENT ON A
VEHICLE CONTAINMENT SYSTEM AND
SET CONSISTING OF A VEHICLE
CONTAINMENT SYSTEM AND SUCH AN
APPARATUS
VOLKMANN & ROSSBACH GMBH & CO.
KG
DE
102009005477.4 21/06/2009
718.4 012 09
07/10/2009
EP
13/08/2008
203461
POLISHING PAD
CABOT MICROELECTRONICS
CORPORATION
US
60/956293
16/08/2007
PCT/US/2008/009687
WO/2009/025748
35
C07D )2010.01(
B62D )2010.01(
‫מכשיר לטעינת ציוד עזר על מחסום‬
‫ ומערכת המורכבת ממחסום‬,‫לרכב‬
‫וממכשיר הטעינה‬
B24D )2010.01(
‫כרית ליטוש‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
203462
24/01/2010
‫תומך בטיחות אלקטרוני לעבודת‬
‫משקולות חופשיות‬
‫ניצן נחום‬
AN ELECTRONIC SAFETY DEVICE
FOR FREE WEIGHT WORK OUT
NITZAN NAHUM
24/01/2010
SEAT CUSHION
MAAYAN IZINGER
US
61/146669
24/01/2010
203463
23/01/2009
203464
A61F )2010.01(
‫צמיד לתזכורת זמנים וכמויות האכלה של‬
‫תינוקות‬
‫סיון יתח‬
203465
SYSTEM AND METHOD FOR MASS
CALIBRATION OF RADIO
FREQUENCY FINGERPRINT (RF-FP)
LOCATION MEASUREMENTS
VERINT SYSTEMS LTD.
36
B62B )2010.01(
‫כרית למניעת החלקה לכיסא גלגלים‬
‫מעין איזינגר‬
BRACELET FOR MEMORIZING TIMES
AND AMOUNTS OF BABY NURSING
SIVAN ITAH
24/01/2010
A63B )2010.01(
G01S )2010.01(
‫מערכת ושיטה לכיול של מדידות מיקום‬
‫המבוססות על טביעת אצבע תדר רדיו‬
‫ורינט מערכות בע"מ‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
24/01/2010
203466
METHODS AND SYSTEMS FOR
DETECTION OF FINANCIAL CRIME
VERINT SYSTEMS LTD.
‫שיטות ומערכות לגילוי פשעים כלכליים‬
‫ורינט מערכות בע"מ‬
203467
24/01/2010
‫ודים מרקובניק אצל גי בי אף ישראל בע"מ‬
203468
HUMAN ANTIBODIES TO HUMAN
CD20 AND METHOD OF USING
THEREOF
REGENERON PHARMACEUTICALS
INC.
US
60/962811
31/07/2007
61/067994
03/03/2008
US
PCT/US/2008/071709
WO/2009/018411
14/08/2008
203469
REFERENCE SIGNAL GENERATION
IN A WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
37
E01F )2010.01(
‫טיוביקסטון‬
TUBICSTONE
MARKOVNIC VADIM G.D.F ISRAEL
LTD.
31/07/2008
G07B )2010.01(
C07K )2010.01(
‫ אנושי ושיטה‬CD20–‫נוגדנים אנושיים ל‬
‫לשימושם‬
H04J )2010.01(
‫יצירת אות ייחוס במערכת תקשורת‬
‫אלחוטית‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
US
60/955801
12/190889
US
PCT/US/2008/073206
WO/2009/023792
13/08/2008
14/08/2007
13/08/2008
203470
FREQUENCY DIVERSE
TRANSMISSIONS IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
60/955543
13/08/2007
12/190432
12/08/2008
US
PCT/US/2008/073063
WO/2009/023736
24/07/2008
‫שידורים בתדרים שונים במערכת תקשורת‬
‫אלחוטית‬
203471
METHOD FOR OBTAINING A
COSMETIC PRODUCT FROM A
CONCENTRATE OF THE TIGER NUT
DRINK
HORCHATERIA DANIEL, S.L.
ES
P200702058 24/07/2007
PCT/ES/2008/000515
WO/2009/013377
25/07/2008
203472
1 - OXO - ISOINDOLINE - 4 CARBOXAMIDE AND-1 - OXO - 1, 2, 3,
4 - TETRAHYDROISOQUINOLINE - 5 CABOXAMIDE DERIVATIVES,
PREPARATION AND THERAPEUTIC
USE THEREOF
SANOFI-AVENTIS
FR
0705499
27/07/2007
PCT/FR/2008/001110
WO/2009/044019
38
H04L )2010.01(
A61K )2010.01(
‫שיטה להפקת מוצר קוסמטי מתרכיז‬
ESCULENTUS CYPERUS –‫משקה ה‬
C07D )2010.01(
– 4 – ‫ – אוקסו – איזואינדולין‬1 ‫נגזרות‬
– 4 ,3 ,2 ,1 – ‫קרבוקסאמיד ו – אוקסו‬
,‫ קרבוקסאמיד‬5 – ‫טטראהידרואיזוקינולין‬
‫הכנתן ושימושן הרפואי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
25/07/2008
203473
DERIVATIVES OF 1 - OXO - 1, 2 DIHYDROISOQUINOLINE - 5 CARBOXAMIDES AND OF 4 - OXO - 3,
4 - DIHYDROQUINAZOLINE -8 CARBOXIMIDES, PREPARATION
THEREOF AND APPLICATION
THEREOF IN THERAPEUTICS
SANOFI-AVENTIS
FR
0705500
27/07/2007
PCT/FR/2008/001109
WO/2009/044018
24/07/2008
29/06/1998
ADVANCED TELEVISION SYSTEM
NDS LIMITED
39
– 2 ,1 – ‫ – אוקסו‬1 ‫נגזרות‬
4‫ – קרבוקסאמידים ו‬5 – ‫דיהידרואיזוקינולין‬
– 8 – ‫ – דיהידרוקינאזולין‬4 ,3 – ‫– אוקסו‬
‫ הכנתם ויישומן ברפואה‬,‫קרבוקסאמידים‬
203474
1, 2, 3, 4 - TETRAHYDROPYRROLO [1,
2 -A] PYRAZINE - 6 - CABOXAMIDE
AND 2, 3, 4, 5 TETRAYDROPYRROLO[1,2-A ] [1, 4] DIAZEPINE - 7 - CARBOXAMIDE
DERIVATIVES, PREPARATION AND
THEREPEUTIC USE THEREOF
SANOFI-AVENTIS
FR
07/05497
27/07/2007
07/05498
27/07/2007
FR
PCT/FR/2008/001096
WO/2009/044007
C07D )2010.01(
C07D )2010.01(
2 ,1[ ‫ – טטראהידרופירולו‬4 ,3 ,2 ,1 ‫נגזרות‬
,4 ,3 ,2 – ‫ – קרבוקסאמיד ו‬6 – ‫] פיראזין‬A –
– 7 – ‫] – דיאזפין‬4 ,1[ ‫ – טראהידרופירולו‬5
‫ הכנתן ושימושן התראפיוטי‬,‫קרבוקסאמיד‬
203475
H04N )2010.01(
‫מערכת טלביזוינית משופרת‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
19/09/2008
203476
POLISHING COMPOSITION AND
METHOD UTILIZING ABRASIVE
PARTICLES TREATED WITH AN
AMINOSILANE
CABOT MICROELECTRONICS
CORPORATION
US
60/974328
21/09/2007
PCT/US/2008/010897
WO/2009/042073
19/09/2008
‫הרכב ליטוש ושיטה בשימוש חלקיקים‬
‫משפשפים מעובדים עם אמינוסיליין‬
203477
POLISHING COMPOSITION AND
METHOD UTILIZING ABRASIVE
PARTICLES TREATED WITH AN
AMINOSILANE
CABOT MICROELECTRONICS
CORPORATION
US
60/974340
21/09/2007
PCT/US/2008/010896
WO/2009/042072
30/06/2008
09/05/2005
40
C07C )2010.01(
– ‫שיטה לייצור הרכבים אמורפיים אמורפי‬
‫גבישיים מופעלים מכנית של חומצה‬
‫גלוקונית סידן‬
203479
MUTANT PNEUMOLYSIM PROTEINS
C09K )2010.01(
‫הרכב ליטוש ושיטה בשימוש חלקיקים‬
‫משפשפים מעובדים עם אמינוסיליין‬
203478
METHOD FOR PRODUCING
MECHANICALLY ACTIVATED
AMORPHOUS AND
AMORPHOCRYSTALLINE
COMPOUNDS OF GLUCONIC ACID
CALCIUM SALT
NIKOLAJ SERGEEVICH STRELKOV
RU
2007127937 20/07/2007
PCT/RU/2008/000403
WO/2009/014471
C09G )2010.01(
C07K )2010.01(
‫חלבוני פנאומוליזין מוטנטים‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
TIMOTHY JOHN MITCHELL
GB
0410220.8
07/05/2004
60/569415
07/05/2004
US
PCT/GB/2005/001792
WO/2005/108580
24/01/2010
203480
SELECTIVE ETCHING AND
FORMATION OF XENON
DIFLUORIDE
AIR PRODUCTS AND CHEMICALS,
INC.
US
12/360588
27/01/2009
‫צריבה ברירתית ויצירה של קסנון‬
‫דיפלואוריד‬
203481
25/07/2008
2 - AZA - BICYCLO [3.3.0] OCTANE
DERIVATIVES
ACTELION PHARMACEUTICALS LTD.
IB
PCT/IB07/052991 27/07/2007
PCT/IB/2008/052989
WO/2009/016564
24/01/2010
203482
MOUNT FOR A COMPRESSION
CONTROL UNIT
TYCO HEALTHCARE GROUP LP
US
12/359793
26/01/2009
21/07/2008
41
C23C )2010.01(
C07D )2010.01(
]0.3.3[ ‫ – אזא – ביציקלו‬2 ‫תולדות‬
‫אוקטן‬
F02B )2010.01(
‫הרכב ליחידת בקרת דחיסה‬
203483
B09B )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫שיטת סילוק עבור מיחזור מלא של‬
‫אשפה מוצקה‬
DISPOSAL METHOD FOR ENTIRELY
RECYCLING SOLID DEFUSE
QIHUI LIAN
CN
200710029339.4 25/07/2007
PCT/CN/2008/001346
WO/2009/012653
23/07/2008
203484
4 - HYDROXY - 4 - METHYL PIPERIDINE - 1 - CARBOXYLIC ACID
(4 - METHOXY - 7 - MORPHOLIN - 4 YL - BENZOTHIAZOL - 2 - YL) AMIDE FOR THE TREATMENT OF
POST - TRAUMATIC STRESS
DISORDER
SYNOSIA THERAPEUTICS
US
60/935035
23/07/2007
PCT/US/2008/070934
WO/2009/015236
23/07/2008
– 1 – ‫ – מתיל – פיפרידין‬4 – ‫ – הידרוקסי‬4
– 7 – ‫ – מתוקסי‬4( ‫חומצה קרבוקסילית‬
– )‫ – יל‬2 – ‫ – יל – בנזותיאזול‬4 – ‫מורפולין‬
‫אמיד לטיפול באי סדר של לחץ לאחר‬
‫טראומה‬
203485
TREATMENT OF POST-TRAUMATIC
STRESS DISORDER
SYNOSIA THERAPEUTICS
US
60/935036
23/07/2007
PCT/US/2008/070948
WO/2009/015248
24/07/2008
INTERSPINOUS SPACER
VERTIFLEX, INC.
US
60/961741
PCT/US/2008/008983
WO/2009/014728
42
A01N )2010.01(
203486
A61K )2010.01(
‫טיפול באי–סדר של לחץ לאחר טראומה‬
A61B )2010.01(
‫מרווח בין חוליות עמוד השדרה‬
24/07/2007
October 31, 2010-‫כ"ג בחשון התשע"א‬
25/07/2008
203487
IMPROVED ORGAN PROTECTION,
PRESERVATION AND RECOVERY
HIBERNATION THERAPEUTICS
LIMITED
AU
2007903999 25/07/2007
PCT/AU/2008/001086
WO/2009/012534
24/07/2008
‫ שימור ושחזור‬,‫הגנה משופרת על איברים‬
203488
METHODS AND APPARATUS FOR
HANDLING PRODUCTS
DOUGLAS MACHINE INC.
US
11/782104
24/07/2007
PCT/US/2008/070980
WO/2009/015259
30/07/2008
26/10/2007
43
A61K )2010.01(
‫תכשיר פרמצבטי לטיפול בפצעים ושיטות‬
‫הקשורות בתכשיר‬
‫עור בע"מ‬-‫היל‬
203491
COLOR-CODED AND SIZED
LOADABLE POLYMERIC PARTICLES
FOR THERAPEUTIC AND/OR
DIAGNOSTIC APPLICATIONS AND
METHODS OF PREPARING AND
USING THE SAME
B65B )2010.01(
‫שיטות והתקן לטיפול במוצרים‬
203490
PHARMACEUTICAL COMPOSITION
FOR TREATING WOUNDS AND
RELATED METHODS
HEAL-OR LTD.
US
60/962706
30/07/2007
PCT/IL/2008/001049
WO/2009/016629
A01N )2010.01(
A61K )2010.01(
‫חלקיקים פולימריים ניתנים להעמסה לפי‬
‫גודל ומוצפנים לפי צבע ליישומים רפואיים‬
‫או אבחוניים ושיטות להכנתם ולשימוש‬/‫ו‬
‫בהם‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
CELONOVA BIOSCIENCES, INC.
US
60/962015
25/07/2007
PCT/US/2007/082659
WO/2009/014549
203492
31/07/2008
LIGHTING APPARATUS
LSI INDUSTRIES, INC.
US
60/953009
12/183403
US
PCT/US/2008/071741
WO/2009/018433
‫מערכת תאורה‬
31/07/2007
31/07/2008
23/05/2001
203493
NRG-2 NUCLEIC ACID MOLECULES,
POLYPEPTIDES, AND DIAGNOSTIC
AND THERAPEUTIC METHODS
CENES PHARMACEUTICALS, INC.
US
60/206495
23/05/2000
PCT/US/2001/016896
WO/2001/089568
25/01/2010
203494
CLOSURE FOR CONTAINERS
PRODUCTOS FLOWER, S.A.
EP
09382016
03/02/2009
31/07/2008
INHALER
VECTURA DELIVERY DEVICES
LIMITED
44
F21V )2010.01(
203495
C07K )2010.01(
,NRG–2 ,‫מולקולות חומצה גרעינית‬
‫פוליפפטידים ושיטות אבחון וטיפול‬
B65D )2010.01(
‫סוגר עבור מיכלים‬
A61M )2010.01(
‫משאף‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
EP
07113624.6
PCT/EP/2008/060078
WO/2009/016238
01/08/2007
01/08/2008
203496
IMPROVED PHARMACEUTICALCOATED MEDICAL PRODUCTS, THE
PRODUCTION THEREOF AND THE
USE THEREOF
INVATEC TECHNOLOGY CENTER
GMBH
10 2007 036
DE
03/08/2007
685.1
PCT/DE/2008/001285
WO/2009/018816
25/01/2010
,‫מוצרי רפואה רוקחות– מצופים משופרים‬
‫ייצורם ושימושיהם‬
203497
203498
APPARATUS AND METHODS FOR
TREATMENT OF BACTERIAL
INFECTION IN SOFT TISSUE
ORTHO-ION, LTD.
25/01/2010
45
F21V )2010.01(
‫מגן רוח לנרות‬
‫אושרי שמואל‬
WIND SHIELD FOR CANDLES
OSHRI SHMUEL
25/01/2010
A61L )2010.01(
A61C )2010.01(
‫מכשיר ושיטות לטיפול בזיהום חיידקי‬
‫ברקמה רכה‬
‫אורתויון בע"מ‬
203499
G09G )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
MULTI-TOUCH SENSOR APPARATUS
AND METHOD
WACOM CO., LTD.
US
12/650400
30/12/2009
13/08/2008
‫מכשיר ושיטה לסנסור רב נגיעתי‬
203500
ARRANGEMENT FOR INSTALLING
CABLES ON OUTER SURFACES OF
CRANE STRUCTURES
KONECRANES PLC
FI
20075570
15/08/2007
PCT/FI/2008/050457
WO/2009/022057
25/01/2010
‫סידור להתקנת כבלים על משטחים‬
‫חיצוניים של מבני מנופים‬
203501
A SYSTEM, METHOD, CIRCUIT AND
ASSEMBLY FOR PROVIDING
HEATED WATER
ISOTERMA LTD
27/07/2008
46
F24H )2010.01(
‫ מעגל חשמלי ומרכב‬,‫ שיטה‬,‫מערכת‬
‫להספקת מים חמים‬
‫איזוטרמה בע"מ‬
203502
POMEGRANATE SPROUTS,
PREPARATIONS DERIVED
THEREFROM AND COMPOSITIONS
COMPRISING SAME
THE STATE OF ISRAEL- MINISTRY
OF AGRICULTURE & RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION
VOLCANI CENTER
US
60/935153
27/07/2007
PCT/IL/2008/001033
B66C )2010.01(
A61K )2010.01(
‫ תכשירים הנוצרים מהם‬,‫נבטי רימונים‬
‫ותרכובות המכילות אותם‬
‫ משרד החקלאות ופיתוח‬- ‫מדינת ישראל‬
‫ מרכז‬,‫ מינהל המחקר החקלאי‬,‫הכפר‬
‫וולקני‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
WO/2009/016620
12/08/2008
203503
FEEDBACK AND RATE ADAPTATION
FOR MIMO TRANSMMISSION IN A
TIME DIVISION DUPLEXED (TDD)
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
60/955622
13/08/2007
12/181732
29/07/2008
US
PCT/US/2008/072932
WO/2009/023681
12/08/2008
MIMO ‫משוב והתאמת מהירות לשידור‬
TDD ‫ברשת תקשורת‬
203504
AD HOC SERVICE PROVIDERS
ABILITY TO PROVIDE SERVICE FOR
A WIRELESS NETWORK
QUALCOMM INCORPORATED
US
60/956658
17/08/2007
11/861279
26/09/2007
US
PCT/US/2008/072866
WO/2009/026034
12/08/2008
47
H04W )2010.01(
‫יכולת של ספק שירות מאולתר לספק‬
‫שירות לרשת אלחוטית‬
203505
AD HOC SERVICE PROVIDER
CONFIGURATION FOR
BROADCASTING SERVICE
INFORMATION
QUALCOMM INCORPORATED
US
60/956658
17/08/2007
11/861280
26/09/2007
US
PCT/US/2008/072863
WO/2009/026033
H04L )2010.01(
H04W )2010.01(
‫תצורת ספק שירות מאולתר לשידור מידע‬
‫שירות‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
12/08/2008
203506
‫מנהל מערכת שירות לספק שירות נייד‬
‫מאולתר‬
SERVICE SET MANAGER FOR AD
HOC MOBILE SERVICE PROVIDER
QUALCOMM INCORPORATED
US
60/956658
17/08/2007
60/980547
17/10/2007
US
12/188979
08/08/2008
US
PCT/US/2008/072872
WO/2009/026037
27/07/2008
203507
SYSTEM AND METHODS FOR THE
MEASUREMENT OF LVNG VOLUME
PULMONE ADAVANCED MEDICAL
DEVICES LTD
US
60/951998
26/07/2007
PCT/IL/2008/001031
03/08/2008
26/01/2010
48
‫פאלם וואן מכשור רפואי מתקדם בע"מ‬
A61K )2010.01(
‫חיסונים מולטימריים מרובי אפיטופים נגד‬
‫שפעת‬
203509
SYSTEM FOR SUPPLYING
ADVANCED RELIGIOUS SERVICES
OSHRIT HADAD
US
61/147769
28/01/2009
A61B )2010.01(
‫מערכת ושיטות למדידת נפחי ריאה‬
203508
MULTIMERIC MULTIEPITOPE
INFLUENZA VACCINES
BIONDVAX PHARMACEUTICALS
LTD
US
60/953498
02/08/2007
PCT/IL/2008/001062
WO/2009/016639
H04W )2010.01(
‫ביונדווקס פרמצבטיקה בע"מ‬
H04W )2010.01(
‫שירותי דת מבוססי מיקום‬
‫חברת נמבר פיינשל בע"מ‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
30/07/2008
203511
PRODRUGS OF CANNABIDIOL,
COMPOSITIONS COMPRISING
PRODRUGS OF A CANNABIDIOL
AND METHODS OF USING THE SAME
ALLTRANZ INC.
US
60/952746
30/07/2007
PCT/US/2008/071659
WO/2009/018389
25/07/2008
‫ תכשירים‬,‫פרו–תרופות של קאננאבידיאול‬
‫המכילים פרו – תרופות של קאננאבידיאול‬
‫ושיטות לשימוש בהן‬
203512
POLYSACCHARIDES GRAFTED BY
POLYAMINES FOR THE PREPARTION
OF RADIOPHARMACEUTICAL
COMPOSITIONS
LABORATOIRES CYCLOPHARMA
FR
0756750
26/07/2007
60/952094
26/07/2007
US
PCT/EP/2008/059825
WO/2009/013358
05/07/2005
203514
SYSTEMS AND METHODS FOR
MINIMIZING STATIC LEAKAGE OF
AN INTEGRATED CIRCUIT
MOSAID TECHNOLOGIES
CORPORATION
US
60/586565
09/07/2004
10/996739
24/11/2004
US
PCT/US/2005/023839
WO/2006/017082
49
C07C )2010.01(
A61K )2010.01(
‫פוליסכארידים מורכבים מפוליאמינים‬
‫להכנת תכשירי רוקחות רדיואקטיבים‬
G05F )2010.01(
‫מערכות ושיטות להקטנה ככל האפשר‬
‫של דליפה בעלת ערך קבוע ממעגל‬
‫משולב‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
25/02/2003
203515
A61K )2010.01(
COMPOSITION COMPRISING ? - 4 INTEGRIN FOR TREATING
INFLAMMATION
ELAN PHARMACEUTICALS, INC.
US
60/360134
25/02/2002
60/374501
23/04/2002
US
PCT/US/2003/005421
WO/2003/072040
? – 4 ‫תכשירים המכילים מעכב של‬
‫אינטגרין לטיפול בדלקת‬
203516
23/07/2008
NANOSIZE STRUCTURES COMPOSED
OF VALVE METALS AND VALV METAL
SUBOXIDES AND PROCESS FOR
PRODUCING THEM
H.C. STARCK GMBH
DE
102007038581.3 16/08/2007
102007057761.5
30/11/2007
DE
PCT/EP/2008/059659
WO/2009/021820
25/07/2008
‫מבנים זעירים המורכבים ממתכות‬
‫שסתום ותת אוקסידים של מתכות אלו‬
‫ותהליך ליצורם‬
203517
USES OF TRIENTINE AND
PENICILLAMINE AS
COUNTERMEASURES TO METAL
CONTAMINATION
ATON PHARMA INC.
US
60/952482
27/07/2007
PCT/US/2008/071194
WO/2009/018152
25/07/2008
COMPLEXES BETWEEN AN
AMPHIPHILIC POLYMER AND AN
OSTEOGENIC PROTEIN OF THE
BMPS FAMILY
50
B22F )2010.01(
A61K )2010.01(
‫שימושים בטריאנטין ופניצילאמין‬
‫כאמצעים נגד זיהום מתכתי‬
203518
A61K )2010.01(
‫קומפלקסים בין פולימר אמפיפילי וחלבון‬
BMPS – ‫אוסטאוגני ממשפחת ה‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
ADOCIA
FR
07/05536
60/952407
US
PCT/EP/2008/059832
WO/2009/016131
27/07/2007
27/07/2007
203519
12/02/2008
‫מחצלת השקייה לחלוקת מים באיזור‬
‫גדול‬
WATERING MAT FOR THE LARGEAREA DISTRIBUTION OF WATER
IGG-INTERNATIONALE GEOTEXTIL
GESELLSCHAFT MBH
DE
102007036018.7 30/07/2007
PCT/EP/2008/051657
WO/2009/015911
29/07/2008
203520
COMPOSITE BALLISTIC FABRIC
STRUCTURES FOR HARD ARMOR
APPLICATIONS
HONEYWELL INTERNATIONAL INC.
US
11/888479
01/08/2007
PCT/US/2008/071486
WO/2009/048674
01/08/2008
MILK FROTHER
FOREMOST B.V.
NL
NL1034240
PCT/NL/2008/000186
WO/2009/020384
29/07/2008
51
A01G )2010.01(
F41H )2010.01(
‫מבני בד בליסטיים מרוכבים עבור יישומי‬
‫שריון קשה‬
203521
A47J )2010.01(
‫מקציף חלב‬
08/08/2007
203522
A61J )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
DEVICE AND USE FOR STORING AND
PROVIDING PHARMACEUTICAL
WAFERS
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
DE
102007037374.2 06/08/2007
PCT/EP/2008/006223
WO/2009/018938
26/01/2010
203523
RESERVOIR ELUTING STENT
CORDIS CORPORATION
US
61/148610
30/01/2009
12/652996
06/01/2010
US
01/06/1999
203524
NOVEL SERPENTINE
TRANSMEMBRANE ANTIGENS
EXPRESSED IN HUMAN CANCERS
AND USES THEREOF
AGENSYS, INC.
US
60/087520
01/06/1998
60/091183
30/06/1998
US
PCT/US/1999/012157
WO/1999/062941
28/07/2008
203525
INJECTION DEVICE WIHT LOCKING
MECHANISM FOR SYRINGE
CARRIER
CILAG GMBH INTERNATIONAL
GB
0715457.8
08/08/2007
PCT/GB/2008/002583
WO/2009/019440
52
‫התקן ושימוש לאחסון והספקה של‬
‫תכשירי רוקחות בצורת לוחות דקיקים‬
A61F )2010.01(
‫סטנט משחרר מאגר‬
C07K )2010.01(
‫אנטיגנים סרפטין טרנסממברנליים‬
‫המבוטאים בסרטן הומני ושימוש בם‬
A61M )2010.01(
‫התקן הזרקה עם מנגנון נעילה לנשא‬
‫מזרק‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
26/01/2010
203526
‫ניטור יריות של כלי ירייה‬
‫אהוד דריבן‬
MONITORING SHOTS OF FIREARMS
EHUD DRIBBEN
24/07/2008
203527
STEREOSELECTIVE PROCESS FOR
PREPARING PURINE DIOXOLANE
NUCLEOSIDE DERIVATIVES
RFS PHARMA, LLC
US
60/962550
30/07/2007
PCT/US/2008/071069
WO/2009/018106
26/01/2010
203528
E04D )2010.01(
‫לוח לשימוש בגג ירוק‬
‫פוליביד‬
203529
METHOD FOR PRODUCING ? NITROSTYRENE COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2007JP
31/07/2007
199547
PCT/JP/2008/063521
WO/2009/017091
53
A61K )2010.01(
‫תהליך לייצור סטריאו סלקטיבי של נגזרות‬
‫פורין דיאוקסוליין נוקלאוזיד‬
GREEN ROOF PANEL
POLYBID
28/07/2008
F41B )2010.01(
C07C )2010.01(
‫שיטה לייצור תרכובת ? – ניטרוסטירין‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
17/07/2008
203530
‫מכשירי הדמיה לקספאז‬
CASPASE IMAGING PROBES
SANOFI AVENTIS
EP
07015256.6 03/08/2007
PCT/EP/2008/059358
WO/2009/019115
30/07/2008
203531
INTERLAYERS COMPRISING
STABILIZED TUNGSTEN OXIDE
AGENTS
SOLUTIA INCORPORATED
US
11/833480
03/08/2007
PCT/US/2008/071527
WO/2009/020806
23/07/2008
17/09/2002
54
G01N )2010.01(
‫ מערכות‬,AS160 ‫חלבונים חדשים דמויי‬
‫ שיטות ושימושים המערבים אותם‬,‫בדיקה‬
2 ‫לצורך זיהוי תרופות לסוכרת סוג‬
203533
LACTAM-CONTAINING COMPOUNDS
AND DERIVATIVES THEREOF AS
FACTOR XA INHIBITORS
BRISTOL-MYERS SQUIBB COMPANY
B32B )2010.01(
‫שכבות פנים המכילות חומרים מיוצבים‬
‫של תחמוצת טונגסטן‬
203532
NOVEL AS160-LIKE PROTEIN, TEST
SYSTEMS, METHODS AND USES
INVOLVING IT FOR THE
IDENTIFICATION OF DIABETES TYPE
2 THERAPEUTICS
SANOFI AVENTIS
EP
07015086.7 01/08/2007
PCT/EP/2008/006024
WO/2009/015808
C12Q )2010.01(
C07D )2010.01(
‫תרכובות המכילות לקטם ונגזרותיהן‬
XA ‫כמעכבי פקטור‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
US
60/324165
PCT/US/2002/029491
WO/2003/026652
28/07/2008
21/09/2001
203534
SKIN - PATCH PUMP COMPRISING A
CHANGING - VOLUME
ELECTROCHEMICAL ACTUATOR
ENTRA PHARMACEUTICALS INC.
US
60/952217
26/07/2007
60/989605
21/11/2007
US
PCT/US/2008/071368
WO/2009/015389
23/07/2008
203536
MICROPARTICLES COMPRISING PCL
AND USES THEREOF
AQTIS IP BV
US
60/952056
26/07/2007
07113251.8
26/07/2007
EP
PCT/NL/2008/050506
WO/2009/014441
07/08/2008
203538
UV AIR TREATMENT METHOD AND
DEVICE
LEE ANTIMICROBIAL SOLUTIONS
LLC
US
60/954566
07/08/2007
61/031580
26/02/2008
US
PCT/US/2008/072454
WO/2009/021108
55
A61M )2010.01(
‫משאבה מדבקת – עור הכוללת מתג‬
‫הפעלה אלקטרוכימי משנה נפח‬
A61K )2010.01(
‫חלקיקים מיקרוניים המכילים‬
‫פוליקפרולקטון ושימושיהם‬
A61L )2010.01(
UV ‫שיטה והתקן לטיפול באוויר על ידי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
26/01/2010
203539
MODULAR PERCUTANEOUS VALVE
STRUCTURE AND DELIVERY
METHOD
VALVE MEDICAL LTD.
US
61/144007
12/01/2009
26/01/2010
‫מבנה של שסתום מלעורי מודולרי ושיטה‬
‫להחדרתו‬
203540
SYSTEM AND METHOD FOR
PLACING A PERCUTANEOUS VALVE
DEVICE
VALVE MEDICAL LTD.
US
61/144007
12/01/2009
26/01/2010
26/01/2010
56
A61B )2010.01(
‫שיטה ומכשיר להתאמה מעולה של מבנה‬
‫של שסתום מלעורי‬
203542
SELF-ASSEMBLING MODULAR
PERCUTANEOUS VALVE AND
METHODS OF FOLDING, ASSEMBLY
AND DELIVERY
VALVE MEDICAL LTD.
US
12/686338
12/01/2010
A61B )2010.01(
‫מערכת ושיטה למיקום התקן שתסום‬
‫מלעורי‬
203541
METHOD AND APPARATUS FOR
FINE ADJUSTMENT OF A
PERCUTANEOUS VALVE
STRUCTURE
VALVE MEDICAL LTD.
US
61/144007
12/01/2009
A61B )2010.01(
A61B )2010.01(
‫שסתום מלעורי מודולרי בהרכבה עצמית‬
‫ הרכבה והחדרה‬,‫ושיטות לקיפול‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
27/01/2010
203543
‫כרית חכמה‬
‫דוד מרציאנו‬
SMART PILLOW
DAVID MARSIANO
04/08/2008
203544
IMMUNOGLOBULIN CLEAVAGE
FRAGMENTS AS DISEASE
INDICATORS AND COMPOSITIONS
FOR DETECTING AND BINDING
SUCH
CENTOCOR ORTHO BIOTECH INC.
US
60/955162
10/08/2007
PCT/US/2008/072083
WO/2009/023457
28/07/2008
203545
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0715459.4
08/08/2007
PCT/GB/2008/002580
WO/2009/019439
28/07/2008
203546
INJECTION DEVICE
CILAG GMBH INTERNATIONAL
GB
0715461.0
08/08/2007
PCT/GB/2008/002579
WO/2009/019438
57
A47B )2010.01(
C07K )2010.01(
‫קטעי אימונוגלובולין מבוקעים כסמני‬
‫מחלה ותכשירים לגילויים וקישורם‬
A61M )2010.01(
‫התקן הזרקה‬
A61M )2010.01(
‫התקן הזרקה‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
28/07/2008
203547
INJECTION DEVICE WITH LOCKING
MECHANISM FOR SYRINGE
CARRIER
CILAG GMBH INTERNATIONAL
GB
0715460.2
08/08/2007
PCT/GB/2008/002578
WO/2009/019437
28/07/2008
‫התקן הזרקה עם מנגנון נעילה לנשא‬
‫מזרק‬
203548
INJECTION DEVICE WITH LOCKING
MECHANISM FOR SYRINGE
CARRIER
CILAG GMBH INTERNATIONAL
GB
0715456.0
08/08/2007
PCT/GB/2008/002573
WO/2009/019436
29/07/2008
06/08/2008
58
A61M )2010.01(
‫התקן הזרקה עם מנגנון נעילה לנשא‬
‫מזרק‬
203549
APPARATUS SYSTEMS AND
METHODS TO SYNCHRONIZE
COMMUNICATION OF CONTENT TO
A PRESENTATION DEVICE AND A
MOBILE DEVICE
ECHOSTAR TECHNOLOGIES L.L.C.
US
11/836462
09/08/2007
PCT/US/2008/071489
WO/2009/023433
A61M )2010.01(
H04L )2010.01(
‫ מערכות ושיטות לסנכרון העברת‬,‫התקנים‬
‫תוכן להתקן הצגה והתקן נייד‬
203550
C07D )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
PYRROLIDIN-2- ONE DERIVATIVES
AS ANDROGEN RECEPTOR
MODULATOR
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2007JP
07/08/2007
205966
2007-299658 19/11/2007
JP
PCT/JP/2008/064500
WO/2009/020234
07/08/2008
203551
METHOD FOR A HETEROGENEOUS
WIRELESS AD HOC MOBILE
SERVICE PROVIDER
QUALCOMM INCORPORATED
US
11/840905
17/08/2007
PCT/US/2008/072464
WO/2009/026001
07/08/2008
‫ – און כמאפנן קולטן‬2 – ‫נגזרות פירולידין‬
‫אנדרוגן‬
‫שיטה לספק שירות נייד מאולתר אלחוטי‬
‫הטרוגני‬
203552
METHOD FOR HETEROGENEOUS
WIRELESS AD HOC MOBILE
INTERNET ACCESS SERVICE
QUALCOMM INCORPORATED
US
11/840910
17/08/2007
PCT/US/2008/072515
WO/2009/026007
16/08/2008
203553
HETEROGENEOUS WIRELESS AD
HOC NETWORK
QUALCOMM INCORPORATED
US
60/956658
17/08/2007
60/980547
17/10/2007
US
60/980557
17/10/2007
US
60/980575
17/10/2007
US
59
H04L )2010.01(
H04W )2010.01(
‫שיטה לשירות גישה לאינטרנט נייד‬
‫מאולתר אלחוטי הטרוגני‬
H04W )2010.01(
‫מערכת הטרוגנית אלחוטי מאולתרת‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
60/980565
US
12/192833
US
PCT/US/2008/073409
WO/2009/026192
14/08/2008
17/10/2007
15/08/2008
203554
‫ בתוך‬PDCP ‫ של בקרת‬PDUS ‫העברת‬
MAC ‫מסגרת‬
TRANSPORT OF PDCP CONTROL
PDUS WITHIN MAC FRAMES
QUALCOMM INCORPORATED
US
60/955860
14/08/2007
12/190875
13/08/2008
US
PCT/US/2008/073208
WO/2009/023794
15/08/2008
203555
CHANNEL ALLOCATION IN A
NETWORK COMPRISING AN AD-HOC
SMALL-COVERAGE BASE STATION
QUALCOMM INCORPORATED
US
60/965164
17/08/2007
12/191250
13/08/2008
US
PCT/US/2008/073333
WO/2009/026157
01/08/2008
60
H04W )2010.01(
‫הקצאת ערוצים ברשת הכוללת תחנת‬
‫בסיס מאולתרת בעלת כיסוי קטן‬
203556
PREVENTIVE AGENT OR
THERAPEUTIC AGENT FOR DISEASE
CAUSED BY ABNORMAL BONE
METABOLISM
TEIJIN PHARMA LIMITED
US
60/935262
02/08/2007
PCT/JP/2008/063864
WO/2009/017222
H04L )2010.01(
A61K )2010.01(
‫גורם מנוע או תרפואטי למחלות הנגרמות‬
‫על ידי מטבוליזם לא תקין של העצם‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
01/08/2008
203557
PROCESS FOR THE RESOLUTION OF
ZOPICLONE AND INTERMEDIATE
COMPOUNDS
ESTEVE QUIMICA, S.A.
EP
07380226.6 02/08/2007
PCT/EP/2008/060115
WO/2009/016251
08/08/2008
27/01/2010
‫תהליך להפרדה של זופיקלון ותרכובות‬
‫ביניים‬
203558
HIGH AFFINITY HUMAN
ANTIBODIES TO HUMAN NERVE
GROWTH FACTOR
REGENERON PHARMACEUTICALS,
INC.
US
60/964224
10/08/2007
60/994526
20/09/2007
US
61/062860
28/01/2008
US
61/079259
09/07/2008
US
PCT/US/2008/072561
WO/2009/023540
203559
203560
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
61
A61K )2010.01(
‫נוגדנים אנושיים באפיניות גבוהה לפקטור‬
‫גדילה עצבי אנושי‬
INTEGRAL WIRELESS MOUSE THAT
PULL OUT OF LAPTOP
ADAM MISHOL
27/01/2010
C07B )2010.01(
H04W )2010.01(
‫עכבר אלחוטי אינטרגלי הנשלף מתוך‬
‫מחשב נייד‬
‫אדם משעול‬
G06F )2010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
27/01/2010
203561
A61B )2010.01(
‫משאף לתרופה אבקתית יבשה‬
‫אספירה בע"מ‬
DRY POWDER INHALER
AESPIRA LTD
203562
24/07/2008
A SYSTEM FOR FEEDING GAS INTO
LIQUID
FRESH WATER (BEIJING)
TECHNOLOGY CO. LTD
CN
200710119934.7 03/08/2007
PCT/CN/2008/071733
WO/2009/018745
27/01/2010
23/12/2004
C08J )2010.01(
‫חומרי אריזה תפקודיים לשמירת האיכות‬
‫של מאכלים‬
‫פוסט הרביסט סולושנס בע"מ‬
203564
METHOD FOR THE HUMANIZATION OF
ANTIBODIES AND HUMANIZED
ANTIBODIES THEREBY OBTAINED
S.I.S.S.A. SCUOLA INTERNAZIONALE
SUPERIORE DI STUDI AVANZATI
62
‫מערכת להזנת נוזל בגז‬
203563
FUNCTIONAL PACKAGING
MATERIALS FOR PRESERVATION OF
THE QUALITY OF FOODSTUFFS
POST HARVEST SOLUTIONS LTD
B01F )2010.01(
C07K )2010.01(
‫שיטה ליצירת נוגדנים הומניים ונוגדנים‬
‫הומניים תוצרי השיטה‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
IT
RM2003000601
PCT/IT/2004/000722
WO/2005/061540
24/12/2003
28/01/2010
203565
‫כלי פנאומטי יד‬
‫בוריס מלין‬
PNEUMATIC HAND-HELD TOOL
BORIS MALIN
28/01/2010
203566
A NATURAL COSMETIC
PREPARATION THE HAIR GROWTH
OF THE SCALP
SIBONI RCHEL
28/01/2010
203567
A NATURAL COSMETIC
PREPARATION FOR THE HAIR
GROWTH OF THE EYEBROW
SIBONI RCHEL
13/08/2007
63
B44B )2010.01(
A61K )2010.01(
‫תכשיר טבעי קוסמטי להצמחת שיער‬
‫הקרקפת‬
‫סיבוני רחל‬
A61K )2010.01(
‫תכשיר טבעי קוסמטי להצמחת שיער‬
‫הגבה‬
‫סיבוני רחל‬
203569
C12P )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
OVER-PRODUCTION OF DIHOMO
GAMMA LINOLENIC ACID BY A
MUTANT STRAIN OF
PARIETOCHLORISW INCISA
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
‫ייצור–יתר של חומצה די–הומו–גמה‬
‫ על– ידי זן מוטנטי של‬,‫לינולנית‬
‫פריאטוכלוריס אינסיזה‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
PCT/IL/2007/001012
WO/2009/022323
28/01/2010
203570
‫מערכת להעלאה בחזקה‬
EXPONENTIATION SYSTEM
NDS LIMITED
01/08/2008
203571
PHARMACEUTICAL COMPOSITION
OF CANDESARTAN
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/963014
01/08/2007
PCT/US/2008/009295
WO/2009/017812
08/08/2003
203572
COMPOSITIONS COMPRISING A
CARBOXYLIC ACID AND ACTIVE
INGREDIENT SELECTED FROM THE
TRIAZOLE CLASS
BASF AKTIENGESELLSCHAFT
DE
10237885.1 19/08/2002
PCT/EP/2003/008837
WO/2004/023875
64
G06F )2010.01(
A61K )2010.01(
‫תרכובת רוקחית של קנדסרטן‬
‫טבע תעשיות פרמצבטיות בע"מ‬
A01N )2010.01(
‫תכשירים המכילים חומצה קרבוקסילית‬
‫וחומר פעיל ממשפחת הטריאזול‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
25/08/2008
203573
A PROCESS FOR ISOLATION AND
PURIFICATION OF A TARGET
PROTEIN FREE OF PRION PROTEIN
(PRPsc)
OCTAPHARMA AG
EP
07114856.3 23/08/2007
PCT/EP/2008/061068
WO/2009/024620
28/01/2010
31/07/2007
‫תהליך לבידוד וטיהור של חלבון מטרה‬
)PRPsc( ‫ללא חלבון פריון‬
203574
PULSED ELECTRICAL REMOTE
CONTROL INTERFACE, EQUIPMENT
AND SATELLITE COMPRISING SUCH
AN INTERFACE
THALES
FR
09/00677
13/02/2009
09/01096
10/03/2009
FR
A61L )2010.01(
H02M )2010.01(
‫ ציוד‬,‫ממשק בקרה חשמלי פולסי מרחוק‬
‫ולווין המכילים ממשק כזה‬
203575
METHOD FOR IDENTIFYING AND
SELECTING CARDIOMYOCYTES
ES CELL INTERNATIONAL PTE LTD.
A61K )2010.01(
‫שיטה לזיהוי ובחירת קרדיומיוציטים‬
PCT/SG/2007/000226
WO/2009/017460
23/07/2008
MOUSE AND STAY THEREOF
JONG MUN WANG
65
203576
G06F )2010.01(
‫עכבר ומעמד עבורו‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
10-20070077650
PCT/KR/2008/004312
WO/2009/017326
KR
05/08/2008
02/08/2007
203577
FOAMED SLURRY AND BUILDING
PANEL MADE THEREFROM
UNITED STATES GYPSUM COMPANY
US
11/893759
17/08/2007
PCT/US/2008/072214
WO/2009/025988
29/07/2008
‫תערובת דלילה מוקצפת ולוח מבנה העשוי‬
‫ממנה‬
203578
PYRIMIDE - 4 CARBOXAMIDE
DERIVATIVES, THEIR PREPARTION
AN PHARACEUTICAL
COMPOSITIONS CONTAINING THEM
MERCK SERONO S.A.
EP
07113992.7 08/08/2007
60/964864
15/08/2007
US
PCT/EP/2008/059933
WO/2009/019167
02/06/1999
66
C07D )2010.01(
,‫ – קרבאוקסאמיד‬4 – ‫תולדות פירימידין‬
‫הכנתן ותכשירי רוקחות המכילים אותן‬
203579
SECRETED AND TRANSMEMBRANE
POLYPEPTIDES AND NUCLEIC
ACIDS ENCODING THE SANE
GENENTECH, INC.
US
60/087827
03/06/1998
60/088326
04/06/1998
US
60/088029
04/06/1998
US
60/088030
04/06/1998
US
60/088033
04/06/1998
US
60/088021
04/06/1998
US
60/088025
04/06/1998
US
C04B )2010.01(
C12N )2010.01(
‫פוליפפטידים מופרשים וטרנסממברנליים‬
‫וחומצות גרעין המקודדים אותם‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
60/088028
US
60/088212
US
60/088217
US
60/088167
US
60/088202
US
60/088655
US
60/088824
US
60/088825
US
60/088826
US
60/088742
US
60/088810
US
60/088811
US
60/088738
US
60/088740
US
60/088741
US
60/088722
US
60/088730
US
60/088734
US
60/088858
US
60/088861
US
60/088863
US
60/088876
US
60/089090
US
60/089105
US
60/089440
US
60/089512
US
60/089514
US
60/089599
US
60/089600
US
60/089653
US
60/089532
US
60/089538
US
60/089598
US
60/089801
US
PCT/US/1999/012252
WO/1999/063088
28/01/2010
04/06/1998
05/06/1998
05/06/1998
05/06/1998
05/06/1998
09/06/1998
10/06/1998
10/06/1998
10/06/1998
10/06/1998
10/06/1998
10/06/1998
10/06/1998
10/06/1998
10/06/1998
10/06/1998
10/06/1998
10/06/1998
11/06/1998
11/06/1998
11/06/1998
11/06/1998
12/06/1998
12/06/1998
16/06/1998
16/06/1998
16/06/1998
17/06/1998
17/06/1998
17/06/1998
17/06/1998
17/06/1998
17/06/1998
18/06/1998
203580
ACQUISITION CIRCUIT COMPRISING
A BUFFER CAPACITOR
SOCIETE FRANCAISE DE
DETECTEURS INFRAROUGESSOFRADIR
FR
0900395
30/01/2009
67
H03M )2010.01(
‫מעגל רכישה הכולל קבל באפר‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
21/07/2008
203581
METHOD FOR CONVERTING
THERMAL ENERGY AT A LOW
TEMPERATURE INTO THERMAL
ENERGY AT A RELATIVELY HIGH
TEMPERATURE BY MEANS OF
MECHANICAL ENERGY, AND VICE
VERSA
BERNHARD ADLER
A
AT
31/07/2007
1203/2007
PCT/AT/2008/000265
WO/2009/015402
‫שיטה להמרת אנרגיה תרמית‬
‫בטמפרטורה נמוכה לאנרגיה תרמית‬
‫בטמפרטורה גבוהה יחסית באמצעות‬
‫אנרגיה מכנית ולהיפך‬
203582
18/04/2008
APPARATUS AND METHOD FOR
COMPACTING WEBS
MARIA FRANCESCA MARCHESI
IT
MI2007A001571 31/07/2007
PCT/EP/2008/003203
WO/2009/015711
24/04/2006
203583
MAC MULTIPLEXING AND TFC
SELECTION PROCEDURE FOR
ENHANCED UPLINK
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/676345
29/04/2005
60/683214
20/05/2005
US
11/408415
21/04/2006
US
PCT/US/2006/015275
WO/2006/118831
68
F25B )2010.01(
D06C )2010.01(
‫מערכת ושיטה לדחיסת אריגים‬
H04J )2010.01(
TEC ‫ וכפל ותהליך בחירה של‬MAC
‫לאפלינק מוגבר‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
06/01/2003
203584
G01J )2010.01(
‫כיסוי לאמצעי המשמש לבדיקה של‬
‫מדחום תפי‬
TYMPANIC THERMOMETER PROBE
COVER
SHERWOOD SERVICES AG
PCT/US/2003/000224
WO/2004/063686
06/01/2003
203585
G01K )2010.01(
‫כיסוי לאמצעי המשמש לבדיקה של‬
‫מדחום תפי‬
TYMPANIC THERMOMETER PROBE
COVER
SHERWOOD SERVICES AG
PCT/US/2003/000224
WO/2004/063686
30/07/2008
203586
USE OF GESTAGENS IN
COMBINATION WITH (6S) - 5 METHYLTETRAHYDROFOLATE FOR
THE THERAPY OF ENDOMETRIOSIS
WITH SIMULTANEOUS REDUCTION
OF THERAPY SIDE EFFECTS AND
THE REDUCTION OF THE RISK OF
CONGENITAL MALFORMATIONS IN
CASE OF PREGNANCY
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
EP
07016642.6 24/08/2007
PCT/EP/2008/006253
WO/2009/027003
01/08/2008
69
A61K )2010.01(
– S6) – 5( ‫שימוש בגסטגנים בשילוב עם‬
‫מתילטטראהידרופולאט לטיפול במחלת‬
‫רירית הרחם עם הפחתה בו – זמנית של‬
‫תופעות הלוואי של הטיפול והקטנת‬
‫הסיכון למומים מולדים במקרה של היריון‬
203587
A61K )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
ANTI-INFLAMMATORY
COMPOSITION
CAMBRIDGE ENTERPRISE LIMITED.
GB
0715068.3
02/08/2007
PCT/GB/2008/002635
WO/2009/016390
31/07/2008
203588
POLYPEPTIDE - NUCLEIC ACID
CONJUGATE FOR
IMMUNOPROPHYLAXIS OR
IMMUNOTHERAPY FOR
NEOPLASTIC OR INFECTIOUS
DISORDERS
THE JOHNS HOPKINS UNIVERSITY
US
61/007895
31/07/2007
61/022173
18/01/2008
US
PCT/US/2008/071858
WO/2009/018500
04/07/2008
‫תכשיר אנטי–דלקתי‬
‫תצמיד פוליפפטיד – חומצת גרעין עבור‬
‫טיפול מונע חיסוני או טיפול רפואי חיסוני‬
‫עבור הפרעות של גידולי שאת או הפרעות‬
‫מדבקות‬
203589
SYSTEM AND METHOD FOR
PROVIDING A DISTRIBUTED
WORKFLOW THROUGH A
PLURALITY OF HANDHELD DEVICES
INTUITION PUBLISHING LIMITED
US
11/831054
31/07/2007
PCT/EP/2008/058653
WO/2009/015985
01/08/2008
70
G06Q )2010.01(
‫מערכת ושיטה לאספקת חלוקת עבודה‬
‫באמצעות מספר רב של התקנים‬
‫המוחזקים ביד‬
203590
PROCESS FOR SYNTHESIS OF
INHIBITORS OF E1 ACTIVATING
ENZYMES
MILLENNIUM PHARMACEUTICALS,
INC.
US
60/963008
02/08/2007
C07H )2010.01(
C07D )2010.01(
‫תהליך לסינתזה של מעכבים של מפעילי‬
E1 ‫אנזימי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
61/062378
US
PCT/US/2008/009338
WO/2009/042013
20/08/2008
25/01/2008
203591
‫מערכת להפחתת לחץ ושיטה לשימוש‬
‫באטם‬
REDUCED- PRESSURE SYSTEM AND
METHOD EMPLOYING A GASKET
KCI LICENSING, INC.
US
60/965755
21/08/2007
PCT/US/2008/073749
WO/2009/026385
07/08/2008
203592
PREDICTIVE MARKERS FOR EGFR
INHIBITORS TREATMENT
F. HOFFMANN-LA ROCHE AG
EP
07114336.6 14/08/2007
PCT/EP/2008/006512
WO/2009/021673
07/08/2008
203593
203594
PREDICTIVE MARKER FOR EGFR
INHIBITOR TREATMENT
F. HOFFMANN-LA ROCHE AG
EP
07114309.3 14/08/2007
71
C12Q )2010.01(
EGFR ‫סמנים לניבוי לטיפול במעכבים של‬
PREDICTIVE MARKER FOR EGFR
INHIBITOR TREATMENT
F. HOFFMANN-LA ROCHE AG
EP
07114300.2 14/08/2007
PCT/EP/2008/006522
WO/2009/021683
07/08/2008
A61B )2010.01(
C12Q )2010.01(
EGFR ‫סמן לניבוי לטיפול במעכב של‬
C12Q )2010.01(
EGFR ‫סמן לניבוי לטיפול במעכב של‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
PCT/EP/2008/006521
WO/2009/021682
04/08/2008
203595
NOVEL PIPERAZINE AMIDE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
07114219.4 13/08/2007
PCT/EP/2008/060213
WO/2009/021868
18/07/2008
203596
STIRRING DEVICE FOR ACTIVATED
SLUDGES
INVENT UMWELT-UND
VERFAHRENSTECHNIK AG
10 2007 037
DE
09/08/2007
585.0
PCT/EP/2008/005923
WO/2009/018915
18/07/2008
203597
STIRRING DEVICE FOR ACTIVATED
SLUDGES
INVENT UMWELT-UND
VERFAHRENSTECHNIK AG
10 2007 037
DE
09/08/2007
586.9
PCT/EP/2008/005924
WO/2009/018916
19/06/2008
203598
STIRRING DEVICE FOR ACTIVATED
SLUDGES
72
C07D )2010.01(
‫נגזרות חדשות של פיפראזין אמיד‬
B01F )2010.01(
‫מתקן ערבוב לטיפול בשפכים‬
B01F )2010.01(
‫מתקן ערבוב לטיפול בשפכים‬
B01F )2010.01(
‫מתקן ערבוב לטיפול בשפכים‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
INVENT UMWELT-UND
VERFAHRENSTECHNIK AG
10 2007 037
DE
09/08/2007
584.2
PCT/EP/2008/004915
WO/2009/018873
07/08/2008
203599
EGFR INHIBITOR TREATMENT
MARKER
F. HOFFMANN-LA ROCHE AG
EP
07114312.7 14/08/2007
08156511.1
20/05/2008
EP
PCT/EP/2008/006520
WO/2009/021681
28/01/2010
203600
MULTI-CHANNEL IMAGING
DEVICES
L-3 COMMUNICATIONS CINCINNATI
ELECTRONICS CORPORATION
US
12/364164
02/02/2009
28/07/2008
203602
ANTI-MITOTIC AGENT AND
AURORA KINAS INHIBITOR
COMBINATION AS ANTI-CANCER
TREATMENT
SCHERING CORPORATION
US
60/953087
31/07/2007
61/023985
28/01/2008
US
PCT/US/2008/009108
WO/2009/017701
73
C12Q )2010.01(
EGFR ‫סמן לטיפול במעכב של‬
H04N )2010.01(
‫התקני הדמייה רב–ערוצים‬
A61K )2010.01(
‫שילוב של גורם אנטי – מיטוטי ומעכב‬
‫אורורה קינאז כטיפול נגד סרטן‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
06/08/2008
203603
SUBSTITUTED HYDANTOINS
F. HOFFMANN-LA ROCHE AG
US
60/956145
16/08/2007
PCT/EP/2008/060326
WO/2009/021887
13/08/2008
203604
CYTOTOXICITY MEDIATION OF
CELLS EVIDENCING SURFACE
EXPRESSION OF CD9
F. HOFFMANN-LA ROCHE AG
US
60/965165
17/08/2007
61/026584
06/02/2008
US
61/124019
11/04/2008
US
PCT/CA/2008/001452
WO/2009/023955
07/08/2008
203605
PREDICTIVE MARKER FOR EGFR
INHIBITOR TREATMENT
F. HOFFMANN-LA ROCHE AG
EP
07114326.7 14/08/2007
PCT/EP/2008/006514
WO/2009/021675
07/08/2008
203606
PREDICTIVE MARKER FOR EGFR
INHIBITOR TREATMENT
F. HOFFMANN-LA ROCHE AG
EP
07114305.1 14/08/2007
PCT/EP/2008/006518
WO/2009/021679
74
C07D )2010.01(
‫הידאנטואנים מותמרים‬
C07K )2010.01(
‫מוות תאי המתווך על ידי תאים המציגים‬
‫ על פני התא‬CD9 ‫ביטוי של‬
C12Q )2010.01(
EGFR ‫סמן לניבוי לטיפול במעכב של‬
C12Q )2010.01(
EGFR ‫סמן לניבוי לטיפול במעכב של‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
04/08/2008
203607
NOVEL PROCESS FOR PREPARING
HIGHLY PURE LEVOCETIRIZINE
AND SALTS THEREOF
CHEMAGIS LTD.
US
60/964894
15/08/2007
PCT/IL/2008/001065
WO/2009/022327
29/07/2008
‫תהליך לניקוי לבוצטריזין‬
‫כימאגיס בע"מ מחלקת קניין רוחני‬
203608
PROCESS FOR PRODUCING
TOLUIDINE COMPOUND
ISHIHARA SANGYO KAISHA LTD.
2007JP
02/08/2007
202210
2007-202220 02/08/2007
JP
2007-266000 12/10/2007
JP
2008-037841 19/02/2008
JP
PCT/JP/2008/063933
WO/2009/017241
30/07/2008
75
C07D )2010.01(
‫תהליך לייצור תרכובת טולואידין‬
203609
SEX-PEPTIDES RESISTANT TO
PROTEOLYTIC DEGRADATION AND
THEIR USE IN BIOLOGICAL
CONTROL OF INSECTS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
US
60/952785
03/07/2007
PCT/IL/2008/001047
WO/2009/016626
A61K )2010.01(
C07K )2010.01(
‫ עמידים לפירוק‬PEPTIDES – SEX
‫פרוטאוליטי ושימוש בהם בבקרה ביולוגית‬
‫של חרקים‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
29/07/2008
203610
DIAGNOSIS, STAGING AND
MONITORING OF INFLAMMATORY
BOWEL DISEASE
ISS IMMUNE SYSTEM STIMULATION
AB
SE
0701807-0
02/08/2007
PCT/SE/2008/000464
WO/2009/017444
01/08/2008
‫ קביעה וניטור של מחלת מעיים‬,‫אבחנה‬
‫דלקתית‬
203611
IMIDAZOLONE DERIVATIVES,
PREPARTION METHOD THEREOF
AND BIOLOGICAL USE OF SAME
UNIVERSITE DE RENNES 1
FR
0705632
01/08/2007
PCT/FR/2008/001152
WO/2009/050352
30/07/2008
01/08/2008
76
H01Q )2010.01(
‫מסגרת תומכת משופרת עבור צלחת של‬
‫צלחת אנטנה גדולה‬
203613
METHODS AND COMPOSITIONS FOR
TREATING SCHIZOPHRENIA USING
ANTIPSYCHOTIC COMBINATION
THERAPY
MEDIVATION NEUROLOGY, INC.
RU
2007129568 01/08/2007
2007129567
01/08/2007
RU
C07D )2010.01(
‫ שיטה להכנתם‬,‫תולדות אימידאזולון‬
‫ושימושן הביולוגי‬
203612
IMPROVED SUPPORT FRAME FOR
THE DISH OF A LARGE DISH
ANTENNA
STEPHEN KANEFF
AU
2007904057 30/07/2007
PCT/AU/2008/001092
WO/2009/015424
G01N )2010.01(
A01N )2010.01(
‫שיטות ותכשירים לטיפול בסכיזופרניה‬
–‫באמצעות שימוש בטיפול משולב אנטי‬
‫פסיכוטי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
PCT/US/2008/009357
WO/2009/017836
15/08/2008
203614
APPARATUS AND METHOD OF
DETERMINING A PRECODING
MATRIX IN A MULTI-INPUT MULTI OUTPUT (MIMO) SYSTEM
QUALCOMM INCORPORATED
US
60/956106
15/08/2007
12/189483
11/08/2008
US
PCT/US/2008/073386
WO/2009/023860
15/08/2008
‫מערכת ושיטה לקביעת מטריצת קידוד‬
MIMO ‫טרומי במערכת‬
203615
UPLINK CONTROL CHANNEL
FORMAT
QUALCOMM INCORPORATED
US
60/964962
15/08/2007
12/191577
14/08/2008
US
PCT/US/2008/073367
WO/2009/023850
08/08/2008
77
H04L )2010.01(
‫פורמט ערוץ בקרת קשר ללוויין‬
203616
COMPUTER - IMPLEMENTED
METHODS, CARRIER MEDIA, AND
SYSTEMS FOR GENERATING A
METROLOGY SAMPLING PLAN
KLA-TENCOR CORPORATION
US
11/837208
10/08/2007
PCT/US/2008/072636
WO/2009/023571
H04B )2010.01(
H01L )2010.01(
‫ אמצעי נשיאה‬,‫שיטות מיושמות במחשב‬
‫ומערכות ליצירת תכנית דגימה מטרולוגית‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
22/08/2008
203617
METHOD AND APPARATUS FOR
TRANSMISSION OF CIRCUIT
SWITCHED VOICE OVER PACKET
SWITCHED NETWORKS
QUALCOMM INCORPORATED
US
60/957305
22/08/2007
12/195749
21/08/2008
US
PCT/US/2008/074080
WO/2009/026549
31/07/2008
‫שיטה והתקן לשידור קולות מיתוג מעגלים‬
‫ברשתות מיתוג מנות‬
203618
TRICYCLIC N - HETEROARYL CARBOXAMIDE DERIVATIVES,
PREPARATION THEREOF AND
THERAPEUTIC USE OF SAME
SANOFI-AVENTIS
FR
07/05677
02/08/2007
PCT/FR/2008/001141
WO/2009/050348
14/08/2008
203619
SYSTEM AND METHOD FOR
ACQUIRING OR DISTRIBUTING
INFORMATION RELATED TO ONE OR
MORE ALTERNATE AD HOC
SERVICE PROVIDERS
QUALCOMM INCORPORATED
US
60/956658
17/08/2007
60/980565
17/10/2007
US
12/147240
26/06/2008
US
PCT/US/2008/073217
WO/2009/026108
14/08/2008
78
H04L )2010.01(
203620
C07D )2010.01(
‫ – הטרואריל – קרבוקסאמיד‬N ‫נגזרות‬
‫ הכנתן ושימוש תראפיוטי‬,‫טריצקליות‬
‫שלהן‬
H04W )2010.01(
‫שיטה והתקן לאסיפת או הפצת מידע‬
‫הקשור לאחד או יותר ספקי שירות‬
‫מאולתרים שונים‬
H04W )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
HANDOFF AT AN AD - HOC MOBILE
SERVICE PROVIDER
QUALCOMM INCORPORATED
US
60/956658
17/08/2007
60/980557
17/10/2007
US
12/188990
08/08/2008
US
PCT/US/2008/073218
WO/2009/026109
19/09/2008
203621
EFFICIENT DESIGN OF MDCT /
IMDCT FILTERBANKS FOR SPEECH
AND AUDIO CODING APPLICATIONS
QUALCOMM INCORPORATED
US
60/973709
19/09/2007
60/989400
20/11/2007
US
12/212920
18/09/2008
US
PCT/US/2008/077129
WO/2009/039451
13/08/2008
‫העברה בספק שירות נייד מאולתר‬
‫עיצוב יעיל של מערכי מסננים‬
‫ ליישומי קידוד דיבור ואודיו‬IMDCT/MDCT
203622
AD HOC SERVICE PROVIDER
TOPOLOGY
QUALCOMM INCORPORATED
US
60/956658
17/08/2007
60/980575
17/10/2007
US
12/147231
26/06/2008
US
PCT/US/2008/073031
WO/2009/026072
15/08/2008
79
H04W )2010.01(
‫טופולוגיית ספק שירות מאולתר‬
203623
METHOD AND APPARATUS FOR
BEAMFORMING OF CONTROL
INFORMATION IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
60/956106
15/08/2007
G10L )2010.01(
H04B )2010.01(
‫שיטה והתקן לעיבוד אות של מידע בקרה‬
‫במערכת תקשורת אלחוטית‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
12/189548
US
PCT/US/2008/073394
WO/2009/023863
15/08/2008
11/08/2008
203624
PROCESS FOR PREPARING AND
PURIFYING ALKALI METAL AND
ALKALINE EARTH METAL
TRICYANOMETHANIDES
LONZA LTD.
EP
07016100.5 16/08/2007
07020980.4
26/10/2007
EP
PCT/EP/2008/006730
WO/2009/021751
23/07/2008
‫תהליך להכנת וטיהור טריציאנומתאנידים‬
‫של מתכות אלקליות ומתכות אלקליות‬
‫עפרוריות‬
203625
STABLE HIGHLY PURE AZACITIDINE
AND PREPARATION METHODS
THEREFOR
CHEMAGIS LTD.
US
60/963113
02/08/2007
PCT/IL/2008/001015
WO/2009/016617
06/08/2008
80
A01N )2010.01(
‫אזציטידין נקי ותהליך להכנתו‬
‫כימאגיס בע"מ מחלקת קניין רוחני‬
203627
NOVEL POLYOLEFIN
COMPOSITIONS AND DRAWN
TAPES, FIBRES AND FILAMENTS
PRODUCED THEREFROM
BOREALIS TECHNOLOGY OY
EP
07114113.9 09/08/2007
PCT/EP/2008/060312
WO/2009/019280
C07C )2010.01(
C08L )2010.01(
,‫תרכיב המכיל פוליאולפין ומוצרי רצועות‬
‫סיבים ופילמנטים המיוצרים ממנו‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
31/01/2010
203628
SYSTEMS AND METHODS FOR WEB
DECODING
VERINT SYSTEMS LTD.
31/01/2010
G06F )2010.01(
‫מערכות ושיטות לפענוח תעבורת רשת‬
‫ורינט מערכות בע"מ‬
203630
MODULAR HOT WATER STORAGE
TANK
SHMUEL BEN-ISHAI
B65D )2010.01(
‫מיכל מודולארי לאגירת מים חמים‬
‫ישי‬-‫שמואל בן‬
203631
31/07/2008
GLYCOSAMINOGLYCANANTAGONISING MCP - 1 MUTANTS
AND USES THEREOF
C07K )2010.01(
MCP – 1 ‫אנטגוניסטי‬
‫ ושימושים‬,‫ מוטנטים‬,‫גליקוסאמינוגליקניים‬
‫בהם‬
PROTAFFIN BIOTECHNOLOGIE AG
US
60/953140
31/07/2007
07450166.9
27/09/2007
EP
PCT/EP/2008/006298
WO/2009/015884
04/08/2008
203632
ANTI-RANTES ANTIBODIES AND
USES THEREOF
NOVIMMUNE S.A.
US
60/963271
02/08/2007
PCT/US/2008/009382
WO/2009/054873
81
C12P )2010.01(
‫נוגדנים נגד רנטס ושימושיים בהם‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
01/08/2008
203633
‫פפטידים מאפנני חיסון‬
IMMUNOMODULATORY PEPTIDES
SYNTONIX PHARMACEUTICALS,
INC.
US
60/954968
09/08/2007
PCT/US/2008/071960
WO/2009/020867
15/08/2008
203634
203635
203636
METHOD AND APPARATUS FOR
MITIGATING TEMPORARY LOSS OF
SYNCHRONIZATION IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
82
H04W )2010.01(
‫העברה ברשתות פס רחב ניידות‬
‫מאולתרות‬
HANDOFF IN AD - HOC MOBILE
BROADBAND NETWORKS
QUALCOMM INCORPORATED
US
60/956658
17/08/2007
60/980557
17/10/2007
US
12/188985
08/08/2008
US
PCT/US/2008/073017
WO/2009/026071
22/08/2008
H04W )2010.01(
‫בקרת גישה לתחנת בסיס מאולתרת‬
‫בעלת כיסוי קטן‬
ACCESS CONTROL FOR AN AD - HOC
SMALL - COVERAGE BASE STATION
QUALCOMM INCORPORATED
US
60/965164
17/08/2007
12/191256
13/08/2008
US
PCT/US/2008/073341
WO/2009/026162
13/08/2008
C07K )2010.01(
H04W )2010.01(
‫שיטה ומערכת להקלה על אובדן זמני של‬
‫סינכרוניזציה במערכת תקשורת אלחוטית‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
US
60/957515
12/178157
US
PCT/US/2008/074095
WO/2009/026557
15/08/2008
23/08/2007
23/07/2008
203637
SECURITY FOR A HETEROGENEOUS
AD HOC MOBILE BROADBAND
NETWORK
QUALCOMM INCORPORATED
US
60/956658
17/08/2007
12/189008
08/08/2008
US
PCT/US/2008/073321
WO/2009/026154
13/08/2008
‫אבטחה לרשת פס רחב ניידת מאולתרת‬
‫הטרוגנית‬
203638
METHODS AND APPARATUSES FOR
TRANSMITTING NON-DECODABLE
PACKETS
QUALCOMM INCORPORATED
US
60/956251
16/08/2007
12/188851
08/08/2008
US
PCT/US/2008/073079
WO/2009/026077
31/07/2008
203639
COMPACT TWO-ELEMENT
INFRARED OBJECTIVE LENS AND IR
OR THERMAL SIGHT FOR WEAPON
HAVING VIEWING OPTICS
H04W )2010.01(
H04L )2010.01(
‫שיטות ומערכות לשידור חבילות מידע‬
‫שאינן ניתנות לפענוח‬
F41G )2010.01(
‫עדשות אובייקטיב אינפרא – אדום‬
‫קומפקטית בעלת שני אלמנטים וכוונת‬
‫אינפרא – אדום או תרמית לנשק בעל‬
‫אופקיטת צפייה‬
GOODRICH CORPORATION
US
11/895375
23/08/2007
PCT/US/2008/009408
WO/2009/048495
83
October 31, 2010-‫כ"ג בחשון התשע"א‬
06/08/2007
203641
PROTEASOME INHIBITORS
MILLENNIUM PHARMACEUTICALS,
INC
C07F )2010.01(
‫מעכבי פרוטיאזום‬
PCT/US/2007/017440
WO/2009/020448
01/02/2010
203642
APPARATUS AND METHOD FOR
OPTIMIZINMG CURRENT USE
DURING CONTROL OF MULTIPLE
MOTORS
REDLER YESAIAHU
17/07/2003
‫מערכת ושיטה לאופטימיזציה של ניצול‬
‫זרם חשמצלי בבקרה של מנועים‬
‫ישעיהו רדלר‬
203643
PHARMACEUTICAL COMPOSITIONS
COMPRISING
DEXTROMETHORPHAN AND
QUINIDINE FOR THE TREATMENT
OF NEUROLOGICAL DISORDERS
AVANIR PHARMACEUTICALS
US
60/396661
17/07/2002
PCT/US/2003/022303
WO/2004/006930
30/11/2001
84
F01B )2010.01(
203644
A61K )2010.01(
‫תכשירי רוקחות המכילים‬
‫דקסטרומתורפאן וקווינידין לטיפול‬
‫בהפרעות עצביות‬
C07D )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
MANDELIC ACID DERIVATIVES,
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM AND
PROCESSES FOR THEIR
PREPARATION
ASTRAZENECA AB
SE
0004458-6
01/12/2000
0100965-3
19/03/2001
SE
0101239-2
06/04/2001
SE
0102921-4
30/08/2001
SE
PCT/SE/2001/002657
WO/2002/044145
29/07/2008
203645
PYRIMIDINE AND PYRIDINE
DERIVATIVES AND THEIR
PHARMACEUTICAL USE AND
COMPOSITIONS
PFIZER INC.
US
60/953604
02/08/2007
61/015533
20/12/2007
US
PCT/IB/2008/002046
WO/2009/016498
04/08/2008
‫ תכשירים‬,‫נגזרות של חומצה מנדלית‬
‫רוקחיים המכילים אותן ותהליכים להכנתן‬
‫תולדות פירימידין ופירידין ושימושן הרוקחי‬
‫ותכשירים שלהן‬
203646
PROCESS FOR PREPARING
VORICONAZOLE
HANMI PHARM. CO., LTD.
10-2007KR
06/08/2007
0078439
PCT/KR/2008/004516
WO/2009/020323
07/08/2008
PREDICTIVE MARKER FOR EGFR
INHIBITOR TREATMENT
F. HOFFMANN-LA ROCHE AG
85
C07D )2010.01(
203647
C07D )2010.01(
‫שיטה להכנת ווריקונאזול‬
C12Q )2010.01(
EGFR ‫סמן לניבוי לטיפול במעכב של‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
EP
07114302.8
PCT/EP/2008/006523
WO/2009/021684
07/08/2008
14/08/2007
203648
PREDICTIVE MARKERS FOR EGFR
INHIBITOR TREATMENT
F. HOFFMANN-LA ROCHE AG
EP
07114292.1 14/08/2007
PCT/EP/2008/006513
WO/2009/021674
07/08/2008
203649
PREDICTIVE MARKER FOR EGFR
INHIBITOR TREATMENT
F. HOFFMANN-LA ROCHE AG
EP
07114319.2 14/08/2007
08156523.6
20/05/2008
EP
PCT/EP/2008/006516
WO/2009/021677
07/08/2008
EXERCISE PLATFORM
DAHARY DORON
US
60/954321
PCT/IL/2008/001092
WO/2009/019702
21/07/2008
203650
EGFR ‫סמנים לניבוי לטיפול במעכב של‬
C12Q )2010.01(
EGFR ‫סמן לניבוי לטיפול במעכב של‬
A63B )2010.01(
‫פלטפורמת אימון‬
‫דהרי דורון‬
07/08/2007
203653
PYRAZOLE COMPOUNDS AND THEIR
USE AS RAF INHIBITORS
PFIZER INC.
US
60/953235
01/08/2007
86
C12Q )2010.01(
C07D )2010.01(
‫תרכובות פירזול ושימושן כמעכבי ראף‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
61/080054
US
PCT/IB/2008/001952
WO/2009/016460
11/07/2008
02/02/2010
203654
IILI,OMATOMG LEYBOARD
STICKERS
GALIT SCHWARTZ
02/02/2010
‫אותיות זוהרות למקלדת מחשב‬
‫גלית שוורץ‬
203655
PLASTIC PIPE FITTINGS FOR USE IN
PLASTIC PIPE SYSTEMS AND CLAMP
FOR USE THEREWITH
HULIOT (A.C.S) LTD
01/08/2008
203656
203657
THERAPEUTIC COMPOUNDS
RUTGERS, THE STATE UNIVERSITY
OF NEW JERSEY
87
F16L )2010.01(
‫אביזרי צינור פלסטיק לשימוש במערכות‬
‫מצינורות פלסטיק ומלחציים לשימוש‬
‫איתם‬
‫חוליות (אגש"ח) בע"מ‬
THERAPEUTIC COMPOUNDS
RUTGERS, THE STATE UNIVERSITY
OF NEW JERSEY
US
60/953648
02/08/2007
PCT/US/2008/072025
WO/2009/018551
01/08/2008
B41J )2010.01(
C07D )2010.01(
‫תרכובות רפואיות‬
C07D )2010.01(
‫תרכובות רפואיות‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
US
60/953660
PCT/US/2008/072023
WO/2009/018549
02/08/2007
203658
24/09/2005
SOLID ELECTROLYTE CAPACITORN
ANODES MADE FROM TANTALUM
H.C. STARCK GMBH
DE
102004049040.6 08/10/2004
PCT/EP/2005/010361
WO/2006/037497
01/08/2008
203659
NOVEL HETEROCYCLIC
COMPOUNDS AS MGLU5
ANTAGONISTS
RECORDATI IRELAND LIMITED
US
60/953677
02/08/2007
61/045175
15/04/2008
US
PCT/EP/2008/006351
WO/2009/015897
12/08/2008
NOVEL PREPARATION PROCESS
88
‫אנודות של קבלים אלקטרוליטים‬
‫מוצקים העשויות מטנטלום‬
C07D )2010.01(
‫תרכובות הטרוציקליות חדשות‬
MGLU5–‫כאנטגוניסטים ל‬
203660
NOVEL PREPARATION PROCESS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
102007038250.4 13/08/2007
PCT/EP/2008/060559
WO/2009/021942
12/08/2008
B22F )2010.01(
203661
C07D )2010.01(
‫תהליך הכנה חדש‬
C07D )2010.01(
‫תהליך הכנה חדש‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
102007038251.2
PCT/EP/2008/060560
WO/2009/021943
29/07/2008
13/08/2007
203662
DYNAMIC INSTANT COMMENTS
MICROSOFT CORPORATION
US
11/861688
26/09/2007
PCT/US/2008/071467
WO/2009/042288
13/08/2008
203663
TRIAZOLE COMPOUNDS THAT
MODULATE HSP90 ACTIVITY
SYNTA PHARMACEUTICALS CORP.
US
60/964447
13/08/2007
PCT/US/2008/009667
WO/2009/023211
02/09/2008
203664
POST-HARVEST TREATMENT
BAYER CROPSCIENCE AG
EP
07116248.1 12/09/2007
PCT/EP/2008/007139
WO/2009/033582
13/08/2008
203665
COMPOSITIONS AND METHODS FOR
CENTROLLING NEMATODES
DIVERGENCE, INC.
US
60/955448
13/08/2007
89
G06Q )2010.01(
‫תגובות מיידיות דינאמיות‬
C07F )2010.01(
‫תרכובות טריאזול המסדירות פעילות‬
HSP90
A01N )2010.01(
‫טיפול לאחר קציר‬
A01N )2010.01(
‫תכשירים ושיטות לבקרה על נמטודות‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
PCT/US/2008/073029
WO/2009/023721
08/08/2008
203666
BICYCLIC AMIDES FOR ENHANCING
GLUTAMATERGIC SYNAPTIC
RESPONSES
CORTEX PHARMACEUTICALS, INC.
US
60/964362
10/08/2007
PCT/US/2008/009508
WO/2009/023126
08/08/2008
‫אמידים ביציקליים להגברת תגובות‬
‫סינפטיות גלוטאמטרג'יות‬
203667
BICYCLIC AMIDES FOR ENHANCING
GLUTAMATERGIC SYNAPTIC
RESPONSES
CORTEX PHARMACEUTICALS, INC.
US
60/964362
10/08/2007
PCT/US/2008/009508
WO/2009/023126
20/08/2008
METHODS OF PREPARING 4PHENYL-6-(2,2,2-TRIFLUORO-1PHENYLETHOXY)PYRIMIDINEBASED COMPOUNDS
90
A61K )2010.01(
‫אמידים ביציקליים להגברת תגובות‬
‫סינפטיות גלוטאמטרג'יות‬
203668
C07D )2010.01(
‫תרכובות אימידאזופיראזין‬
IMIDAZOPYRAZINE COMPOUNDS
BIOFOCUS DPI LIMITED
GB
0716292.8
21/08/2007
PCT/EP/2008/060896
WO/2009/024585
22/08/2008
A61K )2010.01(
203669
A61K )2010.01(
4 ‫שיטות להכנת תרכובות המבוססות על‬
– 1 – ‫ – טריפלואורו‬2 ,2 ,2( – 6 – ‫– פניל‬
‫פניל אתוקסי) פירימידין‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
LEXICON PHARMACEUTICALS, INC.
US
60/957744
24/08/2007
PCT/US/2008/073950
WO/2009/029499
203670
27/08/2008
‫קו צינורות מכוסה‬
ENCASED PIPELINE
SALZGITTER MANNESMANN LINE PIPE
GMBH
DE
102007040683.7 29/08/2007
PCT/EP/2008/061216
WO/2009/027429
28/08/2008
203671
TSH RECEPTOR ANTAGONIZING
TETRAHYDROQUINOLINE
COMPOUNDS
N.V. ORGANON
EP
07115368.8 31/08/2007
08150398.9
18/01/2008
EP
PCT/EP/2008/061325
WO/2009/027482
28/08/2008
IN-SITU HYBRIDIZATION TO
DETECT RNA AND DNA MARKERS
91
A61K )2010.01(
‫תרכובות טטראהידרו קווינולין‬
TSH ‫כאנטגוניסטים של רצפטור‬
203672
C11D )2010.01(
‫שיטה לטיפול בבד‬
A METHOD OF TREATING FABRIC
UNILEVER PLC,
IN
1691/MUM/2007 05/09/2007
PCT/EP/2008/061287
WO/2009/030634
04/08/2008
F16L )2010.01(
203673
C12Q )2010.01(
–‫ ו‬RNA ‫היברידיזציה ברקמה לגילוי סמני‬
DNA
October 31, 2010-‫כ"ג בחשון התשע"א‬
BIOCEPT, INC.
US
60/953812
PCT/US/2008/072143
WO/2009/020932
03/08/2007
203674
22/07/2008
WIRELESS SWITCHING
APPLICATION
MASCO CORPORATION
US
60/954007
PCT/US/2008/070699
WO/2009/020756
‫אפליקצית מיתוג אלחוטי‬
05/08/2007
22/07/2008
203675
SECURITY SYSTEM INCLUDING
WIRELESS SELF-ENERGIZING
SWITCH
MASCO CORPORATION
US
60/954007
05/08/2007
PCT/US/2008/070720
WO/2009/020762
25/07/2008
MASCO CORPORATION
US
60/954007
WO
PCT/US2008/071120
PCT/US/2008/071120
WO/2009/020775
92
G08B )2010.01(
‫מערכת בטחון הכוללת מתג אלחוטי בעל‬
‫אספקת אנרגיה עצמונית‬
203676
NOTIFICATION SYSTEM UTILIZING SELEENERGIZING SWITCHES
22/07/2008
H05B )2010.01(
H05B )2010.01(
‫מערכת התרעה המשתמשת‬
‫במתגים בעלי אספקת אנרגיה‬
‫עצמונית‬
05/08/2007
25/07/2008
203677
G08B )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
DOOR NOTIFICATION SYSTEM
MASCO CORPORATION
US
60/954007
05/08/2007
WO
PCT/US2008/070700 22/07/2008
PCT/US/2008/070700
WO/2009/020757
25/07/2008
203678
‫מערכת התראה לדלת‬
H05B )2010.01(
WIRELESS SCENE ARRANGEMENT
MASCO CORPORATION
US
60/954007
05/08/2007
61/033838
05/03/2008
US
WO
PCT/US2008/071124 25/07/2008
PCT/US/2008/071124
WO/2009/020776
‫מערכת ארגון ושליטה אלחוטית‬
203679
A61H )2010.01(
02/02/2010
‫טלאי מעסה טיפולי‬
‫סלמן עופר‬
THERAPEUTIC MASSAGE PATCH
SALMAN OFER
02/08/2007
203680
FRONT CARRIER FOR
MOTORCYCLES
OXYGEN, S.P.A.
B62J )2010.01(
‫מנשא קידמי לאופנועים‬
PCT/IT/2007/000557
WO/2009/016666
17/09/2008
93
203681
G06Q )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
A SYSTEM AND A METHOD OF
HANDLING A MULTIFUNCTION
TRANSACTION
OMARCO NETWORK SOLUTIONS
LTD
US
60/953768
03/08/2007
PCT/IB/2008/002424
WO/2009/019602
01/08/2008
–‫מערכת ושיטה לטיפול בעסקאות רב‬
‫שימושיות‬
203682
–‫שיטות ומערכת עדשות תוך– עינית רב‬
‫מוקדית‬
MULTI - FOCAL INTRAOCULAR
LENS SISTEM AND METHODS
OCULAR OPTICS, INC.
US
60/953640
02/08/2007
PCT/US/2008/071957
WO/2009/042289
08/08/2008
203683
MATERIALS AND METHODS FOR
TREATING SKELETAL SYSTEM
DAMAGE AND PROMOTING
SKELETAL SYSTEM REPAIR AND
REGENERATION
PERVASIS THERAPEUTICS, INC.
US
60/963929
08/08/2007
61/066933
25/02/2008
US
PCT/US/2008/009543
WO/2009/020651
31/07/2008
94
A61F )2010.01(
A61L )2010.01(
‫חומרים ושיטות לטיפול בנזק למערכת‬
‫שלדית ולקידום תיקון וחידוש של מערכת‬
‫שלדית‬
203684
C07D )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
CRYSTALLINE FORM OF METHYL
((1S)-1-(((2S)-2-(5-(4'-(2-((2S)-1-((2S)-2((METHOXYCARBONYL)AMINO)-3METHYLBUTANOYL)-2PYRROLIDINYL)-1H-IMIDAZOL-5YL)-4-BIPHENYLYL)-1H-IMIDAZOL2-YL)-1PYRROLIDINYL)CARBONYL)-2METHYLPROPYL)CARBAMATE
DIHYDROCHLORIDE SALT
BRISTOL-MYERS SQUIBB COMPANY
US
60/954592
08/08/2007
PCT/US/2008/071734
WO/2009/020828
31/07/2008
S1) – 1 – (( ‫צורות גבישייות של מלחי מיטל‬
(((S2) – 2 – (5 – ('4 (2 – ((S2) – 1 – ((S2) –
– 3 – )‫ – ((מטוקסיקרבוניל) אמינו‬2
– H1 – )‫ – פירולידיניל‬2 – )‫מטילביוטאנויל‬
H1 – )‫ – ביפניליל‬YL) – 4 – 5 – ‫אמידאזול‬
)‫ – פירולידיניל‬YL) – 1 – 2 – ‫– אימידאזול‬
‫–מטילפרופיל) קרבמט‬2–)‫קרבוניל‬
‫דיהידרוכלור‬
203685
PROCESS FOR SYNTHESIZING
COMPOUNDS USEFUL FOR
TREATING HEPATITIS C
BRISTOL-MYERS SQUIBB COMPANY
US
60/954595
08/08/2007
PCT/US/2008/071696
WO/2009/020825
18/07/2008
6-THIOXOPYRIDAZINE
DERIVATIVES
MERCK PATENT GMBH
10 2007
DE
038957.6
PCT/EP/2008/005928
WO/2009/024221
31/07/2008
203686
‫שיטה לייצור תרכובות יעילות בטפול‬
C ‫בהפטיטוס‬
C07D )2010.01(
‫ – תיאוקסופירידאזין‬6 ‫תולדות של‬
17/08/2007
203687
FLAME RETARDED FORMULATIONS
ALBEMARLE CORPORATION
95
C07D )2010.01(
C08L )2010.01(
‫פורמולציות מעכבי בערה‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
US
60/954516
60/954513
US
60/981005
US
60/982028
US
61/056303
US
PCT/US/2008/071687
WO/2009/020822
07/08/2007
07/08/2007
18/10/2007
23/10/2007
27/05/2008
203688
30/07/2008
FUSED HETEROCYCLES
SEPRACOR INC.
US
11/833903
PCT/US/2008/071642
WO/2009/020814
‫הטרוציקליים מאוחים‬
03/08/2007
03/02/2010
203689
03/02/2010
203690
SWITCH FOR BI-DIRECTIONAL
MOTOR
MEIR ELIMELECH
96
B60J )2010.01(
‫מגן שמש לרכב‬
‫ניצן דפנה‬
SUNSHADE FOR MOTOR VEHICLE
NITZAN DAPHNA
03/02/2010
A01N )2010.01(
H01H )2010.01(
‫מפסק למנוע דו כיווני‬
‫מאיר אלימלך‬
203691
A45D )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
A LICE COMB, A METHOD FOR THE
PRODUCTION THEREOF AND A USE
THEREOF
AVERBUCH ARIEL
03/02/2010
203692
A PILL TRAY AND AN APPARATUS
COMPRISING THEREOF
AVERBUCH ARIEL
03/02/2010
B65D )2010.01(
‫אורבוך אריאל‬
203693
A45D )2010.01(
‫ספח לעיצוב שיער‬
‫גדעון קוסמטיקס בע"מ‬
203694
LENTIVIRAL GENE TRANSFER
VECTORS AND THEIR MEDICINAL
APPLICATIONS
THERAVECTYS
EP
07290979.9 03/08/2007
07290980.7
03/08/2007
EP
07291251.2
12/10/2007
EP
08156405.6
16/05/2008
EP
PCT/IB/2008/002930
WO/2009/019612
97
‫אורבוך אריאל‬
‫מגש לגלולות והתקן המכיל אותו‬
HAIR STYLING ATTACHMENT
GIDON COSMETICS LTD.
01/08/2008
‫ שיטה לייצורו ושימוש בו‬,‫מסרק לכינים‬
A61K )2010.01(
‫וקטורים לנטיוירליים להעברת גנים‬
‫ושימושיהם הרפואיים‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
203695
12/08/2008
NEW COMPOUNDS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
PCT/EP07/058408
EP
PCT/EP08/052157
08102043.0
EP
PCT/EP/2008/060562
WO/2009/021944
06/08/2008
‫תרכובות חדשות‬
14/08/2007
21/02/2008
26/02/2008
203696
AMINOPYRAZOLE AMIDE
DERIVATIVE
DAINIPPON SUMITOMO PHARMA
CO., LTD.
2007JP
06/08/2007
204739
2008-074895 24/03/2008
JP
PCT/JP/2008/064085
WO/2009/020137
07/08/2008
98
C07D )2010.01(
‫נגזרת אמינופיראזול אמידית‬
203697
PREPARATION OF SYNTHETIC
NUCLEOSIDES VIA ? - ALLYL
TRANSITION METAL COMPLEX
FORMATION
EMORY UNIVERSITY
US
60/954449
07/08/2007
PCT/US/2008/072478
WO/2009/021114
13/08/2008
C07D )2010.01(
C07D )2010.01(
‫הכנה של נוקליאוזידים מלאכותיים‬
‫באמצעות יצירת קומפלקס ? – אלילי של‬
‫מתכת מעבר‬
203698
C07D )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
PROCESS FOR PRODUCING
PYRIPYROPENE DERIVATIVES AND
INTERMEDIATES FOR THE
PRODUCTION THEREOF
‫תהליך להכנת תולדות פיריפירופן והכנת‬
‫חומרי ביניים עבורן‬
MEIJI SEIKA KAISHA, LTD.
2007JP
13/08/2007
210804
PCT/JP/2008/064520
WO/2009/022702
203699
02/09/2008
PROCESS FOR PREPARING
CYANIMINO - 1,3 - THIAZOLIDINES
BAYER CROPSCIENCE AG
EP
07116434.7 14/09/2007
PCT/EP/2008/007141
WO/2009/033583
203700
03/08/2008
FIBROUS SURGICALLY
IMPLANTABLE MIESH
NICAST LTD
US
60/935283
PCT/IL/2008/001061
WO/2009/019685
C07D )2010.01(
– 3 , 1 – ‫תהליך להכנת ציאנאמינו‬
‫תיאזולידינים‬
A61L )2010.01(
‫רשת עשויה מסיבים להשתלה ניתוחית‬
‫ניקסט בע"מ‬
03/08/2007
03/08/2007
203701
SOLID OXIDE FUEL CELL SYSTEMS
WITH IMPROVED GAS CHANNELING
AND HEAT EXCHANGE
H01M )2010.01(
‫מערכות תאי דלק תחמוצת מוצקה‬
‫) עם חילוף חום ותיעול דלק‬SOFC(
‫משופרים‬
NANO-DYNAMICS ENERGY. INC.
PCT/US/2007/017405
WO/2009/020445
99
October 31, 2010-‫כ"ג בחשון התשע"א‬
31/07/2008
203702
FLAME RETARDANTS SUITABLE
FOR USE IN VISCOELATIC
POLYURETHANE FOAMS
ALBEMARLE CORPORATION
US
60/954500
07/08/2007
PCT/US/2008/071678
WO/2009/029378
06/08/2008
‫מעכבי בעירה המתאימים לשימוש‬
‫בקצפים פוליאורתיניים ויסקו – אלסטיים‬
203703
FLAME RETARDED FLEXIBLE
POLYURETHANE FOAMS AND
FLEXIBLE POLYURETHANE FOAM
FORMULATIONS
ALBEMARLE CORPORATION
US
60/954505
07/08/2007
PCT/US/2008/072333
WO/2009/021036
06/08/2008
203704
FLAME RETARDED RIGID
POLYURETHANE FOAMS AND RIGID
POLYURETHANE FOAM
FORMULATIONS
ALBEMARLE CORPORATION
US
60/954510
07/08/2007
PCT/US/2008/072331
WO/2009/021035
03/02/2010
COLLAR FOR A BABY BOTTLE
S.M.L. SUCCESS LTD
100
C08G )2010.01(
203705
C08K )2010.01(
‫קצפים פוליאורתניים גמישים מעכבי‬
‫בערה ופורמולציות מבוססות קצף‬
‫פוליאורתני גמיש‬
C08J )2010.01(
‫קצפים פוליאורתניים קשיחים מעכבי‬
‫בערה ופורמולציות מבוססות קצף‬
‫פוליאורתני קשיח‬
A61J )2010.01(
‫צווארון עבור בקבוק לתינוק‬
‫ הצלחה בע"מ‬.‫ל‬.‫מ‬.‫ס‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
02/09/2008
203706
METHOD FOR PRODUCING N METHACRYLOYL - 4 - CYANO - 3 TRIFLUOROMETHYLANILINE
SUMITOMO CHEMICAL COMPANY,
LIMITED
2007JP
12/09/2007
236507
PCT/JP/2008/066143
WO/2009/034936
13/08/2008
18/02/2004
B64D )2010.01(
‫שיטה ומערכות לתדלוק כלי רכב אוויריים‬
‫לא מאויישים תוך כדי טיסה‬
203708
METHOD AND APPARATUS TO
COUNT BROADCAST CONTENT
RECIPIENTS IN A WIRELESS
TELEPHONE NETWORK
QUALCOMM INCORPORATED
US
10/368876
18/02/2003
PCT/US/2004/004789
WO/2004/075516
101
– 4 – ‫ – מת'הקרילואיל‬N ‫שיטה עבור ייצור‬
‫ – טריפלואורומת'ילאנילין‬3 – ‫צ'יאנו‬
203707
METHOD AND SYSTEM FOR
INFLIGHT REFUELING OF
UNMANNED AERIAL VEHICLES
RAYTHEON COMPANY
US
11/891959
13/08/2007
PCT/US/2008/009682
WO/2009/073052
C07C )2010.01(
H04W )2010.01(
‫שיטה ומתקן לספור מקבלי תוכן שידור‬
‫בטלפון אלחוטי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
09/09/2008
203710
USE OF INSULIN C - PEPTIDE, ALONE
OR IN COMBINATION WITH GLP - 1,
AS A THERAPEUTIC AGENT
MONDOBIOTECH LABORATORIES
AG
EP
07017765.4 11/09/2007
PCT/EP/2008/007448
WO/2009/039963
07/08/2008
17/07/2008
102
C07D )2010.01(
‫ – פירידיניל אלקיל‬2 – ‫ – פניל‬1 ‫תולדות של‬
‫אלכוהולים כמעכבי פוספודיאסטראז‬
203713
PHARMACEUTICAL COMPOSITIONS
AND METHODS FOR THE
TREATMENT OF CANCER
URIFER LTD.
US
60/935364
09/08/2007
61/006455
15/01/2008
US
C08G )2010.01(
‫תכשיר ציפוי בעל תכולה גובהה של מוצקי‬
‫אפוקסי‬
203712
DERIVATIVES OF 1-PHENYL-2PYRIDINYL ALKYL ALCOHOLS AS
PHOSPHODIESTERASE INHIBITORS
CHIESI FARMACEUTICI S.P.A.
EP
07114019.8 08/08/2007
PCT/EP/2008/005843
WO/2009/018909
10/08/2008
‫ לבד או‬,C – ‫שימוש באינסולין פפטיד‬
‫ כגורם טיפולי‬,GLP – 1 ‫בשילוב עם‬
203711
HIGH SOLIDS EPOXY COATING
COMPOSITION
AKZO NOBEL COATINGS
INTERANTIONAL B.V.
EP
07114118.8 09/08/2007
60/968435
28/08/2007
US
PCT/EP/2008/060368
WO/2009/019296
A61K )2010.01(
A61K )2010.01(
‫תכשירי רוקחות ושיטות לטיפול בסרטן‬
‫אוריפר בע"מ‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
PCT/IL/2008/001099
WO/2009/019708
08/08/2008
203714
COMPOSITION AND THERAPEUTIC
ANTI - TUMOUR VACCINE
ERYTECH PHARMA
FR
0705767
08/08/2007
60/954917
09/08/2007
US
PCT/EP/2008/060492
WO/2009/019317
19/08/2008
‫תכשיר ותרכיב טיפולי נגד גידולים‬
203715
HUMAN C - FMS ANTIGEN BINDING
PROTEINS
AMGEN INC.
US
60/957148
21/08/2007
61/084588
29/07/2008
US
PCT/US/2008/073611
WO/2009/026303
26/08/2008
18/07/2008
INJECTION SYSTEM WITH BASE
STATION
103
C07K )2010.01(
‫ אנושי‬FMS – C ‫חלבונים קושרי אנטיגן‬
203716
PYRAZOLE COMPOUNDS FOR
CONTROLLING INVERTEBRATE
PESTS
BASF SE
US
60/968109
27/08/2007
PCT/EP/2008/061136
WO/2009/027393
A61K )2010.01(
A01N )2010.01(
‫תרכובות פיראזול לשליטה במזיקים חסרי‬
‫חוליות‬
203717
A61M )2010.01(
‫מערכת הזרקה עם עמדת בסיס‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
CILAG GMBH INTERNATIONAL
GB
0716774.5
29/08/2007
PCT/GB/2008/002475
WO/2009/027621
04/02/2010
203718
‫פקק‬
‫חלאבין תעשיות בע"מ‬
CAP
HLAVIN INDUSTRIES LTD.
04/02/2010
203719
RANDOM NUMBER GENERATOR
GENERATING RANDOM NUMBERS
ACCORDING TO AN ARBITRARY
PROBABILITY DENSITY FUNCITON
SIONET LTD
10/08/2008
203720
PROCESS FOR RECOVERING
SUBSTANCES FROM HIGH SALINITY
LIQUIDS
ECOCHEMTECH, LTD
US
60/954871
09/08/2007
PCT/IL/2008/001100
WO/2009/019709
07/08/2008
104
B67B )2010.01(
203721
G06F )2010.01(
‫התקן היוצר מספריים אקראיים על פי‬
‫פונקצית צפיפות הסתברותית נתונה‬
‫שיאונט בע"מ‬
C01F )2010.01(
‫תהליך להפקת חומרים מנוזלים מליחים‬
G01N )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
THERMOGRAPHY BASED SYSTEM
AND METHOD FOR DETECTING
COUNTERFEIT DRUGS
SEMI-CONDUCTOR DEVICES - AN
ELBIT SYSTEMS - RAFAEL
PARTNERSHIP
IL
185130
08/08/2007
PCT/IL/2008/001088
WO/2009/019698
06/08/2008
203722
METHOD FOR TREATING
DEPENDENCE
SYNOSIA THERAPEUTICS, INC.
US
60/935323
06/08/2007
60/956555
17/08/2007
US
60/960591
04/10/2007
US
PCT/US/2008/072357
WO/2009/021055
21/08/2008
203723
TOOL AND METHOD FOR
REMOVING AND INSTALLING A
TAMPER - RESISTANT CAP OF A
PEST CONTROL DEVICE
BASF CORPORATION
US
11/844875
24/08/2007
PCT/US/2008/073887
WO/2009/029489
05/08/2008
203724
PULSE SHAPING FOR EGPRS - 2
‫מערכת מבוססת חום ושיטה לגילוי‬
‫תרופות מזויפות‬
‫ שותפות אלביט‬- ‫התקני מצב מוצק‬
‫ רפא"ל‬- ‫מערכות‬
A01N )2010.01(
‫שיטות לטיפול בתלות‬
B67B )2010.01(
‫כלי ושיטה להסרה והתקנה של פקק‬
‫אבטחה להתקן לשליטה במזיקים‬
H04L )2010.01(
– 2 ‫תהליך לשינוי צורת פולסים עבור‬
EGPRS
INTERDIGITAL PATENT HOLDINGS,
INC.
US
60/954197
06/08/2007
PCT/US/2008/072244
105
October 31, 2010-‫כ"ג בחשון התשע"א‬
WO/2009/020975
13/08/2008
203725
METHOD AND APPARATUS TO
REDUCE RADIO RESOURCE
OVERHEAD ASSOCIATED WITH
INTERMITTENT DATA TRAFFIC
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/955579
13/08/2007
PCT/US/2008/073067
WO/2009/023740
11/09/2008
H04B )2010.01(
‫שיטה ומערכת להקטנת תקורת משאב‬
‫רדיו הקשור לתנועת נתונים תקופתית‬
203727
METAL POWDER MIXTURE AND THE
USE THEREOF
BAYER BETEILIGUNGSVERWALTUNG
GOSLAR GMBH
DE
102007052198.9 26/10/2007
102008027523.9
04/06/2008
DE
PCT/EP/2008/062060
WO/2009/053156
26/05/2008
203728
TOOL
BAYER BETEILIGUNGSVERWALTUNG
GOSLAR GMBH
DE
102007047312.7 02/10/2007
PCT/EP/2008/004166
WO/2009/046777
04/08/2008
106
203729
B22F )2010.01(
‫תערובת אבקה מתכתית ושימושה‬
C23C )2010.01(
‫כלי‬
A61K )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫תרופה אבקתית אבקתית לנתינה דרך‬
‫האף של חומצה אסקורבית להקטנת‬
‫רעילות הנגרמת מאפומורפין לרקמה‬
‫ריסנית‬
POWDERED MEDICAMENT FOR
NASAL DELIVERY OF ASCORBIC
ACID FOR REDUCING
APOMORPHINE INDUCED TOXICITY
TO CILIATED TISSUE
BRITANNIA PHARMACEUTICALS
LIMITED
GB
0715285.3
06/08/2007
PCT/GB/2008/002648
WO/2009/019463
06/08/2008
203730
SUPPORT OF DOWNLINK DUAL
CARRIERS AND OTHER FEATURES
OF EVOLVED GERAN NETWORKS
INTERDIGITAL PATENT HOLDINGS,
INC.
US
60/954400
07/08/2007
60/965630
20/08/2007
US
PCT/US/2008/072298
WO/2009/021012
05/08/2008
06/08/2008
MULTI-PURPOSE PURPOSE
CONTROL CIRCUIT
SHAKERSCOPE LTD
107
‫תמיכה לנשאים דואלים לתקשורת לווינית‬
GERAN ‫ואפיונים נוספים של רשתות‬
‫מפותחות‬
203731
DISPOSABLE OSTEOGENESIS AND
OSSEOINTEGRATION PROMOTION
AND MAINTENANCE DEVICE FOR
ENDOSSEOUS IMPLANTS
CELLECTRIC MEDICAL LTD
US
60/954168
06/08/2007
PCT/IL/2008/001070
WO/2009/019688
H04W )2010.01(
A61N )2010.01(
‫התקן שליף לעידוד צמחית עצם ושימורה‬
203732
‫סלקטריק מדיקל בע"מ‬
H05B )2010.01(
‫מעגל בקרה רב–שימושי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
GB
0715332.3
PCT/GB/2008/002685
WO/2009/019482
07/08/2008
07/08/2007
203733
A SYSTEM FOR EXTENDING THE
OBSERVATION, SURVEILLANCE,
AND NAVIGATIONAL CAPABILITIES
OF A ROBOT
WAVE GROUP LTD.
IL
185124
08/08/2007
PCT/IL/2008/001089
WO/2009/019699
06/08/2008
SANOFI-AVENTIS
FR
07/05789
08/01819
FR
PCT/FR/2008/001172
WO/2009/056692
19/08/2008
‫קבוצת גל בע"מ‬
C07D )2010.01(
– 6 ‫תולדות חדשות של‬
‫טריאזולופירידאזינסולפניל בנזותיאזול‬
‫ שיטה להכנתן ושימוש‬,‫ובנזימידאזול‬
‫כתרופות ותכשירים רפואיים ושימוש חדש‬
MET ‫כמעכבי‬
09/08/2007
02/04/2008
203735
5- (4- (HALOALKOXY) PHENYL)
PYRIMIDINE-2-AMINE COMPOUNDS
AND COMPOSITIONS AS KINASE
INHIBITORS
108
‫ המעקב ויכולות‬,‫מערכת להרחבת הצפייה‬
‫הניווט של רובוט‬
203734
NOVEL 6TRIAZOLOPYRIDAZINESULFANYL
BENZOTHIAZOLE AND
BENZIMIDAZOLE DERIVATIVES,
METHOD FOR PRODUCTION
THEREOF AND APPLICATION AS
MEDICAMENTS AND
PHARMACEUTICAL COMPOSITIONS
AND NOVEL USE AS MET
INHIBITORS
G05B )2010.01(
C07D )2010.01(
– 4( – 5 ‫תרכובות ותכשירי‬
‫ – אמין‬2 – ‫(האלואלקוקסי) פניל) פירימידינ‬
‫כמעכבי קינאז‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
IRM LLC
US
60/957260
PCT/US/2008/073573
WO/2009/026276
13/08/2008
22/08/2007
203736
IMPROVEMENTS IN OR RELATING
TO ORGANIC COMPOUNDS
SYNGENTA LIMITED
GB
0716592.1
24/08/2007
PCT/GB/2008/002730
WO/2009/027624
12/08/2008
22/08/2008
‫שיפורים בתרכובות אורגניות או הקשורים‬
‫אליהן‬
203737
IMPROVEMENTS IN OR RELATING
TO ORGANIC COMPOUNDS
SYNGENTA LIMITED
GB
0716593.9
24/08/2007
PCT/GB/2008/002738
WO/2009/027626
109
A01N )2010.01(
‫שיפורים בתרכובות אורגניות או בקשר להן‬
203738
MIPO INHIBITORS FOR THE
TREATMENT OF HUNTINGTON'S
DISEASE AND MULTIPLE SYSTEM
ATROPHY
ASTRAZENECA AB
US
60/957525
23/08/2007
60/957523
23/08/2007
US
PCT/SE/2008/050950
WO/2009/025618
12/08/2008
A01N )2010.01(
203739
A61K )2010.01(
‫ לטיפול במחלת הנטינגטון‬MIPO ‫מעכבי‬
‫וניוון מערכות מרובות‬
C07D )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
PYRROLIDINE ARYL - ETHER AS
NK3 RECEPTOR ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
07114790.4 22/08/2007
PCT/EP/2008/060566
WO/2009/024502
20/08/2008
CYCLOPROPYL AMIDE
DERIVATIVES
ASTRAZENECA AB
US
60/957181
PCT/GB/2008/050723
WO/2009/024823
07/08/2008
203740
22/08/2007
203742
203744
PHENYLACETIC ACID COMPOUND,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
ONO PHARMACEUTICALS CO, LTD
2007JP
10/08/2007
208815
PCT/JP/2008/064429
WO/2009/022687
110
C07D )2010.01(
‫נגזרות של ציקלופרופיל אמיד‬
HUGHES MOLECULAR MIXER AND
CATALYTIC REACTOR
NATHANIEL HUGHES
US
60/963752
07/08/2007
PCT/US/2008/072538
WO/2009/021148
11/08/2008
‫פירולידין אריל – אתר כאנטאגוניסטים‬
NK3 –‫לרצפטור ל‬
B01F )2010.01(
‫מערבב יווז מולקולארי וכור קטליטי‬
C07D )2010.01(
‫ תכשירים‬,‫תרכובת חומצת פניל אמינו‬
‫המכילים אותו ושימוש בו‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
13/08/2008
203745
CELLULOSIC FEEDSTOCK
COMPOSITONS AND METHOD FOR
PRODUCING THE SAME
APPLIED CLEANTECH INC.
US
60/935429
13/08/2007
61/071842
21/05/2008
US
PCT/US/2008/009679
WO/2009/023216
01/08/2008
203746
HEPATITIS C INHIBITORY
COMPOUNDS, COMPOSITIONS
COMPRISING THE SAME OR USES
THEREOF
BRISTOL-MYERS SQUIBB COMPANY
US
60/954814
09/08/2007
61/049944
02/05/2008
US
12/180994
28/07/2008
US
PCT/US/2008/071881
WO/2009/029384
08/08/2008
203747
DHEA COMPOSITIONS FOR USE IN
TREATING MENOPAUSE
ENDORECHERCHE INC.
US
60/964270
10/08/2007
60/964673
13/08/2007
US
PCT/CA/2008/001444
WO/2009/021323
07/08/2008
111
203748
C07C )2010.01(
‫תכשירי חומר גלם להזנה צלולוזיים‬
‫ושיטות לייצורם‬
C07D )2010.01(
‫ תכשירים‬,C ‫תרכובות מעכבי הפטיטוס‬
‫המכילים אותם ושימושים בהם‬
A61K )2010.01(
‫ לשימוש בטיפול‬DHEA ‫תכשירי‬
‫במנופאזה‬
A61K )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
USE OF A SEROTONIN 3 (5-HT3)
RECEPTOR ANTAGONIST AND A
SELECTIVE CHLORIDE CHANNEL
MODULATOR FOR THE
PREPARATION OF A MEDICAMENT
FOR TREATMENT OF DRUG
ADDICTION OR DRUG DEPENDENCE
OF CENTRAL NERVOUS SYSTEM
DISORDERS
JUAN JOSE LEGARDA IBANEZ
US
60/963957
08/08/2007
PCT/ES/2008/000552
WO/2009/027564
04/02/2010
HT – 3( 3 ‫שימוש בנוגדן לקולטן סרוטונין‬
‫) ואפנן ערוץ כלוריד בררני להכנת‬5
‫תרופה לטיפול בהתמכרות לסמים או‬
‫בתלות בסמים או בהפרעות מערכת‬
‫העצבים המרכזית‬
203750
‫לוח הודעות מואר‬
‫יעקב כהן‬
ILLUMINATED MESSAGE BOARD
COHEN JACOB
US
61/153700
19/02/2009
09/09/2008
203751
USE OF PNEUMADIN AS A
THERAPEUTIC AGENT
MONDOBIOTECH LABORATORIES
AG
EP
07017763.9 11/09/2007
PCT/EP/2008/007649
WO/2009/043469
09/09/2008
112
A61K )2010.01(
‫שימוש בפנאומנדין כגורם טיפולי‬
203752
USE OF PEPTIDE ARG-ASN-ILE-ALAGLU-ILE-ILE-LYS-ASP-ILE-OH OR ITS
COMBINATION WITH THE PEPTIDE
ASP-ARG-GLY-ASP-SER-OH AS A
THERAPEUTIC AGENT
G09F )2010.01(
A61K )2010.01(
OH – ILE – ASP – LYS – ‫שימוש בפפטיד‬
ILE – ILE – GLU – ALA – ILE – ASN –
OH – SER – ‫ או בשילובו עם פפטיד‬ARG
‫ כגורם טיפולי‬ASP – GLY – ARG – ASP
October 31, 2010-‫כ"ג בחשון התשע"א‬
MONDOBIOTECH LABORATORIES
AG
EP
07017746.4 11/09/2007
PCT/EP/2008/007515
WO/2009/039973
09/09/2008
203753
USE OF PEPTIDE ASP-ARG-GLY-ASPSER-OH AS A THERAPEUTIC AGENT
MONDOBIOTECH LABORATORIES
AG
EP
07017748.0 11/09/2007
PCT/EP/2008/007516
WO/2009/039974
09/09/2008
203754
USE OF PEPTIDE AS A
THERAPEUTIC AGENT
MONDOBIOTECH LABORATORIES
AG
EP
07017747.2 11/09/2007
PCT/EP/2008/007518
WO/2009/039976
09/09/2008
203755
USE OF ALPHA - CASEIN (90 - 96) AS
A THERAPEUTIC AGENT IN THE
TREATMENT OF HBV INFECTION
MONDOBIOTECH LABORATORIES
AG
EP
07017747.2 11/09/2007
PCT/EP/2008/007519
WO/2009/039977
113
A61K )2010.01(
ASP – ARG – GLY – ‫שימוש בפפטיד‬
‫ כגורם טיפולי‬ASP – SER – OH
A61K )2010.01(
‫שימוש בפפטיד כגורם טיפולי‬
A61K )2010.01(
‫) כגורם‬96 – 90( ‫שימוש באלפא–קסאין‬
HBV ‫טיפולי בטיפול בזיהום‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
07/08/2008
203756
‫התקן בעל צורה הניתנת לשינוי לקיבוע‬
‫באתר דנטלי‬
RESHAPABLE DEVICE FOR
FIXATION AT A DENTAL SITE
COLL PARTNERS LTD.
US
11/890986
08/08/2007
PCT/IL/2008/001087
WO/2009/019697
07/08/2008
203757
THERMALLY BASED SYSTEM AND
METHOD FOR DETECTING
COUNTERFEIT DRUGS
SEMI-CONDUCTOR DEVICES - AN
ELBIT SYSTEMS - RAFAEL
PARTNERSHIP
IL
185130
08/08/2007
PCT/IL/2008/001090
WO/2009/019700
11/08/2008
18/08/2008
114
‫ שותפות אלביט‬- ‫התקני מצב מוצק‬
‫ רפא"ל‬- ‫מערכות‬
B65B )2010.01(
‫מילוי אוטומטי במהירות גבוהה של אריזות‬
‫מוצרי רוקחות מוצקים באמצעות מערכת‬
‫מסוע‬
203759
WORKFLOW ENGINE SYSTEM AND
METHOD
RAYTHEON COMPANY
US
11/841311
20/08/2007
PCT/US/2008/073464
G01N )2010.01(
‫מערכת מבוססת חום לזיהוי תרופות‬
‫מזויפות‬
203758
HIGH SPEED AUTOMATED FILLING
OF SOLID PHARMACEUTICAL
PRODUCT PACKAGING VIA A
CONVEYOR SYSTEM
MTS MEDICATION TECHNOLOGIES,
INC.,
US
11/838106
13/08/2007
PCT/US/2008/072794
WO/2009/023632
A61C )2010.01(
G05B )2010.01(
‫מערכת מנוע זרימת עבודה ושיטה‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
WO/2009/026216
11/08/2008
203760
‫חיסונים‬
VACCINES
GLAXOSMITHKLINE BIOLOGICALS
S.A.
US
60/955445
13/08/2007
60/957338
22/08/2007
US
60/982801
26/10/2007
US
PCT/EP/2008/060505
WO/2009/021931
05/09/2008
203761
METHOD FOR PRODUCING 4 AMINOBUT - 2 - ENOLIDES
BAYER CROPSCIENCE AG
EP
07116639.1 18/09/2007
PCT/EP/2008/007270
WO/2009/036899
06/08/2008
115
C07D )2010.01(
‫ – אנולידים‬2 – ‫ – אמינובוט‬4 ‫שיטה ליצור‬
203763
SYSTEM AND METHOD FOR
AUTHENTICATION, DATA
TRANSFER AND PROTECTION
AGAINST PHISHING
STEPHANE MOREAU
US
60/954259
06/08/2007
60/973590
19/09/2007
US
12/187224
06/08/2008
US
PCT/US/2008/072381
WO/2009/021070
07/08/2007
A61K )2010.01(
203764
H04L )2010.01(
‫ העברת מדיע‬,‫מערכת ושיטה לאימות‬
‫והגנה נגד הוצאה לא חוקית של מדיע‬
F41A )2010.01(
October 31, 2010-‫כ"ג בחשון התשע"א‬
AUTHENTICATION AND
AUTHORIZATION DEVICE
RAUL DELGADO ACARRETA
‫התקן לאימות והרשאה‬
PCT/ES/2007/070150
WO/2009/022031
19/10/2007
203765
RADIAL COUNTERFLOW INDUCTIVE
DESALINATION
MCCUTCHEN CO.
US
11/893454
16/08/2007
PCT/US/2007/081892
WO/2009/023036
08/03/2005
‫התפלה השראתית בזרימה נגדית רדיאלית‬
203766
IMPROVED APPARATUS FOR
ELECTRICALLY MEDIATED
DELIVERY OF THERAPEUTIC
AGENTS
ICHOR MEDICAL SYSTEMS , INC
US
60/551679
08/03/2004
PCT/US/2005/007936
WO/2005/087311
08/08/2008
203767
A USER CO-ROUTINE INTERFACE
FOR CUSTOMIZING SIP AND SDP
PROTOCOLS
REDCOM LABORATORIES, INC.
US
60/964027
08/08/2007
PCT/US/2008/072565
WO/2009/021160
116
B01D )2010.01(
A61N )2010.01(
‫מכשיר להולכה של חומרים רפואיים‬
‫באמצעות חשמל‬
G06F )2010.01(
‫ממשק משתמש קו – רוטיני להתאמה‬
SDP ‫ ו‬SIP ‫אישית של פרוטוקולי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
06/08/2008
203768
METHOD FOR PRODUCING
HYDRAZINE COMPOUND, AND
PRODUCTION INTERMEDIATES OF
HYDRAZINE COMPOUND, AND
METHODS FOR PRODUCING THE
INTERMEDIATES
SUMITOMO CHEMICAL COMPANY,
LIMITED
2007JP
14/08/2007
211325
2007-211326 14/08/2007
JP
PCT/JP/2008/064113
WO/2009/022600
08/08/2008
‫ חומרי ביניים‬,‫שיטה לייצור תרכובת הידרזין‬
‫ ושיטות לייצור‬,‫בייצור תרכובת הידרזין‬
‫חומרי הביניים‬
203769
NEAR FIELD COMMUNICATIONS
SYSTEM HAVING ENHANCED
SECURITY
RADEUM, INC. dba FREELINC
US
60/954784
08/08/2007
PCT/US/2008/072709
WO/2009/021220
07/02/2010
HAIR FOLLICLE TARGETING
J.P.M.E.D. LTD.
117
C07D )2010.01(
203770
H04B )2010.01(
‫מערכת לתקשורת לטווח קצר בעלת‬
‫בטיחות משופרת‬
A61K )2010.01(
‫הכוונה לזקיקי השיער‬
‫ בע"מ‬.‫די‬.‫אי‬.‫אם‬.‫פי‬.‫גי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note:, patent applications published in this
journal were classified according to the
International Classification version that was
in force when this journal was prepared.
118
- ‫ לחוק הפטנטים תשכ"ז‬26 ‫הודעה לפי סעיף‬
1976
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬17 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬30 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬57 ‫הפטנטים בדרך הקבועה בתקנה‬
.1968 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
‫ בקשות הפטנטים שפורסמו ביומן‬:‫**הערה‬
‫זה סווגו בהתאם לגרסת הסיווג הבינלאומי‬
‫שהייתה בתוקף בעת הכנת הבקשות‬
.‫לפרסום‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
]54[
APPARATUS AND METHOD FOR
EXPANDING COMMUNICATION
NETWORKS
]22[
]51[
]71[
13.03.1997
Int. Cl.(2008.04) H04L 1/00
URIZEN NETWORK SYSTEMS
LTD.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]74[
]57[
120449
‫התקן ושיטה להרחבת רשתות תקשורת‬
‫אביב‬-‫ תל‬,‫יוריזן בע"מ‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method for increasing the total capacity of a network, the network including a first
plurality of communication edges interconnecting a second plurality of
communication nodes, the first plurality of communication edges and the second
plurality of communication nodes having corresponding first and second pluralities of
capacity values respectively, said first and second pluralities of capacity values
determining the total capacity of the network, the method comprising:
expanding the capacity value of at least an individual communication edge from
among said first plurality of communication edges, the individual edge connecting
first and second
communication nodes from among said second plurality of communication nodes,
without expanding the capacity value of said first communication node;
wherein the expanding step comprises reducing the capacity value of at least one
additional communication edge connecting the first communication node and a third
node, different from the second node.
__________________
]11[]21[
]54[
]22[
119
COMPOSITIONS FOR
TREATMENT OF ATTENTION
DEFICIT DISORDER AND
ATTENTION DEFICIT/HYPER
ACTIVITY DISORDER WITH
METHYLPHENIDATE
136760
‫תכשירים לטיפול בהפרעת חוסר קשב ובהפרעת‬
‫יתר פעילות קשב באמצעות מתילפנידאט‬/‫חסר‬
14.12.1998
October 31, 2010-‫כ"ג בחשון התשע"א‬
]31[
]51[
]71[
]87[
]74[
]57[
60/069510
]32[ 15.12.1997
]33[ US
09/163351
30.09.1998
US
Int. Cl.(2009.01) A61K 09/06, 09/70, 31/435, A61P 25/00, C07D 213/00
NOVEN PHARMACEUTICALS, INC.,
U.S.A.
WO/1999/030694
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The invention relates to a method of treating Attention Deficit Disorder (ADD) and
Attention Deficit/Hyperactivity Disorder (ADHD) and compositions for topical
application of methylphenidate comprising methylphenidate in a flexible, finite system
wherein the methylphenidate is present in an amount sufficient to achieve substantially
zero order kinetics for delivery to the skin or mucosa of a patient in need thereof over a
period of time at least 10 hours.
The applications for division
from this application have
not yet been published
,204248
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
139586
]54[
4 - SUBSTITUTED - PYRROLO [2,3-D]
PYRIMIDINE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
]22[
]31[
14.06.1999
60/089866
]32[
19.06.1998
]33[
US
60/104787
19.10.1998
US
Int. Cl.(2009.01) A61K 31/395, 31/519, 45/06, A61P 01/00, 03/10, 05/00, 17/00, 25/00,
35/00, 37/06, C07D 487/04, 498/18, 519/00, C12P 17/18
PFIZER PRODUCTS, INC., U.S.A.
WO/1999/065908
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
]57[
‫] פירימידין‬d–2,3[ ‫תולדות פירולו‬
‫ ותכשירי רוקחות‬4 ‫מותמרות בעמדה‬
‫המכילים אותו‬
A compound of formula (I) wherein R1, R2 and R3 are as defined in the description, and are
inhibitors of the enzyme protein tyrosine kinases such as Janus Kinase (3) and as such are
120
October 31, 2010-‫כ"ג בחשון התשע"א‬
useful therapy as immunosuppressive agents for organ transplants, lupus, multiple sclerosis,
rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer,
asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease,
Alzheimer's disease, Leukemia and other autoimmune diseases.
__________________
]11[]21[
141586
‫פפטידים ציקלים הנגזרים מפרוזפוסין‬
‫והשימוש בהם‬
]54[
CYCLIC PROSAPOSIN-DERIVED
PEPTIDES AND USES THEREOF
]22[
]31[
]51[
20.08.1999
60/098359
]32[ 28.08.1998
]33[ US
Int. Cl.(2009.01) A61K 38/12, 38/18, A61P 09/10, 25/00, 25/04, 25/16, 25/28, 27/02,
43/00, C07K 07/64, 14/475
MYELOS CORPORATION, U.S.A.
WO/2000/012553
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]71[
]87[
]74[
]57[
121
Cyclic neurotrophic and analgesic peptides derived from the active region of
prosaposin having the consensus sequence X1X2X3NNX4TX5X6X7X8 (SEQ ID
NO:4), wherein X1 is a hydrophobic amino acid (leucine, isoleucine, valine, tyrosine,
tryptophan, phenylalanine or methionine); X2 is a hydrophobic amino acid, X3 is
aspartic acid, glutamic acid, lysine or arginine; N is asparagine, X4 is any amino acid;
T is threonine; X5 is glutamic acid or aspartic acid; X6 is any amino acid, X7 is a
hydrophobic amino acid; and X8 is a hydrophobic amino acid. The peptides are useful
October 31, 2010-‫כ"ג בחשון התשע"א‬
in the promotion of neural outgrowth, prevention of cell death, promotion of
myelination, treatment of neurodegenerative disorders and treatment and prevention of
neuropathic pain.
__________________
]11[]21[
142023
‫חיקוים לפפטיד דימרי של תרומבופואיטין‬
‫הנקשרים לקולט‬
‫ ושיש להם פעילות תרומבופואיטית‬MPI–‫ה‬
]54[
DIMERIC THROMBOPOIETIN
PEPTIDE MIMETICS BINDING TO
MPI RECEPTOR AND HAVING
THROMBOPOIETIC
ACTIVITY
]22[
]31[
]51[
22.10.1999
60/105348
]32[ 23.10.1998
]33[ US
Int. Cl.(2009.01) A61K 38/19, A61P 07/00, C07K 14/52, 19/00, C12N 01/15, 01/19,
01/21, 05/10, 15/19, 15/63, C12P 21/02
KIRIN-AMGEN INC.,
SWITZERLAND
WO/2000/024770
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]71[
]87[
]74[
]57[
The invention relates to the field of compounds, especially peptides or polypeptides,
that have thrombopoietic activity. The peptides and polypeptides of the invention may
be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
__________________
]11[]21[
]54[
122
SUSTAINED RELEASE
PHARMACEUTICAL
COMPOSITION COMPRISING 5 [4 - [2- (N - METHYL - N - (2 PYRIDYL) AMINO) ETHOXY]
143088
2–4–5 ‫תכשיר רוקחי בעל שחרור מושהה המכיל‬
]‫–פירידיל)אמינו)אתוקסי‬N–(2–‫–מתיל‬N(
‫–דיון ושימוש בהכנת‬2,4–‫בנזיל] תיאזולידינ‬
‫ ומצבים הקשורים‬2 ‫תרופה לטיפול בסוכרת סוג‬
‫לסוכרת‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
BENZYL] THIAZOLIDINE - 2,4 DIONE AND USE THEREOF IN
THE MANUFACTURE OF A
MEDICAMENT FOR THE
TREATMENT OF TYPE 2
DIABETES MELLITUS AND
CONDITIONS ASSOCIATED
WITH DIABETES MELLITUS
]22[
]31[
]51[
]71[
]87[
]74[
]57[
12.11.1999
9824893.3
]32[ 12.11.1998
]33[ GB
Int. Cl.(2009.01) A61K 09/22, 31/00, A61P 03/10
GLAXOSMITHKLINE LLC, U.S.A.
WO/2000/027341
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
A method for the treatment of Type 2 diabetes mellitus and conditions associated with
diabetes mellitus, which method comprises the administration to a human or nonhuman mammal in need thereof, of an effective non-toxic amount of an insulin
sensitiser so as to provide a plasma concentration of the insulin sensitiser of at least a
threshold level (the 'Threshold Plasma Concentration') from within the range of
effective plasma levels of the insulin sensitiser, compositions for use in such method
and methodology for determining plasma concentrations of active agent use in such
methods.
__________________
]11[]21[
143346
]54[
(AIB8,35) HGLP - 1 (7-36) NH2, AN
ANALOGUE OF GLP-1 AND USES
THEREOF
]22[
]31[
07.12.1999
09/206601
]32[ 07.12.1998
]33[ US
60/111255
07.12.1998
US
Int. Cl.(2009.01) A61K 38/26, A61P 03/00, 03/04, 03/08, 03/10, 09/00, 19/10, 25/00,
C07K 14/605
IPSEN PHARMA S.A.S., FRANCE
WO/2000/034331
]51[
]71[
]87[
123
‫ אנלוג‬, )NH (36–7)1 – hGLP (8,35 Aib 2
‫ ושימושים שלו‬GLP–1 ‫של‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
The present invention is directed to peptide analogues of glucagon-like peptide-1, the
pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat
mammals and to pharmaceutical compositions useful therefor comprising said
analogues.
.
,187907
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
PREPARATION OF CELLS AND
ITS USE IN PREVENTION OF
GRAFT REJECTION WITHOUT
MYELOABLATION
]22[
]31[
]51[
]71[
23.12.1999
09/222011
]32[ 31.12.1998
Int. Cl.(2009.01) A61K 35/28
BAXTER INTERNATIONAL INC.,
U.S.A.
HADASIT MEDICAL RESEARCH
SERVICES AND DEVELOPMENT
LTD.
WO/2000/040701
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]87[
]74[
]57[
124
143485
‫תכשיר של תאים ושימושו במניעת דחיה של‬
‫שתלים ללא סילוק מיאלוציטים‬
]33[
US
,‫הדסית שרותי מחקר רפואי ופתוח בע"מ‬
‫ירושלים‬
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
‫רמת גן‬
The present invention features a method of inducing bilateral transplantation tolerance;
host specific tolerance of the graft is especially considered. Tolerogenic treatments of
the present invention may be administered to a host prior to transplantation of donorderived materials. The tolerogenic treatment involves (1) administering an
immunosuppressive agent to a host mammal in a non-myeloablative regimen sufficient
to decrease, but not necessarily to eliminate, the host mammal's functional T
lymphocyte population; (2) infusing donor antigens from a non-syngeneic donor into
the host mammal; (3) eliminating those host T lymphocytes responding to the infused
October 31, 2010-‫כ"ג בחשון התשע"א‬
donor antigens using a non-myeloablative dose of lymphocytotoxic or tolerizing agent;
and (4) administering donor hematopoietic cells to the host mammal. Donor lymphoid
cells used for cell therapy of a host mammal can be depleted of host specific
immunological reactivity by methods essentially similar to those used for tolerizing a
host mammal prior to transplantation.
__________________
]11[]21[
144424
,‫ רשת תקשורת ניידת‬,‫שיטה לאספקת מידע‬
‫ומסוף תקשורת נייד‬
]54[
INFORMATION PROVIDING
METHOD, MOBILE
COMMUNICATION NETWORK,
AND MOBILE COMMUNICATION
TERMINAL
]22[
]31[
]51[
]71[
]72[
]87[
]74[
07.12.2000
350403/99
]32[ 09.12.1999
]33[ JP
Int. Cl.(2009.01) G01S 05/02, G08G 01/09, H04Q 05/00, H04W 04/22
NTT DOCOMO, INC., JAPAN
KOICHI OGASAWARA
WO/2001/043323
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
]57[
125
In a mobile communication network having multiple mobile communication terminals,
base station control devices (22A, 22B) include memories (223A, 223B) in which
position-related information on areas where subordinated base stations (21A to 21C,
21D to 21F) are located. An information signal representing the position-related
information is always broadcasted through the base stations (21A to 21C, 21D to 21F).
A mobile station (10) located in the radio cell of any one of the base stations (21A to
21F) receives and interprets the information signal, and displays the position related
information represented by the information signal on a liquid crystal display.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
145361
‫מגן אצבעות‬
]54[
FINGER GUARD
]22[
]51[
]71[
10.09.2001
Int. Cl.(2009.01) E06B 03/88
MATECHET KFAR-SABA
SHAHARBANI BROS. (1980) LTD.
]74[
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST
REHOVOT 76209
]57[
A finger guard (10) comprising:
a flexible member (14) having two opposite edge portions (16, 18), said flexible
member having a folded configuration and a spread configuration, the edge portion
being convexly rounded, said flexible member having convexly rounded knuckles (15)
at joints thereof; and
a pair of attachment members (20, 22), one being securable to a door (24) and the
other being securable to a door jamb )26(, each of said attachment members
October 31, 2010-‫כ"ג בחשון התשע"א‬
126
‫תעשיות מתכת כפר סבא האחים שהרבני‬
‫סבא‬-‫ כפר‬,‫) בע"מ‬1980(
,‫דוד קליין עו"פ‬
‫דקל פטנט בע"מ בית הרופאים מנוחה‬
18 ‫ונחלה‬
‫רחובות‬
comprising a concavely rounded receiving portion (28, 30) for pivotally receiving
therein one of said edge portions of said flexible member, wherein said edge portions
generally freely rotate in said receiving portions when said flexible member moves
between said folded and spread configurations, wherein the convexly rounded
knuckles and the convexly rounded edge portions have different diameters.
__________________
]11[]21[
]54[
METHOD AND SYSTEM FOR
NOTE TAKING
]22[
]31[
24.05.2000
PQ0559
]32[ 25.05.1999
PQ1313
30.06.1999
Int. Cl.(2009.01) G06F 03/03
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2000/072125
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
127
146621
‫שיטה ומערכת לעיבוד הערות‬
]33[
AU
AU
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A method and system for enabling handwritten note taking and retrieval, whereby a
user is able to electronically capture, manage and search notes handwritten on paper by
the user using one or more forms printed on paper and using a sensing device which
senses coded data included in the printed forms.
October 31, 2010-‫כ"ג בחשון התשע"א‬
The applications for division
from this application have
not yet been published
,203935
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
148445
‫השימוש בלפטין להכנת תרופה לעיכוב של ריבוי‬
‫תאים אנדותליים‬
]54[
USE OF LEPTIN IN THE
PREPARATION OF A
MEDICAMENT FOR INHIBITION
OF ENDOTHELIAL CELL
PROLIFERATION
]22[
]31[
04.09.2000
131739
]32[ 05.09.1999
]33[ IL
132312
10.10.1999
IL
Int. Cl.(2009.01) A61K 38/22, C07K 14/00
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
MENACHEM RUBINSTEIN, DALIT
BARKAN, BATYA COHEN
WO/2001/018040
INTERLAB LTD.,
,‫אינטר לאב בע"מ‬
18 HAKISHON ST.
18 ‫הקישון‬
YAVNE 81220
‫יבנה‬
]51[
]71[
]72[
]87[
]74[
]57[
128
Disclosed is the use of leptin, optionally together with VEGF inhibitors, in inhibition
October 31, 2010-‫כ"ג בחשון התשע"א‬
of endothelial cell proliferation and modulation of angiogenesis.
__________________
]11[]21[
]54[
METHODS AND COMPOSITIONS
FOR DETECTING
PATHOLOGICAL EVENTS
]22[
]31[
]51[
]71[
05.09.2000
99/11563
]32[ 16.09.1999
Int. Cl.(2009.01) C12Q 01/68
EXONHIT THERAPEUTICS S.A.,
FRANCE
WO/2001/020027
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
]57[
148613
‫שיטות והרכבים לגילוי מקרים פתולוגיים‬
]33[
FR
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
The invention concerns novel compositions and methods for detecting pathological
events. More particularly, it concerns methods for detecting in vitro the presence of a
pathology or a pathological event in a subject, which consists in taking a sample of the
subject's blood cells and in determining the presence, in said sample, blood cells
having a physiological condition characteristic of the pathology. The invention also
concerns instruments, kits and compositions for implementing said methods, and their
used in the field of human and animal health care, or in experimental research for
example.
__________________
]11[]21[
]54[
EARTH SCREW ANCHOR
ASSEMBLY
]22[
]51[
129
24.03.2002
Int. Cl.(2009.01) E02D 05/80
148847
‫יתד ספירלית‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]71[
]74[
]57[
ELI TIAR
‫אלי תייר‬
NAOMI ASSIA & CO. LAW
,‫נעמי אסיא ושות' משרד עורכי דין‬
OFFICES,
‫ רמת החייל‬32 ‫רח' הברזל‬
32 HABARZEL ST.
‫אביב‬-‫תל‬
RAMAT HACHAYAL
TEL AVIV 69710
A portable screw-type anchor device (10) comprising:
(a) a primary elongated bar (12) having an above-ground portion (30) and a
below-ground portion (32);
an auger member (16) located on said below-ground portion, sad auger member
adapted to facilitate rotational peretration of said below-ground portion into the
earth about a longitudinal axis of said primary bar;
(b) a secondary mooring element (18), wherein an upper end of said mooring
element is attachable to an object (20, 22); and a lower end of said mooring
element is fastened at an oblique angle to said below-ground portion of said
elongated bar (a); wherein said lower end of secondary mooring element is
fastened via a free-rotating axis (24) to said primary elongated bar (a);
wherein in use, said auger member (16) is rotated to penetrate the earth, until a
ready state is reached in which said auger member and said below-ground portion
of the primary elongated bar, anchor said device in the earth; said free-rotating
axis preventing rotation of said secondary mooring element during rotation of said
primary elongated bar;
in said ready state, the upper end of said secondary mooring element protrudes
from the earth surface at an oblique angle and is attachable to an object; said
oblique angle of said secondary mooring element aiding in preventing extraction
of said anchor device by a pulling force generated by said object.
__________________
130
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
]54[
SYSTEMS AND METHODS FOR
AUTHENTICATING AN
ELECTRONIC MESSAGE
]22[
]31[
]51[
]71[
02.10.2000
60/157168
]32[ 30.09.1999
Int. Cl.(2009.01) H04L 09/00
UNITED STATES POSTAL
SERVICE, U.S.A.
LEO J. CAMPBELL, JON L. COOK,
CHARLES R. CHAMBERLAIN,
MICHAEL J. MCGRATH, ISADORE
SCHOEN
WO/2001/024437
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]72[
]87[
]74[
]57[
148918
‫מערכות ושיטות לאימות מסר אלקטרוני‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Systems and methods are disclosed for authenticating electronic messages. A data
structure is generated by a computer server which allows for the authentication of the
contents and computer server identity of a received electronic message and provides a
trusted stamp to authenticate when the message was sent. Data which can authenticate
the message, the computer server identity, and the time the message was sent is
included into a data structure which is called an Electronic PostMark (EPM).
__________________
]11[]21[
149240
‫התקנים ושיטות לאיחסון ושיחרור חומר מצנרת‬
]54[
APPARATUS AND METHODS FOR
STORAGE AND RELEASE OF
MATERIAL FROM TUBING
]22[
]31[
20.10.2000
60/161130
]32[ 22.10.1999
]33[
60/170051
10.12.1999
Int. Cl.(2009.01) A61L 29/00, A61M 25/00
BIOSYNERGETICS, INC., U.S.A.
WO/2001/028606
WOLFF, BREGMAN AND GOLLER,
]51[
]71[
]87[
]74[
131
US
US
,‫ ברגמן וגולר‬,‫וולף‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
P.O.B. 1352,
JERUSALEM 91013
]57[
Apparatus and methods for delivery of a drug or compound (25) into a fluid flowing
within a tube or catheter (20). In one embodiment a catheter includes an inner surface
coated with a polymer matrix (55) such as a hydrogel. The hydrogel includes captured
within it a therapeutic agent (65). The method of capture may be by various means,
including photolabile bonds between the therapeutic agent (65) and the hydrogel (55).
The therapeutic agent (65) is released from the hydrogel (55) by the application of
energy to the hydrogel (55), such as by laser emitting wavelength (35) which resonates
and breaks the photolabile bond. The released therapeutic agent (65) diffuses out of the
hydrogel (55) into the liquid flowing within a lumen (60) of the catheter (20).
__________________
]11[]21[
]54[
]22[
]31[
132
METHOD OF ENHANCING
EXPRESSION BY SUPPRESSING
OF POST - TRANSCRIPTIONAL
GENE SILENCING (PTGS), AND A
METHOD OF INDENTIFYING A
SUPPRESSOR OF GENE
SILENCING
22.11.2000
9927609.9
]32[
22.11.1999
149388
‫שיטה להגברת ביטוי באמצעות דיכוי מנגנון בתר‬
‫)ׂ ושיטה‬PTGS( ‫– שעתוק להשתקת גנים‬
‫לזיהוי מדכא למנגנון השתקת גנים‬
]33[
GB
October 31, 2010-‫כ"ג בחשון התשע"א‬
]51[
]71[
]87[
]74[
]57[
0022960.9
19.09.2000
GB
0023668.7
27.09.2000
GB
Int. Cl.(2009.01) A01H 01/00, 05/00, C12N 15/29, 15/82
PLANT BIOSCIENCE LIMITED,
UNITED KINGDOM
WO/2001/038512
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Disclosed are a variety of methods for achieving enhanced expression from a target
nucleotide sequence in a plant e.g. comprising the step of transiently introducing into a
tissue of a plant (e.g. a leaf) a first nucleic acid comprising the target nucleotide
sequence and a second nucleic acid encoding a Post Transcriptional Gene Silencing
(PTGS) suppressor protein (preferably of viral or plant origin), wherein the first and
second nucleic acids are comprised within a single binary vector, construct, or the first
and second nucleic acid sequences are comprised within a first binary vector and a
second binary vector construct respectively. The plant tissue may then be harvested for
the protein. Such methods can give much higher levels of gene expression than are
obtainable using stable transgenes, or certain replicating vectors. Also disclosed are
specific PTGS suppressor proteins: potato virus X (pvx), p25 protein; african cassava
mosaic virus (acmv) AC2 protein; rice yellow mottle virus (rymv) P1 protein; tomato
bushy stunt virus (tbsv) 19K protein; plus variants of these. These suppressors may be
used in any PTRS context, including the enhancement of transient expression systems.
__________________
]11[]21[
]54[
PLANAR RAY IMAGING
STEERED BEAM ARRAY
(PRISBA) ANTENNA
]22[
]51[
]71[
01.05.2002
Int. Cl.(2009.01) H01Q 01/00, 03/26
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]74[
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
133
149431
‫מערך אנטנה לינארית עם ניתוב קרניים‬
,‫רפא"ל רשות לפיתוח אמצעי לחימה בע"מ‬
‫חיפה‬
,‫ד"ר מרק פרידמן בע"מ‬
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
A ray-imaging, electronic beam-steering antenna (20) comprising:
(a) at least one antenna segment (24), each said at least one antenna segment having at
least one output and including a plurality of horizontally-polarized radiating columnarray elements (20) and an elevation beam-forming assembly (30), said plurality of
radiating column-array elements disposed adjacently on a common line, and
(b) an electrically conductive ground reflector plane (22) positioned perpendicular to
said common line, said ground reflector plane allowing gain-enhanced, horizontalpolarization beam generation and steering in planes perpendicular to said ground
reflector plane;
wherein said elevation beam-forming assembly includes:
(i) a microwave multiple beam network (50) having a first plurality of element
ports (80) and a second plurality of beam ports (82),
(ii) a set of two-way power dividers (26), each of said set having a pair of output
ports, and incorporating an 180º phase shift between two ports of said pair of
output ports,
(iii) a set of two-way power combiners (26), each of said set having a pair of input
ports, and incorporating an 180º phase shift between two ports of said pair of
input
ports, and
(iv) a beam selection switching module (54)connected to said set of power
combiners.
__________________
134
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
150438
‫שיטה למדידת שכבות דקות‬
]54[
METHOD OF THIN FILM
MEASUREMENT
]22[
]51[
]71[
26.06.2002
Int. Cl.(2009.01) G01B 11/28
NOVA MEASURING
‫ רחובות‬,‫נובה מכשירי מדידה בע"מ‬
INSTRUMENTS LTD.
NOVA MEASURING
,‫נובה מכשירי מדידה בע"מ‬
INSTRUMENTS LTD.,
‫וייצמן פארק למדע‬
WEIZMANN SCIENTIFIC PARK,
‫רחובות‬266 .‫ד‬.‫ ת‬,
P.O.B 266,
REHOVOT 76100
A method for use in controlling processing of a structure, the method comprising:
providing first measured data including at least one of the following parameters: a
thickness of at least one layer of the structure in at least selected sites of the structure
prior to said processing of the structure, and a surface profile of the structure prior to
said processing;
applying spectral optical measurement to at least said selected sites in the structure
after said processing and generating second measured data indicative of a spectral
response of at least said selected sites of the processed structure;
analyzing the second measured data using the first measured data, and outputting data
comprising a thickness of at least one layer of the processed structure, said output data
being indicative of the quality of said processing.
]74[
]57[
__________________
]11[]21[
150935
]54[
SELECTIVE KILLING OF CELLS
EXPRESSING ∆ 2 - 7 EGFR BY
ACTIVATION OF DOUBLESTRANDED RNA DEPENDENT
PROTEIN KINASE-PKR
]22[
]31[
31.01.2001
60/179361
]32[ 31.01.2000
]33[ US
60/258010
22.12.2000
US
Int. Cl.(2009.01) A61K 31/713, 38/21, 48/00, C12N 15/11
YISSUM RESEARCH
‫יישום חברה לפיתוח המחקר של‬
]51[
]71[
135
EGFR 7 ‫הריגה ברירתית של תאים המבטאים‬
PKR ‫ – ∆ על ידי אקטיבציה של חלבון קינאזה‬2
‫ דו גדילי‬RNA –‫התלוי ב‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]72[
]87[
]74[
]57[
‫ אלכסיי שיר‬,‫אלכסנדר לויצקי‬
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
‫רמת גן‬
Novel methods and compositions for selective killing of cells by activation of PKR are
disclosed. In a preferred embodiment, a method is provided for causing cell death in a
targeted population of cells that includes the steps of: selecting a nucleotide sequence
at a single genetic locus in the targeted population that is absent from the equivalent
locus in a population of non-targeted cells; obtaining one or more anti-sense RNA
having sequence homology with the locus in the targeted population; permitting the
anti-sense RNA to hybridize with an RNA transcribed from the locus in the targeted
population so as to form a contiguous double stranded RNA for interacting with PKR.
The activation of PKR gives rise to selective cell death in the targeted population.
The applications for division
136
,‫האוניברסיטה העברית בירושלים בע"מ‬
‫ירושלים‬
DEVELOPMENT COMPANY OF
THE HEBREW UNIVERSITY OF
JERUSALEM LTD.
ALEXANDER LEVITZKI, ALEXEI
SHIR
WO/2001/057205
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
,204416
‫בקשות חלוקה מבקשה זו‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
.‫שטרם פורסמו‬
from this application have
not yet been published
__________________
]11[]21[
151860
‫קומפלקסים היסטוקומפטיביליים חד–גדיליים‬
‫ ופפטידים אנטיגנים המוכרים ע"י תא‬1 ‫מסוג‬
‫לימפוציטי ציטוטוקסי אחד וקונסטרוקטים‬
‫המקודדים עבורם ושיטות ליצורם‬
]54[
PLURALITY OF MHC AND
ANTIGENIC PEPTIDE
COMPLEXES RECOGNIZABLE
BY ONE CTL CLONE AND
CONSTRUCTS ENCODING SAME
AND METHODS OF
GENERATING SAME
]22[
]31[
]51[
]71[
19.03.2001
09/534966
]32[ 27.03.2000
]33[ US
Int. Cl.(2009.01) C07K 14/705, 14/74, C12N 15/62
TECHNION RESEARCH AND
‫ חיפה‬,‫מוסד הטכניון למחקר ופיתוח בע"מ‬
DEVELOPMENT FOUNDATION
LTD.
YORAM REITER
‫יורם רייטר‬
WO/2001/072768
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]72[
]87[
]74[
]57[
Methods of generating a functional mammalian single chain MHC class I complex in
prokaryotic expression systems and a functional human single chain MHC class I
complex in eukaryotic or prokaryotic expression systems, which complexes are
capable of presenting specific antigenic peptides restricted to specific CTL clones.
,204140
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
137
MULTIMEDIA PERSONALIZED
CALL MANAGEMENT (MPCM)
151957
‫ניהול שיחות מולטימדיה אישי‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]22[
]31[
]51[
]71[
]72[
]74[
]57[
26.09.2002
09/968847
]32[ 02.10.2001
]33[ US
Int. Cl.(2009.01) H04L 12/66, H04M 03/42
COMVERSE, INC., U.S.A.
SESHADRI MOHAN, HAIPING LUO,
ZHONGSU FU
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A system (100) for managing a call, the system comprising: a database (126) operative
to store data associated with subscribers; and a MPCM server (124) in communication
with the database, having an interface for communicating over a network, and
operative to:
receive over the network first data related to a call sent by a calling party to a called
party, in response to the first data related to the call, obtain, from the database, second
data related to the call, wherein at least one of the first data related to the call, the
second data related to the call, and a combination of the first and second data related to
the call comprising multimedia data, and manage the call based at least in part on the
multimedia data; wherein the MPCM server includes a session management module
adapted to receive data related to the call from a user and operative to store session
states and control call/session flow; and a provisioning unit adapted to receive
provisioning data from the session management module and to communicate with the
database, the provisioning unit operative to provide facilities for personal
configuration, customization and call flow setup.
__________________
138
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
152957
‫–קרבוציקליות‬17 ,16 ‫תרכובות סטרואידיות‬
‫דחוסות בעלות פעילות אסטרוגנית ייחודית‬
]54[
16, 17-CARBOCYCLIC
CONDENSED STEROID
COMPOUNDS HAVING
SELECTIVE ESTROGENIC
ACTIVITY
]22[
]31[
]51[
]71[
01.05.2001
00201986.7
]32[ 06.06.2000
]33[ EP
Int. Cl.(2009.01) A61K 31/565, A61P 05/00, C07J 53/00
N.V. ORGANON, THE
NETHERLANDS
WO/2002/000682
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
139
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention discloses a steroid compound having the formula (1), wherein dotted
bonds represent optional double bonds; R6 is H, =CH2, or -CH3, or -CH2-CH3; R7 is
H, C1-4-alkyl, C2-5 alkenyl or C2-5-alkynyl, wherein the alkyl, alkenyl or alkynyl
group may be substituted with 1 to 3 halogen atoms independently chosen from the
group of fluorine or chlorine atoms; R11 is H, C1-4-alkyl, C2-4-alkenyl, C2-4-alkynyl
or C1-4-alkylidene, wherein the alkyl, alkenyl, alkynyl or alkylidene group may be
substituted with 1 to 3 halogen atoms independently chosen from the group of fluorine
or chlorine atoms; E represents together with carbon atoms 16 and 17 of the steroid
skeleton a four to seven-membered ring, said ring being α and in cis-configuration
with respect to the steroid skeleton, optionally comprising one or two endocyclic
bonds; or a prodrug thereof. Such compounds can be used in therapy and for methods
for selective modification of the activity of estrogen receptors.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
QS-21 AND IL-12 AS AN
ADJUVANT COMBINATION
]22[
]31[
]51[
]71[
21.06.2001
60/213143
]32[ 22.06.2000
Int. Cl.(2009.01) A61K 39/39
WYETH HOLDINGS
CORPORATION, U.S.A.
WO/2001/097841
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
]57[
153133
‫ כתשלובת אדג'ובאנט‬IL –12–‫ – ו‬QS21
]33[
US
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
Adjuvant compositions comprising an effective amount IL-12 and QS-21 are
disclosed. Immunogenic, vaccine and pharmaceutical compositions comprising a
mixture of antigen and an adjuvant composition comprising an effective amount of IL12 and QS-21 are also disclosed. These compositions elicit functional cell-mediated
and humoral immune responses against at least one antigen. Methods of using the
disclosed compositions are also disclosed.
__________________
]11[]21[
140
153290
October 31, 2010-‫כ"ג בחשון התשע"א‬
]54[
ASSEMBLY OF WILD-TYPE AND
CHIMERIC INFLUENZA VIRUSLIKE PARTICLES (VLPS)
]22[
]31[
21.06.2001
60/213656
]32[ 23.06.2000
]33[ US
60/284411
17.04.2001
US
Int. Cl.(2009.01) A61K 39/145, C07K 14/11, C12N 15/44, 15/62
WYETH HOLDINGS
CORPORATION, U.S.A.
WO/2002/000885
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
]51[
]71[
]87[
]74[
]57[
141
‫ של‬VLPS(( ‫הרכב של חלקיקים דמויי–וירוס‬
‫שפעת מסוג בר ושפעת כימרית‬
Influenza virus-like particles (VLPs) comprising the structural proteins HA, NA, M1
and M2 are described. VLPs are also generated containing M1 alone, as are VLPs with
M1 and any one or two of HA, Na and M2. VLPs with HA from one influenza subtype
and NA from a different influenza subtype are also described, as are VLPs in which a
portion or all of HA or NA is replaced by a heterologous moiety not produced by
influenza virus, so as to comprise chimeric VLPs.
__________________
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
153779
‫ קוטל‬,‫תולדות בנזואילפירידין או מלח שלה‬
‫פטריות המכיל אותה כמרכיב פעיל ותהליך‬
‫הפקתה‬
]54[
BENZOYLPYRIDINE
DERIVATIVE OR ITS SALT,
FUNGICIDE CONTAINING IT AS
AN ACTIVE INGREDIENT AND
ITS PRODUCTION PROCESS
]22[
]31[
05.07.2001
2000-203909 ]32[ 05.07.2000
]33[ JP
2001-034182
09.02.2001
JP
2001-094222
28.03.2001
JP
Int. Cl.(2009.01) A01N 43/40, C07D 213/26, 213/50, 213/69, 405/06
ISHIHARA SANGYO KAISHA LTD.,
JAPAN
HISAYA NISHIDE, MUNEKAZU
OGAWA, HIDEMASA KOMINAMI,
KOJI HIGUCHI, AKIHIRO
NISHIMURA
WO/2002/002527
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
]51[
]71[
]72[
]87[
]74[
]57[
142
The present invention relates to a fungicide containing a novel benzoylpyridine
derivative or its salt. The present invention provides a fungicide containing a
benzoylpyridine derivative represented by formula (I) or its salt: wherein X is a
halogen atom, a nitro group, a substitutable alkoxy group, a substitutable aryloxy
group, a substitutable cycloalkoxy group, a hydroxyl group, a substitutable
hydrocarbon group, a substitutable alkylthio group, a cyano group, a carboxyl group
which may be esterified or amidated, or a substitutable amino group; n is 1, 2, 3 or 4;
R1 is a substitutable alkyl group; R2 is a substitutable alkyl group, a substitutable
alkoxy group, a substitutable aryloxy group, a substitutable cycloalkoxy group or a
hydroxyl group; and m is 1, 2, 3 or 4, provided that when m is at least 2, R2 may
contain an oxygen atom to form a condensed ring.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
154304
‫הרכבים פעילים בעלי תכונות קוטלות חרקים‬
‫וקוטלות אקריות‬
]54[
ACTIVE INGREDICENT
COMBINATIONS WITH
INSECTICIDAL AND
ACARICIDAL PROPERTIES
]22[
]31[
]51[
21.08.2001
10042736.7
]32[ 31.08.2000
]33[ DE
Int. Cl.(2009.01) A01N 43/36, 43/38, 43/84, 47/10, 57/36, C07D 207/38, 209/54,
413/12, 487/04, C07F 09/28
BAYER CROPSCIENCE AG,
GERMANY
WO/2002/017715
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]71[
]87[
]74[
]57[
143
The invention relates to novel active ingredient combinations made from specific
cyclic ketoenoles and the active ingredients cited in the description (1 - 43) exhibit
very good insecticidal and acaricidal properties.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
154881
–‫שיטה לקביעת רגישות תאים להדבקה ב‬
‫ ודיאגנוזה של מחלה סרטנית‬REOVIRUS
]54[
METHOD FOR DETERMINING
SUSCEPTIBILITY OF CELLS TO
REOVIRUS INFECTION AND
DIAGNOSING A PROLIFERATIVE
DISEASE
]22[
]31[
]51[
]71[
26.10.2001
60/246728
]32[ 09.11.2000
]33[ US
Int. Cl.(2009.01) A61K 35/76, 39/15, A61P 35/00, G01N 33/53, 33/574
ONCOLYTICS BIOTECH INC.,
CANADA
WO/2002/039117
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]87[
]74[
]57[
The present invention relates to methods of identifying the susceptibility of cells to
reovirus infection by measuring constituive ras-MAP signaling. The invention also
pertains to methods using reovirus for the treatment of cellular proliferative disorders,
and particularly cellular proliferative disorders wherein the proliferating cells exhibit
constitutive MAPK phosphorylation, in mammals. In particular, the methods provide
for reovirus treatment of mammals to treat proliferative disorders which include breast
tumors, a subset of tumors in which mutation of the ras gene is not believed to play a
significant role.
__________________
]11[]21[
]54[
CONTROL OF A PERSONAL
TRANSPORTER
]22[
]31[
11.10.2001
09/687757
09/687789
144
]32[
13.10.2000
13.10.2000
155390
‫שליטה על מוביל אישי‬
]33[
US
US
October 31, 2010-‫כ"ג בחשון התשע"א‬
]51[
]71[
]87[
]74[
]57[
09/687557
13.10.2000
09/739192
18.12.2000
Int. Cl.(2009.01) A63C 17/12, B62K 11/00
DEKA PRODUCTS LIMITED
PARTNERSHIP, U.S.A.
WO/2002/030730
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
US
US
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
Methods for controlling a motorized balancing transporter that has two wheels in
contact with the ground in normal operation. Upon detection of a fault condition, a
control variable is adjusted at a specified increment in the direction of a goal value
until the control variable equals the goal value. A user is afforded accelerated access to
operation of the balancing transporter by first initializing a single-axis stabilizer, and,
while intializing a 3-axis stabilizer, allowing operation of the transporter, and then
completing initialization of the 3-axis stabilizer. Traction is maintained between
wheels of a transporter and an underlying surface by comparing acceleration of a
wheel with a specified pre-set value and incrementally reducing the torque applied to
the wheel based on the existence of slip condition, with the slip condition cleared on
the basis of a determined value of a dynamic characteristic of the wheel such as the
inverse moment of inertia.
The applications for division
from this application have
145
,187560
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
not yet been published
__________________
]11[]21[
156058
]54[
ISOLATED HCV SELFREPLICATING
POLYNUCLEOTIDE
]22[
]31[
]51[
]71[
20.12.2001
60/257857
]32[ 22.12.2000
]33[ US
Int. Cl.(2009.01) C12N 05/10, 15/51, 15/63, 15/86, C12Q 01/68, C12R 01/91
BOEHRINGER INGELHEIM
(CANADA) LTD., CANADA
WO/2002/052015
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]87[
]74[
]57[
146
C ‫פולינוקלאוטיד מבודד מוירוס הפטיטיס‬
‫המשתכפל בעצמו‬
A unique HCV RNA molecule is provided having an enhanced efficiency of
establishing cell culture replication. Novel adaptive mutations have been identified
within the HCV non-structural region that improves the efficiency of establishing
persistently replicating HCV RNA in cell culture. This self-replicating polynucleotide
molecule contains, contrary to all previous reports, a 5'-NTR that can be either an A as
an alternative to the G already disclosed and therefore provides an alternative to
existing systems comprising a self-replicating HCV RNA molecule. The G-->A
mutation gives rise to HCV RNA molecules that, in conjunction with mutations in the
HCV non-structural region, such as the G(2042)C/R mutations, possess greater
efficiency of transduction and/or replication. These RNA molecules when transfected
in a cell line are useful for evaluating potential inhibitors of HCV replication.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
156096
‫נגזרות של חומצה מנדלית‬
]54[
MANDELIC ACID DERIVATIVES
]22[
]31[
30.11.2001
0004458-6
]32[ 01.12.2000
]33[ SE
0100965-3
19.03.2001
SE
0101239-2
06.04.2001
SE
0102921-4
30.08.2001
SE
Int. Cl.(2009.01) A61K 31/397, A61P 07/02, C07D 205/04
ASTRAZENECA AB, SWEDEN
TORD INGHARDT, ARNE
SVENSSON, ANDERS JOHANSSON
WO/2002/044145
S. HOROWITZ & CO.,
31 AHAD HAAM STREET
P.O. BOX 2499
TEL AVIV 65202
]51[
]71[
]72[
]87[
]74[
]57[
There is provided a compound of formula (I) wherein Ra, R1, R2, Y and R3 have
meanings given in the description and pharmaceutically-acceptable derivatives
(including prodrugs) thereof, which compounds and derivatives are useful as, or are
useful as prodrugs of, competitive inhibitors of trypsin-like proteases, such as
thrombin, and thus, in particular, in the treatment of conditions where inhibition of
thrombin is required (e.g. thrombosis) or as anticoagulants.
The applications for division
from this application have
not yet been published
147
,'‫ הורוביץ ושות‬.‫ש‬
31 ‫רחוב אחד העם‬
‫תל אביב‬2499 .‫ד‬.‫ ת‬,
,203644
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
156275
‫שיטות ומתקן עבור עיבוד ברירתי של ביצים‬
‫בעלי איפיון מזוהה‬
]54[
METHODS AND APPARATUS FOR
SELECTIVELY PROCESSING
EGGS HAVING IDENTIFIED
CHARACTERISTICS
]22[
]31[
]51[
]71[
]87[
]74[
10.04.2002
60/284267
]32[ 17.04.2001
]33[ US
Int. Cl.(2009.01) A01K 43/00, G01N 33/00, 33/08, 33/50
EMBREX, INC., U.S.A.
WO/2002/083848
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]57[
148
,‫ד"ר יצחק הס ושותפיו‬
279 ‫רחוב הירקון‬
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
Methods and apparatus for processing eggs (1000) based upon a characteristic such as
gender are provided. Material (2000) is extracted from each of a plurality of live eggs
(1000), the extracted material (2000) is assayed to identify eggs (4000) having the
characteristic, and then eggs (4000) identified as having the characteristic are
processed accordingly.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
157130
‫תכשיר תרופתי המבוסס על קנבוס‬
]54[
CANNABIS BASED
PHARMACEUTICAL
FORMULATION
]22[
]31[
14.02.2002
0103638.3
]32[ 14.02.2001
]33[ GB
60/280044
30.03.2001
US
827158
05.04.2001
US
0111597.1
11.05.2001
GB
0121715.7
07.09.2001
GB
951022
12.09.2001
US
Int. Cl.(2009.01) A61K 09/08, 09/107, 31/352, 31/353, 35/00, 36/18, 47/10, 47/14,
47/34, 47/36, 47/42, A61P 03/04, 09/00, 25/04, 25/06, 25/08, 29/00, 39/00
GW PHARMA LIMITED, UNITED
KINGDOM
WO/2002/064109
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]51[
]71[
]87[
]74[
]57[
149
The invention relates to pharmaceutical formulations for use in the administration of
lipophilic medicaments via mucosal surfaces. In particular the invention provides
pharmaceutical formulations for use in administration of a lipophilic medicament via a
mucosal surface which upon hydration form an emulsion containing the lipophilic
medicament which is capable of adhering to a mucosal surface and allowing controlled
release of the medicament. The invention further provides pharmaceutical formulations
which contain, as active ingredients, specific combinations of cannabinoids in preOctober 31, 2010-‫כ"ג בחשון התשע"א‬
defined ratios.
__________________
]11[]21[
]54[
COMPOSITIONS COMPRISING
LOW LEVELS OF ANTIBODIES
FOR ALLEVIATING SYMPTOMS
ASSOCIATED WITH DIABETES
AND DIABETIC NEUROPATHY
]22[
]31[
13.12.2001
09/774770
]32[ 31.01.2001
09/918343
30.07.2001
Int. Cl.(2009.01) A61K 39/395
MILKHAUS LABORATORY, INC.,
U.S.A.
WO/2002/060478
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
150
157164
‫הרכבים הכוללים רמות נמוכות של נוגדנים‬
‫לשיכך תסמינים הקשורים עם סכרת ועם מחלת‬
‫עצבים סוכרתית‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]57[
The invention provides methods and compositions for alleviating the symptoms of
diabetes with a pharmaceutical composition including a combination of anti-glutamic
acid decarboxylase (anti-GAD) and anti-insulin antibodies.
__________________
]11[]21[
157333
‫שילובים המכילים נוגד שלשול ואפותילון או‬
‫נגזרת של אפותילון‬
]54[
COMBINATIONS COMPRISING
AN ANTIDIARRHEAL AGENT
AND AN EPOTHILONE OR AN
EPOTHILONE DERIVATIVE
]22[
]31[
18.03.2002
60/277153
]32[ 19.03.2001
]33[ US
60/277207
20.03.2001
US
Int. Cl.(2009.01) A61K 31/425, 31/427, 31/445, 33/24, 38/31, A61P 35/00
NOVARTIS AG, SWITZERLAND
WO/2002/074042
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
]57[
Epothilone derivatives are co-administered with an antidiarrheal agent, e.g., a DPP-IV
inhibitor, in the treatment of a proliferative disease.
__________________
]11[]21[
157335
‫קונסטרוקטים לנטיוויראליים לאריזה‬
]54[
LENTIVIRAL PACKAGING
CONSTRUCTS
]22[
]31[
]51[
13.03.2002
60/275275
]32[ 13.03.2001
]33[ US
Int. Cl.(2009.01) C07K 14/16, C12N 05/10, 15/49, 15/867
151
October 31, 2010-‫כ"ג בחשון התשע"א‬
]71[
]87[
]74[
]57[
NOVARTIS AG, SWITZERLAND
WO/2002/072851
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention provides novel lentiviral packaging constructs that are useful for
the establishment of stable packaging cell lines and producer cell lines. In particular,
the present invention provides novel packaging cell lines that are capable of
constitutively expressing high levels of lentiviral proteins.
.
,185142
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
157414
‫ תא‬,‫ פלסמיד‬,‫ חלבון‬,‫דנא המקודד לחלבון איחוי‬
‫פונדקאי ותהליך להכנת חלבון איחוי‬
]54[
DNA CODING FOR A FUSION
PROTEIN, PROTEIN OF
INTEREST, PLASMID, HOST
CELL AND PROCESS FOR THE
PRODUCTION OF THE FUSION
PROTEIN
]22[
]31[
]51[
08.02.2002
10108212.6
]32[ 20.02.2001
]33[ DE
Int. Cl.(2009.01) C07K 14/62, 14/815, 19/00, C12N 01/21, 15/62, 15/70, C12P 21/02,
21/06
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2002/068660
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]71[
]87[
]74[
]57[
152
The invention relates to fusion proteins comprising a fusion part and a protein of
interest, the combination of the two proteins leading to the fusion protein being
secreted into the supernatant of a bacterial host and the protein of interest being present
in its correct three-dimensional structure.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
157415
‫ תהליך‬,‫פפטידים המופרשים באופן מוגבר‬
‫לייצורים ושיפור מקביל של הצורה המופרשת‬
‫של אחד או יותר פוליפפטידים אחרים‬
]54[
SUPERSECRETABLE PEPTIDES,
PROCESSES FOR THEIR
PRODUCTION AND PARALLEL
IMPROVEMENT OF THE
SECRETED FORM OF ONE OR
MORE OTHER POLYPEPTIDES
]22[
]31[
]51[
]71[
08.02.2002
10108100.6
]32[ 20.02.2001
]33[ DE
Int. Cl.(2009.01) C07K 14/815, 19/00, C12N 01/19, 15/62, 15/81, C12P 21/02
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2002/066628
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]87[
]74[
]57[
153
The invention relates to an expression cassette of the form Px-Sx-Bn-(ZR)-transport
peptide-(Z1Z2)-protein(Y)-(Z1Z2)-protein (Ym)-T; wherein the expression cassette
codes for a transport peptide linked via a sequence Z1Z2 to a second protein which in
turn is linked via Z1Z2 to a protein Y1 which either corresponds to Y or can be
different from Y and the transport peptide improves the rate of secretion and Y and/or
Ym where Px is any promoter DNA sequence selected in such a way that optimal
yields of the protein of interest become obtainable; Sx is any DNA which, accordingly,
encodes any signal or leader sequence which allows optimal yields; Bn is 1-15
genetically encodable amino acids or a chemical bond; Z is the codon of an amino acid
selected from the group comprising Lys and Arg; Z1 is the codon of an amino acid
selected from the group comprising Lys and Arg; Z2 is the codon of an amino acid
selected from the group comprising Lys and Arg; protein Ym is a DNA sequence
encoding any protein which can be produced and secreted by yeast (m=1-5) or is a
chemical bond (m=0); R is an arginine codon; transport peptide is a DNA sequence
encoding a peptide which can be transported efficiently and which can pass
membranes; protein Y is a DNA sequence encoding any protein which can be
produced and secreted by yeast and whose biological activity, when Ym is not a
chemical bond, is not impaired by a basic dipeptide extension or allows degradation of
the extension by carboxypeptidases; T is an untranslated DNA sequence advantageous
to the expression, and to processes for the production and use thereof.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
KIT FOR DELIVERY OF
BIOCOMPATIBLE MATERIAL
]22[
]31[
08.02.2002
09/788930
]32[ 20.02.2001
09/788943
20.02.2001
Int. Cl.(2009.01) A61B 17/56
ORTHOVITA, INC., U.S.A.
WO/2002/065926
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
154
157486
‫ערכה למתן חומר התואם ביולוגית‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Novel delivery of restorative biocompatible material to intraosseous spaces (64) are
provided comprising accessing a space (64), placing a first aliquot (62) of restorative
material (46) into the space (64), and after a period of time sufficient for first aliquot
(64) to set, placing a second aliquot (71) into the space (64) using kits comprising
cannulae (10)for accessing an intraosseous space (64), mandarins (32) insertable into
the cannulae (10) and movable therein, one or more catheters(13) and a system for the
delivery of aliquots (70,71) of restorative compositions (46) into the space (64) via the
catheters(13).
October 31, 2010-‫כ"ג בחשון התשע"א‬
The applications for division
from this application have
not yet been published
,203779
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
157551
]54[
CCR5 ANTAGONISTS AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME FOR TREATING AIDS
]22[
]31[
]51[
]71[
]87[
]74[
27.03.2002
60/279938
]32[ 29.03.2001
]33[ US
Int. Cl.(2009.01) A61K 31/395, A61P 31/00, C07D 401/14, 409/14
SCHERING CORPORATION, U.S.A.
WO/2002/079194
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
]57[
155
‫ ותכשירים‬CCR5–‫אנטיגוניסטים חדשים ל‬
AIDS–‫רוקחיים המכילים אותם לטיפול ב‬
Compounds of the formula (I) or a pharmaceutically acceptable salt or isomer thereof,
wherein: Q, X and Z are CH or N; R, R4-R7 and R13 are H or alkyl; R1 is H, alkyl,
fluoroalkyl, R9-arylalkyl, R9-heteroarylalkyl, alkyl-SO2-, cycloalkyl-SO2-,
fluoroalkyl-SO2-, R9-aryl-SO2-, R9-heteroaryl-SO2-, N(R22)(R23)-SO2-, alkyl-C(O), cycloalkyl-C(O)-, fluoroalkyl-C(O)-, R9-aryl-C(O)-, NH-alkyl-C(O)- or R9-aryl-NHC(O)-; R2 is H and R3 is H, alkyl, alkoxyalkyl, cycloalkyl, cycloalkylalkyl, R9-aryl,
R9-arylalkyl, R9-heteroaryl, or R9-heteroarylalkyl, and when X and Z are each CH,
R3 is alkoxy, R9-aryloxy, R9-heteroaryloxy, alkylC(O)O-, alkylaminoC(O)O-,
alkylC(O)NR13-, alkylOC(O)NR13- or alkylaminoC(O)NR13-; or R2 and R3 together
are = O, = NOR10, = N-NR11R12 or = CH-alkyl; R8 is substituted phenyl, substituted
heteroaryl, naphthyl, fluorenyl, diphenymethyl, alpha-substituted benzyl or alphaOctober 31, 2010-‫כ"ג בחשון התשע"א‬
substituted heteroarylmethyl; R9-R12 are as defined; are disclosed for the treatment of
HIV, solid organ transplant rejection, graft v. host disease, inflammatory diseases,
atopic dermatitis, asthma, allergies or multiple sclerosis, as well as pharmaceutical
compositions and combinations with antiviral or anti-inflammatory agents.
__________________
]11[]21[
157860
‫ הרכב‬,9,7 ‫תרכובות טטרציקלין מותמרות‬
‫פרמצטי ואריזה מסחרית הכוללים את‬
‫התרכובות ושימוש בתרכובות להכנת תרופה‬
‫לטיפול במצב שמגיב לתרכובות טטרציקלין‬
]54[
7,9-SUBSTITUTED
TETRACYCLINE COMPOUNDS,
PHARMACEUTICAL
COMPOSITIONS AND
COMMERCIAL PACKAGES
COMPRISING SAID COMPOUNDS
AND USE OF SAID COMPOUNDS
IN THE PREPARATION OF A
MEDICAMENT FOR TREATING A
TETRACYCLINE RESPONSIVE
STATE
]22[
]31[
]51[
29.06.2001
60/275620
]32[ 13.03.2001
]33[ US
Int. Cl.(2009.01) A61K 31/65, 31/66, 31/695, A61P 31/04, C07C 235/84, 237/48,
247/16, 251/24, 255/44, 309/38, 311/16, 317/14, 323/22, 327/24, C07D 209/48,
213/82, 215/14, 221/18, 307/24, 311/78, 317/60, 335/04, 403/10, 407/10, C07F 07/10,
09/30, 09/38
PARATEK PHARMACEUTICALS,
INC., U.S.A.
WO/2002/072532
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]71[
]87[
]74[
]57[
156
The present invention pertains to novel 7,9-substituted tetracycline compounds. These
tetracycline compounds can be used to treat numerous tetracycline compoundresponsive states, such as bacterial infections and neoplasms, as well as other known
applications for minocycline compounds in general, such as blocking tetracycline
efflux and modulation of gene expression.
October 31, 2010-‫כ"ג בחשון התשע"א‬
,203884
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
DISSOLVABLE THRUST VECTOR
CONTROL VANE FOR A MISSILE
]22[
]31[
]51[
]71[
]87[
]74[
13.03.2002
804897
]32[ 13.03.2001
Int. Cl.(2009.01) F42B 10/66
RAYTHEON COMPANY, U.S.A.
WO/2002/073118
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
157
157861
‫שבשבת בקרה של ווקטור דחיפה הניתנת‬
‫להמסה עבור טיל‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A dissolvable jet vane (22/30) is a composite structure, having a support frame (38), a
plug leading edge (40) connected to the forward edge (42) of the frame (38), and an
insulation layer (44) on the side walls of the support frame (38). The dissolvable jet
vane materials withstand the pressure and thermal loads associated with missile
steering during the first few seconds of rocket boost until the missile attains sufficient
speed to use conventional external aerodynamic control fins for steering control. Once
control passes to the external fins, the jet vanes rapidly and uniformly dissolve in the
exhaust stream. The dissolvable jet vane provides a lightweight, reliable means of
removing steering jet vanes from the exhaust stream of a solid rocket motor nozzle.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
158189
‫ תוכנה ושיטה לסריקת מטענים מרחוק‬,‫מערכת‬
]54[
REMOTE BAGGAGE SCREENING
SYSTEM, SOFTWARE AND
METHOD
]22[
]31[
]51[
]71[
03.04.2002
60/281068
]32[ 03.04.2001
]33[ US
Int. Cl.(2009.01) G01N 09/00, G01T 01/38, G01V 05/00, G06K 17/00, G06N 05/00
L-3 COMMUNICATIONS SECURITY
& DETECTION SYSTEMS, U.S.A.
WO/2002/082372
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]87[
]74[
]57[
158
A method of advance baggage screening (104, 106) includes steps of transmitting a
threat file (532) corresponding to an item under inspection to a processing center,
analyzing the treat file according to a detection algorithm (530) at the processing
center to determine a screening result for the item under inspection, and transmitting
the screening result to a remotely located operator interface for access by an operator
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
SYSTEM FOR NAVIGATING AND
MANEUVERING OF AN IN VIVO
VEHICLE BY
EXTRACORPOREAL DEVICES
]22[
]31[
08.04.2002
142682
]32[ 18.04.2001
60/331559
19.11.2001
Int. Cl.(2009.01) A61B 19/00
BBMS LTD.
ALEX HAREL, EHUD
KATZNELSON, UZI DAN, ZVI
RAVIV
WO/2002/082979
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]51[
]71[
]72[
]87[
]74[
159
158243
‫מערכת לניווט וניהוג של נשא בתוך הגוף על ידי‬
‫מכשירים חוץ גופיים‬
]33[
IL
US
‫ סביון‬,‫ בע"מ‬.‫אס‬.‫אם‬.‫בי‬.‫בי‬
‫ צבי‬,‫ עוזי דן‬,‫ אהוד כצנלסון‬,‫אלכס הראל‬
‫רביב‬
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
‫רמת גן‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
A device for mobilizing, rotating and maneuvering an in vivo vehicle introduced into a
subject by extracorporeal devices which control the position and motion of such a
vehicle by detection and modulation of the strength and direction of the
electromagnetic field vector of the vehicle. This invention employs a series of pulses,
with specific characteristics over time, to induce magnetic field changes. The changes
that result from the vehicle movement are measured and used to calculate the location
and movement of the vehicle. A system and method for controlling the movement of
the vehicle are also provided.
__________________
]11[]21[
158383
‫שימוש בדסאוקסיפגאנין להכנת תרופה לטיפול‬
‫בסימפטומים של מערכת העצבים הנגרמים‬
‫מהרעלה על ידי פסיכוטרופים‬
]54[
USE OF DESOXYPEGANINE FOR
THE MANUFACTURE OF A
MEDICAMENT FOR TREATING
CENTRAL NERVOUS SYSTEM
SYMPTOMS RESULTING FROM
INTOXICATIONS BY
PSYCHOTROPS
]22[
]31[
]51[
]71[
18.04.2002
10119863.9
]32[ 24.04.2001
]33[ DE
Int. Cl.(2009.01) A61K 31/505, A61P 25/32, C07D 487/04
HF ARZNEIMITTELFORSCHUNG
GMBH, GERMANY
160
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
WO/2002/087553
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
The invention relates to the use of desoxypeganine, as a free base or as an acid
addition salt, for treating cerebral, central nervous or psychiatric symptoms,
deficiencies or disorders, which occur following absorption of psychotropic
substances, resulting from occasional or chronic abuse of drug, narcotic or medicine,
from side effects of normal use according to prescription, especially repeated or
continued use of medicines, or from the effect of use not according to prescription,
especially repeated or continued use of medicines, or resulting from acute intoxication
by toxic psychotropic substances or from chronic influence of toxic psychotropic
substances in humans or other vertebrate animals.
__________________
]11[]21[
158588
]54[
COMPOUND 3 - {(3R, 4R) - 4 METHYL - 3 - [METHYL - (7H PYRROLO [2, 3 - D] PYRIMIDIN - 4
- YL) - AMINO] - PIPERIDIN - 1 YL} - 3 - OXO - PROPIONITRILE
OR A PHARMACEUTICALLY
ACCEPTABLE SALT THEREOF,
PHARMACEUTICAL
COMPOSITONS COMPRISING IT,
AND USE THEREOF IN THE
PREPARATION OF
MEDICAMENTS
]22[
]31[
29.05.2002
60/294775
]32[ 31.05.2001
]33[ US
60/341048
06.12.2001
US
Int. Cl.(2009.01) A61K 31/505, A61P 37/06, C07D 487/04
PFIZER PRODUCTS, INC., U.S.A.
WO/2002/096909
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
161
– ‫ – [מתיל‬3 – ‫ מתיל‬R, 4R) – 43({ – 3 ‫תרכובת‬
– )‫ – יל‬4 – ‫] פירמידינ‬D – 3 ,2[ ‫ – פירולו‬H7(
– ‫ – אוקסו‬3 – }– 1 – ‫אמינו] – פיפרידינ‬
‫פרופיאוניטריל או מלחים רפואיים מקובלים‬
‫ תכשירים רפואיים המכילים אותה‬,‫שלה‬
‫ושימושה בהכנתה תרופות‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
A method for resolving enantiomers of a compound containing the structure of the
formula (I): wherein R4 or R5 may contain one or more asymmetric centers, by mixing
a racemic mixture of enantiomers of a compound, containing the structure of said
formula; in a solvent, with a resolving compound having a defined stereospecificity, to
form a solution and with said resolving agent being capable of binding with at least
one but not all of said enantiomers to form a precipitate, containing said at least one of
said enantiomers in stereospecific form and collecting either the precipitate and
purifying it or collecting the solution with contained other of said enantiomers and
recrystalizing the enantiomer contained in said solution.
__________________
]11[]21[
158618
‫פולינוקליאוטידים לאיפנון תפקוד קרדיאלי‬
‫ופעילות חשמלי‬
]54[
POLYNUCLEOTIDES FOR
MODULATION OF CARDIAC
FUNCTION AND ELECTRICAL
ACTIVITY
]22[
]31[
]51[
29.04.2002
60/287088
]32[ 27.04.2001
]33[ US
Int. Cl.(2009.01) A61K 38/02, 38/17, 48/00, A61P 09/06, C07H 21/00, C07K 14/705,
C12N 15/09, C12Q 01/68
JOHNS HOPKINS UNIVERSITY,
U.S.A.
WO/2002/087419
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]71[
]87[
]74[
]57[
Disclosed are methods and systems for modulating electrical behavior of cardiac cells.
Preferred methods include administering a polynucleotide or cell-based composition
that can modulate cardiac contraction to desired levels, i.e., the administered
composition functions as a biological pacemaker.
__________________
162
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
158984
‫שימוש בירוקת בסינון בעל תפוקה גבוהה‬
]54[
USE OF DUCKWEED IN HIGH
THROUGHPUT SCREENING
]22[
]31[
]51[
]71[
30.05.2002
60/294351
]32[ 30.05.2001
]33[ US
Int. Cl.(2009.01) A01H 01/00, 05/00, C12N 15/82, G01N 33/68
BIOLEX THERAPEUTICS, INC.,
U.S.A.
WO/2002/097433
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]87[
]74[
]57[
Methods for high-throughput screening in duckweed are disclosed. In one aspect, these
methods are used to identify nucleotide sequences encoding polypeptides of interest. In
another aspect, these methods are used to identify nucleotide sequences that modulate
the expression of a target nucleotide sequence. The methods combine the predictive
benefits of screening in whole plants with the speed and efficiency of a high
throughput system.
__________________
]11[]21[
159067
]54[
USE OF 1 A ,24 (S) DIHYDROXYVITAMIN D2 IN THE
MANUFACTURE OF A
MEDICAMENT FOR THE
TREATMENT OF
HYPERPROLIFERATION AND A
PHARMACEUTICAL
COMPOSITION COMPRISING 1A
, 24(S) - DIHYDROXYVITAMIN D2
]22[
]31[
]51[
]71[
26.06.2002
891963
]32[ 26.06.2001
]33[ US
Int. Cl.(2009.01) A61K 31/592, A61P 35/00, C07C 401/00
BONE CARE INTERNATIONAL,
INC., U.S.A.
WO/2003/002110
]87[
163
‫ – דיהידרוקסיוויטמין‬a 1,(S) 24 –‫שימוש ב‬
‫ לייצור תרופות לטיפול בשגשוג יתר ותכשיר‬D2
– a 1,(S) 24 ‫רוקחי המכיל‬
D2 ‫דיהידארוקסיוויטיין‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
A method of inhibiting the hyperproliferation of malignant or neoplastic cells,
comprising treating the cells with an antiproliferative amount of 1-alpha, 24(S)dihydroxyvitamin D2. The method also includes the co-administration of cyotoxic
agents with the 1-alpha, 24(S)-dihydroxyvitamin D2. The figure illustrates the
preparative steps for the synthesis of 24-hydroxyvitamin D2.
__________________
]11[]21[
]54[
164
PHENYLACETAMIDO-THIAZOLE
DERIVATIVES, PROCESS FOR
THEIR PREPARATION AND
THEIR USE IN THE
MANUFACTURE OF
MEDICAMENTS AND
PHARMACEUTICAL
COMPOSITIONS AND KITS
COMPRISING THEM
159570
‫ תהליך להכנתן‬,‫נגזרות פנילאצטמידו–תיאזולי‬
‫ושימושם להכנת תרופות ותכשירים רוקחיים‬
‫וערכות המכילות אותן‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
02.07.2002
907947
]32[ 19.07.2001
]33[ US
60/357642
20.02.2002
US
Int. Cl.(2009.01) A61K 31/427, A61P 25/28, 31/12, 35/00, 37/00, 43/00, C07D
277/44, 417/12
PFIZER ITALIA S.R.L., ITALY
WO/2003/008365
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
Compounds represented by formula (I), as defined in the description, wherein R is a
hydrogen atom or a methyl group and R1 is a group as defined in the specification, or a
pharmaceutically acceptable salt thereof, are disclosed; the said compounds are useful
in the treatment of cell proliferative disorders, e.g. cancer, associated with an altered
cell cycle dependent kinase activity.
The applications for division
from this application have
not yet been published
,204947
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
THERMOELECTRIC MODULE
WITH THIN FILM SUBSTRATES
]22[
]31[
16.04.2002
60/304898
]32[ 12.07.2001
09/998090
29.11.2001
Int. Cl.(2009.01) H01L 35/32
FERROTEC (USA) CORPORATION,
U.S.A.
ROBERT W. OTEY
WO/2003/007391
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]51[
]71[
]72[
]87[
]74[
]57[
165
159707
‫מודול תרמו–חשמלי עם מצעים בעלי שכבה דקה‬
]33[
US
US
,‫ד"ר מרק פרידמן בע"מ‬
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
A flexible thermoelectric module having a pair of flexible substrates, a plurality of
October 31, 2010-‫כ"ג בחשון התשע"א‬
electrically conductive contacts on one side of each of the flexible substrates, and a
plurality of P-type and N-type thermoelectric elements electrically connected between
opposing sides of the pair of flexible substrates having the plurality of conductive
contacts where the plurality of conductive contacts connect adjacdnt P-type and N-type
elements to each other in series and where each of the P-type and N-type elements has
a first end connected to one of the plurality of conductive contacts of one of the
substrates and a second end connected to one of the plurality of electrical contacts of
the other of the substrates.
__________________
]11[]21[
159996
]54[
PHARMACEUTICAL
COMPOSITIONS COMPRISING
EP4 AGONIST FOR TREATMENT
OF DISEASES ASSOCIATED
WITH BONE MASS LOSS, AND
SOME SUCH NOVEL
COMPOUNDS
]22[
]31[
22.07.2002
2001-222148 ]32[ 23.07.2001
]33[ JP
2001-239895
07.08.2001
JP
2002-56449
01.03.2002
JP
Int. Cl.(2009.01) A61K 31/5575, 31/559, 45/06, A61P 19/08, 19/10, C07C 405/00,
C07D 207/22, 207/26, 263/24, 277/12, 401/10, 403/12, 405/12, 409/12, 413/06,
]51[
166
‫ לטיפול‬EP4 ‫תכשירי רוקחות הכוללים אגוניסט‬
,‫במחלות הקשורות לאיבוד מסה של עצם‬
‫ותרכובות חדשות כנ''ל‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]71[
]87[
]74[
]57[
417/00, C07K 05/06
ONO PHARMACEUTICAL CO.,
LTD., JAPAN
WO/2003/009872
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Drugs for topical administration which contain an EP 4 agonist as the active ingredient
for preventing and/or treating diseases in association with bone mass loss. EP4 agonists
typified by compounds with the prostaglandin skeleton have an effect of promoting
osteogenesis. Thus, topical administration thereof is highly useful in preventing
and/or treating diseases in association with bone mass loss (for example, bone
diseases such as primary osteoporosis, secondary osteoporosis, bone metastasis of
cancer, hypercalcemia, Behcet’s disease, bone loss and bone necrosis, postoperative
osteogenesis, alternative therapy for bone transplantation).
__________________
]11[]21[
160080
‫מונה רצפים עבור זרם אודיו ויזואלי‬
]54[
SEQUENCE COUNTER FOR AN
AUDIO VISUAL STREAM
]22[
]31[
]51[
]71[
28.06.2002
60/316373
]32[ 31.08.2001
]33[ US
Int. Cl.(2009.01) G11B 20/10, H04N 05/91, 05/913, 07/16
THOMSON LICENSING S.A.,
FRANCE
WO/2003/021959
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
167
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A conditional access system and method including a first source device and a first sink
device coupled to the first source device, wherein the source device includes a module
for generating sequence counter values and appending the values to content
transmitted from the source device to the sink device.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
FLOW-DIRECTED CATHETER
GUIDE WITH VARIABLE
RIGIDITY SHAFT
]22[
]31[
]51[
]71[
]87[
]74[
31.07.2002
60/309268
]32[ 31.07.2001
Int. Cl.(2009.01) A61M 25/00
AMIR BELSON, U.S.A.
WO/2003/047675
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
168
160137
‫צנתר מדריך מונחה זרם המכיל מוט בעל‬
‫קשיחות משתנה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A flow-directed catheter guide includes a selectively deployable flow-directed member
and a variable rigidity shaft. The variable rigidity shaft can be selectively changed
between a flexible state and a rigid state. The flow-directed member can be deployed
to direct the distal end of the catheter guide downstream following the blood flow in
the vessel.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
160219
‫ תכרישי רוקחות‬,‫תרכובות בנזאמיד‬
‫ תהליך להכנתן‬,‫המכילים אותן‬
‫והשימוש בהן להכנת תרופות וכתרופות‬
‫לטיפול או למניעה של מחלות או מצבים‬
GLK ‫המתווכים על ידי‬
]54[
BENZAMIDE COMPOUNDS,
PHARMACEUTICAL COMPOSITIONS
COMPRISING THEM, PROCDESS FOR THEIR
PREPARATION AND USE THEREOF IN THE
PREPARATION OF MEDICAMENTS AND AS
MEDICAMENTS FOR THE TREATMENT OR
PREVENTION OF DISEASES OR
CONDITIONS MEDIATED THROUGH GLK
]22[
]31[
]51[
15.08.2002
0102764-8
]32[
17.08.2001
]33[
SE
Int. Cl.(2009.01) A61K 31/34, 31/41, 31/425, 31/435, C07D 213/72, 233/48, 285/12,
307/66, 417/12
ASTRAZENECA AB, SWEDEN
RODNEY BRIAN HARGREAVES, CRAIG
JOHNSTONE, MICHAEL HOWARD BLOCK,
CLIFFORD DAVID JONES, DARREN
MCKERRECHER, PETER WILLIAM RODNEY
CAULKETT, SCOTT BOYD, SUZANNE SAXON
BOWKER, ROGER JAMES
WO/2003/015774
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM STREET
31 ‫רחוב אחד העם‬
P.O. BOX 2499
‫תל אביב‬2499 .‫ד‬.‫ ת‬,
TEL AVIV 65202
]71[
]72[
]87[
]74[
]57[
169
The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug
thereof, wherein R1, R2, R3, n and m are as described in the specification, in the preparation
of a medicament for the treatment or prevention of a disease condition mediated through
glucokinase (GLK), such as type 2 diabetes. The invention also relates to a novel group of
compounds of Formula (I) and to methods for preparing compounds of Formula (I).
October 31, 2010-‫כ"ג בחשון התשע"א‬
,203923
The applications for division from
this application have not yet been
published
‫בקשות חלוקה‬
‫מבקשה זו שטרם‬
.‫פורסמו‬
__________________
]11[]21[
160382
–‫–פירידיל‬4 ‫שילובים של סוכן אנטיאנגיואגני‬
‫או‬/‫מתיל–פתאלאזינים ותרכובת פלטינום ו‬
‫ תכשירים‬,‫אנטימטבוליט אנטיניאופלסטי‬
‫רפואיים המכילים אותם ושימושם להכנת‬
‫תרופות לטיפול במחלות פרוליפרטיביות‬
]54[
COMBINATIONS OF A 4PYRIDYLMETHYLPHTHALAZINE
ANTIANGIOGENIC AGENT AND
A PLATINUM COMPOUND
AND/OR AN ANTINEOPLASTIC
ANTIMETABOLITE,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF FOR
THE PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF
PROLIFERATIVE DISEASES
]22[
]31[
11.09.2002
60/331025
]32[ 12.09.2001
]33[ US
60/318694
12.09.2001
US
60/322044
14.09.2001
US
60/388163
12.06.2002
US
Int. Cl.(2009.01) A61K 31/495, 31/4985, 31/555, 45/06, A61P 35/00, C07D 239/22,
401/06, 405/04, 475/08, C07F 17/00
NOVARTIS AG, SWITZERLAND
WO/2003/022282
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
]57[
Patients suffering from renal carcinoma are treated with a 4-pyridylmethyl-phthalazine
anti-angiogenesis agents. Patients having different tumor types, e.g. renal cancer, are
treated with a 4-pyridylmethyl-phthalazine anti-angiogenesis agent while undergoing
chemotherapy.
__________________
170
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
160492
‫תרכובת פוטוראקטיבית המתקשרת ספציפית‬
‫לחלבונים קושרי סידן‬
]54[
PHOTOREACTIVE COMPOUND
SPECIFICALLY BINDING TO
CALCIUM BINDING PROTEINS
]22[
]51[
]71[
19.02.2004
Int. Cl.(2009.01) A61K 51/00, G01N 33/68
VARDA SHOSHAN-BARMATZ
ADRIAN ISRAELSON
]72[
VARDA SHOSHAN-BARMATZ,
ADRIAN ISRAELSON
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A photoreactive azido-ruthenium (AR) compound which binds to a calcium-binding
protein, wherein the molar ratio between ruthenium and azide in said compound is 2:1.
]74[
]57[
‫ עומר‬,‫ברמץ‬-‫ורדה שושן‬
‫שבע‬-‫ באר‬,‫אדריאן ישראלסון‬
‫ אדריאן ישראלסון‬,‫ברמץ‬-‫ורדה שושן‬
__________________
]11[]21[
160571
‫צינור עיבוד מידע עבור שטף מידע‬
]54[
MESSAGE PROCESSING
PIPELINE FOR STREAMS
]22[
]31[
]51[
]71[
25.02.2004
401220
]32[ 26.03.2003
]33[ US
Int. Cl.(2009.01) G06F 13/00, 17/00, H04L 12/56, 29/06
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
171
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
In a messaging system with a given buffer size for sending or receiving massages via
one or more message transports, a method of processing a message that reduces buffer
requirements for at least a portion of the message, thereby allowing the messaging
system to send or receive relatively larger messages using the given buffer size, the
method coprising acts of:
October 31, 2010-‫כ"ג בחשון התשע"א‬
defining one or more message handlers, each identifying a corresponding processing
operation to perform on a message object that comprises at least one streamed portion
having a stream oriented interface;
identifying and ordering one or more message handlers to be included in at least one of
a plurality of message pipelines, at least one of the message pipelines being nested in
another message pipeline; and
calling the one or more message handlers of each message pipeline to process the
message object, wherein at least one message handler wraps the at least one streamed
portion of the message object with its corresponding processing operation which is to
be performed at a future time, without materializing the at least one streamed portion
of the message object in a buffer.
__________________
]11[]21[
160655
‫נגזרות פניל–פיפרזין כמעכבי ספיגה מחדש של‬
‫סרוטונין‬
]54[
PHENYL-PIPERAZINE
DERIVATIVES AS SEROTONIN
REUPTAKE INHIBITORS
]22[
]31[
]51[
02.10.2002
PA200101466 ]32[ 04.10.2001
]33[ DK
Int. Cl.(2009.01) A61K 31/495, 31/551, A61P 25/00, C07D 241/04, 241/36, 243/08,
243/10, 295/096, 405/12, 409/12
H. LUNDBECK A/S, DENMARK
WO/2003/029232
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
]71[
]87[
]74[
]57[
172
The invention provides compounds represented by the general formula I wherein the
substituents are defined in the application. The compounds are useful in the treatment
of an affective disorder, including depression, anxiety disorders including general
anxiety disorder and panic disorder and obsessive compulsive disorder.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
160891
‫מחט עם ערבול אוטומטי‬
]54[
AUTO-MIX NEEDLE
]22[
]51[
]71[
16.03.2004
Int. Cl.(2009.01) A61M 05/20
DAVID DAILY
LIOR RADAY
]74[
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
A pumping, mixing and administering device comprising:
(a) a medicinal enclosure adapter, the medicinal enclosure adapter including a spike
arranged to establish a fluid pathway with the interior of the medicinal enclosure upon
introducing the medicinal enclosure into the medicinal enclosure adapter; the
medicinal enclosure adapter further having a port arranged for receiving a syringe, the
syringe being coupled to or integral with said port; the medicinal enclosure adapter
having a fluid tunnel establishing fluid communication between the interior of the
medicinal enclosure and the syringe; and,
(b) an auto-needle device having a housing, a needle and a needle-shield extending
towards the distal end; said housing comprising a port arranged for receiving a syringe
or the medicinal enclosure adapter spike, the syringe having a barrel coupled to or
integral with said port; said housing port being in fluid communication with a needle,
said needle and needle-shield movably located on said housing; said auto-needle
device being arranged such that upon pressing an activation button and/or when force
is applied to the needle-shield the needle is fired, and after the force is removed the
needle is covered by the needle-shield.
173
‫ הרצליה‬,‫דוד דיילי‬
‫ חוף אשקלון‬.‫נ‬.‫ ד‬,‫ליאור רדאי‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
160918
‫אנלוגים של הימבצין כאנטגוניסטים‬
‫לרצפטור הקושר טרומבין‬
]54[
HIMBACINE ANALOGUES AS THROMBIN
RECEPTOR ANTAGONISTS
]22[
]31[
]51[
]71[
]87[
]74[
16.10.2002
60/330359
]32[
18.10.2001
]33[
US
Int. Cl.(2009.01) A61K 31/4355, A61P 09/00, 19/02, 29/00, C07D 491/04
SCHERING CORPORATION, U.S.A.
WO/2003/033501
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
]57[
174
Heterocyclic-substituted tricyclics of the formula (I) or a pharmaceutically acceptable salts
thereof, wherein: n1 and n2 are independently 0-2; Het is an optionally substituted mono-, bior tricyclic heteroaromatic group; B is alkyl or optionally substituted alkenyl; R22 is -COR23
or a carboxy, sulfinyl, sulfonyl, sulfonamide or amino acid derivative; R23 is haloalkyl;
alkenyl; haloalkenyl; alkynyl; optionally substituted cycloalkyl; cycloalkyl-alkyl; aryl;
arylalkyl; heteroaryl; heterocycloalkyl; or -COOH and/or -SO3H substituted alkyl; R1, R2,
R3, R9, R10 and R11 are as defined in the specification; are disclosed, as well as
pharmaceutical compositions containing them and a method of treating diseases associated
with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart
failure, and cancer by administering said compounds.
October 31, 2010-‫כ"ג בחשון התשע"א‬
,195588
The applications for division from
this application have not yet been
published
‫בקשות חלוקה‬
‫מבקשה זו שטרם‬
.‫פורסמו‬
__________________
]11[]21[
]54[
AUTOMATIC INJECTOR WITH
ANTI-CORING NEEDLE
]22[
]31[
]51[
]71[
04.11.2002
09/985466
]32[ 02.11.2001
Int. Cl.(2009.01) A61M 05/20
MERIDIAN MEDICAL
TECHNOLOGIES, INC., U.S.A.
WO/2003/039633
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
175
161681
‫מזרק אוטומטי בעל מחט נוגדת גרעון‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The automatic injector (100) comprises a cartridge (104) adapted to contain a charge
of medicament, a seal structure (118) disposed toward a forward end of the cartridge, a
plunger (126) normally disposed in a generally rearward end of the cartridge and
movable through the cartridge toward a generally forward end thereof in response to
an actuating procedure. The movable plunger rearwardly confines the medicament
within the cartridge. A needle (130) normally disposed in communication with the
medicament container provides a passage in which the medicament is released into an
individual's flesh in response to an actuating procedure projecting the needle into the
flesh of the individual. The cartridge having an increased friction region (215) so as to
slow the motion of the plunger when the forward end of the needle travels through the
seal in order to eliminate coring.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
SAFETY NEEDLE ASSEMBLY
]22[
]31[
]51[
]71[
]87[
]74[
28.11.2002
PA200101772 ]32[ 30.11.2001
Int. Cl.(2009.01) A61M 05/32
NOVO NORDISK A/S, DENMARK
WO/2003/045480
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
161709
‫מחט עם מנגנון ביטחון‬
]33[
DK
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a safety needle assembly for injecting a fluid into a human
body comprising a cylindrical housing with a bottom surface supporting a needle
cannula and a shield telescopically movable relative to the housing. A spring located
within the housing urges the shield in a distal needle covering direction and a locking
member also provided inside the housing moves simultaneously with the shield during
injection and automatically locks the shield in a position where the sharp end of the
needle cannula is concealed thereby irreversible immobilizing the safety needle
assembly.
__________________
]11[]21[
]54[
176
PROCESS FOR THE PREPARATION
OF 4 - (8 - CHLORO - 5,6 - DIHYDRO
- 11H - BENZO (5,6) - CYCLOHEPTA
- (1,2B)- PYRIDIN - 11 - YLIDENE) - 1
161734
‫ – דיהידרו‬6,5 – ‫ – כלורו‬8( – 4 ‫תהליך להכנת‬
– )B2 ,1( ‫) – ציקלוהפטא‬5 ,6( ‫ – בנזו‬H11 –
‫ – פיפרידין‬1 – )‫ – אילידן‬11 – ‫פירידין‬
)‫חומצה קרביקסילית אתיל אסטר (לורתאדין‬
‫ותרכובות‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
- PIPERIDINECARBOXYLIC ACID
ETHYL ESTER (LORATADINE) AND
SOME NOVEL COMPOUNDS
]22[
]31[
]51[
]71[
]87[
]74[
]57[
29.10.2002
MI2001A002308 ]32[ 05.11.2001
]33[ IT
Int. Cl.(2009.01) C07D 221/16, 401/04, 413/00, 413/04
ZAMBON GROUP S.P.A., ITALY
WO/2003/040140
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A process and new oxazolinic intermediates for the preparation of 4-(8-chloro-5,6dihydro-11H-benzo-[5,6]-cyclohepta-[1,2-b]-pyridin-11-ylidene)-1piperidinecarboxylic acid ethyl ester (loratadine) is described. The process starts from
2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-3-methyl-pyridine, a new intermediate to
obtain loratadine. 2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-3-methyl-pyridine is
condensed with 3-chloro-benzyl-chloride and the resultant product is treated with
Grignard reagent of 4-chloro-N-methyl-piperidine. [3-(2-(3-chloro-phenyl)-ethyl]pyridin-2-yl]-1-(methyl-piperidin-4-yl)-methanone is obtained for subsequent
hydrolysis. Starting from this last compound it is possible to obtain loratadine with
known methods.
__________________
]11[]21[
162025
‫מערכת ראש לעקיבת עין ותצוגה‬
]54[
HEAD MOUNTED EYE
TRACKING AND DISPLAY
SYSTEM
]22[
]51[
]71[
]74[
17.05.2004
Int. Cl.(2009.01) A61B 03/14, F41G 03/00, G02B 27/01
ELBIT SYSTEMS LTD.
‫ חיפה‬,‫אלביט מערכות בע"מ‬
BOROCHOV, KORAKH & CO.,
,'‫בורוכוב קורח ושות‬
15TH FLOOR, ATIDIM TOWER,
‫מגדל כלל עתידים‬
KIRYAT ATIDIM,
‫אביב‬-‫תל‬58100 .‫ד‬.‫ ת‬,
P.O.B. 58100,
TEL AVIV 61580
System for tracking the eye of a user, the system comprisinf:
an image detector, directed at said eye, for detecting an eye image of at least said eye;
]57[
177
October 31, 2010-‫כ"ג בחשון התשע"א‬
at least one pupil-illuminating light source emitting a respective pupil-illuminating
light beam, at least a portion of the optical axis of said image detector, each said pupililluminating light beam at least partially illuminating the pupil of said eye;
at least one reference light source, each said at least one reference light source
emitting a respective reference light beam, for illuminating a portion of the face of
said user; and
an imaging processor, coupled with said image detector, for analyzing said eye image,
wherein at least a portion of each of said at least one pupil-illuminating light beam is
reflected towards said image detector, thereby indicating a pupil region in said eye
image, said pupil region being associated with said pupil,
wherein at least a portion of each of said at least one reference light beam is reflected
towards said image detector, thereby indicating at least one reference region in said
eye image, each said reference region being associated with a recognizable portion of
the face,
wherein said imaging processor identifies said pupil region and at least one of said at
least one reference region, and
wherein said imaging processor determines the line of sight of said user according to
said pupil region and according to at least one of said at least one reference region.
__________________
]11[]21[
162066
‫משקעים לא–נדיפים רב שכבתיים של גטר‬
‫המושגים על ידי השקעה קתודית ותהליך‬
‫לייצורם‬
]54[
NON-EVAPORABLE GETTER
MULTILAYER DEPOSITS
OBTAINED BY CATHODIC
DEPOSITION AND PROCESS FOR
THEIR MANUFACTURE
]22[
]31[
]51[
]71[
19.05.2004
MI2003A001178 ]32[ 11.06.2003
]33[
Int. Cl.(2009.01) B01J 20/32, C23C 14/14, 14/34
SAES GETTERS S.P.A., ITALY
178
IT
October 31, 2010-‫כ"ג בחשון התשע"א‬
]74[
]57[
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A multilayer deposit of non-evaporable getter materials, said multilayer deposit having
an activation temperature not higher than 3000ºC and large surface area, characterized
by comprising at least two layers on a support (10), a first layer (11) directly deposited
over said support being made of a non-evaporable getter material having surface area
equivalent to at least 20 times its geometrical area and, upon said first layer, at least a
second layer (12), having thickness not greater than 1 µm, of a non-evaporable getter
alloy with an activation temperature not higher than 3000ºC, any of said layers being
obtained by cathodic deposition and being made of different materials.
__________________
]11[]21[
162505
‫תכשירים רפואיים והשימוש בהם להכנת‬
‫תרופה לטיפול במחלות של מערכות העצבים‬
‫וכלי הדם ההיקפיים‬
]54[
COMPOSITIONS AND THEIR USE
FOR THE MANUFACTURE OF A
MEDICAMENT FOR TREATING
PERIPHERAL NEURAL AND
VASCULAR AILMENTS
]22[
]31[
]51[
06.11.2002
PCT/US01/49297 ]32[ 19.12.2001
]33[ WO
Int. Cl.(2009.01) A61K 31/07, 31/352, 31/353, 31/375, 31/7048, 38/00, A61P 03/00,
09/00, 17/00, 21/00, 25/00, 29/00, 39/00, C07D 311/00
THE QUIGLEY CORPORATION, U.S.A.
WO/2003/053336
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
]71[
]87[
]74[
]57[
179
Compositions and methods for the treatment of peripheral neural and vascular ailments
are disclosed. The method comprises administering a flavonoid compound with
antioxidant properties, optionally formulated in a pharmaceutically acceptable carrier.
This compound or combination of compounds provides significant, effective relief of
the symptoms of peripheral neural or vascular ailments. In addition, the compositions,
when used according to the methods of the present invention, do not exhibit the severe
side effects of many prior art compositions proposed for treatment of these ailments.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
BLIND FASTENER WITH A BLIND
SIDE HEAD HAVING A CLAMP
SUPPORT AND LOCK SECTION
]22[
]31[
]51[
]71[
04.12.2002
10/034666
]32[ 27.12.2001
Int. Cl.(2009.01) F16B 19/10
HUCK INTERNATIONAL, INC.,
U.S.A.
WO/2003/058078
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
180
162521
‫תפס אטום עם ראש צד אטום בעל תמיכת חבק‬
‫וקטע נעלה‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A two piece blind fastener (10) for securing a plurality of workpieces (20, 22)
including a hollow sleeve (12) having an enlarged sleeve head (26) at one end and a
pin (14) having an enlarged shear ring (46) at the end opposite the sleeve head
followed by an elongated retention portion (48) of reduced diameter. The shear ring is
adapted to engage and move inside the sleeve to form a tuliped shaped blind head in
response to a relative axial force applied between the pin and sleeve and to shear off
proximate to the inner or blind sheet line (64) of the workpieces. The retention portion
is then moved with the pin shank (40) into the shear ring and with the shear ring finally
located at a position on the retention portion depending upon the overall thickness of
the workpieces. This provides a clamp and lock section between the pin and sleeve at
the inner or blind side of the workpieces. The pin and sleeve have a lock structure
actuated after final formation of the clamp and lock section to provide a lock between
the pin and sleeve.
__________________
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
162973
‫מולקולת חוצמצת –גרעין מבודדת‬
]54[
ISOLATED NUCLEIC ACID
MOLECULE
]22[
]31[
]51[
]71[
20.01.2003
02001401.5
]32[ 19.01.2002
]33[ EP
Int. Cl.(2009.01) A61K 38/43, C12N 15/54, C12Q 01/68, G01N 33/68
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2003/060130
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]87[
]74[
]57[
The invention relates to isolated nucleic acid molecules and to host cells comprising
such nucleic acid molecules. Moreover, the invention relates to a polypeptide having
PIM-3, activity and having a definite amino acid sequence, as well as to the use of
PIM-3 as a screening agent for identifying anti-type 2 diabetes mellitus drugs and for
preparing a medicament for the treatment of insulin resistance or type 2 diabetes
mellitus.
,194074
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
163270
]54[
HSP PEPTIDE ANALOG FOR
MODULATION OF IMMUNE
RESPONSES VIA ANTIGEN
PRESENTING CELLS
]22[
]31[
]51[
]71[
]72[
30.01.2003
60/352594
]32[ 31.01.2002
]33[ US
Int. Cl.(2009.01) A61K 38/17, C07K 14/435, 14/47
ANDROMEDA BIOTECH LTD.
DANA ELIAS, YORAM KARMON,
‫ אן אברון‬,‫ יורם כרמון‬,‫דנה אליאס‬
ANN AVRON
181
‫ לויסות תגובות של‬HSP ‫פפטיד–אנלוג של חלבון‬
‫המערכת החיסונית דרך תאים מציגי אנטיגנים‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
WO/2003/063759
WEBB & CO.,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
,'‫ד"ר וב ושות‬
2 ‫רח' פקריס‬
‫רחובות‬2189 .‫ד‬.‫ ת‬,
According to the present invention it is now disclosed that exposure of antigen
presenting cells, particularly dendritic cells, to peptides or peptide analogs derived
from heat shock proteins will subsequently activate T cells to produce
immunomodulatory cytokines and will directly influence the cytokines, chemokines,
and surface antigens produced by the exposed antigen presenting cells. The present
invention relates to peptides and peptide analogs of heat shock proteins capable of
interacting directly with dendritic cells. The present invention further relates to
pharmaceutical compositions comprising dendritic cells exposed to such peptides and
analogs, useful for prevention or treatment of either inflammatory disorders and
autoimmune diseases or malignancies, viral infections and allergy.
__________________
]11[]21[
]54[
COMPOSITIONS COMPRISING
POLYCARBONATES
]22[
]31[
]51[
]71[
24.01.2003
10204524.0
]32[ 05.02.2002
Int. Cl.(2009.01) C08K 03/00
BAYER MATERIALSCIENCE AG,
GERMANY
WO/2003/066720
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
182
163326
‫תכשירים המכילים פוליקרבונטים‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to compositions comprising a polymer selected from the group
polycarbonate, a transparent polycarbonate/polyester blend, a co-polyestercarbonate
and a transparent polyester and ester of branched alcohols and carboxylic acids,
whereby said carboxylic acids have esterified OH functions and objects produced from
said compositions, in particular sheets.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
163477
]54[
ANTI-CD20 ANTIBODIES,
METHODS FOR THEIR
EXPRESSION AND
COMPOSITIONS COMPRISING
THEM
]22[
]31[
14.02.2003
60/356132
]32[ 14.02.2002
]33[ US
60/416232
07.10.2002
US
Int. Cl.(2009.01) C07K 16/18, 16/28, C12N 15/13
IMMUNOMEDICS, INC., U.S.A.
WO/2003/068821
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
‫ שיטות לביטויים‬,CD20 ‫נוגדי נוגדנים‬
‫ותכשירים רוקחיים המכילים אותם‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention provides humanized, chimeric and human anti−CD20 antibodies
and CD 20 antibody fusion proteins that bind to a human B cell marker, referred to as
CD20, which is useful for the treatment and diagnosis of B−cell disorders, such as
B−cell malignancies and autoimmune diseases, and methods of treatment and
diagnosis.
The applications for division
from this application have
not yet been published
,204848,204847,204846
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
163498
‫מדפסת–סורק המופעלת ידנית‬
]54[
MANUALLY OPERABLE
PRINTER-SCANNER
]22[
]31[
]51[
]71[
12.02.2003
PS0486
]32[ 13.02.2002
]33[ AU
Int. Cl.(2009.01) B41J 03/28, 03/36, G06T 01/00, H04N 01/047
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
183
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
WO/2003/069890
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
A portable printer-scanner device (10) includes a printhead arrangement and a scanner
head. A pre-printed image (22) can be scanned by passing the device over it. The
printer-scanner is movable by a user relative to a page (20) to print an image (22)
stored during the scanning operation.
__________________
]11[]21[
163518
‫מערכת ושיטה לזיהוי וחישוב מאפייני מטרה‬
]54[
SYSTEM AND METHOD FOR
TARGET SIGNATURE
CALCULATION AND
RECOGNITION
]22[
]31[
]51[
]71[
14.03.2003
60/364030
]32[ 15.03.2002
]33[ US
Int. Cl.(2009.01) G01S 07/02, 07/41, 13/00, 13/46
LOCKHEED MARTIN
CORPORATION, U.S.A.
RICHARD A LODWIG, BONNIE L.
ADAMS
WO/2003/079041
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]72[
]87[
]74[
]57[
184
,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
The present invention is directed to a system and method for the identification of a
October 31, 2010-‫כ"ג בחשון התשע"א‬
target object in PCL radar applications. The disclosed embodiments describe the
systems and methods used in the identification of a target object from the collection of
data representing specific target object features, such as velocity, altitude, fuselage
length, wing length, or wing sweepback angle, and the comparison of selected target
object features with a database of known aircraft features. The present invention also
provides for the calculation of feature dimensions, such as the fuselage length, wing
length, or wing sweepback angle from measurements associated with a peak signal
lobe as a function of a bistatic aspect angle.
__________________
]11[]21[
]54[
POLYMER COATING FOR
MEDICAL DEVICES
]22[
]31[
]51[
]71[
]87[
]74[
14.02.2003
60/357573
]32[ 15.02.2002
Int. Cl.(2009.01) A61L 31/06, 33/16
GILEAD PALO ALTO, INC., U.S.A.
WO/2003/068289
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
185
163535
‫ציפוי פולימרי להתקנים רפואיים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Coatings are provided in which surfaces may be activated by covalently bonding a
silane derivative (A) to the metal surface, covalently bonding a lactone polymer (B) to
the silane derivative by in situ ring opening polymerization, and depositing at least one
layer of a polyester (C) on the bonded lactone. Biologically active agents may be
deposited with the polyester layers. Such coated surfaces may be useful in medical
devices, in particular stents.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
163696
]54[
HFA-SUSPENSION
FORMULATION OF AN
ANHYDRATE
]22[
]31[
]51[
]71[
20.03.2003
10214264.5
]32[ 28.03.2002
]33[ DE
Int. Cl.(2009.01) A61K 09/00, 09/08, 09/72, 31/33, 31/46, C07D 498/02
BOEHRINGER INGELHEIM
PHARMA GMBH & CO. KG,
GERMANY
WO/2003/082244
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]87[
]74[
]57[
‫ של אנהידראט‬HFA–‫הרכב סוספנסיית‬
The invention relates to propellant formulations containing suspensions of a crystalline
anhydrate of (1alpha,2beta,4beta,5alpha,7beta)-7-[(hydroxydi-2-thienylacetyl)oxy]9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide.
__________________
]11[]21[
]54[
HUMANIZED RS7 ANTIBODIES
]22[
03.03.2003
186
163852
‫ ממקור אנושי‬RS7 ‫נוגדנים‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]31[
]51[
]71[
]87[
]74[
]57[
60/360229
]32[ 01.03.2002
]33[ US
Int. Cl.(2009.01) A61K 39/395, 49/16, 51/10, A61P 35/00, C07K 16/28, 16/30, 19/00,
C12N 15/13
IMMUNOMEDICS, INC., U.S.A.
WO/2003/074566
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
This invention relates to monovalent and multivalent, monospecific binding proteins
and to multivalent, multispecific binding proteins. One embodiment of these binding
proteins has one or more binding sites where each binding site binds with a target
antigen or an epitope on a target antigen. Another embodiment of these binding
proteins has two or more binding sites where each binding site has affinity towards
different epitopes on a target antigen or has affinity towards either a target antigen or a
hapten. The present invention further relates to recombinant vectors useful for the
expression of these functional binding proteins in a host. More specifically, the present
invention relates to the tumor−associated antigen binding protein designated RS7, and
other EGP−1 binding−proteins. The invention further relates to humanized, human and
chimeric RS7 antigen binding proteins, and the use of such binding proteins in
diagnosis and therapy.
__________________
]11[]21[
164048
‫תאי גזע קדמוניים ופרוקסימלים מכבד‬
]54[
PRIMITIVE AND PROXIMAL
HEPATIC STEM CELLS
]22[
]31[
]51[
]71[
14.03.2003
60/365361
]32[ 15.03.2002
]33[ US
Int. Cl.(2009.01) A61K 35/407, C12N 05/08, 05/10
UNIVERSITY OF NORTH
CAROLINA AT CHAPEL HILL,
U.S.A.
VESTA THERAPEUTICS, INC.,
U.S.A.
WO/2003/078588
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
187
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
Hepatic progenitors comprise two populations of human hepatic stem cells, primitive
and proximal hepatic stem cells, and two populations of committed progenitors, one
for biliary cells and one for hepatocytes. Human primitive hepatic stem cells are a very
small fraction of the liver cell population and give rise to proximal hepatic stem cells
constituting a much larger fraction of the liver. Human proximal hepatic stem cells
give rise to biliary and hepatocyte committed progenitors. Primitive and proximal stem
cells are the primary stem cells for the human liver. Human primitive hepatic stem
cells may be isolated by immunoselection from human livers or culturing human liver
cells under conditions which select for a human primitive hepatic stem cell. Proximal
hepatic stem cells may be isolated by immunoselection, or by culturing human liver
cells under conditions which include a developmental factor. Proximal hepatic stem
cells may also be isolated by culturing colonies comprising a primitive hepatic stem
cell under conditions which include a developmental factor. Resulting compositions
may be used for treating liver disorders and for producing bioartificial organs.
__________________
]11[]21[
164247
‫תהליכים להכנת קומברטסטטינים‬
]54[
PROCESSES FOR PREPARING
COMBRETASTATINS
]22[
]31[
]51[
]71[
]87[
]74[
09.04.2003
02/04499
]32[ 11.04.2002
]33[ FR
Int. Cl.(2009.01) C07C 217/54, 237/06, C07D 263/06
AVENTIS PHARMA S.A., FRANCE
WO/2003/084919
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]57[
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
7 ‫רחוב שנקר‬
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
The invention concerns novel methods for preparing combretastatins by Wittig
condensation between nitromethoxy-benzaldehyde and a trimethoxybenzyl
phosphonium salt or inversely a nitromethoxybenzyl phosphonium salt with
trimethoxybenzylaldehyde or further by a Wittig reaction on the same derivatives
whereof the nitro function has been reduced into an amino group.
__________________
188
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
164560
‫מאפנן של נזקי אור לטיפול בנזקי אור הנגרמים‬
UV ‫ע"י‬
]54[
PHOTODAMAGE MODULATOR
FOR TREATING UV
PHOTODAMAGE
]22[
]31[
]51[
]71[
17.04.2003
60/374,033
]32[ 19.04.2002
]33[ US
Int. Cl.(2009.01) A61K 45/00, 45/06, C07D 207/28, 213/62
ARIZONA BOARD OF REGENTS ON
BEHALF OF THE UNIVERSITY OF
ARIZONA, U.S.A.
WO/2003/088909
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention relates to methods for modulating photodamage via the use of collagen
derived molecules which either enhance or inhibit damage caused by ultraviolet light.
,203968
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
DATA MANAGEMENT SYSTEM
]22[
]31[
]51[
]71[
]87[
]74[
29.04.2003
02/05469
]32[ 30.04.2002
Int. Cl.(2009.01) G06F 19/00
PATIENT ON LINE, FRANCE
WO/2003/094085
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
189
164863
‫מערכת לניהול נתונים‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention concerns a data management system, each information concerning a first
entity and having been generated by a second entity. It comprises means (12) for
October 31, 2010-‫כ"ג בחשון התשע"א‬
generating at least one event inseparably assembling in a common elementary data: an
information concerning the first entity, an identifier of the first entity, and an identifier
of the second entity, means (12, 44, 48) for final storage of the content of each event
after validation, each as elementary data in a database (48). Access to an information is
only possible by an entity whereof the identifier is included in the elementary data
containing said information.
__________________
]11[]21[
]54[
CLEANING SYSTEM
]22[
]31[
28.03.2003
200205422-9 ]32[ 09.09.2002
200203246-4
30.12.2002
Int. Cl.(2009.01) F28G 01/12
HYDROBALL TECHNICS
HOLDINGS PTE LTD., SINGAPORE
WO/2003/102487
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]51[
]71[
]87[
]74[
]57[
190
164943
‫מערכת ניקיון‬
]33[
SG
SG
,‫ד"ר מרק פרידמן בע"מ‬
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
A cleaning system for cleaning tubing using cleaning balls (20) circulated with the
fluid through tubing (8). The system includes a separator (12) having a perforated
funnel, which permits the fluid, but not the cleaning balls (20), to pass through. A
housing (21) having an apertured partition (28) is used to divide the housing (21) into
an first compartment (19) and a second compartment (27). An entrance (2) of a fluid
supply pipe (23) and an exit (3) of a ball supply pipe (24) are formed for creating a
difference in pressure to create a suction force to recirculate the cleaning balls (20)
from the housing (21) via the ball supply pipe (24), back to the tubing (8) for cleaning
October 31, 2010-‫כ"ג בחשון התשע"א‬
the walls of the tubing (8). An entrance (13) of a ball return pipe (17) and an exit (14)
of a fluid return pipe (16) are formed for creating a difference in pressure to create a
suction force to recirculate the cleaning balls (20) from the separator (12) via the ball
return pipe (17), into the housing (21).
__________________
]11[]21[
164948
–‫חומרים ושיטה לציפוי משטחים באופן תואם‬
‫דם‬
]54[
COMPOUNDS AND METHOD FOR
COATING SURFACES IN A
HAEMOCOMPATIBLE MANNER
]22[
]31[
15.04.2003
60/378676
]32[ 09.05.2002
]33[ US
10221055.1
10.05.2002
DE
Int. Cl.(2009.01) A61L 31/16, 33/08, C07H 03/06, C08B 37/10, C08L 05/06
HEMOTEQ AG, GERMANY
WO/2003/094990
WEBB & CO.,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
2 ‫רח' פקריס‬
REHOVOT 76121
‫רחובות‬2189 .‫ד‬.‫ ת‬,
]51[
]71[
]87[
]74[
]57[
191
The invention relates to oligo- and polysaccharides containing the sugar structural
element N-acylglucosamine or N-acylgalactosamine, in addition to the use thereof for
producing haemocompatible surfaces and to methods for coating surfaces in a
haemocompatible manner with said oligo- and polysaccharides, which constitute the
common biosynthetic precursor substances of heparin, heparan sulphates and chitosan.
The invention also relates to methods for producing the oligo- and/or polysaccharides,
in addition to diverse application options involving haemocompatible surfaces. The
October 31, 2010-‫כ"ג בחשון התשע"א‬
invention specifically relates to the use of the oligo- and/or polysaccharides on stents
involving at least one haemocompatible coating that has been applied according to the
invention and that contains an anti-proliferative, anti-inflammatory and/or
athrombogenic active ingredient, to methods for producing said stents and to the use of
the latter for preventing restenosis.
__________________
]11[]21[
165330
‫סולפונים ארומטיים ושימושם הרפואי‬
]54[
AROMATIC SULFONES AND
THEIR MEDICAL USE
]22[
]31[
28.05.2003
0212401.4
]32[ 29.05.2002
]33[ GB
0230053.1
23.12.2002
GB
Int. Cl.(2009.01) A61K 31/4035, 31/426, 31/44, 31/47, 31/55, A61P 25/00, C07D
209/44, 217/02, 223/16, 401/12, 405/12, 409/12, 413/12, 417/12
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2003/099786
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
]57[
192
The invention provides compounds of formula (I): wherein A and B represent the
groups -(CH2)m- and -(CH2)n- respectively;R1 represents hydrogen or C1-6alkyl;R2
represents hydrogen, halogen, hydroxy, cyano, nitro, hydroxyC1-6alkyl,
trifluoromethyl, trifluoromethoxy, C1-6alkyl, C1-6alkoxy, C1-6fluoroalkoxy, (CH2)pC3-6cycloalkyl, -(CH2)pOC3-6cycloalkyl, -COC1-6alkyl, -SO2C1-6alkyl, SOC1-6alkyl, -S-C1-6alkyl, -CO2C1-6alkyl, -CO2NR5R6, -SO2NR5R6, (CH2)pNR5R6, -(CH2)pNR5COR6, optionally substituted aryl ring, optionally
substituted heteroaryl ring or optionally substituted heterocyclyl ring;R3 represents
October 31, 2010-‫כ"ג בחשון התשע"א‬
optionally substituted aryl ring or optionally substituted heteroaryl ring;R4 represents
hydrogen, hydroxy, C1-6alkyl, C1-6alkoxy, trifluoromethyl, trifluoromethoxy,
halogen, -OSO2CF3, -(CH2)pC3-6cycloalkyl, -(CH2)qOC1-6alkyl or -(CH2)pOC36cycloalkyl;R5 and R6 each independently represent hydrogen, C1-6alkyl or, together
with the nitrogen or other atoms to which they are attached, form an azacycloalkyl ring
or an oxo-substituted azacycloalkyl ring;Z represents -(CH2)rX- wherein the -(CH2)rgroup is attached to R3, or -X(CH2)r- wherein X is attached to R3, and wherein any of
the -CH2- groups may be optionally substituted by one or more C1-6alkyl groups;X
represents oxygen, -NR7 or -CH2- wherein the -CH2- group may be optionally
substituted by one or more C1-6alkyl groups;R7 represents hydrogen or C1-6alkyl;m
and n independently represent an integer selected from 1 and 2;p independently
represents an integer selected from 0, 1, 2 and 3; q independently represents an integer
selected from 1, 2 and 3; r independently represents an integer selected from 0, 1, and
2; or a pharmaceutically acceptable salt or solvate thereof.The compounds are useful in
therapy, in particular as antipsychotic agents.
__________________
]11[]21[
165434
‫תרכובות אזה – בייסיקלו – אוקטן ונונאן עם‬
DPP–IV ‫פעילות מדכאת של‬
]54[
AZA-BICYCLO - OCTANE AND
NONANE DERIVATIVES WITH
DPP - IV INHIBITING ACTIVITY
]22[
]31[
]51[
11.06.2003
P0202001
]32[ 14.06.2002
]33[ HU
Int. Cl.(2009.01) A61K 31/439, 31/444, 31/496, 31/506, A61P 03/00, 03/10, 13/12,
17/00, 25/18, 25/22, 29/00, 31/18, 35/00, 37/06, 37/08, 43/00, C07D 207/06, 207/16,
263/06, 277/06, 451/04, 451/14
SANOFI-AVENTIS, FRANCE
WO/2003/106456
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
]71[
]87[
]74[
193
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
The present invention relates to the novel compounds of the general formula (I)
possessing DPP-IV inhibitory activity. These compounds contain tropane (B) building
blocks.
__________________
]11[]21[
]54[
DATA MANAGEMENT SYSTEM
FOR EMERGENCY SITUATION
]22[
]31[
]51[
]71[
]87[
]74[
03.06.2003
02/07499
]32[ 18.06.2002
Int. Cl.(2009.01) G06F 19/00
PATIENT ON LINE, FRANCE
WO/2003/107150
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
194
165607
‫מערכת ניהול מידע למקרה חירום‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention concerns a system comprising: at least one database (48) for storing said
data, one identifier of the first entity concerned by each data; and at least one querying
station (36) including means for accessing the databases (48); means for defining
warning data among the data; means (49) for associating an emergency access code
with the warning data. The access means include means for inputting the emergency
access code and means for providing the warning data concerning a first entity without
providing the identifier of the first entity.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
165640
]54[
PROCESS AND APPARATUS FOR
REDUCING THE CONTENT OF
NOX AND N2O IN GASES
]22[
]51[
]71[
]87[
]74[
10.06.2003
Int. Cl.(2009.01) B01D 53/86, B01J 08/02
UHDE GMBH, GERMANY
WO/2003/105998
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]57[
N2O –‫ ו‬NOX ‫תהליך ומתקן להפחתת תכולת‬
‫בגזים‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
7 ‫רחוב שנקר‬
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
The method comprises the following steps: conduction of the gas containing N 2O and
NOx over a series of two catalyst beds consisting of one or more zeolites charged with
iron; addition of a reduction agent for NOx between the catalyst beds; setting of a
temperature of less than 500 °C in the first and second catalyst bed; setting of a gas
pressure of at least 2 bar in the two catalyst beds; and the selection of a space velocity
in the first and second catalyst bed that achieves a degradation of the N2O content of
the gas in the first catalyst bed by a maximum of up to 90 %, in relation to the N 2O
content at the entrance to the catalyst bed and an additional degradation of the N 2O
content of the gas in the second catalyst bed by at least 30 % in relation to the N2O
content at the entrance to the second catalyst bed. The first reaction zone is used to
degrade the N2O and the second reaction zone reduces the NOx and breaks down at
least part of the remaining N2O. The inventive device comprises at least one radially
traversed catalyst bed.
__________________
195
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
165754
,‫תכשירים המכילים דוחי אלומון מאווזים‬
‫שיטות לדחיית עכבישים בשימוש בתכשירים‬
‫אלו ושיטה לטיפול ומניעה קרדית באפרוחים‬
‫בשימוש בתכשירים אלו‬
]54[
COMPOSITION COMPRISING
DUCK REPULSIVE ALLOMONE,
METHOD FOR REPULSING
ARACHNIDS USING SAID
COMPOSITION, AND A METHOD
OF TREATING OR PREVENTING
CHICKEN MITES USING SAID
COMPOSITION
]22[
]31[
19.06.2003
60/389768
]32[ 19.06.2002
]33[
02291533.4
19.06.2002
Int. Cl.(2009.01) A61K 35/00, 35/12, 35/55
FIDELINE, FRANCE
WO/2004/000337
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
US
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Compositions of allomones and kariomones derived from the uropygial gland of ducks
and chickens are described, as well as methods to treat Arachnida.
__________________
]11[]21[
165847
‫שיטת הדמייה רב–גלאית של טומוגרפיה‬
‫ממוחשבת והתקן עם הפחתת פיזור קרינה‬
]54[
MULTIDETECTOR CT IMAGING
METHOD AND APPARATUS
WITH REDUCING RADIATION
SCATTERING
]22[
]31[
]51[
]71[
19.12.2004
748612
]32[ 30.12.2003
]33[ US
Int. Cl.(2009.01) A61B 01/00, G01T 01/00, H01J 35/24
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC,
U.S.A.
SELIGSOHN GABRIELI & CO.,
]74[
196
,'‫זליגסון גבריאלי ושות‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A method for scanning an object to reduce image degradation, said method
comprising:
scanning the object in a helical mode using a multi-slice CT imaging system having a
plurality of detector arrays arranged along a z-axis direction, said z-axis direction
being along a scanning direction of a longitudinal axis of a patient, and a radiation
source having a beam focal spot;
controlling a wobble of the focal spot of the radiation source in the x-axis direction
during said scanning to selectively preferentially illuminate individual said detector
arrays through the scanned object for each view;
collecting data from each said detector array for each view only when the detector
array from which data is being collected is selectively illuminated.
__________________
]11[]21[
165968
‫מפעל בכוח אויר בצינור‬
]54[
DUCTED AIR POWER PLANT
]22[
]31[
27.06.2003
0214961.5
]32[ 28.06.2002
]33[ GB
0301177.2
20.01.2003
GB
Int. Cl.(2009.01) B64C 15/02, 29/00, F02K 01/00
VTOL TECHNOLOGIES LIMITED,
UNITED KINGDOM
WO/2004/002821
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
197
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A ducted air power plant, comprising a motor driven fan (7) situated in a duct (4), the
fan (7) having an air intake side and in operation providing a high pressure air stream
in the duct, and the fan being located adjacent air splitter means (18), the air splitter
means (18) being arranged to divert the air stream into two or more subsidiary streams
for delivery to respective jet nozzles (9) of the plant. The plant may be used in a
vehicle such as an aircraft in order to provide a vertical take-off and hover capability
as well a level flight power source.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
METHODS FOR USE IN DENTAL
ARTICULATION
]22[
]31[
]51[
]71[
14.01.1998
08/935238
]32[ 22.09.1997
Int. Cl.(2009.01) A61C 11/00
3M COMPANY, U.S.A.
CADENT LTD.
]87[
]74[
WO/1999/015100
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]57[
198
166053
‫שיטות לשימוש בארטיקולציה דנטלית‬
]33[
US
‫יהודה‬-‫ אור‬,‫קדנט בע"מ‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
A computer implemented method of creating a dental model for use in dental
articulation includes providing a first set of digital data corresponding to an upper arch
image of at least a portion of an upper dental arch of a patient, providing a second set
of digital data corresponding to a lower arch image of at least a portion of a lower
dental arch of the patient, and providing hinge axis data representative of the spatial
orientation of at least one of the upper and lower dental arches relative to a condylar
axis of the patient. A reference hinge axis is created relative to the upper and lower
arch images based on the hinge axis data. Further, the method may include bite
alignment data for use in aligning the lower and upper arch images. Yet further, the
method may include providing data associated with condyle geometry of the patient,
so as to provide limitations on the movement of at least the lower arch image when the
arch images are displayed. Further, a wobbling technique may be used to determine an
occlusal position of the lower and upper dental arches. Various computer implemented
methods of dental articulation are also described.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
166058
‫ תרופות המכילות‬,‫נגזרות תיאופניל–גליקוסיד‬
‫ שיטות לייצור התרופות‬,‫תרכובות אלו‬
‫ושימושים שלהן‬
]54[
THIOPHENYLGLYCOSIDE
DERIVATIVES, MEDICAMENTS
COMPRISING SAID COMPOUNDS,
PROCESS FOR THE
PRODOCTION OF SAID
MEDICAMENTS AND USE
THEREOF
]22[
]31[
]51[
]71[
27.06.2003
10231370.9
]32[ 11.07.2002
]33[ DE
Int. Cl.(2009.01) A61K 31/7042, A61P 07/00, C07H 17/00
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2004/007517
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
7 ‫רחוב שנקר‬
P.O.B. 12688,
‫הרצליה‬12688 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]87[
]74[
]57[
199
The invention relates to novel thiophenylglycoside derivatives of formula (I), where
the groups have the given meanings, the physiologically-acceptable salts and methods
for production thereof. The compounds are suitable as anti-diabetics for example.
October 31, 2010-‫כ"ג בחשון התשע"א‬
The applications for division
from this application have
not yet been published
,191926
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
PROCESS FORTHE PRODUCTION
OF HIGH-PURITY ENAMINES
]22[
]31[
]51[
]71[
17.07.2003
2002-209623 ]32[ 18.07.2002
Int. Cl.(2009.01) C07C 211/21
DAIICHI SANKYO COMPANY
LIMITED, JAPAN
WO/2004/009530
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
]57[
166196
‫תהליך להכנת אנאמינים בעלי דרגת טיהור גבוה‬
]33[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
A process for the production of compounds represented by the general formula (3) and
having high purity: (3) [wherein R1 is C1-6 alkyl or the like and R2 is hydrogen or the
like, or R1 and R2 may be united to form C1-6 alkylene; and R3 and R4 are each C1-6
alkyl or the like], which comprises the step of reacting a compound represented by the
general formula (1): (1) [wherein R1 and R2 are each as defined above] with a
compound represented by the general formula (2): (2) [wherein R 3 and R4 are each as
defined above] and the step of treating the obtained reaction mixture with acidic water
at 0 to 30°C.
__________________
200
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
166311
]54[
SYSTEM AND METHOD FOR THE
TRANSMISSION, STORAGE AND
RETRIEVAL OF
AUTHENTICATED DOCUMENTS
]22[
]31[
17.07.2003
60/397178
]32[ 18.07.2002
]33[
10/620817
16.07.2003
Int. Cl.(2009.01) G06Q 20/00, H04L 09/32
EORIGINAL, INC., U.S.A.
WO/2004/010271
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
]57[
201
‫ איחסון ושיזור של‬,‫מערכת ושיטה לשידור‬
‫מסמכים מאומתים‬
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
Certificate Status Service that is configurable, directed, and able to retrieve status from
any approved Certification Authority (CA) is disclosed. The CSS may be used by a
Trusted Custodial Utility (TCU) and comparable systems or applications whose roles
are validating the right of an individual to perform a requisite action, the authenticity
of submitted electronic information objects, and the status of authentication certificates
used in digital signature verification and user authentication processes. The validity
check on authentication certificates is performed by querying an issuing CA.
Traditionally, to create a trusted Public Key Infrastructure (PKI) needed to validate
certificates, complex relationships are formed by cross- certification among CAs or by
use of PKI bridges. The PKI and CA interoperability problem is addressed from a
different point of view, with a focus on establishing a trust environment suitable for
the creation, execution, maintenance, transfer, retrieval and destruction of electronic
original information objects that may also be transferable records (ownership may
change hands). A TCU is concerned only with a known set of 'approved CAs' although
they may support a multitude of business environments, and within that set of CAs,
only with those certificates that are associated with TCU user accounts. Building
PKI/CA trusted relationships is not required as the CSS achieves a trusted environment
by querying only approved CAs and maintaining caches of valid certificates' status.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
166383
‫תכשיר רוקחי פומי בצורת מספר רב של‬
‫מיקרוקפסולות לשיחרור מוארך של חומר פעיל‬
‫בעל מסיסות נמוכה‬
]54[
ORAL PHARMACEUTICAL
FORMULATION IN THE FORM
OF A PLURALITY OF
MICROCAPSULES FOR
PROLONGED RELEASE OF
ACTIVE PRINCIPLE(S) WITH
LOW SOLUBILITY
]22[
]31[
]51[
]71[
28.07.2003
02.09532
]32[ 26.07.2002
]33[ FR
Int. Cl.(2009.01) A61K 09/00, 09/50, 09/52, 09/56
FLAMEL TECHNOLOGIES,
FRANCE
WO/2004/010983
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention concerns microcapsules with prolonged release of active principles with
low solubility, consisting of a core containing the active principle and coated with a
polymer layer which controls the release of the active principle. The aim is that said
oral microcapsules containing hardly soluble active principles, should have a coating
film of sufficient thickness to ensure controlled permeability and should be adapted to
industrial reproduction. This is achieved by the inventive microcapsules of mean
diameter less than 1000 microns, and whereof the coating film contains a film-forming
polymer (P1) insoluble in gastrointestinal tract fluids, a water-soluble polymer (P2), a
plasticizer (PL), and optionally a lubricating surfactant (TA). Said microcapsules are
characterized in that their coating films represents at least 3 % p/p of dry matter,
relative to their total weight and their core contains a hardly soluble active principle
and a solubilizing agent (polyoxyethylene hydrogenated castor oil) which provides the
core wherein it is contained with properties such that the behaviour of the exposed core
(non-coated) in a given dissolving test (TD), is as follows: release of 80 % of active
principle in less than two hours. The invention also concerns the use of such
microcapsules in galenic formulation.
__________________
202
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
166404
‫ ייצורן‬,6 ‫תולדות אינדוליניות מותמרות בעמדה‬
‫והשימוש בהן כתרופות‬
]54[
INDOLINE DERIVATIVES
SUBSTITUTED IN POSITION 6,
PRODUCTION AND USE
THEREOF AS MEDICAMENTS
]22[
]31[
22.07.2003
10233366.1
]32[ 23.07.2002
]33[ DE
10328533.4
24.06.2003
DE
Int. Cl.(2009.01) A61K 31/404, A61P 35/00, C07D 209/34, 403/12
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH,
GERMANY
WO/2004/009547
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]51[
]71[
]87[
]74[
]57[
The invention relates to indoline derivatives substituted in position 6 of general
formula (I) wherein R1 - R6 and X are defined in Claim 1, the tautomers, enantiomers
thereof, the mixtures and salts thereof, especially physiologically compatible salts
which have valuable pharamaceutical properties, especially an inhibiting effect on
various receptor tyrosine kinases and on the proliferation of enthethelial cells and
various tumor cells, medicaments containing said compounds, the use thereof and a
method for the production thereof.
__________________
]11[]21[
]54[
203
POLYSACCHARIDE OF
ECHINACEA ANGUSTIFOLIA
166554
‫פוליסכריד של אכינציאה אנגוסטיפוליה‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
26.06.2003
MI2002A001692 ]32[ 30.07.2002
]33[
Int. Cl.(2009.01) A61K 31/715, C08B 37/00
INDENA S.P.A., ITALY
WO/2004/014958
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
IT
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a polysaccharide of Echinacea angustifolia roots,
having molecular weight of 1.3 x 105 Da and consisting of rhamnose, arabinose,
galactose and galacturonic acid in ratio 0.5:2.5:1.75:10.25. The polysaccharide is
recovered from spontaneous or cultivated Echinacea angustifolia roots by means of a
process comprising the following steps: a) depriving the roots of non polysaccharidic
constituents by extraction with solvent; b) extracting the polysaccharidic fraction from
the roots as directly obtained from the preceding step; c) isolating the polysaccharide
by chromatography of the polysaccharidic fraction. Due to its immune-stimulating
properties, the polysaccharide can be used for the preparation of medicaments, food
supplements' or nutraceutical compositions to administer whenever it is desirable to
strenghthen the immune system body defenses.
__________________
]11[]21[
]54[
APPARATUS AND METHOD FOR
CONTROLLING AERIAL
REFUELING HOSE
]22[
]31[
]51[
]71[
]87[
]74[
03.08.2002
10/199134
]32[ 22.07.2002
Int. Cl.(2009.01) B64D 37/00, 39/00
ASHER BARTOV, U.S.A.
WO/2004/016505
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]57[
204
166573
‫מתקן ושיטה לבקרה של זרנוק לתדלוק אווירי‬
]33[
US
,‫ד"ר מרק פרידמן בע"מ‬
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
The invention is a variable displacement hydraulic motor-controlled hose reel drive
system (10) for aerial refueling of a receiver aircraft from a tanker aircraft. The system
includes a variable displacement hydraulic motor (26), a tachometer (34), position
October 31, 2010-‫כ"ג בחשון התשע"א‬
sensor (34), a reaction torque sensor (36) and a microprocessor (29) which, depending
upon data received from the system's position and reaction torque sensors, sends
appropriate signals to the motor. The invention is also a method for deploying a hose
and drogue so as to reduce the likelihood that the hose (22) would go into oscillation
after initial engagement of a receiver aircraft's probe with the drogue (24). In an
embodiment of the invention, the hose (22) is retracted prior to hook up of the probe
and drogue (24), and the force required to retract the hose (22) is recorded. After initial
engagement of the probe with the drogue (24), the hose (22) is retracted until the force
required to retract the hose rises to about the same force previously recorded.
__________________
]11[]21[
]54[
METHOD OF WELDING, BY
USING FOR EXAMPLE FRICTION
STIR WELDING, SURFACES
WITH POLYMERS SEALANT AND
WELDED STRUCTURE
]22[
]31[
]51[
]71[
05.08.2003
60/402505
]32[ 07.08.2002
Int. Cl.(2009.01) B23K 20/12, 31/02
ECLIPSE AVIATION
CORPORATION, U.S.A.
WO/2004/014593
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
]57[
205
166643
‫שיטות ריתוך על ידי השימוש לדוגמה בריתוך‬
‫ ' שטחים עם פולימרי איטום‬STIR ‫חיכוך‬
‫ומבנה מרותך‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
An assembly (10), such as an aircraft component, is formed with a weld joint by, for
example, using friction stir welding, (FSW), to form a lap joint between a stiffer (14)
and the interior surface of the skin of the component (12). A sealant layer (24), such as
a monomer sealant/adhesive is applied to the surfaces to be joined, and is cured in
place by the elevated temperatures of the welding process to form an elastomeric fay
October 31, 2010-‫כ"ג בחשון התשע"א‬
surface sealing, such as a fluoroelastomeric coating, to protect the component (12)
from corrosion at the welds (16, 18). Additional heat for curing may be applied by
laser (30) or induction heating (30) or the like.
__________________
]11[]21[
166813
‫תרשים מבוסס על תג להספקת מידע במערכת‬
‫הספקת מידע מעודכנת‬
]54[
TAG-BASED SCHEMA FOR
DISTRIBUTING UPDATE
METADATA IN AN UPDATE
DISTRIBUTION SYSTEM
]22[
]31[
]51[
]71[
10.02.2005
799440
]32[ 12.03.2004
]33[ US
Int. Cl.(2009.01) G06F 09/445, H04L 29/06, 29/08
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
206
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A computer-implemented method for communicating update metadata
corresponding to a software update to a client computer, the method comprising:
with a computer, receiving a synchronization request from a client computer for
information regarding a software update corresponding to a software product, and
responsive to the synchronization request:
determining whether a software update is available for the software product;
generating a tag-based data structure storing metadata corresponding to a software
update available for installation on the client computer, the tag-based data
structure comprising:
a relationship element storing metadata identifying relationships the software
update has to other software updates, the relationship element including bundle
information that identifies a plurality of software updates that must be installed
coextensively, wherein the plurality of software updates are joined together with
October 31, 2010-‫כ"ג בחשון התשע"א‬
Boolean operators into a logical statement, such that evaluation of the logical
statement determines the suitability of the plurality software updates for
installation on the client computer; and
at least one additional element of the following tag-based elements:
a property element storing metadata identifying general properties relating to the
software update including update handler information identifying an update
handler for installing the identified software update on the client computer;
a localized property element storing metadata identifying language specific
information directed to a computer user relating to the software update;
a rule element storing metadata identifying rules for determining the applicability
of the software update to a client computer;
a file element storing metadata identifying the identified software update's payload
and information relating to the software update's payload; and
a handler element storing metadata identifying information for executing the
update handler identified in the property elements for installing the identified
software update on the client computer; and
providing the tag-based data structure to the client computer.
__________________
]11[]21[
166907
‫מערך משרן המשתמש בסימטרית מדרגה עבור‬
‫משרנים‬
]54[
INDUCTOR LAYOUT USING STEP
SYMMETRY FOR INDUCTORS
]22[
]31[
15.02.2005
60/550000
]32[ 03.03.2004
]33[ US
10/836160
29.04.2004
US
Int. Cl.(2009.01) H01L 27/00
ATHEROS COMMUNICATIONS,
INC.
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A differential circuit layout can advantageously use step symmetry for inductors and
mirror symmetry for the rest of the circuit, interconnect segments can be used to
connect the terminals of the inductors to other components in the circuit. These
interconnect segments facilitate the transition from the step symmetry of the inductors
to the mirror symmetry of the other components. To provide this transition, the
terminals of an inductor and its associated interconnect segments are formed on a
middle axis of the inductor. This mixed symmetry can advantageously cancel the
common-mode magnetic field, reduce the parasitic inductor coupling, and balance
parasitic wiring capacitances between the two sides of the differential circuit.
]51[
]71[
]74[
]57[
207
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
METHOD AND DEVICE FOR THE
TRANSMISSION OF
NOTIFICATIONS
]22[
]31[
]51[
]71[
]87[
]74[
15.08.2003
10238345.6
]32[ 16.08.2002
Int. Cl.(2009.01) G06F 17/30
DEUTSCHE POST AG, GERMANY
WO/2004/019242
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]57[
166913
‫שיטה והתקן להעברת הודעות‬
]33[
DE
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
The invention relates to a method for the transmission of notifications. According to
the invention the method is characterised in that data from at least one data bank is
transmitted to a central dispatch centre, converted there into notification information
and the notification information transmitted to a communication interface and from the
communication interface onto one or several receiver devices. The invention further
relates to a logistic system suitable for application to the method.
__________________
]11[]21[
]54[
208
LIQUID STABLE COMPOSITION
OF OXAZAPHOSPHORINE WITH
MESNA
167228
‫תרכובת נוזל יציבה של‬
MESNA ‫ עם‬OXAZAPHOPHORINE
October 31, 2010-‫כ"ג בחשון התשע"א‬
]22[
]31[
]51[
]71[
]72[
]87[
]74[
]57[
04.09.2003
809/MUM
]32[ 05.09.2002
]33[ IN
Int. Cl.(2009.01) A61K 09/00, 31/185, 31/675, 31/724, A61P 35/00
BHARAT SERUMS AND VACCINES
LTD., INDIA
GAUTAM VINOD DAFTARY,
SRIKANTH ANNAPPA PAI,
SANGEETA HANURMESH
RIVANKAR, KUMAR SUBBAPPA
PRAVEEN
WO/2004/022699
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A low toxicity, stable oxazaphosphorine containing compositions with mesna for
parenteral administration has been described. The process essentially requires addition
of an oxazaphosphorine antineoplastic to the aqueous solution of an etherified bcyclodextrin followed by addition of mesna as such or as an aqueous solution
containing optionally, an etherified b-cyclodextrin. Preferably, the oxazaphosphorine
antineoplastic is Ifosfamide and the etherified b-cyclodextrin is 2-hydroxypropyl-bcyclodextrin.
__________________
]11[]21[
]54[
METHOD AND APPARATUS FOR
IMPROVING RADIO LOCATION
ACCURACY
]22[
]31[
17.10.2003
60/433055
]32[ 13.12.2002
10/418799
18.04.2003
60/419680
17.10.2009
Int. Cl.(2009.01) G01S 05/14
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/036240
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
209
167438
‫שיטה ומתקן לשיפור דיוק של מיקום רדיו‬
]33[
US
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
A method and apparatus to utilize a set of measurements (either partial or compete) to
improve the accuracy of an initial position estimate for a wireless terminal. The initial
position estimate for the terminal is first obtained (e.g., based on a cell-ID or an
enhanced cell-ID solution). Measurements are obtained for the terminal. The initial
position estimate is then updated with the measurements to obtain a revised position
estimate for the terminal. The updating may be performed by (1) deriving a
measurement vector based on the initial position estimate and the measurements, (2)
forming an observation matrix for the measurements, (3) determining a matrix of
weights, (4) deriving a correction vector based on the measurement vector, the
observation matrix, and the weight matrix, and (5) updating the initial position
estimate with the correction vector.
__________________
]11[]21[
]54[
MULTI-MODE TERMINAL IN A
WIRELESS MIMO SYSTEM WITH
SPATIAL MULTIPLEXING
]22[
]31[
24.10.2003
60/421309
]32[ 25.10.2002
10/693535
23.10.2003
Int. Cl.(2009.01) H04L 01/00
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/038985
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
210
167442
‫ אלחוטית‬MIMO ‫טרמינל רב–אופנים במערכת‬
‫עם מלטיפלקס מרחבי‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A user terminal supports multiple spatial multiplexing (SM) modes such as a steered
mode and a non-steered mode. For data transmission, multiple data streams are coded
and modulated in accordance with their selected rates to obtain multiple data symbol
streams. These streams are then spatially processed in accordance with a selected SM
mode (e.g., with a matrix of steering vectors for the steered mode and with the identity
matrix for the non-steered mode) to obtain multiple transmit symbol streams for
transmission from multiple antennas. For data reception, multiple received symbol
streams are spatially processed in accordance with the selected SM mode (e.g., with a
matrix of eigenvectors for the steered mode and with a spatial filter matrix for the nonsteered mode) to obtain multiple recovered data symbol streams. These streams are
demodulated and decoded in accordance with their selected rates to obtain multiple
decoded data streams.
October 31, 2010-‫כ"ג בחשון התשע"א‬
The applications for division
from this application have
not yet been published
,202480
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
LOADING LEDGE
]22[
]31[
]51[
]71[
15.09.2003
0202779-5
]32[ 18.09.2002
Int. Cl.(2009.01) B65D 19/18, 19/40
INTER IKEA SYSTEMS B.V., THE
NETHERLANDS
WO/2004/026713
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
]57[
211
167481
‫מדף עמיסה‬
]33[
SE
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
The present invention concerns a loading ledge (1) to be used e.g. in transport and
storing and a system for creation of load units. The loading ledge (1) has an upper leg
(4) and a lower leg (2) forming a substantially L-shaped cross-section. The lower leg
(2) is furnished with one or more projections (3), to make it possible to use handling
equipment. One or more locking means (5) are integrated in the loading ledge (1) to
grip straps or the like. A load unit is created in that two or more loading ledges (1) are
used together with straps to fixate the goods (19) on the loading ledges (1).
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
‫מתקן לחקלאות פירות–ים‬
]54[
DEVICE FOR SHELLFISH
FARMING
]22[
]31[
]51[
]71[
17.10.2003
20025122
]32[ 25.10.2002
Int. Cl.(2009.01) A01K 61/00
TORMOD DRENGSTIG, NORWAY
ASBJORN DRENGSTIG, NORWAY
IVAR KOLLSGARD, NORWAY
]87[
]74[
WO/2004/036987
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]57[
167510
]33[
NO
,‫ד"ר מרק פרידמן בע"מ‬
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
Device for cage (1) for shellfish farming, where the cage is placed in the sea or in a
tank with water and where the cage's one side (11) is provided with openings, for
instance a grid (13) and where the cage's other sides (3, 5, 7, 9) preferably are closed
and where the cage (1) is arranged so it can be turned so that said one side provided
with openings (11) faces upwards in a vertical feeding position, or faces sideways in a
horizontal eating and resting position, or faces downwards in a vertical emptying
position, as these positions are achieved by means of the fish farming cage (1) being
placed on or by a transporter (25, 55).
__________________
212
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
]54[
PROPELLANT SYSTEM FOR A
PROJECTILE
]22[
]31[
]51[
]62[
]71[
02.12.1999
09/206085
]32[ 04.12.1998
Int. Cl.(2009.01) F42B 05/16
DIVISION FROM 143500
BAE SYSTEMS LAND AND
ARMAMENTS L.P., U.S.A.
WO/2000/039520
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
167926
‫מערכת הדף עבור קליע‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention provides an improved propellant system for firing projectiles (12) in
large caliber guns. Strips (50, 51, 52, 53) of energetic propellant are placed in the
cartridge case (11) so that the lengths of the strips are parallel to the length of the
cartridge. Preferably, the strips are placed in a radially symmetric pattern. The strips
provide passageways that allow ignition gases to flow radially in the cartridge case and
along the length of the cartridge case.
__________________
]11[]21[
]54[
METHOD OF REDUCING NEAREND CROSSTALK IN AN MXU
NETWORKING ARCHITECTURE
]22[
]31[
]51[
]71[
09.10.2003
10/272881
]32[ 17.10.2002
Int. Cl.(2009.01) H04J 03/06
COPPERGATE COMMUNICATIONS
213
167973
‫שיטה להפחתת העברה של מידע ממשדר‬
‫למקלט בטווח קצר ברשת תקשורת ביתית‬
]33[
US
‫ תל אביב‬,‫קופרגייט תקשורת בע"מ‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
LTD.
WO/2004/036761
BOROCHOV, KORAKH & CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
,'‫בורוכוב קורח ושות‬
‫מגדל כלל עתידים‬
‫אביב‬-‫תל‬58100 .‫ד‬.‫ ת‬,
HPNA MXU network (200) for an MxU including a plurality of HPNA LANs (1151115N), each operating according to a synchronous communication specification, each
including a plurality of nodes, one of the nodes being a gateway node (122 1-122N), a
selected one of the nodes within each HPNA LAN being defined a LAN-master-node,
each HPNA LAN being coupled with a WAN (120) via the respective gateway node,
wherein communication lines (124a-124n) within the HPNA LANs, directly coupled to
the gateway nodes, are at least partially bound together (118), wherein the transmission
direction within a selected HPNA LAN, by the respective gateway node, is defined
downstream wherein the transmission direction within a selected HPNA LAN,
between nodes other than the respective gateway nodes
The applications for division
from this application have
not yet been published
,200963
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
METHOD FOR PREPARING A
DEVICE STRUCTURE HAVING A
WAFER STRUCTURE DEPOSITED
ON A COMPOSITE SUBSTRATE
HAVING A MATCHED
COEFFICIENT OF THERMAL
EXPANSION
]22[
16.04.2004
214
168120
‫שיטה להכנת מבנה התקן המכיל מבנה פרוסת‬
‫סיליקון הנתונה על סובסטראט מרוכב המכיל‬
‫מקדם מתואם להתפשטות בחום‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]31[
]51[
]71[
]87[
]74[
]57[
10/418870
]32[ 18.04.2003
Int. Cl.(2009.01) H01L 21/20
RAYTHEON COMPANY, U.S.A.
WO/2004/095554
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A wafer structure is deposited on a composite substrate structure having at least two
substrate layers bonded together. A first substrate layer is made of a first substrate
material having a first-substrate-layer material transverse coefficient of thermal
expansion, greater than the wafer transverse coefficient of thermal expansion, and a
second substrate layer is made of a second substrate material having a secondsubstrate-layer material transverse coefficient of thermal expansion, measured parallel
to the transverse direction, less than the wafer transverse coefficient of thermal
expansion. The substrate layers are present in relative proportions such that the
substrate transverse coefficient of thermal expansion differs from the wafer transverse
coefficient of thermal expansion by not more than about 2 x 10 -6/°F.
__________________
]11[]21[
168222
‫מעבד וויסות סיגנליים כשכבות בעל מורכבות‬
‫נמוכה‬
]54[
LOWER COMPLEXITY LAYERED
MODULATION SIGNAL
PROCESSOR
]22[
]31[
]51[
]71[
]87[
]74[
10.10.2003
60/421331
]32[ 25.10.2002
]33[ US
Int. Cl.(2009.01) H03F 01/32, H04B 07/185, 17/00, H04L 27/20, 27/34
THE DIRECTV GROUP, INC., U.S.A.
WO/2004/040403
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
215
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
A method and apparatus for transmitting and receiving a coded signal having an upper
layer signal (130) and a lower layer signal (1312) is disclosed. The method comprises
the steps of combining the upper layer signal and the lower layer signal, encoding the
combined upper layer signal and lower layer signal, delaying the upper layer signal,
modulating the delayed upper layer signal, modulating the lower layer signal,
transmitting the delayed upper layer signal and transmitting the lower layer signal. The
apparatus comprises an encoder (1301), for encoding a combined upper layer signal
and lower layer signal, a delay communicatively coupled to the encoder, for delaying
the upper layer signal, a first modulator, for modulating the upper layer signal, a
second modulator, for modulating the lower layer signal, a transmitter (1314),
communicatively coupled to the first modulator, for transmitting the delayed upper
layer signal, and a second transmitter (13, 16), communicatively coupled to the second
modulator.
__________________
]11[]21[
168223
–‫הערכת נקודת הפעלה במגבר צינור גל נוסע לא‬
‫קווי‬
]54[
ESTIMATING THE OPERATING
POINT ON A NONLINEAR
TRAVELING WAVE TUBE
AMPLIFIER
]22[
]31[
17.10.2003
60/421289
]32[ 25.10.2002
]33[ US
60/510368
10.10.2003
US
Int. Cl.(2009.01) H01J 25/20, H03F 03/58, H04B 07/185
THE DIRECTV GROUP, INC., U.S.A.
WO/2004/040406
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
]57[
216
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method, apparatus, article of manufacture, and a memory structure provide the
October 31, 2010-‫כ"ג בחשון התשע"א‬
ability to determine an input operating point and an output operating point on a nonlinear traveling wave tube amplifier (TWTA). The non-linearity of the TWTA is
measured (1302). An input roots mean-square (RMS) value of an input signal used to
measure the non-linearity of the TWTA is computed (1304). The RMS value identifies
an input operating point of the measured non-linearity of the TWTA. Lastly, an output
operating point is obtained (1306).
__________________
]11[]21[
168226
‫התאמת שיפעה ופאזה עבור קליטת וויסות‬
‫בשכבות‬
]54[
AMPLITUDE AND PHASE
MATCHING FOR LAYERED
MODULATION RECEPTION
]22[
]31[
]51[
]71[
]87[
]74[
03.10.2003
60/421332
]32[ 25.10.2002
]33[ US
Int. Cl.(2009.01) H04B 03/04, 07/212, H04L 27/06, H04N 05/76
THE DIRECTV GROUP, INC., U.S.A.
WO/2004/040806
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]57[
217
An apparatus and method for receiving layered modulation signals is disclosed. A
typical method includes receiving a layered modulation signal (602) including an
upper layer signal and a lower layer signal, demodulating and decoding (604) the
upper layer signal from the received layered modulation signal, estimating an upper
layer amplitude factor and an upper layer phase factor (618) from the received layered
modulation signal. A substantially ideal upper layer signal is reconstructed from the
demodulated and decoded upper layer signal including matching an ideal amplitude
and an ideal phase (620) by applying the upper layer amplitude factor and the upper
layer phase factor to the reconstructed ideal upper layer signal. Finally, the
reconstructed ideal upper layer signal is subtracted from the received layered
October 31, 2010-‫כ"ג בחשון התשע"א‬
modulation signal (622) to produce the lower layer signal for processing.
__________________
]11[]21[
168230
‫שיטה ומתקן להתאמה מחויטת של דרישות כוח‬
‫להעברה לפי זמינות במערכות וויסות עם שכבות‬
]54[
METHOD AND APPARATUS FOR
TAILORING CARRIER POWER
REQUIREMENTS ACCORDING
TO AVAILABILITY IN LAYERED
MODULATION SYSTEMS
]22[
]31[
]51[
]71[
]87[
]74[
15.10.2003
60/421333
]32[ 25.10.2002
]33[ US
Int. Cl.(2009.01) H04B 07/185, H04L 27/34, 27/36
THE DIRECTV GROUP, INC., U.S.A.
WO/2004/040924
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
218
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A method and apparatus transmitting a layered modulation signal having a first signal
layer having first signal symbols and a second signal layer having second signal
symbols is disclosed. The method comprises the steps of determining a first signal
layer modulation carrier power CL at least in part according to a first signal layer clear
sky margin ML and a first signal layer availability, determining an second signal layer
modulation carrier power CU at least in part according to an second signal layer clear
sky margin MU and an second signal layer availability, modulating the first signal
symbols according to a first carrier at the determined first signal layer modulation
carrier power; modulating the second signal symbols according to a second carrier at
the determined second signal layer modulation carrier power, and transmitting the two
layers independently.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
METHOD FOR IDENTIFICATION
OF A PERSON BY RECOGNITION
OF DIGITAL FINGERPRINT
]22[
]31[
]51[
]71[
]87[
]74[
03.11.2003
02/14030
]32[ 08.11.2005
Int. Cl.(2009.01) G06K 09/00
SAGEM SECURITE, FRANCE
WO/2004/044826
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
168406
‫שיטה לזיהוי אדם באמצעות הכרה של טביעת‬
‫האצבע האלקטרונית‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method for identification of a person by recognition of a
digital fingerprint, whereby the characteristic points on a digitised image of a digital
fingerprint (E) are determined and transmitted (16) to a bank holding (17) the
characteristic points of a number of digital fingerprints for comparison and
identification (18) of the person to whom the photographed fingerprint belongs. When
the fingerprint (E) is taken on a curved surface (3) of an object (12), the digitised mage
is transformed (13) into a plane-projection corrected digitised image, by means of an
algorithm, in which the characteristic points are detected (15).
__________________
]11[]21[
219
168737
October 31, 2010-‫כ"ג בחשון התשע"א‬
]54[
USE OF PPAR ALPHA AGONIST,
METFORMIN AND
PHARMACEUTICAL
ACCEPTABLE CARRIER, FOR
THE PREPARATION OF
MEDICAMENTS FOR TREATING
OBESITY
]22[
]31[
]51[
]71[
26.11.2003
02292940.0
]32[ 28.11.2002
]33[ EP
Int. Cl.(2009.01) A61K 31/155, 31/192, 45/06, A61P 03/04, C07C 281/00
FOURNIER LABORATORIES
IRELAND LIMITED, IRELAND
WO/2004/047831
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
]87[
]74[
]57[
‫ מטפורמין‬,‫ אלפא‬PPAR ‫שימוש באגוניסט של‬
‫ לייצור תרופות לטיפול בהשמנת‬,‫ונשא מתאים‬
‫יתר‬
The present invention relates to the combined use of a PPARalpha agonist and
metformin for decreasing serum triglycerides.
__________________
]11[]21[
]54[
THERMAL TYMPANIC
THERMOMETER TIP
]22[
]31[
]51[
]71[
15.04.2003
60/432904
]32[ 12.12.2002
Int. Cl.(2009.01) G01K 13/00
SHERWOOD SERVICES AG,
SWITZERLAND
WO/2004/055488
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
220
168913
‫טיפ של מדחום להכנסה לתוף‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present disclosure provides a tympanic thermometer including a heat sensing
probe defining a longitudinal axis and an outer surface extending from a distal end of
the tympanic thermometer. The heat sensing probe includes a sensor housing
extending to a distal end thereof. A sensor can is mounted with the sensor housing and
a nozzle is mounted onto the sensor housing. The sensor can includes temperature
October 31, 2010-‫כ"ג בחשון התשע"א‬
sensing electronics for sensing temperature via the heat sensing probe. The nozzle
includes a base disposed with the sensor housing and an elongated cylindrical nose
portion disposed about the sensor housing. The nozzle is configured to direct heat flux
to the distal end of the heat sensing probe. A probe cover is mountable to the distal end
of the tympanic thermometer. The probe cover has an inner surface configured to
engage an outer surface of the nozzle. The sensor can preferably include a lip
extending radially therefrom and contacting the nozzle at at least one contact point to
provide heat flux to the sensor can.
The applications for division
from this application have
not yet been published
,181374
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
169215
‫שיטת ומערכת פרוקסי עבור אדמיניסטרציה של‬
‫ישויות מנוהלות אלחוטיות מאובטחות‬
]54[
PROXY METHOD AND SYSTEM
FOR SECURE WIRELESS
ADMINISTRATION OF MANAGED
ENTITIES
]22[
]31[
19.12.2003
2414830
]32[ 19.12.2002
]33[ CA
10/326226
19.12.2002
US
Int. Cl.(2009.01) H04L 09/08, 12/24, 29/06, 29/08
AVOCENT HUNTSVILLE
CORPORATION, U.S.A.
KEVIN KERSTENS, ALLAN VAN
SCHAICK, JIM DOREE
WO/2004/057823
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
]51[
]71[
]72[
]87[
]74[
]57[
221
A method, system and apparatus for providing network administration services
October 31, 2010-‫כ"ג בחשון התשע"א‬
remotely to managed entities using wireless technology via a proxy device. The proxy
device is used to pre-process all command traffic from the wireless input device
(WID). The Proxy isolates the managed entities from the WID. The communications
between WID and managed entities is encoded. A security model based on multiple
pre-shared keys and algorithms together with identifiers and passwords that are not
transmitted enhancing security and reducing bandwidth consumption. It is possible to
deliver TELNET services across the Internet and behind a firewall.
__________________
]11[]21[
]54[
METHOD AND DEVICE FOR
TRANSMITTING LCAS
PROTOCOL VIA AN OPTICAL
COMMUNICATION LINE
]22[
]51[
]71[
]74[
27.06.2005
Int. Cl.(2009.01) H04J 03/16
ECI TELECOM LTD.
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517
]57[
222
169416
‫ דרך קו‬LCAS ‫שיטה והתקן להעברת פרוטוקול‬
‫תקשורת אופטי‬
‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
30 ‫רחוב הסיבים‬
‫פתח תקוה‬
A method for bidirectional exchange of LCAS control information for controlling
a virtual concatenated group (VCG) binary stream (42) transmitted between a first
network element (NEI) and a second network element (NE2) via a bi-directional
optical communication line (16) interconnecting said two network elements, while
said VCG binary stream (42) forms substantially unidirectional data traffic
transmitted in a first direction via said bi-directional optical communication line
(16), with no or negligible data traffic transmitted in a second direction opposite
to said first direction;
the method being characterized by the following arrangement for exchanging the
LCAS control information:
(a) in the first direction, transmitting said LCAS control information via said bidirectional optical communication line (16) in said VCG binary stream (42), by
October 31, 2010-‫כ"ג בחשון התשע"א‬
placing the LCAS control information in one or more overhead bytes (35)
conventionally specified for said VCG binary stream (42),
(b) in the second direction, transmitting said LCAS control information by placing
it in one or more overhead bytes (35, 48,57) of an existing binary stream (47, 19)
and passing, in said second direction, via a communication trail (46, 17)
connecting said first network element (NEI) and said second network element
(NE2), wherein said existing binary stream (47) has no relation to said VCG
binary stream (42) to be controlled by said LCAS control information, and
is not provisioned specifically for transmitting said LCAS control information.
__________________
]11[]21[
]54[
POLYTUNNEL SYSTEM FOR
CULTIVATION OF CROPS
]22[
]31[
]51[
]71[
05.01.2004
0300253.2
]32[ 07.01.2003
Int. Cl.(2009.01) A01G 09/16
HAYGROVE LIMITED, UNITED
KINGDOM
WO/2004/060046
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
223
169566
‫מערכת של תעלת פוליאתילן לגידול צמחים‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A polytunnel system comprises a plurality of cover support members (14), a series of
leg members (12) and a cover. The cover support members (14) are supported by
associated ones of the leg members (12). The cover support members (14) are
securable to the leg members (12) at a plurality of different heights.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
169704
‫שיטה לחיבור הדדי ומבנה‬
]54[
INTERCONNECTION METHOD
AND STRUCTURE
]22[
]31[
]51[
]62[
]71[
09.12.2001
681066
]32[ 18.12.2000
]33[ US
Int. Cl.(2009.01) H05K 03/06
DIVISION FROM 146999
GENERAL ELECTRIC COMPANY,
U.S.A.
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
An interconnection structure comprising:
a dielectric layer (10);
a first portion (14) of cured adhesive;
a second portion (38) of cured adhesive;
at least one electrical device being attached to the dielectric layer by the second portion
of cured adhesive such that an active area of at least one electrical device is aligned
with the at least one predetermined area defined by the first portion of cured adhesive,
the first portion of the cured adhesive being adhesively attached to the dielectric layer
and not adhesively attached to the at least one electrical device.
]74[
]57[
224
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
‫חבל למעלית‬
]54[
ELEVATOR ROPE
]22[
]31[
]51[
]71[
]87[
]74[
29.01.2004
03100473.2
]32[ 27.02.2003
Int. Cl.(2009.01) B66B 07/06
N.V. BEKAERT S.A., BELGIUM
WO/2004/076327
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]57[
169785
]33[
EP
,‫ד"ר יצחק הס ושותפיו‬
279 ‫רחוב הירקון‬
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
An elevator rope comprising an elastomer coated, multistrand steel wire cable is
claimed. In such a cable strands have a lay-length of at least 6.5 times the diameter of
the bare cable diameter D. The cable is further coated with an elastomeric jacket,
which adheres to the strands with a pull-out force not less than 15xD+15 newton per
mm. The advantages of such an elevator rope are amongst others its limited
elongation, its reduced diameter and its improved fatigue life.
__________________
]11[]21[
169887
‫פרופיל של תא חלול המפיק תועלת מאנרגיה‬
‫סולרית‬
]54[
HOLLOW-CHAMBER PROFILE
FOR UTILIZING SOLAR ENERGY
]22[
]31[
]51[
]71[
07.01.2004
10304536.8
]32[ 04.02.2003
]33[
Int. Cl.(2009.01) E04C 02/54, F24J 02/24
BAYER MATERIALSCIENCE AG,
GERMANY
WO/2004/070287
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
225
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a hollow-chamber profile (10, 70) for utilizing solar energy,
October 31, 2010-‫כ"ג בחשון התשע"א‬
especially for roofing absorption roofs or the like. Said hollow-chamber profile
comprises a transparent top part (12, 72) and a radiation-absorbing bottom part (14)
that are jointly produced by two-component extrusion from a plastic material and that
are interlinked in the interior of the hollow-chamber profile (10, 70) by longitudinally
extending webs (20, , 30) in such a manner as to form parallel flow channels (34, , 48)
for a heat-transfer medium. The exterior of the top part (12, 72) is provided with a
coating layer (50) that is produced jointly with the top part (12, 72) and the bottom part
(14) by two-component extrusion combined with coextrusion from a transparent
plastic material that absorbs the ultraviolet radiation fraction.
__________________
]11[]21[
170373
( 15 ‫נוגדנים אנושיים הספציפיים לאינטרלוקין‬
‫ ) ושימושיהם‬IL–15
]54[
HUMAN ANTIBODIES SPECIFIC
FOR INTERLEUKIN 15 (IL-15)
AND USES THEREOF
]22[
]31[
25.02.2004
10/374932
]32[ 26.02.2003
]33[ US
10/379741
05.03.2003
US
Int. Cl.(2009.01) A61K 39/395, A61P 07/00, 09/00, 11/00, 17/00, C07K 16/24, C12N
15/13
GENMAB A/S, DENMARK
WO/2004/076620
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]51[
]71[
]87[
]74[
]57[
226
Isolated human monoclonal antibodies which specifically bind to IL-15 (e.g., human
IL-15), and related antibody-based compositions and molecules, are disclosed. The
human antibodies can be produced in a transfectoma or in a non-human transgenic
animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human
monoclonal antibodies by undergoing V-D-J recombination and isotype switching.
Also disclosed are pharmaceutical compositions comprising the human antibodies,
non-human transgenic animals, and hybridomas which produce the human antibodies,
October 31, 2010-‫כ"ג בחשון התשע"א‬
and therapeutic and diagnostic methods for using the human antibodies.
__________________
]11[]21[
170659
‫שיטת הספגה לאנודות של קבל עם אלקטרוליט‬
‫מוצק נקבוביות על–ידי פולימר מוליך‬
]54[
METHOD FOR IMPREGNATION
OF CONDUCTIVE POLYMER
INTO POROUS SOLID
ELECTROLYTE CAPACITOR
ANODES
]22[
]51[
]71[
04.09.2005
Int. Cl.(2009.01) H01G 09/028
CEREL (CERAMIC
TECHNOLOGIES) LTD.
]72[
ASSAF THON, MARTIN IVANOV
ZARBOV
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method of producing an outer conductive polymer coating on the surface of an
anode impregnated with cathode material, said method comprising:
(a) immersing said anode body of a solid electrolyte capacitor in an electrophoretic
deposition (EPD) cell, said cell containing a dispersion of particles of said conductive
polymer in a liquid;
(b) using a power supply to apply a voltage between said anode body and a counter
electrode, thereby forming a current that deposits a continuous conductive polymer
cathode layer on the outer surface of said anode body;
characterized in that said voltage is near or above the anode dielectric formation
voltage, where said anode body is positively biased relative to said counter electrode,
thereby allowing a current to be driven through the dielectric layer of said node and
said conductive polymer dispersions are chosen such that said dispersed particles are
negatively charged, thereby allowing them to be deposited onto the outer surface of
said positively biased anode.
]74[
]57[
‫ טירת‬,‫קראל (טכנולוגיות קרמיקה) בע"מ‬
‫הכרמל‬
‫ מרטין איבנוב זרבוב‬,‫אסף טהון‬
__________________
227
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
]54[
MULTI-HOP TIME
RESERVATION USING ADAPTIVE
CONTROL FOR ENERGY
EFFICIENCY
]22[
]31[
]51[
]71[
28.03.2003
10/388762
]32[ 17.03.2003
Int. Cl.(2009.01) H04B 07/14
UNIVERSITY OF ROCHESTER,
U.S.A.
WO/2004/084434
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]87[
]74[
]57[
170916
‫שמירת זמן מרובת–קפיצות המשתמשת בבקרה‬
‫מותאמת לחסכון באנרגיה‬
]33[
US
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
The present invention extends the TRACE (Time Reservation Using Adaptive Control
for Energy Efficiency) protocol (Fig. 1) to allow multi-hop communication in
dispersed radio networks. The nodes in the network are dynamically clustered based
on proximity and interference level. Time is divided into superframes, each cluster
choosing a frame within the superframe for data transmission to reduce the likelihood
of interference.
__________________
]11[]21[
170941
]54[
FASTENER HAVING IMPROVED
PENETRATION CAPABILITY
]22[
]31[
]51[
]71[
19.03.2004
10/393878
]32[ 21.03.2003
]33[
Int. Cl.(2009.01) F16B 15/00, 15/06, 15/08
EVENING STAR INVESTMENTS,
L.L.C., U.S.A.
228
‫מהדק בעל יכולת חדירה משופר‬
US
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
WO/2004/113024
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A metal piercing fastener having an elongated flat body having first and second
surfaces with a head at one end and a piercing point at the other. The thickness
dimension of the flat body is greater proximate the head than proximate the point. The
first and second surfaces of the body are devoid of protrusions extending outwardly
therefrom.
__________________
]11[]21[
171141
]54[
MULTI-COMPARTMENT
STORAGE AND MIXING VESSEL
]22[
]51[
]71[
]72[
]74[
27.09.2005
Int. Cl.(2009.01) B65D 25/08, B67D 05/56
ALEXANDER DVERIN
ALEXANDER DVERIN
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]57[
229
‫כלי קיבול רב תאי לאחסון מרכיבים בנפרד‬
‫ולערבובם‬
‫ נתניה‬,‫אלכסנדר דברין‬
‫אלכסנדר דברין‬
,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
A multi-compartment storage and mixing container for separately storing two or
more components and for mixing the components in said container before
consumption, the container comprising:
an outer container having walls and a bottom defining the container volume and a
mouth for providing an access to the container volume; and
An inner assembly adapted to be housed within said outer container, the inner
assembly comprising a plunger assembly, the plunger assembly comprising a
stem and two or more spaced apart partitions fixedly mounted thereon;
wherein said inner assembly is transformable from a first storage position, where
two or more separated sealed compartments are defined within said container
volume, to a second mixing position, where there is free communication between
all portions within said container volume and wherein said stem and two or more
spaced apart partitions maintain their position with respect to each other when
said inner assembly is transformed from the first storage position to the second
mixing position.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
171212
]54[
METHOD FOR
MANUFACTURING AN
ELECTRONIC MODULE AND AN
ELECTRONIC MODULE
]22[
]31[
]51[
]71[
31.03.2004
20030493
]32[ 01.04.2003
]33[
Int. Cl.(2009.01) H01L 21/60, H05K 01/18
IMBERA ELECTRONICS OY,
FINLAND
RISTO TUOMINEN, PETTERI PALM
WO/2004/089048
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]72[
]87[
]74[
]57[
230
‫שיטה לייצור מודול חשמלי ומודול חשמלי‬
FI
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
This publication discloses an electronic module and a method for manufacturing an
electronic module, in which a component (6) is glued (5) to the surface of a conductive
layer, from which conductive layer conductive patterns (14) are later formed. After
gluing the component (6), an insulating-material layer (1), which surrounds the
component (6) attached to the conductive layer, is formed on, or attached to the surface
of the conductive layer. After the gluing of the component (6), feed-throughs are also
made, through which electrical contacts can be made between the conductive layer and
the contact zones (7) of the component. After this, conductive patterns (14) are made
from the conductive layer, to the surface of which the component (6) is glued.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
METHOD AND DEVICE FOR THE
AUTHENTICATION OF
DOCUMENTS AND GOODS
]22[
]31[
]51[
]71[
05.04.2004
03009605.1
]32[ 29.04.2003
Int. Cl.(2009.01) G06K 07/10
SICPA HOLDING S.A.,
SWITZERLAND
WO/2004/097716
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
231
171335
‫שיטה והתקן לאימות מסמכים וסחורות‬
]33[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention discloses a method and a device for the authentication of a document, a
valued good or a packaging, carrying a marking (M) exhibiting a viewing-angle
dependent light reflection spectrum. The authentication method is based on a
measurement of the intensity of light reflected by the marking at least at two different
viewing angles in response to a sequential wide-angle illumination with light of
different spectral characteristics, and the comparison of the measured intensity values
with corresponding reference values. The authentication device (1) has at least two
light sources (4) of different spectral characteristics, a wide-angle illumination optics
(3), and at least two photodetectors (5) collecting light reflected by said markings at
least at two different viewing angles. It may further have a programmed 'learning
mode' for measuring and storing a set of reflected intensity values of a reference item,
and a programmed 'testing mode', for measuring a corresponding set of intensity values
on an item to be authenticated and comparing them with the previously stored set of
reference values, hereby deriving and indicating a test result.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
171425
‫מטהר דלק דיזל‬
]54[
DIESEL FUEL PURIFIER
]22[
]51[
]71[
16.10.2005
Int. Cl.(2009.01) B01D 29/50, 35/18, F02M 37/22
ALI HASAN HAMBAN
ABDELQADER, SAUDI ARABIA
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
232
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The diesel purifier produces a fuel of high purity that meets the full ignition
requirements at the combustion chamber of the engine. The purifier comprises a
purification chamber encapsulated by an external body of the unit wherein the
purification chamber has a barrier with conical and cylindrical parts surrounded
by a filter, such that fuel flows from the unit inlet through a pipe to the conical
part, further wherein the upper part of the unit has a relief value, the lower part
has a heating element, and a water sensor connectable to sound and light
indicators at a cabin dash board, and at the bottom there is a drain value and filter,
which is secured at the outlet of the unit. The above purification process depends
on causing of some differences in the density of contaminants which contributes
towards the settling of heavy impurities and the light contaminants are separated
by a wire filter assembly.
__________________
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
171859
‫מיקרואורגניזמים לרפואה‬
]54[
MICROORGANISMS FOR
THERAPY
]22[
]31[
18.06.2004
03013826.7
]32[ 18.06.2003
]33[ EP
03018478.2
14.08.2003
EP
03024283.8
22.10.2003
EP
Int. Cl.(2009.01) A61K 39/275, 39/285, 48/00, C12N 07/04, 15/39, 15/863
GENELUX CORPORATION, U.S.A.
WO/2005/047458
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]51[
]71[
]87[
]74[
]57[
Recombinant vaccinia viruses useful as tumor-specific delivery vehicle for cancer
gene therapy and vaccination Therapeutic methods and microorganisms therefore are
provided. The microorganisms are designed to accumulate in immunoprivileged
tissues and cells, such as in tumors and other proliferating tissue and in inflamed
tissues, compared to other tissues, cells and organs, so that they exhibit relatively low
toxicity to host organisme. The microorganisms also are designed or modified to result
in leaky cell membranes of cells in which they accumulate, resulting in production of
antibodies reactive against proteins and other cellular products and also permitting
exploitation of proliferating tissues, particularly tumors, to produce selected proteins
and other products. Methods for making tumor specific antibodies and also methods of
making gene products encoded by the microorganism as well as antibodies reactive
therewith are provided.
__________________
]11[]21[
]54[
APPARATUS AND METHOD
THAT ACCOMMODATE
MULTIPLE INSTRUCTION SETS
AND MULTIPLE DE-CODE
MODES
]22[
]31[
20.01.2004
0313770.0
233
]32[
13.06.2003
172114
‫התקן ושיטה מותאמים למערכת מרובת הוראת‬
‫ואופני פעולה מרובי מפענחים‬
]33[
GB
October 31, 2010-‫כ"ג בחשון התשע"א‬
]51[
]71[
]87[
]74[
]57[
Int. Cl.(2009.01) G06F 09/318
ARM LIMITED, UNITED KINGDOM
WO/2004/111836
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
A data processing apparatus (2) is provided which supports two instruction sets. These
two instruction sets share a common subset of instructions including at least one class
of instructions, such as all of the coprocessor instructions. The common subset of
instructions have the same instruction encoding once any differences due to storage
order within memory have been compensated for e.g. endianness.
__________________
]11[]21[
]54[
PHOTO-DETECTING
APPARATUS
]22[
]31[
]51[
]71[
21.05.2004
2003-146663 ]32[ 23.05.2003
Int. Cl.(2009.01) H01L 27/146
HAMAMATSU PHOTONICS K.K.,
JAPAN
SEIICHIRO MIZUNO, YASUHIRO
SUZUKI
WO/2004/105137
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]72[
]87[
]74[
]57[
234
172123
‫חיישן אור‬
]33[
JP
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
A photo-detection device includes: a first substrate on which M x N photodiodes and
October 31, 2010-‫כ"ג בחשון התשע"א‬
switches are arranged; a second substrate on which signal processing sections are
arranged for processing an output signal of the respective photodiodes; and a third
substrate arranged between the first and the second substrate. The third substrate has a
first surface opposing to the first substrate and a second surface opposing to the second
substrate. On the first surface of the third substrate, M common wires are arranged for
electrically connecting the photodiodes to the signal processing sections. On the
second surface of the third substrate, bonding pads respectively connected to the
common wires are arranged. Each of the photodiodes on the first substrate is
electrically connected to each of the common wires on the third substrate via a first
bump while each of the signal processing sections on the second substrate is
electrically connected to each of the bonding pads on the third substrate via a second
bump.
__________________
]11[]21[
172156
]54[
USE OF 2H- [1,3] - OXAZINONO
[3,2 - A] INDOLE DERIVATIVES
FOR THE TREATMENT OF
NEUROPATHIC PAIN
]22[
]31[
08.07.2004
MI2003
]32[ 18.07.2003
]33[
A001467
Int. Cl.(2009.01) A61K 31/5365, A61P 25/00
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.P.A., ITALY
WO/2005/014001
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
235
– H2 ‫שימוש בנגזרות של‬
‫] אינדול לטיפול בכאב‬A – 3,2[ ‫] אוקסזינו‬1,3[
‫נוירופאטי‬
IT
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
Use of a compound of formula (I), wherein R is H, a linear or branched alkyl chain
having from 1 to 12 carbon atoms or an arylalkyl group, and of the acid addition salts
thereof with pharmaceutically acceptable organic or inorganic acids, to prepare a
pharmaceutical composition active in the treatment of neuropathic pain.
__________________
]11[]21[
]54[
KINETIC ENERGY ROD
WARHEAD WITH LOWER
DEPLOYMENT ANGLES
]22[
]31[
]51[
]71[
]72[
]87[
]74[
03.06.2004
10/456777
]32[ 06.06.2003
Int. Cl.(2009.01) F42B 12/58
RAYTHEON COMPANY, U.S.A.
RICHARD M. LLOYD
WO/2005/022074
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]57[
236
172284
‫ראש קרב מסוג מוט אנרגיה קינטית עם זויות‬
‫הצבה מוקטנות‬
]33[
US
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
A kinetic energy rod warhead including a projectile core including a plurality of
individual projectiles, an explosive charge about the core, at least one detonator for the
explosive charge, and structure for reducing the deployment angles of the projectiles
when the detonator detonates the explosive charge.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
METHOD AND SYSTEM FOR
MEASURING AVERAGE Q FACTOR IN OPTICAL
NETWORKS
]22[
]51[
]71[
]74[
01.12.2005
Int. Cl.(2009.01) H04B 10/08, 17/00
ECI TELECOM LTD.
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517
]57[
237
172301
‫ ממוצע ברשתות‬Q – ‫שיטה ומערכת למדידת גורם‬
‫אופטיות‬
‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
30 ‫רחוב הסיבים‬
‫פתח תקוה‬
A method for determining averaged Q-factor, Qavg , or an optical binary signal
transmitted via an optical communications line at a bit rate X, based on amplitude
histogram evaluation and asynchronous sampling, the method comprising:
(a) providing sampling pulses having bit rate Y lower than X and not synchronized
with the optical signal, and applying the sampling pulses to the optical signal at a
randomly selected initial phase, during a pre-selected sampling session;
(b) measuring amplitude values of the optical signal at moments of time defined by the
sampling pulses during the pre-selected sampling session;
(c) building an amplitude histogram using the amplitude values obtained at step (b),
said amplitude histogram comprising at least two peaks and among them two
extremely positioned peaks corresponding to two average levels "1" and "0" of the
optical binary signal, the amplitude histogram also comprising cross-point data
between said two extremely positioned peaks;
(d) shifting phase of the sampling pulses;
(e) repeating steps (b), (c), (d) N-1 number of times thereby obtaining N amplitude
histograms for N respective different phases of the sampling pulses;
(f) comparing the obtained N amplitude histograms and selecting therefrom such an
amplitude histogram where a cumulative value of the cross-point data is minimal;
(g) determining a value of Qavg for the histogram selected at step (f).
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
‫עזר ציפה לכלי שייט‬
]54[
BUOYANCY AID FOR
WATERCRAFT
]22[
]31[
]51[
]71[
03.06.2004
10325695.4
]32[ 06.06.2003
Int. Cl.(2009.01) B63B 43/12
DIEHL BGT DEFENCE GMBH & CO.
KG, GERMANY
WO/2004/108520
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]87[
]74[
]57[
172373
]33[
DE
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
A floating bag (27) is secured in a positive fit by a welt (35) by means of a two-part
sliding connection (7, 19) which is devoid of shear stress in a lifting aid which is used
in times of distress at sea in watercrafts. The floating bag (27) can be inflated by
means of a gas generator (23) which is arranged inside the floating bag.
__________________
]11[]21[
]54[
COMPACT PIFA ANTENNA FOR
AUTOMATED MANUFACTURING
]22[
]31[
09.06.2004
10/460958
238
]32[
13.06.2003
172550
‫ דחוסה ליצור אוטומטי‬PIFA ‫אנטנת‬
]33[
US
October 31, 2010-‫כ"ג בחשון התשע"א‬
]51[
]71[
]87[
]74[
]57[
Int. Cl.(2009.01) H01Q 01/24
MOTOROLA, INC., U.S.A.
WO/2005/001990
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
An RF Parallel Inverted 'F' Antenna (PIFA) antenna (101) that is suitable for
incorporation into wireless devices constructed with automated manufacturing
techniques. The PIFA antenna (101) includes a first arm (102) and a parallel second
arm (104) connected by a conductive bridge (106). An RF feed (108) is attached to one
end of the first arm (102) and is used to physically and electrically mount the compact
PIFA antenna (101). An opposite end of the compact PIFA antenna (101) includes a
support structure (150) that provides stability and support of the compact PIFA
antenna (101) during construction of a circuit board on which it is mounted. The end
support (150) is designed to minimize the use of insulating material to minimize
dielectric effects upon the radiation pattern of the conductive elements of the compact
PIFA antenna (101) all while maximizing the mechanical stability of the component
during secondary manufacturing operations.
__________________
]11[]21[
173112
‫פורמולציות מתחלבות ומיקרו–מתחלבות מעצמן‬
‫למתן פומי של טקסואידים‬
]54[
SELF-EMULSIFYING AND SELFMICROEMULSIFYING
FORMULATIONS FOR THE ORAL
ADMINISTRATION OF TAXOIDS
]22[
]31[
]51[
]71[
15.07.2004
03291798.1
]32[ 18.07.2003
]33[ EP
Int. Cl.(2009.01) A61K 09/107, 31/337, 47/14, 47/44
AVENTIS PHARMA S.A., FRANCE
239
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
WO/2005/014048
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
Self-emulsifying and self-microemulsifying formulations for the oral administration of
taxoids. The present invention relates to novel formulations of taxoids for oral
administration.
__________________
]11[]21[
173496
]54[
DEVICE WITH COOLED
CRYOSTAT
]22[
]31[
]51[
]71[
02.02.2006
0501098
]32[ 03.02.2005
]33[
Int. Cl.(2009.01) F25D 19/00, G01J 05/06
SAGEM DEFENSE SECURITE,
FRANCE
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
240
‫התקן בעל מד קור מקורר‬
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A cooled cryostat device (1) comprising: a cold finger (2); an infrared detector means
(3) secured to a terminus of said cold finger; an outer casing (4) surrounding said cold
finger; a stiffener means (5) for stiffening said cold finger, said stiffener means
interposed between said outer casing and said cold finger in the vicinity of said
terminus, wherein said stiffener means comprises: first eyelets (8) distributed around
the periphery of a first ring (11), wherein said first ring is attachable by a first securing
means (15) to the inside of said outer casing; second eyelets (9) distributed around the
periphery of a second ring (12), wherein said second ring is attachable by a second
securing means (16) to the outside of said cold finger; said first eyelets and said second
eyelets being mutually angularly offset; and a cable (10), passing freely through said
first and second eyelets, said cable, once said cold finger has been placed in a balanced
situation, being secured under tension, to provide radial support, as a closed loop to
said first ring and said second ring.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
173617
‫הפרדה יבשה של מזהמים מחומרים‬
‫פוליאסטרים‬
]54[
DRY SEPARATION OF
CONTAMINANTS FROM
POLYESTER MATERIALS
]22[
]31[
]51[
]71[
03.09.2004
60/499862
]32[ 03.09.2003
]33[ US
Int. Cl.(2009.01) B02C 17/02, B07B 01/20, 09/00
UNITED RESOURCE RECOVERY
CORPORATION, U.S.A.
WO/2005/023895
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
241
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A method for separating polyester materials from contaminants is disclosed suitable
for, for example, a polyester recycling system. The method is a dry separation method
and includes rapidly spinning a mixture of polyester and contaminants within a
cleaning chamber. During the spinning of the mixture, the contaminants can be
degraded and pass through a screen at the chamber wall while the polyester materials
are not substantially degraded and can remain in the cleaning chamber. Polyester fines
can also remain in the cleaning chamber. A cleaning device suitable for use in the
process is also disclosed. The device can include a screen of a hardened material that
can help degrade the contaminants and a plurality of rotating blades that can spin the
mixture within the device and can also help to degrade the contaminant materials.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
NON-FOIL BARRIER LAMINATES
]22[
]31[
]51[
]71[
26.08.2004
10/647955
]32[ 26.08.2003
Int. Cl.(2009.01) B32B 27/32
EVERGREEN PACKAGING
INTERNATIONAL B.V., THE
NETHERLANDS
WO/2005/018932
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
]87[
]74[
]57[
173899
‫שכבות חציצה שאינן רדיד‬
]33[
US
,'‫ד"ר שלמה כהן ושות‬
124 ‫אבן גבירול‬
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
A non-foil laminate for an extended long life juice, punch or beverage container,
which can be hot filled or cold filled and provides an effective barrier to oxygen
ingress, for the containment of flavors and aroma and prevents the loss of Vitamin C
by virtue of its reduced permeability to oxygen is provided. The laminate comprises an
inner barrier layer sandwich of polyamide/EVOH/polyamide, layers of polyolefin on
both the matte side (interior) and the gloss side (exterior) of the laminate and a second
barrier layer of EVOH closer to the product contact surface which is not in contact
with the polyaniide/EVOHjpolyamide sandwich or layer of polyolefin on the matte
(interior) side of the laminate.
__________________
242
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
173958
]54[
ßD-CRYSTALLINE FORM OF
IVABRADINE HYDROCHLORIDE,
A PROCESS FOR ITS
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING IT
]22[
]31[
]51[
]71[
27.02.2006
05.01987
]32[ 28.02.2005
]33[ FR
Int. Cl.(2009.01) A61K 31/55, A61P 09/00, C07D 233/16
LES LABORATOIRES SERVIER,
FRANCE
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
243
,‫ של איובראדין הידרוכלוריד‬ßD ‫צורה גבישית‬
‫תהליך להכנתה ותכשירי רוקחות המכילים‬
‫אותם‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
βD-Crystalline form of ivabradine hydrochloride of formula (I) as set forth in the
specification,
characterized by the following powder X-ray diffraction diagram measured using a
PANalytical X'Pert Pro diffractometer together with an XCelerator detector and
expressed in terms of ray position (Bragg's angle 2 theta, expressed in degrees), ray
height (expressed in counts), ray area (expressed in counts x degrees), ray width at
half-height ("FWHM", expressed in degrees) and interplanar distance d (expressed in
A):
Ray no.
Angle 2
theta
(degrees)
Height
(counts)
Area
(counts x
degrees)
FWHM
(degrees)
Interplanar
Distance (A)
1
2
3
4
5
6
7
8
9
10
11
12
4.0
5.9
6.9
9.2
11.8
12.5
13.6
14.5
16.0
17.3
18.4
19.6
244
377
94
1975
136
1826
1834
51
1441
4472
546
1025
80
56
50
293
27
241
303
20
214
738
108
169
0.3346
0.1506
0.5353
0.1506
0.2007
0.1338
0.1673
0.4015
0.1506
0.1673
0.2007
0.1673
22.139
14.829
12.835
9.623
7.473
7.083
6.491
6.119
5.525
5.134
4.808
4.524
October 31, 2010-‫כ"ג בחשון התשע"א‬
Ray no.
Angle 2
theta
(degrees)
Height
(counts)
Area
(counts x
degrees)
FWHM
(degrees)
Interplanar
Distance (A)
13
14
15
16
17
18
19
20
21
22
23
24
20.0
20.4
21.4
22.3
22.8
23.0
24.4
25.0
25.5
26.6
28.3
29.1
688
1027
102
1903
674
623
845
3749
512
289
275
126
91
186
24
283
89
62
56
557
84
76
91
21
0.1338
0184
02342
0.1506
0.1338
0.1004
0.0669
0.1506
0.1673
0.2676
0.3346
0.1673
4.448
4.262
4.143
3.990
3.897
3.866
3.647
3.554
3.497
3.346
3.151
3.066
__________________
]11[]21[
173960
]54[
GAMMA D-CRYSTALLINE FORM
OF IVABRADINE
HYDROCHLORIDE, PROCESS
FOR ITS PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING IT
]22[
]31[
]51[
]71[
27.02.2006
05.01990
]32[ 28.02.2005
]33[ FR
Int. Cl.(2009.01) A61K 31/55, A61P 09/00, C07D 233/16
LES LABORATOIRES SERVIER,
FRANCE
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
244
‫–גאמה של איובראדין‬D ‫צורה גבישית‬
‫ תהליך להכנתה ותכשירי רוקחות‬,‫הידרוכלוריד‬
‫המכילים אותה‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Gamma D-Crystalline form of ivabradine hydrochloride of formula (I) as set forth in
the specification,
characterized by the following powder X-ray diffraction diagram measured using a
PANalytical X'Pert Pro diffractometer together with an XCelerator detector and
October 31, 2010-‫כ"ג בחשון התשע"א‬
expressed in terms of ray position (Bragg's angle 2 theta, expressed in degrees), ray
height (expressed in counts), ray area (expressed in counts x degrees), ray width at
half-height ("FWHM", expressed in degrees) and interplanar distance d (expressed in
A):
245
Ray no.
Angle 2
theta
(degrees)
Height
(counts)
Area
(counts x
degrees)
FWHM
(degrees)
Interplanar
Distance (A)
1
2
3
4
5
6
7
8
9
10
11
12
13
4.3
6.9
.8
10.6
11.9
12.5
13.4
14.4
15.8
16.3
19.9
17.8
18.9
1077
132
269
322
733
1406
2975
825
1036
540
1007
499
1062
124
70
35
26
97
278
442
122
205
107
183
58
140
0.1171
0.5353
0.1338
0.0836
0.1338
0.2007
0.1506
0.1506
0.2007
0.2007
0.184
0.1171
0.1338
20.633
12.787
10.482
8.310
7.414
7.069
6.619
6.134
5.598
5.450
5.233
4.978
4.686
Ray no.
Angle 2
theta
(degrees)
Height
(counts)
Area
(counts x
degrees)
FWHM
(degrees)
Interplanar
Distance (A)
14
15
16
17
18
19
20
21
22
23
24
25
26
27
19.8
20.2
20.9
21.6
22.3
23.4
24.1
24.4
24.8
25.4
26.2
26.8
27.2
27.9
570
549
2565
531
213
278
1404
1526
676
702
1737
258
182
838
85
63
635
105
35
27
185
176
100
139
401
51
24
249
0.506
0.1171
0.2509
0.2007
0.1673
0.1004
0.1338
0.1171
0.1506
0.2007
0.2342
0.2007
0.1338
0.3011
4.485
4.399
4.241
4.104
3.981
3.807
3.694
3.650
3.591
3.504
3.403
3.331
3.282
3.193
October 31, 2010-‫כ"ג בחשון התשע"א‬
28
29.1
152
20
0.1338
3.071
__________________
]11[]21[
174018
‫קופסא עם שרוולים קולטי גלולה לשם איחסון‬
‫והנפקת גלולות‬
]54[
CASE WITH PILL RECEIVING
SLEEVES FOR STORING AND
DISPENSING PILLS
]22[
]31[
]51[
]71[
]87[
]74[
02.09.2004
60/500207
]32[ 04.09.2003
]33[
Int. Cl.(2009.01) A61J 01/03, B65D 83/04
PHARMADESIGN INC., U.S.A.
WO/2005/023657
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]57[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
A case for receiving and dispensing pills, having an optional top cover having a
forward edge and a rearward edge, an optional bottom cover having a forward edge
and a rearward edge, a spine extending between the top cover and the bottom cover, to
which the top cover and the bottom cover are affixed at the rearward edges thereof,
and at least one sleeve containing a plurality of pills secured within the sleeve and
adapted to be dispensed therefrom, the sleeve having a forward edge and a rearward
edge and being attached to the spine at the rearward edge thereof between the top
cover and the bottom cover.
__________________
246
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
174105
‫שיטה ומערכת לאיתור נזילה בצנרת‬
]54[
SYSTEM AND METHOD FOR
DETECTING A LEAK IN A
PIPING SYSTEM
]22[
]51[
]71[
]74[
05.03.2006
Int. Cl.(2009.01) G08B 21/00
SHMUEL KAPLAN
‫ ירושלים‬,‫שמואל קפלן‬
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A system for detecting a leak in a piping system (4), comprising:
a monitoring unit (2) disposed at a gateway of said piping system for indicating fluid
flow (6);
a gauging unit for gauging the duration of continuous fluid flow, and
an indication unit for determining the existence of a leak based on said duration.
]57[
__________________
]11[]21[
]54[
247
ARRANGEMENT FOR DAMPING
OF VIBRATIONS AND
174423
‫סידור לשיכוח רטט ועריקה במחזיק כלים‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
DEFECTION IN A TOOL HOLDER
]22[
]31[
]51[
]71[
]87[
]74[
]57[
01.11.2004
20034883
]32[ 31.10.2003
]33[ NO
Int. Cl.(2009.01) B23B 31/00, B23Q 01/34, 11/00
TEENESS ASA, NORWAY
WO/2005/042195
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
The invention relates to a device for damping vibrations and/or controlling the flexion
of an object (2, 10) in machining, said device comprising at least one force exchange
device (7) which could be a force applying device or a damping device. A such force
applying device (7) is for applying a force having a force component directed at right
angles to the surface of the object and/or for applying a moment to the object (2, 10).
A damping device (7) of this type is for absorbing vibrations from the object (2, 10)
and is adapted to absorb a force component directed at right angles to the surface of the
object or to absorb a moment from the object.
__________________
]11[]21[
174488
‫שתל ביו–מלאכותי בעל סיכון מופחת להווצרות‬
‫רקמת חיבור לאחר ההשתלה‬
]54[
BIOARTIFICIAL IMPLANT WITH
REDUCED RISK FOR
FORMATION OF CONNECTIVE
TISSUE AFTER IMPLANTATION
]22[
]31[
]51[
04.10.2004
0302599-6
]32[ 02.10.2003
]33[
Int. Cl.(2009.01) A61F 02/02, A61L 27/50
248
SE
October 31, 2010-‫כ"ג בחשון התשע"א‬
]71[
]72[
]87[
]74[
]57[
TIKOMED AB, SWEDEN
LARS BRUCE, ADAM BRUCE, BO
NILSSON, OLLE KORSGREN
WO/2005/030283
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
A bioartificial implant comprises a semipermeable barrier designed from one side to
allow diffusion or prevent diffusion of predetermined
substances/materials/molecules/cells/cell lines produced in the human body to the
other opposite side of the barrier, and from said other opposite side to allow diffusion
or prevent diffusion of predetermined substances which are the same as or different
from the first mentioned substances/materials/molecules/cells/cell lines. The
semipermeable barrier has a surface coating at least on said one side a bioactive metal,
such as titanium, which surface coating is permeable to allow said diffusions. In a
method for reducing the risk of formation/growth of connective tissue in connection
with an implant which comprises a semipermeable barrier, the barrier is provided at
least on one side with a permeable coating of bioactive metal. An example of the use
of the implant is bioartificial pancreas
__________________
]11[]21[
]54[
MECHANICAL ADVANTAGE
TOURNIQUET
]22[
]31[
12.10.2004
60/509917
]32[ 10.10.2003
60/615027
04.10.2004
Int. Cl.(2009.01) A61B 17/132
]51[
249
174851
‫חוסם כלי דם בעל יתרון מכני‬
]33[
US
US
October 31, 2010-‫כ"ג בחשון התשע"א‬
]71[
]72[
]87[
]74[
]57[
PYNG MEDICAL CORP., CANADA
THOMAS J. HEINZ, ROYCE
RUMSEY, ED BANNISTER
WO/2005/053506
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
A pressure control apparatus for restricting a flow of blood through or from a body
part includes at least one arcuate member for attaching to the body part. The at least
one arcuate member has a first end and an opposite second end. The first end includes
a hook for fastening to a buckle mounted at the opposite second end. A mechanical
advantage power system includes a turnkey and is connected to the at least one arcuate
member and serves to adjusting a pressure of the apparatus on the body part by turning
the turnkey. An elongated strap is disposed on at least a circumferential portion of the
arcuate member for circumferentially tightening the apparatus around the body part. A
looking device closes the apparatus around the body part and is attached to the at least
one arcuate member. A cover or shroud is disposed on an outer perimeter of the at
least one arcuate member for enclosing a portion of the mechanical advantage power
system.
__________________
]11[]21[
174889
‫קפיץ פנימי הסוגר קצף עם רכיבי קצף פנימיים‬
)‫(אריזה משולשת‬
]54[
FORM ENCASED INNERSPRING
WITH INTERNAL FOAM
COMPONENTS (TRIPLE CASE)
]22[
]31[
]51[
08.09.2004
60/511849
]32[ 15.10.2003
]33[
Int. Cl.(2009.01) A47C 23/04, B29C 31/10
250
US
October 31, 2010-‫כ"ג בחשון התשע"א‬
]71[
]87[
]74[
]57[
SEALY TECHNOLOGY LLC, U.S.A.
WO/2005/039849
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A molded foam-encased integrated flexible support device includes an innerspring
(110) positioned upon a three-dimensional thermoplastic foam deck (200) as a flexible
foundation, and a molded foam encasement (600) which structurally integrates the
foam deck with the innerspring by attachment to perimeter coils of the innerspring. A
sculpted fomn topper (700) is adhesively bonded to a support surface of the foamencased innerspring, forming a unitized mattress or support structure with fully
integrated innerspring and internal and external foam components. The sculpted fonm
topper is designed with varying contours and densities to provide the desired support
and feel characteristics for different comfort profiles. The foam encased innerspring
with internal three-dimensional foam structures is upholstered for use as a mattress,
seating, or other flexible support structure.
__________________
]11[]21[
]54[
PHARMACEUTICAL ORAL
DOSAGE FORM COMPRISING A
NON-STEROIDAL ANTIINFLAMMATORY DRUG, AND
HAVING GOOD PALATABILITY
]22[
]31[
]51[
]71[
16.12.2004
MI2003A002523 ]32[ 19.12.2003
Int. Cl.(2009.01) A61K 09/08
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
251
175827
‫צורת מתן רוקחית פומית המכילה תרופה לא‬
‫סטרואידית נוגדת זיהום בעלת התאמה לחיך‬
]33[
IT
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
S.P.A., ITALY
WO/2005/058276
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Oral pharmaceutical dosage form comprising tromethamine and a NSAID selected
from the group comprising ibuprofen, naproxen and flurbiprofen, characterized in that
it also comprises a compound selected from the group comprising glycine, vitamine B6
and mixtures thereof.
__________________
]11[]21[
176167
‫מכשיר מדידת תאוצה‬
]54[
DEVICE FOR MEASURING
ACCELERATION
]22[
]51[
]71[
07.06.2006
Int. Cl.(2009.01) G01P 15/00
MICHAEL NAUMOV
GEORGE NAUMOV
]74[
MICHAEL NAUMOV,
HAZOR 3
TEL AVIV
]57[
A device for measuring acceleration comprising the following interconnected parts:
at least two sealed vessels filled with flowing medium and connected to a mobile
object; each of the said vessels comprising at least two identical in form, counteroriented inner (11;12) cavities, the inner cavity of each vessel comprising at least two
counter-oriented (21; 22; 23; 24) spherical parts of different radii and with a common
center (L1; L2), each inner cavity having the most remote points (A1; B1; A2; B2)
positioned on either side of the said common center; the said most remote points and
common centers being positioned in the said inner cavities on parallel straight lines
which are perpendicular to any axis chosen of the mobile object;
at least two pressure sensors for measuring pressure (U 1; U2) at the said common
centers, the said pressure sensors being connected to the vessels, differential scheme
(31; 32) connected to the said pressure sensors, acceleration signal to be measured
being taken from an output of the differential scheme, the acceleration signal is
independent of tilts of the mobile object.
252
‫ תל אביב‬,‫מיכאל נאומוב‬
‫ אביב‬-‫ תל‬,‫גאורגי נאומוב‬
,‫מיכאל נאומוב‬
3 ‫חצור‬
‫תל אביב‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
COMPACT, WIDE-FIELD-OFVIEW IMAGING OPTICAL
SYSTEM
]22[
]31[
]51[
]71[
]87[
]74[
31.05.2005
10/859886
]32[ 02.06.2004
Int. Cl.(2009.01) G02B 13/06
RAYTHEON COMPANY, U.S.A.
WO/2006/049650
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]57[
253
176188
‫מערכת אופטית קומפקטית להדמיית שדה ראיה‬
‫רחב‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
An imaging optical system (20) includes a first imaging structure (22) having a first
optical axis (34) and a first field of view (24), wherein the first imaging structure (22)
forms an image on a common focal plane (92), and a second imaging structure (26)
having a second optical axis (64) parallel to the first optical axis (34) and a second
field of view (28) different from the first field of view (24), wherein the second
imaging structure (26) forms an image on the common focal plane (92). The imaging
structures preferably contain identical lens modules, most preferably identical Petzval
lenses, and achromatic or apochromatic prisms of different spatial orientations. A
planar sensor structure (90) lies in the common focal plane (92), wherein the first
optical axis (34) and the second optical axis (64) pass through the planar sensor
structure (90).
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
LASER ACTIVE OPTRONIC
SYSTEM WITH IMPROVED
DETECTIVITY
]22[
]31[
]51[
]71[
]87[
]74[
09.12.2004
0314602
]32[ 12.12.2003
Int. Cl.(2009.01) G01S 07/48
THALES, FRANCE
WO/2005/066653
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
254
176241
‫מערכת לייזר אופטרונית פעילה בעלת אבחנה‬
‫משופרת‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a laser active optronic system with improved detectivity,
especially with eye safety. Said system comprises a path (1) for the emission of a
target illuminating laser beam by an emission source (10), and a path (2) for the
reception of the wave backscattered by the target. The reception path contains an
optical switching device (24) which receives the backscattered wave and comprises an
optical gain medium (241), and means for pumping (242) the gain medium, said gain
medium absorbing the wavelength of the laser and becoming essentially transparent
when it is pumped, in such a way that the switching device can be activated
respectively in an on or off mode. The inventive system also comprises a unit for
controlling (243) the pumping means, enabling the switching device to be activated in
the on mode in at least one time window of a pre-determined duration, triggered at a
pre-determined moment following the start of the emission of the illumination laser
beam.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
176359
]54[
IMPLANTABLE MEDICAL
DEVICE WITH INDICATOR
]22[
]31[
]51[
]71[
15.06.2006
11/166968
]32[ 24.06.2005
]33[
Int. Cl.(2009.01) A61F 02/02, A61M 39/00
ETHICON ENDO-SURGERY, INC.,
U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
255
‫התקן רפואי להשתלה עם מחוון‬
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A surgically implantable device:
(a) a medical implant for performing a therapeutic function, said implant having at
least one fastener (10) for attaching said implant to a body (8), said at least one
fastener having a deployed position and an undeployed position and being moveable
therebetween; and
(b) a visual indicator for indicating that said at least one fastener has been moved to its
deployed position.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
TAMPER INDICATING CLOSURE
WITH FOLDABLE TAB
]22[
]31[
]51[
]71[
05.01.2005
10/752074
]32[ 05.01.2004
Int. Cl.(2009.01) B65D 41/34
BERRY PLASTICS CORPORATION,
U.S.A.
WO/2005/067588
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
256
176573
‫מוט נעילה המורה על סגירה עם תג מתקפל‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
A tamper indicating closure (20) includes a top wall (22) and a skirt (24) depending
from the top wall. A tamper indicating band (30) is connected to the skirt along a
frangible line (28). The tamper indicating band includes a ring (32) and at least one tab
(34), the at least one tab having a bi-pair of extending members (36) angled toward one
another and connected by a transverse member (38). The shape of the tab allows it be
molded in a downward orientation and later folded to a stable, upward orientation
without reheating or otherwise resetting the tab. The tab also includes a tab extension
(34a) arranged on at least one of the transverse member (38) and at least one extending
member (36) or at least one tab (34) and extending in a direction of extension of the
extending members from at least one tab (34), the tab extension configured to engage
at least one container profile (16).
__________________
]11[]21[
176710
]54[
DERIVATIVES OF N-'(1,5DIPHENYL-1H-PYRAZOL-3-YL)
SULPHONAMIDE WITH CB1
RECEPTOR AFFINITY
]22[
]31[
]51[
]71[
]87[
]74[
07.01.2005
0400257
]32[ 12.01.2004
]33[ FR
Int. Cl.(2009.01) A61K 31/415, C07D 231/12, 409/12, 413/14
SANOFI-AVENTIS, FRANCE
WO/2005/073197
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]57[
257
–‫– פירוזול‬H1–‫– דיפניל‬N –' (1, 5 ‫תולדות של‬
CB1 ‫) סולפונאמיד בעלת אפיניות לקולטן‬YL–3
The invention relates to compounds having formula (I), the preparation method thereof
and the use of same in therapeutics, wherein: R1 represents a (C1-C6)alkyl, a (C3C7)cycloalkyl which is unsubstituted or is mono- or poly-substituted, a (C3C7)cycloalkylmethyl which is unsubstituted or is mono- or poly-substituted, a phenyl
which is unsubstituted or substituted; a benzyl which is unsubstituted or is mono- or
disubstituted, a thienyl which is unsubstituted or substituted; R2 represents a hydrogen
atom or a (C1-C3)alkyl; R3 represents a hydrogen atom or a (C1-C5)alkyl; R4, R5, R6,
R7, R8 and R9 each represent, independently of each other, a hydrogen atom, a halogen
atom, a (C1-C7)alkyl, a (C1-C5)alkoxy, a trifluoromethyl radical or a S(O) nAlk group; n
represents 0, 1 or 2; and Alk represents a (C1-C4)alkyl. The invention also relates to the
preparation method thereof and to the use of same in therapeutics.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
ELECTROLYTIC CAPACITORS
WITH A POLYMERIC OUTER
LAYER AND PROCESS FOR THE
PRODUCTION THEREOF
]22[
]31[
]51[
]71[
10.07.2006
1020050338399 ]32[ 20.07.2005
Int. Cl.(2009.01) H01G 09/00
BAYER
BETEILIGUNGSVERWALTUNG
GOSLAR GMBH, GERMANY
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
]57[
258
176766
‫קבלים אלקטרוליטים עם שכבה חיצונית‬
‫פולימרית ותהליך ליצורם‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A process for the production of an electrolytic capacitor which comprises applying a
dispersion
(a) to a capacitor body wherein said capacitor body comprises
a porous electrode body of an electrode material,
a dielectric covering the surface of this electrode material,
a solid electrolyte at least comprising a conductive material, that wholly or partially
covers the dielectric surface, and said dispersion
(a) comprises at least particles
(b) of an electrically conductive polymer containing at least one optionally substituted
polyaniline and\or one polythiophene with recurring units of general formula (I) or
formula (II) or recurring units of general formulae (I) and (II)
wherein A represents an optionally substituted C1 to C5 alkylene radical, R represents a
linear or branched, optionally substituted C1 to C18 alkyl radical, an optionally
October 31, 2010-‫כ"ג בחשון התשע"א‬
substituted C5 to C12 cycloalkyl radical,
an optionally substituted C6 to C14 aryl radical, an optionally substituted C7 to C18
aralkyl radical, an optionally substituted C1 to C4 hydroxyalkyl radical or ahydroxyl
radical, x represents an integer from 0 to 8 and if a plurality of radicals R are bound to
A, these may be the same or different, and containing a binder (c) and a dispersing
agent (d), and, for forming an electrically conductive polymeric outer layer, the
dispersing agent (d) is optionally at least partially removed and/or the binder (c) is
cured, wherein the proportion of the particles (b) of the conductive polymer in the
dispersion (a) having a diameter of less than 700 nm forms a solids content of at least
5% by weight of the solids content of the dispersion,and in that, in addition to the
components (b) to (d), solid particles (e) having a diameter in the range from 0.7 to 20
µm are also contained in the dispersion.
__________________
]11[]21[
]54[
AUDIO CODING
]22[
]31[
]51[
]71[
10.02.2005
102004007200.0 ]32[ 13.02.2004
Int. Cl.(2009.01) G10L 19/00
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V., GERMANY
WO/2005/078704
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]87[
]74[
]57[
259
176857
‫קידוד אודיו‬
]33[
DE
,'‫זליגסון גבריאלי ושות‬
31 ‫רח' יבנה‬
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
The aim of the invention is to dispense with the previous procedure, i.e. interpolation
at the filter coefficients and the amplification value in order to obtain interpolated
values for the intermediate audio values starting from the support points. Coding
containing fewer audible artifacts can be obtained by using the performance limit
derived from the masking threshold, preferably from the area below the square sum of
the masking threshold, for each support point, i.e. for each parameterization that is to
be transmitted, instead of interpolating the amplification value, and then performing
interpolation between said performance limits of adjacent support points, e.g. linear
October 31, 2010-‫כ"ג בחשון התשע"א‬
interpolation. An amplification value can then be calculated from the determined
intermediate performance threshold value at the coder end and the decoder end in such
a way that the quantizing noise which is caused by quantizing and whose frequency is
constant before post-filtering is done at the decoder end, lies below the performance
limit or corresponds thereto following post-filtering.
__________________
]11[]21[
]54[
SYSTEM AND METHOD FOR
SECURE TELEPHONE AND
COMPUTER TRANSACTIONS
]22[
]31[
24.01.2005
10/764099
]32[ 23.01.2004
60/538761
23.01.2004
Int. Cl.(2009.01) G06K 05/00
MASTERCARD INTERNATIONAL
INCORPORATED, U.S.A.
JOHN WANKMUELLER
WO/2005/072382
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]51[
]71[
]72[
]87[
]74[
]57[
260
176961
‫מערכת ושיטה עבור עסקאות טלפון ומחשב‬
‫מאובטחות‬
]33[
US
US
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
A secure electronic payment system and method for conducting a secure transaction
(120) using authentication is provided. A merchant's computer (104) transmits an
authorization request to an access control server (112). The access control (112)
obtains authentication (130) to confirm the identity of the purchaser (102), via e.g., an
electronic form or interactive voice response system. The access control server (112)
then transmits a response to the merchant's computer. If the purchaser (102) is
authorized to access the account, payment is processed by the merchant (104) and the
October 31, 2010-‫כ"ג בחשון התשע"א‬
transaction (102) is completed.
__________________
]11[]21[
]54[
SYSTEM AND METHOD FOR
GENERATING COLLISION-FREE
IDENTIFIERS FOR FINANCIAL
TRANSACTION CARDS
]22[
]31[
]51[
]71[
24.01.2005
60/538769
]32[ 23.01.2004
Int. Cl.(2009.01) G06K 05/00
MASTERCARD INTERNATIONAL
INCORPORATED, U.S.A.
PATRIK SMETS, PAUL VANNESTE
WO/2005/070032
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]72[
]87[
]74[
]57[
261
176962
‫מערכת ושיטה לחולל מזהים נטולי התנגשויות‬
‫עבור כרטיסים לביצוע עסקאות כספיות‬
]33[
US
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
A one-way permutation over financial transaction card data provides a merchant with a
unique card identifier for each financial transaction card that is used by a customer to
purchase goods from a merchant. This card identifier, which is not the actual financial
transaction card data, may then be permissibly stored by the merchant and used to
uniquely identify the customer’s financial transaction card, and may also be used to
determine the frequency with which that customer makes purchases using that card.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
177247
]54[
TECHNIQUES FOR PREDICTION
AND MONITORING OF
RESPIRATION- MANIFESTED
CLINICAL EPISODES
]22[
]31[
]51[
]71[
31.01.2005
60/541779
]32[ 05.02.2004
]33[
Int. Cl.(2009.01) A61B 05/00, G01N 33/68
EARLYSENSE LTD.
DANIEL H. LANGE
YOSEF GROSS
AVNER HALPERIN
]87[
]74[
WO/2005/074361
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
]57[
‫שיטות לחיזוי וניתור של ארועים קליניים‬
‫המתבטאים בנשימה‬
US
‫ רמת גן‬,EARLYSENSE LTD
‫ כפר ורדים‬,‫דניאל לאנג‬
‫ מושב מזור‬,‫יוסף גרוס‬
‫ גן‬-‫ רמת‬,‫אבנר הלפרין‬
,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
A method is provided for predicting an onset of a clinical episode, the method
including sensing breathing of a subject, determining at least one breathing pattern of
the subject responsively to the sensed breathing, comparing the breathing pattern with
a baseline breathing pattern, and predicting the onset of the episode at least in part
responsively to the comparison. Other embodiments are also described.
__________________
262
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
‫בקר ניגרים‬
]54[
FLUID CONTROLLER
]22[
]31[
]51[
]71[
]87[
]74[
30.11.2004
2004-032951 ]32[ 10.02.2004
Int. Cl.(2009.01) F16K 31/122
FUJIKIN INCORPORATED, JAPAN
WO/2005/075866
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]57[
177350
]33[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
A fluid controller (71), comprising an operating member (75) for automatic
opening/closing vertically moved by the supply and discharge of a compressed fluid
into and from a compressed fluid lead-in chamber (90) formed in a casing (73) to
move a valve element retainer (5) to an opening position against the energizing force
of a compression coil spring (77) and an operation member (74) for manual
opening/closing vertically moved by manual operation and when moved downward,
directly pressing the valve element retainer (5) downward.
__________________
]11[]21[
]54[
263
CRYSTALLINE (R-R*R*)-2-(4FLUOROPHENYL)-BETA-DELTADIHYDROXY-5-(1METHYLETHYL)3-PHENYL-4(PHENYLAMINO)CARBONYL)-IHPYRROLE-1-HEPTANOIC ACID
HEMI CALCIUM SALT (
177377
–)‫פלואורופניל‬R–(R*R*)–2–(–4( ‫קריסטלין‬
)‫–מתיל–אתיל‬1(–5– ‫בטא–דלתא–דיהידרוקסי‬
–1– ‫ פירול‬IH–)‫–(פניאמינו)קרבוניל‬4–‫–פניל‬3
‫חומצה הפטנואית המי מלחת סידן‬
)‫(אטורואסטטין‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
ATORVASTATIN)
]22[
]31[
]51[
]62[
]71[
]87[
]74[
]57[
08.07.1996
60/001452
]32[ 17.07.1995
]33[ US
Int. Cl.(2009.01) A61K 31/40, A61P 03/06, C07D 207/34
DIVISION FROM 128862
WARNER-LAMBERT COMPANY
LLC, U.S.A.
WO/1997/003959
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Novel crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi
calcium salt designated Form I, Form II, and Form IV are characterized by their X-ray
powder diffraction and/or solid state NMR are described, as well as methods for the
preparation and pharmaceutical composition of the same, which are useful as agents
for treating hyperlipidemia and hypercholesterolemia.
The applications for division
from this application have
not yet been published
,203847
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
FROZEN AERATED PRODUCT IN
A CONTAINER AND A VALVE
FOR DISPENSING SUCH
]22[
]31[
]51[
]71[
28.02.2005
0404715.5
]32[ 03.03.2004
Int. Cl.(2009.01) B65D 83/14, 83/44
UNILEVER PLC, UNITED
KINGDOM
WO/2005/095231
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
264
177738
‫תוצר קפוא מאוורר במיכל ושסתום לחלוקתו‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A frozen aerated product in a container is provided. The product is under a pressure of
between 4 and 18 barg, and the container is provided with a valve. The valve has a
October 31, 2010-‫כ"ג בחשון התשע"א‬
flow rate of above 6 g s-1, preferably between 10 and 30 g s-1. The flow rate of the
valve being the mass flow rate at which the frozen aerated product, having a
temperature of -18oC, is discharged through the fully open valve to atmospheric
pressure. Also provided are valves suitable for dispensing viscous products at high
flow rate whilst retaining a low opening and actuation force.
__________________
]11[]21[
177805
]54[
METHOD FOR PREPARING
THIENO[3,2-C]PYRIDINE
DERIVATIVES
]22[
]31[
03.03.2005
10-2004]32[ 12.03.2004
]33[ KR
0016714
Int. Cl.(2009.01) C07D 333/12, 333/16, 495/04
HANMI PHARM. CO., LTD.,
REPUBLIC OF KOREA
WO/2005/087779
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
]57[
‫] פירידין‬C – 3 , 2[ ‫שיטה להכנת תולדות תיאינו‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
Ticlopidine and clopidogrel having high blood platelet aggregation inhibitory and antithrombotic activities are simply prepared by reacting a substituted thiophene derivative
with a 2-chlorobenzylamine derivative.
__________________
]11[]21[
]54[
COATED ABRASIVE PRODUCTS
AND PROCESSES FOR FORMING
SAME
]22[
]31[
]51[
]71[
265
24.03.2005
10/809197
]32[ 25.03.2004
Int. Cl.(2009.01) B24D 03/28, 11/00
SAINT GOBAIN ABRASIVES, INC.,
178169
‫מוצרים מצופי שכבת שחיקה ותהליכים לייצורם‬
]33[
US
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
U.S.A.
WO/2005/095060
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
A coated abrasive product is disclosed, which includes a substrate and an abrasive
layer overlying the substrate. The abrasive layer includes abrasive grains and a binder,
the binder being formed from a binder formulation having a first and second binder
components mixed together uniformly with the abrasive grains, wherein the first
binder component is radiation curable and the second binder component comprises a
powder and is thermally curable.
__________________
]11[]21[
]54[
LOSSLESS MULTI-CHANNEL
AUDIO CODEC
]22[
]31[
21.03.2005
60/556183
]32[ 25.03.2004
10/911062
04.08.2004
10/911067
04.08.2004
Int. Cl.(2009.01) G10L 19/00
DTS, INC., U.S.A.
WO/2005/098823
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
266
178244
‫קידוד אודיו רב ערוצים‬
]33[
US
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A lossless audio codec segments audio data within each frame to improve compression
performance subject to a constraint that each segment must be fully decodable and less
than a maximum size. For each frame, the codec selects the segment duration and
coding parameters, e.g., a particular entropy coder and its parameters for each
segment, that minimizes the encoded payload for the entire frame subject to the
constraints. Distinct sets of coding parameters may be selected for each channel or a
global set of coding parameters may be selected for all channels. Compression
performance may be further enhanced by forming M/2 decorrelation channels for Mchannel audio. The triplet of channels (basis, correlated, decorrelated) provides two
possible pair combinations (basis, correlated, decorrelated) provides two possible pair
combinations (basis, correlated) and basis, decorrelated) that can be considered during
the segmentation and entropy coding optimization to further improve compression
October 31, 2010-‫כ"ג בחשון התשע"א‬
performance.
,200376
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
INTRAMEDULLARY NAIL
COMPRISING ELEMENTS OF
SHAPE-MEMORY MATERIAL
]22[
]31[
31.03.2005
04007786.9
]32[ 31.03.2004
04007785.1
31.03.2004
Int. Cl.(2009.01) A61B 17/72
ORTHOFIX S.R.L., ITALY
LUIGI ROSSI, DANIELE
VENTURINI, MICHELE COATI,
GRAZIANO MARINI, GRAZIANO
ROSSI, GIANCARLO MARAZZI
WO/2005/094706
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]51[
]71[
]72[
]87[
]74[
]57[
267
178285
–‫מסמר תוך–לשדי המכיל גורמים של חומר זוכר‬
‫צורה‬
]33[
EP
EP
,‫ד"ר מרק פרידמן בע"מ‬
7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
An intramedullary nail (10, 110, 210, 310, 410, 510, 610) suitable for insertion in a
fractured elongate bone (12), of the type comprising a stem (14, 114, 214, 314, 414,
514, 614) extended between a proximal end (16, 116, 216, 416, 516, 616) and a distal
end (18, 118, 218, 418, 518, 618). The nail comprises a plurality of elements (20, 120 ,
220, 320, 420, 520, 620) realised with at least one shape-memory material, a plurality
of seats (19, 119, 219, 319, 419, 519, 619) formed in the stem (14, 114, 214, 314, 414,
514, 614) for housing the elements (20, 120 , 220, 320, 420, 520, 620). The elements
(20, 120 , 220, 320, 420, 520, 620) are suitable to take a first shape wherein they are
retractably housed in the respective seats (19, 119, 219, 319, 419, 519, 619) and a
second shape wherein they project from the respective seats (19, 119, 219, 319, 419,
October 31, 2010-‫כ"ג בחשון התשע"א‬
519, 619).
The applications for division
from this application have
not yet been published
,204280,204279
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
178342
‫משטחי תמיכה ללא מגע לצורך כוון מרחק‬
]54[
NON-CONTACT SUPPORT
PLATFORMS FOR DISTANCE
ADJUSTMENT
]22[
]31[
]51[
]71[
13.04.2005
60/561904
]32[ 14.04.2004
]33[ US
Int. Cl.(2009.01) B65G 49/06, 51/00, H01L 21/677
CORE-FLOW SCIENTIFIC
‫ יוקנעם‬,‫קורפלו פתרונות מדעיים בע"מ‬
SOLUTIONS LTD.
YUVAL YASSOUR, ARIE HARNIK,
‫ הלל ריכמן‬,‫ אריה הרניק‬,‫יובל יסעור‬
HILEL RICHMAN
WO/2005/099350
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]72[
]87[
]74[
]57[
268
An apparatus for supporting a stationary or moving substantially flat object without
physical contact on an fluid-cushion. The object floats on a fluid cushion gap, the
apparatus aimed for globally or locally adjusting the gap. The apparatus comprising: a
first platform for supporting the object without contact, the platform having a
substantially flat active surface comprised of one or more sectors, each sector
comprising at least one of a plurality of basic cells, each basic cell having at least one
of a plurality of pressure outlets fluidically connected through a pressure flow
restrictors to a higher-pressure manifold associated with the sector in which the basic
October 31, 2010-‫כ"ג בחשון התשע"א‬
cell lies, the higher-pressure manifold is fluidically connected through main supply
pipeline to pressurized fluid supply and at least one of a plurality of fluid-evacuation
channels fluidically connected to a lower-pressure manifold associated with the sector
in which the basic cell lies having main evacuation pipeline; wherein the flow
restrictor characteristically exhibiting fluidic return spring behavior; and wherein at
least one pressure control valve is interposed with at least one of the two main
pipelines of at least one sector for controlling pressure levels of at least one of the two
manifolds of that sector.
__________________
]11[]21[
]54[
METHOD AND DEVICE FOR
DISPATCHING A PLURALITY OF
PHYSICAL OBJECTS
]22[
]31[
]51[
]71[
]87[
]74[
13.04.2005
102004019232.4 ]32[ 16.04.2004
Int. Cl.(2009.01) G01C 21/34
DEUTSCHE POST AG, GERMANY
WO/2005/100917
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]57[
269
178449
‫שיטה והתקן לשליחת מספר פריטים פיזיים‬
]33[
DE
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
The inventive method and device for trouble-freely and time-optimally dispatching any
number of objects. Said method consists in assigning at least one delivery address to
each object, in determining a sequence for dispatching the objects to a delivery
location, in assembling several objects for the common delivery thereof, in storing a
delivery addresses on the basis of the determined frequency in a data memory of a
transport means, in transmitting said data to the navigation system of transport means
in such a way that it is possible to determine the delivery locations where a subsequent
October 31, 2010-‫כ"ג בחשון התשע"א‬
object delivery is to be carried out and the navigation system of transport means
determines an optimum itinerary way to the delivery location for a subsequent
delivery.
__________________
]11[]21[
]54[
DEVICE FOR MECHANICAL
DECOUPLING FOR MONOLITHIC
DIFFERENTIAL VIBRATING
SENSOR
]22[
]31[
]51[
]71[
21.04.2005
0404794
]32[ 05.05.2004
Int. Cl.(2009.01) G01P 15/097
ONERA (OFFICE NATIONAL
D'ETUDES ET DE RECHERCHES
AEROSPATIALES), FRANCE
WO/2005/121811
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]87[
]74[
]57[
270
179045
‫התקן לבטול צימוד מכני של חיישן מרטט‬
‫מונוליתי דיפרנציאלי‬
]33[
FR
,'‫זליגסון גבריאלי ושות‬
31 ‫רח' יבנה‬
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
The invention concerns a sensor comprising two identical vibrating elements operating
at a common working frequency and interconnected by a mechanical decoupling
device. The device consists of a frame (DM') and two connecting bridges (7 1, 72) each
supporting one element. The sensor is characterized in that the frame (DM') consists of
a series of solid parts (63, 64, 65, 66) and thinned parts (11, 12, 13, 14, 15, 16) such
that the frequency of a structural resonant mode of the frame is equal to the common
working frequency and that each connecting bridge (7 1, 72) is arranged in a vibrating
node of the structure at said frequency. Thus, the vibrations of the two vibrating
elements are decoupled from each other.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
X-RAY SOURCE WITH
NONPARALLEL GEOMETRY
]22[
]31[
]51[
]71[
23.05.2005
10/854944
]32[ 27.05.2004
Int. Cl.(2009.01) H01J 35/00
CABOT MICROELECTRONICS
CORPORATION, U.S.A.
WO/2005/119730
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]87[
]74[
]57[
271
179112
‫מקור קרני רנטגן עם גיאומטריה לא מקבילית‬
]33[
US
,'‫זליגסון גבריאלי ושות‬
31 ‫רח' יבנה‬
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
An improved x-ray generation system produces a converging or diverging radiation
pattern particularly suited for substantially cylindrical or spherical treatment devices.
In an embodiment, the system comprises a closed or concave outer wall about a closed
or concave inner wall. An electron emitter is situated on the inside surface of the outer
wall, while a target film is situated on the outside surface of the inner wall. An
extraction voltage at the emitter extracts electrons which are accelerated toward the
inner wall by an acceleration voltage. Alternately, electron emission may be by
thermionic means. Collisions of electrons with the target film causes x-ray emission, a
substantial portion of which is directed through the inner wall into the space defined
within. In an embodiment, the location of the emitter and target film are reversed,
establishing a reflective rather than transmissive mode for convergent patterns and a
transmissive mode for divergent patterns.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
PHOTO DETECTOR APPARATUS
]22[
]31[
]51[
]71[
02.05.2005
2004-140073 ]32[ 10.05.2004
Int. Cl.(2009.01) G01J 01/46
HAMAMATSU PHOTONICS K.K.,
JAPAN
SEIICHIRO MIZUNO, YASUHIRO
SUZUKI
WO/2005/108938
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]72[
]87[
]74[
]57[
272
179130
‫חיישן אור‬
]33[
JP
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
A photo detector apparatus having a structure capable of enlarging the dynamic range
of photo detection and further improving the S/N ratio. The photo detector apparatus
comprises pixels, including photodiodes, an integrating circuit, a CDS circuit, a
selection circuit and a switch circuit. The charge occurring in a photodiode is stored
into an integration capacitance part in the integrating circuit, and a first voltage value
(V1) in accordance with the mount of the stored charge is outputted from the
integrating circuit. The CDS circuit receives the first voltage value (V1) and outputs a
second voltage value (V2) that is in accordance with the variation of the first voltage
value relative to the first voltage value at a reference time point. The switch circuit
compares the charge occurring in the photodiode with a threshold value thereof,
instructs, based on the result of that comparison, the establishment of the capacitance
value of the integration capacitance part in the integrating circuit, and instructs the
selection circuit to select one of the first and second voltage values as an output
voltage value.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
METHOD OF STABILIZING
SIGNALS GENERATED BY A
SCINTILLATION DETECTOR
]22[
]51[
]71[
10.05.2004
Int. Cl.(2009.01) G01T 01/40
ICX RADIATION GMBH,
GERMANY
WO/2005/116692
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
]57[
273
179147
‫שיטה לייצוב סיגנלים הנוצרים על ידי גלאי‬
‫הבהוב‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
The invention relates to a method for stabilizing the signals generated by a scintillation
detector for measuring radiation, especially ionizing radiation, using the radiation
which is at least partially absorbed in the detector, said signals depending on the
operating temperature of the detector. According to said method, the temperaturedependent calibration factor K is determined from the signal shape of the signals
generated by the radiation to be measured itself.
October 31, 2010-‫כ"ג בחשון התשע"א‬
,201969
The applications for
division from this
application have not yet
been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
]54[
PROCESS FOR PREPARING 2OXO-1-PYRROLIDINE
DERIVATIVES BY
INTRAMOLECULAR
ALLYLATION
]22[
]31[
]51[
]71[
]87[
]74[
26.05.2005
04013715.0
]32[ 11.06.2004
Int. Cl.(2009.01) C07D 207/26
UCB, S.A., BELGIUM
WO/2005/121082
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
274
179650
‫–פירולידין‬1–‫–אוקסו‬2 ‫תהליך להכנת תולדות‬
‫באמצעות אלילציה תוך–מולקולרית‬
]33[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a new process for preparing 2-oxo-1-pyrrolidine
derivatives of general formula (I), comprising the cyclisation of an intermediate of
general formula (II) wherein the substituents are as defined in the specification
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
METHOD FOR PRODUCING
OPTICALLY ACTIVE
CYCLOPROPANECARBOXYLATE
COMPOUND
]22[
]31[
]51[
]71[
30.06.2005
2004-195253
]32[ 01.07.2004
Int. Cl.(2009.01) C07C 67/347
SUMITOMO CHEMICAL COMPANY,
LIMITED., JAPAN
WO/2006/004180
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]87[
]74[
]57[
275
179703
‫שיטה עבור ייצור תרכובת‬
‫ציקלופרופאנקרבוקסילאט פעילה‬
]33[
JP
,‫ד"ר יצחק הס ושותפיו‬
279 ‫רחוב הירקון‬
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
A method for producing an optically active cyclopropanecarboxylate compound
represented by the following formula (5): (wherein R6, R7, R8, R9 and R10 are as
defined below) is disclosed which is characterized by reacting an olefin represented by
the following formula (3): (wherein R6, R7, R8 and R9 respectively represent an alkyl
group having 1-6 carbon atoms or the like) and a diazoacetate represented by the
following formula (4): N2 CHCO2 10 (4) (wherein R10 represents an alkyl group having
1-6 carbon atoms) in the presence of an asymmetric copper complex obtained by
mixing (A) at least one monovalent or divalent copper compound, (B) at least one
optically active bisoxazoline compound represented by the following formula (1):
(wherein R1 and R2 respectively represent an alkyl group having 1-6 carbon atoms or
the like, R3 represents a tert-butyl group or the like, and R4 and R5 are the same and
respectively represent an alkyl group having 1-3 carbon atoms or the like), and (C) at
least one fluorine compound represented by the following formula (2): A--MF6 (2)
(wherein A represents a trityl group or the like, and M represents a phosphorus atom or
the like).
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
179708
‫פיקוח תחנה ניידת של ערוץ בקרה קדמי יעודי‬
‫במצב שידור מקוטע‬
]54[
MOBILE STATION SUPERVISION
OF THE FORWARD DEDICATED
CONTROL CHANNEL WHEN IN
THE DISCONTINUOUS
TRANSMISSION MODE
]22[
]31[
]51[
]62[
]71[
20.07.2000
09/358634
]32[ 21.07.1999
]33[ US
Int. Cl.(2009.01) H04B 07/185, 07/216, H04J 03/12, H04W 52/00
DIVISION FROM 147628
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/008439
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]87[
]74[
]57[
276
A method and apparatus for supervising a dedicated control channel when in the
discontinuous transmission mode. The mobile station (4) monitors the frames it
receives from a base station (2) and maintains a counter of bad, good, and empty
frames, referred to as COUNT1, COUNT2, COUNT3, respectively. If a received
frame is a good frame, COUNT1 is reset to zero and COUNT2 is incremented. If the
received frame is a bad frame, COUNT1 is incremented and COUNT2 is reset to zero.
If the received frame is an empty frame, COUNT1 and COUNT2 are unchanged but
COUNT3 is incremented. A transmitter coupled to the mobile station is enabled or
disabled depending upon which, if any, of the COUNTs reaches or exceeds a
designated threshold value.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
180028
‫סדר עדיפות לפקודות בדחיסת וידיאו דיגיטלית‬
]54[
DIGITAL VIDEO COMPRESSION
COMMAND PRIORITY
]22[
]31[
]51[
]71[
]72[
]87[
]74[
03.06.2005
10/875678
]32[ 25.06.2004
]33[
Int. Cl.(2009.01) G06K 09/36, H04N 07/34
AVOCENT CORPORATION, U.S.A.
ROBERT L. GILGEN
WO/2006/007263
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
]57[
277
US
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
A video compression system for compressing a stream of digital video data is
disclosed. Known run-length encoding is applied whenever possible to the digital
video data stream (62). When a run is not identified, the encoder determines whether a
consecutive series of pixels are identified from only two different colors, and if so
creates a make-series command to create bytes with bits encoded as a stream of binary
values corresponding to the two pixel colors as they occur in the consecutive series
(64). The make series command continues for as many bytes as the consecutive series
of bits will fill, except that, when a make series command applies again to a byte of
make-series bits, the make series command is preempted by the applicable run length
encoding (65).
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
MICROWAVE GENERATOR
]22[
]31[
]51[
]71[
08.06.2005
102004031333.4 ]32[ 29.06.2004
Int. Cl.(2009.01) H01J 07/00
DIEHL BGT DEFENCE GMBH & CO.
KG, GERMANY
WO/2006/000296
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]87[
]74[
]57[
278
180215
‫מחולל מיקרוגל‬
]33[
DE
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
The invention relates to a microwave generator which comprises a housing having two
opposite electrodes, separated by an electrode gap filled with a dielectric, and a spark
gap in between the two electrodes which sparks, thereby emitting microwaves, when a
high voltage is applied. In order to modify the microwave frequency, the electrode gap
(13, 13a, 13b) can at least be partially filled with a second dielectric (15, 15a, 15b)
having a permittivity that is different from that of the first dielectric (14, 14a, 14b),
present between the electrodes (6, 7). The second dielectric (15, 15a, 15b) is stored in a
reservoir (17, 17a, 17b) which communicates with the electrode gap (13, 13a, 13b).
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
180908
‫משחק חינוכי‬
]54[
EDUCATIONAL GAME
]22[
]31[
]51[
]71[
]74[
23.01.2007
60/766482
]32[ 22.01.2006
]33[ US
Int. Cl.(2009.01) A63F 03/00
MENASHE SCHWARTZ
‫כרכור‬-‫חנה‬-‫ פרדס‬,‫מנשה שורץ‬
YORAM TSIVION,
,‫יורם צביון‬
2 HATOCHEN ST.
‫ פארק התעשיה‬,2 ‫רח' הטוחן‬
P.O.B. 3148,
‫קיסריה‬3148 .‫ד‬.‫ ת‬,
CAESAREA 38900
A multiplication game comprising:
a perforated game board (20), wherein the assemblage of perforations forms a
rectangular matrix;
a horizontal row (24) of numerals printed on the rim of said board wherein said
numerals are evenly increasing in value from one end to the other end, and wherein
below each numeral a column of perforations is disposed;
a column (26) of numerals printed on the edge of said board wherein said numerals are
evenly inceasing in value from one end to the other end, and sideways from each
numeral a row of perforations is disposed;
a set of chips (22) the total number of which equals the product of the largest value in
said column multiplied by the largest value in said horizontal row, wherein each chip
is insertable in a cut-out window of said board, and wherein each chip has one numeric
value inscribed on its upper face, such that for each multiplication of any number in
said row with any number of said column there is found a matching numeral on a chip,
and
two sets of coloured stripes (30) printed on the upper face of said board, wherein all
the stripes in each set are parallel, and wherein each stripe in a set is uniquely
coloured, and
wherein all stripes in a set are perpendicular to all the stripes in the other set.
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
279
__________________
]11[]21[
]54[
SYSTEM AND METHOD FOR A
MULTIPLE TRACK PROFILE
WRAPPING MACHINE
]22[
]31[
]51[
]71[
14.08.2005
60/601115
]32[ 13.08.2004
Int. Cl.(2009.01) B29C 63/02
HARDOOR MECHANISMS
PRODUCTION LTD.
WO/2006/016373
BEN-AMI & ASSOCIATES,
8 PLAUT ST.,
PARK TAMAR,
P.O.B. 94,
REHOVOT 76100
]87[
]74[
]57[
280
181093
‫מערכת ושיטה מרובת מסלולים לציפוי‬
‫פרופילים‬
]33[
US
‫ לציון‬- ‫ ראשון‬,‫הרדור ייצור מנגנונים בע"מ‬
,'‫בן עמי ושות‬
8 ‫מנחם פלאוט‬
‫רחובות‬94 .‫ד‬.‫ ת‬,
Presented herein, is a machine for wrapping profiles utilizing fully operable profile
tracks (220, 221 ) and a glue delivering device including at least one glue delivery
device (20), at least one central axis (250), at least a pair of profile tracks (220, 221),
which rotate around a single axis wherein each pair of tracks may be positioned at a
different angle. The setup procedure is facilitated by allowing the cylinder (300) to
rotate 90 degrees to reposition the profile tracks (220, 221) perpendicularly in front of
the operator, allowing easy access to the adjustment pins.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
181334
]54[
15ß-SUBSTITUTED STEROIDS
HAVING SELECTIVE
ESTROGENIC ACTIVITY
]22[
]31[
05.09.2005
60/608501
]32[ 08.09.2004
]33[ US
04104334.0
08.09.2004
EP
Int. Cl.(2009.01) A61K 31/56, A61P 05/24, C07J 01/00
N.V. ORGANON, THE
NETHERLANDS
WO/2006/027347
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]51[
]71[
]87[
]74[
]57[
‫ בעלי פעילות‬ß 15 ‫סטרואידים מותמרים בעמדה‬
‫אסטרוגנית בררנית‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The invention provides 15beta-substituted steroidal compounds having selective
estrogen receptor activity according to Formula (I) wherein, R 1is H, C 1-5alkyl, C 1-12
acyl, di-(C 1-5alkyl)aminocarbonyl, (C1-5alkyl)oxycarbonyl or sulfamoyl, R 2is H, C13alkyl, C2-3alkenyl or C2-3alkynyl ,each of which may be optionally substituted with a
halogen, R 3is C1-2alkyl, ethenyl or ethynyl, each of which may be optionally
substituted with a halogen, and R 4is H or C 1-12acyl.
__________________
281
October 31, 2010-‫כ"ג בחשון התשע"א‬
]11[]21[
]54[
METHOD OF MIXING AUDIO
CHANNELS USING
CORRELATED OUTPUTS
]22[
]31[
]51[
]71[
]87[
]74[
26.08.2005
10/930659
]32[ 31.08.2004
Int. Cl.(2009.01) H04R 05/00
DTS, INC., U.S.A.
WO/2006/026463
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
181449
‫שיטה לערבוב ערוצי שמע באמצעות פלטים‬
‫מתואמים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A method of mixing audio channels (R, C, L) is effective at rebalancing the audio
without introducing unwanted artifacts or overly softening the discrete presentation of
the original audio. This is accomplished between any two or more input channels (R,
C, L) by processing the audio channels to generate one or more 'correlated' audio
signals for each pair of input channels. The in-phase correlated signal (150, 152)
representing content in both channels that is the same or very similar with little or no
phase or time delay is mixed with the input channels. The present approach may also
generate an out-of-phase correlated signal (same or similar signals with appreciable
time or phase delay) that is typically discarded and a pair of independent signals
(signals not present in the other input channel) that may be mixed with the input
channels.
__________________
]11[]21[
]54[
282
ELECTRIC DRIVE
TRANSMISSION
181491
‫תמסורת להנעה חשמלית‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
10.08.2005
0418967.6
]32[ 26.08.2004
Int. Cl.(2009.01) B62D 11/02, 11/16
QINETIQ LIMITED, UNITED
KINGDOM
WO/2006/021745
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]33[
GB
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
An electric drive transmission for a skid steered vehicle has a central casing (17)
housing a pair of propulsion motors (1a, 1b) comprising respective stators (18a, 18b)
and rotors (19a, 19b), each rotor being coupled to drive a respective through shaft
(21a, 21b) via a respective epicyclic gear change mechanism (22a, 22b). The through
shafts (21a, 21b) are coupled at their inboard ends to a controlled differential (6) with
an input from a steer motor (7), and are coupled at their outboard ends to respective
epicyclic gear reduction mechanisms including planet carriers (27a, 27b). The through
shafts (21a, 21b) are supported in the casing by respective bearings 30a, 30b and (32a,
32b) (the latter via planet carriers (27a, 27b)) and the propulsion motor rotors (19a,
19b) are supported on the through shafts by respective bearings (20a, 20b). By
supporting the rotors (19a, 19b) on the through shafts (21a, 21b) rather than in separate
bearings to the casing (17) the diameter and speed rating of the requisite rotor bearings
can be reduced.
__________________
]11[]21[
]54[
METHOD FOR MANAGING
MEANS FOR ACCESSING
CONDITIONAL ACCESS DATA
]22[
]31[
15.09.2005
04104509.7
283
]32[
17.09.2004
181495
‫שיטה לאמצעי ניהול עבור נגישות לנתוני גישה‬
‫מותנים‬
]33[
EP
October 31, 2010-‫כ"ג בחשון התשע"א‬
]51[
]71[
]87[
]74[
]57[
Int. Cl.(2009.01) H04N 07/16
NAGRAVISION S.A.,
SWITZERLAND
WO/2006/030021
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
The invention relates to a method for managing means for accessing conditional access
data, these data being broadcast to at least one multimedia unit. The access means are
managed by a management center and are associated with an item of time information.
The multimedia unit comprises at least one security module inside of which the means
for accessing data are stored. The multimedia unit also comprises remote means for
communicating with the management center and local means for communicating with
said security module. The inventive method is characterized by comprising the
following steps: determining, according to predetermined time intervals, via the
security module, the next expiration for renewing the access means; if the next
expiration for renewing the access means is nearer than a predefined period, sending,
via the security module, a request to the multimedia unit requesting the renewal of the
access means, this request using said local communication means; sending, via the
multimedia unit, this request for renewing the access means to the management center,
this request using said remote communication means; verifying, via the management
center, if the multimedia unit is authorized to renew the access means, and; in the
event of a positive reply, sending a message for renewing the access means to said
multimedia unit.
__________________
]11[]21[
]54[
SEALING MEANS FOR A CLOSURE,
CLOSURE AND PROCESS
]22[
]31[
02.08.2005
60/606240
60/661983
284
]32[
01.09.2004
14.03.2005
181627
‫ סוגר ותהליך ליצורו‬,‫אמצעי נעילה לסוגר‬
]33[
US
US
October 31, 2010-‫כ"ג בחשון התשע"א‬
]51[
]71[
]87[
]74[
]57[
PCT/EP05/51559
07.04.2005
PCT/EP05/51575
08.04.2005
Int. Cl.(2009.01) B65D 41/04
CREANOVA UNIVERSAL CLOSURES
LTD., UNITED KINGDOM
WO/2006/117024
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
WO
WO
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention is directed to a sealing means (2) for sealing of a neck (25) of a
container, especially a container for carbonated beverages. The sealing means
comprises a radially deformable outer sealing means (20) suitable to be engaged with
an outer free surface (17) of a neck (25) of the container. The outer sealing means (20)
comprises an annular base (22) which blends by a blend (34) into a vertical top surface
(35) and at least one annular sealing ring (23) arranged at a free end of the annular base
(22), protruding radially inwardly above the inner surface of the base (22) and forming
in engaged position with the neck (25) a first contact area (30) with the outer free
surface (17).
__________________
]11[]21[
]54[
DEVICE AND METHOD FOR
GENERATING A MULTI-CHANNEL
SIGNAL OR A PARAMETER DATA
SET
]22[
]31[
]51[
10.08.2005
DE102004043521.9 ]32[ 08.09.2004
Int. Cl.(2009.01) G10L 19/00
285
181743
‫התקן ושיטה לייצור אות רב–ערוצי או‬
‫קבוצת נתוני פרמטר‬
]33[
DE
October 31, 2010-‫כ"ג בחשון התשע"א‬
]71[
]87[
]74[
]57[
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V., GERMANY
WO/2006/027079
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
,'‫זליגסון גבריאלי ושות‬
31 ‫רח' יבנה‬
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
In order to carry out a flexible signaling of a synchronous mode or of an asynchronous
mode during multichannel parameter reconstruction, a parameter configuration
instruction is inserted into the data flow and is used by a configuration device on the
part of a multichannel decoder for configuring a multichannel reconstruction device. If
the parameter configuration instruction has a first meaning, the configuration device
searches within its input data for additional items of configuration information
whereas, when the parameter configuration instruction has another meaning, the
configuration device, based on items of information concerning an encoding algorithm
with which transmission channel data have been encoded, carry out a configuration
setting of the multichannel reconstruction device whereby efficiently and flexibly
ensuring that a correct allocation between parameter data and decoded transmission
channel data is always maintained.
__________________
]11[]21[
181959
‫ אחסונם והפצתם של‬,‫מכשיר ושיטה לקבלתם‬
‫שקיות דם‬
]54[
APPARATUS AND METHOD FOR
RECEIVING, STORING AND
DISTRIBUTING BLOOD BAGS
]22[
]51[
]71[
29.09.2004
Int. Cl.(2009.01) A61M 01/36, B65G 01/137
ANGELANTONI INDUSTRIE SPA,
ITALY
286
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
WO/2006/035465
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5352 .‫ד‬.‫ ת‬,
Method and apparatus (1) for receiving, storing and distributing blood bags
comprising a cabinet (1) for containing all the components of the apparatus (1);a
refrigerated space (21) for containing the bags; a magazine (3) housed inside the
refrigerated space (21) comprising a plurality of cells (31), each capable of containing
a single bag, each of the cells being identified by a cell code. The apparatus (1) further
comprises at least one door (4) for allowing access by an operator to the cells; a
movement system (5) housed inside the cabinet (2) and capable of moving, preferably
rotating, the cells (31); a cooling system (6) housed inside the cabinet (1) and capable
of cooling the refrigerated space (21). The apparatus (1) further comprises a data
processing system (7) housed inside the cabinet (2), capable of controlling the
movement system (5) and the cooling system (6), and capable of controlling the
receiving, the preservation and the releasing of the bags, and capable of exchanging
data from and to an external data-management system (17) with which the apparatus
(1) can interact. Onto the apparatus (1) there are provided a keyboard (8) and a screen
(9), both connected to the processing system (7), and both placed at the walls (23) of
the cabinet (2).
__________________
]11[]21[
]54[
287
PROCESS FOR GOOD PACKAGING,
NAMELY FOOD STUFFS,
PACKAGING AND KITS FOR THEIR
REALIZATION
182040
,‫ במיוחד דברי אוכל‬,‫תהליך לאריזה יעילה‬
‫אריזות וערכות לביצוע התהליך‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]22[
]31[
]51[
]71[
]87[
]74[
]57[
20.01.2005
RM2004A000472 ]32[ 01.10.2004
Int. Cl.(2009.01) B65B 31/04, B65D 88/16
LONG LIFE S.R.L., ITALY
WO/2006/038238
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]33[
IT
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A process for carrying out a packaging for food stuffs, such as hazelnuts, dried fruits,
or powdered milk, packaged in bulk, comprises the steps of: - provision of a big bag
container (2), - carrying out a filling of the above said product (P), into the big bag
container (2),- provision of a seal enclosure (3) susceptible of containing the big bag
container (2) with the above said filling of product (P) therein, and- sealing the
enclosure (3) containing the big bag container (2), with the above said filling of
product (P) therein, a sub atmospheric pressure level. Preferably, a protective inert gas,
such as nitrogen, is inserted into the enclosure (3) containing the big bag container (2).
__________________
]11[]21[
182562
‫שיטות לניקוי וירוסים‬
]54[
VIRAL PURIFICATION
METHODS
]22[
]31[
]51[
]71[
21.10.2005
60/621257
]32[ 22.10.2004
]33[ US
Int. Cl.(2009.01) A61K 35/66, 35/76, C12N 07/02
ONCOLYTICS BIOTECH INC.,
CANADA
288
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
WO/2006/042414
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention is directed to an improved method of purifying virus,
particularly reovirus. Infectious virus can be extracted from a cell culture with a
detergent to produce high titers of virus, and the virus can then be purified by simple
steps such as filtration and column chromatography. Viruses and compositions
comprising the viruses prepared according to the present invention are also provided.
__________________
]11[]21[
182720
‫ממטרה עם מתלבט מבוסס צמיגות‬
]54[
SPRINKLER WITH VISCOUS
HESITATOR
]22[
]31[
]51[
]71[
22.04.2007
11/409069
]32[ 24.04.2006
]33[ US
Int. Cl.(2009.01) B05B 03/04
NELSON IRRIGATION
CORPORATION, U.S.A.
MICHAEL TOWNSEND
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A sprinkler device comprising:
a rotatable shaft (12) having a cam (54), said cam having a radially outwardly
projecting shaft lobe;
a water distribution plate (16) supported on one end of the shaft and adapted to be
impinged upon by a stream (5) emitted from a nozzle causing said water distribution
plate and said shaft to rotate;
a hesitator assembly (10) supported on an opposite end of the shaft said assembly
including a stationary housing (14) having a sealed chamber (50) at least partially
filled with a viscous fluid, said shaft passing through said chamber, with said cam and
October 31, 2010-‫כ"ג בחשון התשע"א‬
]72[
]74[
]57[
289
shaft lobe located within said chamber; and a
rotor ring (56) located within said chamber in substantially surrounding relationship to
said cam, said rotor ring having two or more inwardly projecting hesitator lobes
movable into and out of a path of rotation of the shaft lobe, such that rotation of said
shaft and water distribution plate is slowed during intervals when the shaft lobe
engages and pushes past a respective one of said two or more hesitator lobes.
__________________
]11[]21[
182853
‫שיטת ציון לקביעת התאמת לבלב לבידוד אי‬
]54[
SCORING METHOD FOR
DETERMINING PANCREAS
SUITABILITY FOR ISLET
ISOLATION
]22[
]31[
]51[
]71[
]87[
]74[
14.11.2005
60/629227
]32[ 17.11.2004
]33[ US
Int. Cl.(2009.01) C12N 05/08, C12Q 01/02, G01N 03/50, G06F 19/00
THE ROGOSIN INSTITUTE, U.S.A.
WO/2006/055501
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]57[
290
The invention relates to a method for evaluating a pancreas as a source of
therapeutically useful islets. A scoring system is set forth whereby 5 criteria are listed.
If three criteria are positive, then the pancreas is a suitable source of therapeutically
useful islets.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
TOILET SEAT LIFTING AND
LOWERING DEVICE
]22[
]31[
28.10.2005
10/979039
]32[ 02.11.2004
11/187252
25.07.2005
Int. Cl.(2009.01) A47K 13/10
WILLIAM P. PANTOS, U.S.A.
CURTIS SWORD, U.S.A.
]51[
]71[
]87[
]74[
]57[
182916
‫התקן להרמה והורדה של מושב אסלה‬
]33[
US
US
WO/2006/050090
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
A toilet seat lifting and lowering device for pivoting the seat to its raised position and
for pivoting it back to its horizontal position without having to touch the seat. A first
lever arm is rigidly attached at one end to a first part of a torque transfer mechanism
and at its other end to a foot pedal and a second lever arm is rigidly attached at one end
to a second part of the torque transfer mechanism and at its other end to the toilet seat.
With the toilet seat in its horizontal position, a downward force on the pedal produces
a rotation of the first part of the torque transfer mechanism which produces an opposite
rotation of the second part of the torque transfer mechanism causing the toilet seat to
pivot to its raised position. Lifting the pedal, preferably by providing an upward force
under the pedal, lowers the seat to the horizontal position. In a preferred embodiment,
a counterweight positionable on the first lever arm is provided to provide a constant
torque to partially oppose the torque produced by the weight of the toilet seat about its
pivot axis. In a preferred embodiment, the first and second parts of the torque transfer
mechanism are both cams.
__________________
]11[]21[
]54[
]22[
]31[
]51[
291
182927
‫סוגר עם איוורור עצמי‬
SELF-VENTING CLOSURE
08.11.2005
04105712.6
]32[ 11.11.2004
Int. Cl.(2009.01) B65D 51/16
]33[
EP
October 31, 2010-‫כ"ג בחשון התשע"א‬
]71[
]87[
]74[
]57[
OBRIST CLOSURES SWITZERLAND
GMBH, SWITZERLAND
WO/2006/051068
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A closure 10 for a container, comprises a substantially circular base 20, a skirt 30
extending from the periphery thereof, a bore seal 50 in the form of an annulus and a rib
70 lying on the surface of the base 20 in a substantially radial direction and in contact
with the radially inner surface of the bore seal 50 at one end for transferring any
movement of the centre of the base 20, relative to the skirt 30, to the bore seal 50 such
that the bore seal 50 is pulled radially inward to allow venting of excess pressure
within the container, wherein the end of the rib 70 in contact with the radially inner
surface of the bore seal 50 is substantially thinner, in a plane parallel to the base 20,
than the other end of the rib 70.
__________________
]11[]21[
183098
]54[
HOLDING DEVICE FOR
RECEIVING A MOBILE
TELEPHONE
]22[
]31[
]51[
]71[
]87[
]74[
21.12.2005
102004062177.2 ]32[ 21.12.2004
]33[
Int. Cl.(2009.01) B60R 11/02, H04M 01/04
BURY SP. Z.O.O., POLAND
WO/2006/066893
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]57[
292
‫התקן החזקה לקבלת טלפון נייד‬
DE
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1352 .‫ד‬.‫ ת‬,
The invention relates to a holding device provided with a receiving system for
October 31, 2010-‫כ"ג בחשון התשע"א‬
receiving a mobile telephone (30, 30'), said holding device comprising a housing (1).
The receiving system is formed by at least two lateral jaws (3) projecting from a rear
wall of the housing (1), at least one of said jaws being laterally displaceable and both
of said jaws being provided with padding (5) that can be compressed by from lateral
housing walls of the mobile telephone (30, 30'). The distance between the jaws (3) can
be adjusted to the width of the mobile telephone (30, 30') by means of an adjusting
device (11) provided in the rear wall (2). The adjusted jaws (3) remain fixed for the
insertion and the removal of the mobile telephone (30, 30'), and the mobile telephone is
fixed in the holder exclusively by means of a friction connection produced between the
compressible padding (5, 6) and the mobile telephone (30, 30'). The aim of the
invention is to create a universal holding device for different types of mobile telephone
(30, 30'). To this end, the adjusting device (11) comprises a rotatably arranged plate
(15) that is connected to the two jaws (3), and can be fixed in the rotary position
thereof by means of a centrally arranged screw. The screw head (14) can be actuated
on the rear wall (2) and covered by the inserted mobile telephone (30, 30').
__________________
]11[]21[
183335
‫אנטגוניסטים של לפטין‬
]54[
LEPTIN ANTAGONISTS
]22[
]31[
]51[
]71[
24.11.2005
10/966607
]32[ 26.11.2004
]33[ US
Int. Cl.(2009.01) A61K 38/22, C07K 14/575, C12N 15/10
YISSUM RESEARCH
‫יישום חברה לפיתוח המחקר של‬
DEVELOPMENT COMPANY OF
,‫האוניברסיטה העברית בירושלים בע"מ‬
THE HEBREW UNIVERSITY OF
‫ירושלים‬
JERUSALEM LTD
UNIVERSITE PIERRE ET MARIE
CURIE ( PARIS 6 ), FRANCE
INSTITUT NATIONALE DE LA
RECHERCHE AGRONOMIQUE,
293
October 31, 2010-‫כ"ג בחשון התשע"א‬
]72[
]87[
]74[
]57[
FRANCE
ARIEH GERTLER, ISABELLE
CALLEBAUT, JEAN DJIANE
WO/2006/056987
BEN-AMI & ASSOCIATES,
8 PLAUT ST.,
PARK TAMAR,
P.O.B. 94,
REHOVOT 76100
‫ ז'אן דז'יאן‬,‫ איזבל קייבו‬,‫אריה גרטלר‬
,'‫בן עמי ושות‬
8 ‫מנחם פלאוט‬
‫רחובות‬94 .‫ד‬.‫ ת‬,
The invention relates to synthetic leptin antagonists in which at least two amino acid
residues of the sequence LDFI/S of the hydrophobic binding site at positions 39-42 of
a leptin polypeptide sequence are substituted with different amino acid residues such
that the site becomes less hydrophobic, and fragments of said leptin antagonists.
__________________
]11[]21[
]54[
IN VITRO METHOD FOR
SIMULTANEOUSLY DETECTING
AND IDENTIFYING ANTIBIOTICS
OF DIFFERENT CLASSES AND
CORRESPONDING DIAGNOSTIC
KIT
]22[
]31[
]51[
]71[
]87[
]74[
13.04.2006
05447079.4
]32[ 14.04.2005
Int. Cl.(2009.01) G01N 33/558, 33/94
UNISENSOR S.A., BELGIUM
WO/2006/108248
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]57[
294
186636
‫ לזיהוי אנטיביוטיקה‬IN VITRO ‫שיטת‬
‫מקבוצות שונות וערכה דיאגנוסטית תואמת‬
]33[
EP
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
The invention concerns a diagnostic kit for simultaneous assay of antibiotics of
different classes, characterized in that it comprises: a single reaction mixture
containing at least one first labelled receptor, specific of recognition of ß-lactams, a
second labelled receptor, specifically and competitively identifying a tetracycline and a
biotinylated nucleic acid fragment, an antisulfamide antibody and a labelled sulfamide
analogue; and a recovery system in the form of a solid support comprising a
nitrocellulose membrane whereon are fixed in three separate testing zones,
respectively an antibiotic with ß-lactam nucleus, an avidin and an antibody capable of
October 31, 2010-‫כ"ג בחשון התשע"א‬
specifically identifying the antisulfamide antibody, so that the labelling intensity
detected on the recovery system at the three testing zones results independently from a
competitive recognition of each antibiotic by its labelled receptor.
__________________
]11[]21[
187143
‫נגזרות פניל כמעכבי ספיגה מחדש של סרוטונין‬
]54[
PHENYL DERIVATIVES AS
SEROTONIN REUPTAKE
INHIBITORS
]22[
]31[
]51[
02.10.2002
PA200101466 ]32[ 04.10.2001
]33[ DK
Int. Cl.(2009.01) A61K 31/445, 31/55, A61P 25/00, C07D 211/20, 211/70, 221/20,
223/04, 223/14, 401/12, 405/12, 409/12
DIVISION FROM 160655
H. LUNDBECK A/S, DENMARK
WO/2003/029232
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
124 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11490 .‫ד‬.‫ ת‬,
TEL AVIV 62038
]62[
]71[
]87[
]74[
]57[
295
The invention provides compounds represented by the general formula I Iwherein the
substituents are defined in the application. The compounds are useful in the treatment
of an affective disorder, including depression, anxiety disorders including general
anxiety disorder and panic disorder and obsessive compulsive disorder.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
187185
‫כיול עבור מערכת איתור אלחוטית‬
]54[
CALIBRATION FOR WIRELESS
LOCATION SYSTEM
]22[
]31[
]51[
]62[
]71[
]87[
]74[
13.12.1999
09/227764
]32[ 08.01.1999
]33[
Int. Cl.(2009.01) G01S 01/20, 01/24, 05/02
DIVISION FROM 175537
TRUEPOSITION, INC., U.S.A.
WO/2000/041403
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
An internal calibration method for calibrating a first receiver system, wherein said first
receiver system is characterized by a time- and frequency-varying transfer function,
said transfer function defining how the amplitude and phase of a received signal will
be altered by said first receiver system, and wherein the first receiver system is utilized
in a location system that is operative to determine the location of a mobile transmitter
by, in part, determining a difference in time of arrival of a signal transmitted by a
mobile transmitter and received by said first receiver system and another receiver
system, and wherein the accuracy of the location determination is dependent, in part,
upon the accuracy of time measurements made by said receiver system, the method
comprising the step of:
(A) injecting an internally generated stable, known signal into said first receiver
system;
(B) utilizing the internally generated stable, known signal to obtain an estimate of the
manner in which said transfer function varies across the bandwidth of said first
receiver system; and
(C) utilizing said estimate to mitigate the effects of said variation of the first transfer
function on the time measurements made by the first receiver system.
296
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
187447
]54[
REFILLABLE DEVICE AND
METHOD OF FILLING
]22[
]31[
]51[
]71[
]87[
]74[
04.06.2006
168994
]32[ 03.06.2005
]33[
Int. Cl.(2009.01) B05B 11/00, B65D 83/14
ADORAM LESHEM
WO/2006/129322
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]57[
297
‫התקן המתמלא ושיטה למלא אותו‬
IL
‫אביב‬-‫ תל‬,‫אדורם לשם‬
,'‫זליגסון גבריאלי ושות‬
31 ‫רח' יבנה‬
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
A refillable device for containing and dispensing a product fillable from a donor
container comprising a spray dispenser, the device comprising: a hollow body for
receiving and storing the product, and having a sealable opening wherethrough product
is fillable into the body; a dispensing mechanism for dispensing the product; and an
interface arrangement for facilitating interfacing between the refillable device and the
spray dispenser of the donor container.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
]54[
ONE-WAY INJECTOR WITH
CONTINUOUSLY CHARGED
SPRING ENERGY STORE
]22[
]31[
]51[
]71[
07.12.2006
102005062206.2 ]32[ 24.12.2005
Int. Cl.(2009.01) A61M 05/315
LTS-LOHMANN THERAPIESYSTEME AG, GERMANY
HANS-RAINER HOFFMANN
WO/2007/073839
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]72[
]87[
]74[
]57[
298
187582
‫מזרק חד–כיווני עם מלאי אנרגיה בקפיץ טעון‬
‫ברציפות‬
]33[
DE
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬2081 .‫ד‬.‫ ת‬,
The invention relates to a one-way injector having a housing in which at least one
mechanical spring energy store, at least one piston/cylinder unit, which can be at least
temporarily filled with an active substance, at least one piston-actuating plunger and at
least one tripping unit are arranged. To this end, the spring energy store comprises a
preloaded spring element. The spring element is held in the preloaded position by a
tension means surrounding at least a region of the spring. The tripping unit comprises a
cutting tool which, in order to release the energy of the spring energy store, severs or
weakens the tension means at at least one point, the weakening immediately tearing the
tension means. With the present invention, a one-way injector is developed which,
with a small overall size, has only a few components and ensures reliable mounting
and functioning with simple manipulation.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
188515
‫קוהרנטיות תדר בתוך רשת מיקום‬
]54[
FREQUENCY COHERENCE
WITHIN A LOCATION
NETWORK
]22[
]31[
]51[
]62[
]71[
01.11.2002
PR8634
]32[ 02.11.2001
]33[ AU
Int. Cl.(2009.01) G01S 01/00, 01/02, 05/00, 05/02, H04W 64/00
DIVISION FROM 161718
QX CORPORATION PTY LTD.,
AUSTRALIA
WO/2003/038469
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM STREET
31 ‫רחוב אחד העם‬
P.O. BOX 2499
‫תל אביב‬2499 .‫ד‬.‫ ת‬,
TEL AVIV 65202
A method of generating frequency coherence between a received reference positioning
signal transmitted by at least one reference transmitter and a unique positioning signal
generated by a positioning-unit device, said method comprising the steps of:
(a) receiving said reference positioning signal;
(b) measuring the frequency offset of said received reference positioning signal
relative to a common oscillator;
(c) adjusting a frequency steerable clock by an amount derived from said measured
frequency offset (b);
(d) generating said unique positioning signal, wherein said unique positioning signal is
aligned with said frequency steerable clock;
(e) contimuiusly adjusting said unique positioning signal by applying said measured
frequency offset (b) to said frequency steerable clock, said frequency steerable clock
referenced to said common oscillator;
such that the frequency of said adjusted unique positioning signal is aligned with the
frequency of said reference positioning signal.
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
299
__________________
]11[]21[
188516
‫הפעלה בין–רשתית של רשתות מרובות מיקום‬
]54[
INTER-NETWORK OPERATION
OF MULTIPLE LOCATION
NETWORKS
]22[
]31[
]51[
]62[
]71[
01.11.2002
PR8634
]32[ 02.11.2001
]33[ AU
Int. Cl.(2009.01) G01S 01/24, 03/02, 05/14, H04W 64/00
DIVISION FROM 161718
QX CORPORATION PTY LTD.,
AUSTRALIA
WO/2003/038469
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM STREET
31 ‫רחוב אחד העם‬
P.O. BOX 2499
‫תל אביב‬2499 .‫ד‬.‫ ת‬,
TEL AVIV 65202
A method for allowing a position receiver to determine position solutions from
positioning signals from a plurality of autonomous positioning networks within a
positioning system, wherein:
(a) each autonomous positioning network is synchronized to a different timebase;
(b) each of said plurality of autonomous positioning networks comprises one or more
positioning-unit device;
(c) a position receiver is situated near the boundary of two of said plurality of
autonomous positioning networks;
(i) said method comprising the steps of:
at least one positioning-unit device within a first autonomous positioning network
receives positioning signals from at least one positioning-unit device from a
second autonomous positioning network and measures the timebase difference
between said second autonomous positioning network and said first autonomous
October 31, 2010-‫כ"ג בחשון התשע"א‬
]87[
]74[
]57[
300
positioning network and subsequently calculates a timebase clock correction;
(ii) said at least one positioning-unit device within said first autonomous
positioning network incorporates said timebase clock correction into its
positioning signals for transmission;
(iii) other positioning-unit devices within said first autonomous positioning
network receive and relay said positioning signals incorporating said timebase
clock correction;
(iv) said position receiver receives positioning signals incorporating said timebase
clock correction from any positioning-unit device within said first autonomous
positioning network;
(v) said position receiver receives positioning signals from said one or more
positioning-unit devices from said second autonomous positioning network;
(vi) said position receiver applies said timebase clock correction to said
positioning signals received from said one or more positioning-unit devices from
said second autonomous positioning network; and
(vii) said position receiver calculates its own position using said positioning
signals from said first autonomous positioning network and said positioning
signals from said second autonomous positioning network;
such that positioning signals received from positioning-unit devices from said first
and second autonomous positioning network that are synchronized to different
timebases can be used for position solution.
__________________
]11[]21[
188710
‫חומצת גרעין וחלבון המקודד על–ידה‬
]54[
NUCLEIC ACID AND PROTEIN
ENCODED THEREBY
]22[
]31[
15.01.2002
A60/2001
]32[ 16.01.2001
]33[ AT
A523/2001
03.04.2001
AT
Int. Cl.(2009.01) C07K 19/00, C12N 09/88, 15/29, 15/60, C12P 13/00
DIVISION FROM 147635
DSM FINE CHEMICALS AUSTRIA
]51[
]62[
]71[
301
October 31, 2010-‫כ"ג בחשון התשע"א‬
]74[
]57[
NFG GMBH & CO. KG, AUSTRIA
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
Isolated nucleic acid, comprising the nucleic acid sequence shown in figure 8 from
nucleotide 1 until nucleotide 2083 continuously or without the intron regions from
nucleotide 104 until 249, 907 until 1047 and 1889 until 1993.
__________________
]11[]21[
189157
]54[
CDMA SYSTEM WHICH USES
PRE-ROTATION BEFORE
TRANSMISSION
]22[
]31[
]51[
]62[
]71[
28.03.2001
60/192670
]32[ 28.03.2000
]33[
Int. Cl.(2009.01) H04B 01/707, H04L 27/00
DIVISION FROM 151905
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2001/073968
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]87[
]74[
]57[
302
‫ המשתמשת בקדם–סיבוב לפני‬CDMA ‫מערכת‬
‫העברה‬
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A mobile station comprising a receiver and transmitter, the receiver including:
an antenna configured to receive a communication signal, the communication
signal including a plurality of individual channels;
an adaptive matched filter configured to filter said received signal and generate a
filtered signal using a weighting signal;
an analyzer configured to analyze said received signal for errors and generate a
correction signal for a subset of said individual channels based on said analysis,
said analyzer further including:
at least one despreader configured to despread said filtered signal using a pilot
signal, and provide a despread filtered signal;
a processor configured to perform a hard decision on said despread filtrerd signal
and generate symbol outputs therefrom; and
an error correction generator circuit configured to generate said correction signal;
and
a correction unit configured to correct said received signal at the symbol level by
using said correction signal, said correction removing a phase error from said
October 31, 2010-‫כ"ג בחשון התשע"א‬
dispread filtered signal.
The applications for division
from this application have
not yet been published
,203410
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________________
]11[]21[
190542
‫ריצפי חומצות אמינו העוזרים לחדירת חומר בעל‬
‫התענינות לתוך תאים או גרעיני תאים‬
]54[
AMINO ACID SEQUENCES
FACILITATING PENETRATION
OF A SUBSTANCE OF INTEREST
INTO CELLS OR CELL NUCLEI
]22[
]31[
]51[
01.03.2001
00/02621
]32[ 01.03.2000
]33[ FR
Int. Cl.(2009.01) A61K 48/00, C07K 05/11, 07/06, 07/08, 14/47, 17/14, C12N 01/19,
05/10, 15/87
DIVISION FROM 151399
DIATOS
WO/2001/064738
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
Amino acid sequence having the capability of facilitating penetration of a substance of
interest into cells or cell nuclei, characterized in that said sequence has less than 25
amino acid and consists of a dimer of a peptide derived from the C-terminal portion of
the human superoxide dismutase sequence capable of reaction in vivo with heparintype aminoglycans, chondroitin sulphates and the derivatives thereof.
]62[
]71[
]87[
]74[
]57[
303
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
193813
‫נגזרות אלקילאמין מותמרות ותכשירים‬
‫פרמצבטיים הכוללים אותם‬
]54[
SUBSTITUTED ALKYLAMINE
DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS THEREOF
]22[
]31[
11.01.2002
60/261339
]32[ 12.01.2001
]33[ US
60/323764
19.09.2001
US
10/046681
10.01.2002
US
Int. Cl.(2009.01) A61K 31/395, 31/435, A61P 35/00, C07D 401/12, 401/14, 405/14,
409/14, 413/14, 417/14, 471/04
DIVISION FROM 156751
AMGEN INC., U.S.A.
WO/2002/066470
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬2273 .‫ד‬.‫ ת‬,
]51[
]62[
]71[
]87[
]74[
]57[
Selected heterocyclic compounds are effective for prophylaxis and treatment of
diseases, such as angiogenesis mediated diseases. The invention encompasses novel
compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof,
pharmaceutical compositions and methods for prophylaxis and treatment of diseases
and other maladies or conditions involving, cancer and the like. The subject invention
also relates to processes for making such compounds as well as to intermediates useful
in such processes.
__________________
]11[]21[
]54[
WORM REDUCER
]22[
]51[
]71[
]74[
01.12.2008
Int. Cl.(2009.01) F16H 01/16, 03/06
GRIGORI PERLOV
GRIGORI PERLOV,
6/17 HAHASIDA ST.,
HADERA
304
195629
‫רדוקטור תולעי‬
‫ חדרה‬,‫גרגורי פרלוב‬
,‫גרגורי פרלוב‬
6/17 ‫החסידה‬
‫חדרה‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
]57[
305
A worm reducer which is a two-stage two-worm globoidal mechanism assembled
in a single metal or plastic casing that can be used to transmit rotary motion from
the driving mechanism to the driven one, comprising: a first stage of the worm
reducer contains one worm (1), which is a wheel with a small number of teeth and
is similar to a screw with acme thread, the same first stage also contains two
worm wheels (2,3), the axes of rotation (18, 19) of these worm wheels are
parallel to each othe and intersect in space with the axis of rotation (17) of the
worm, said worm wheels being located symmetrically with respect to the worm so
that their axes of rotation lie in the plane perpendicular to the axis of rotation of
the worm, to increase the length of contact helixes in a worm gearing, the worm
wheels are shaped as arcs in the axial section, the first stage worm gearing is a
globoidal one, where the driving number is the worm, while the driven members
are two worm wheels that receive the load simultaneously and are moving in
synchronism, the first stage of the said reducer is interconnected in its design with
a second stage that has four semi-worms (4, 5, 6, 7), each semi-worm being a
rotating element in the form of a truncated half ellipse , which rotates around its
larger center line, said semi-worms are mounted in pairs on the shafts of the firststage worm wheels in such a way that they resemble a barrel which is cut in two
halves along its larger diameter and the halves are spaced apart along the axis of
rotation and between them one of the first-stage worm wheels is located on the
shaft, the second stage of the reducer also contains a large worm wheel (11) which
is a rim with teeth on its near side where the teeth of the large worm wheel have
the form of arcs in axial section to increase the length of contact helixes when
engaged with the semi-worm, so that the second-stage gearing is an internal worm
globoidal gearing, where the driving members are semi-worms which are rotating
in synchronism both between themselves and the first-stage worm wheels with
which they are rigidly fixed on the shaft, while the driven member is the large
worm wheel, the reducer is built in such a way that the axis of rotation of the fiststage worm shaft (the worm of the first stage being the driving member in the
reducer) and the axis of rotation of the large worm wheel shaft (the large worm
shaft being the driven member of the reducer) are located on the central axis of
rotation of the reducer, and owing to this the reducer is concentric, the said
reducer can also operate as a multiplicator and to this end the following conditions
should be met: the lead angle of the the worm thread helix must be larger than the
friction angle of the worm thread helix and the lead angle of the semi-worms
thread helixes must be larger than the friction angle of the semi-forms thread
helixes, to meet these conditions the worm and semi-worms must be made multithread, that is the number of threads must be not less than three, the reducer and
multiplicator rotate in the same way clockwise and counterclockwise, the said
worm reducer in combination with any motor can form a compact unit such as a
motor reducer.
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
__________________
]11[]21[
]54[
PROJECTION OBJECTIVE,
PROJECTION EXPOSURE
SYSTEM, AND METHOD FOR
FABRICATING
SEMICONDUCTOR DEVICES
]22[
]31[
06.05.2004
2003-128154 ]32[ 06.05.2003
2003-350647
09.10.2003
2003-364596
24.10.2003
Int. Cl.(2009.01) G02B 17/08
]51[
306
196081
‫ ושיטה‬,‫ מערכת חשיפת הקרנה‬,‫מטרת הקרנה‬
‫לייצור התקנים מוליכים למחצה‬
]33[
JP
JP
JP
October 31, 2010-‫כ"ג בחשון התשע"א‬
]62[
]71[
]72[
]87[
]74[
]57[
307
DIVISION FROM 171745
NIKON CORPORATION, JAPAN
YASUHIRO OMURA
WO/2004/107011
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45087 .‫ד‬.‫ ת‬,
JERUSALEM 91450
A catadioptric projection objective (PL1) for imaging an off-axis object field
arranged in an object surface of the projection objective onto an off-axis image
field arranged in an image surface of the projection objective while creating at
least one intermediate image comprising in that order along an optical axis (AX1);
a front lens group (L1-L5) having positive refractive power for converging
radiation coming from the object field towards a mirror group entry of a mirror
group (M1-M4), the mirror group having the object side mirror group entry, an
image side mirror group exit, and a mirror group plane defined transversly to the
optical axis and arranged geometrically between the mirror group entry and the
mirror group exit; and a rear lens group (L1-L8) positive refractive power for
focusing radiation emerging from the mirror group exit onto the image surface;
the mirror group having: a first mirror (M1) for receiving radiation from the
mirror group entry on a first reflecting area; a second mirror (M2) for receiving
radiation reflected from the first mirror on a second reflecting area; a third mirror
(M3) for receiving radiation reflected from the second mirror on a third reflecting
area; and a fourth mirror (M4) for receiving radiation reflected from the second
mirror on a third reflecting area and for reflecting the radiation to the mirror group
exit; at least two of the mirrors being concave mirrors having a concave mirror
surface having a surface of curvature rotationally symmetric to the optical axis;
wherein: the mirrors of the mirror group are arranged such that at least one
intermediate image is positioned inside the mirror group between mirror group
entry and mirror group exit, and that radiation coming from the mirror group entry
passes at least four times through the mirror group plane and is reflected at least
twice at a concave mirror surface of the mirror group prior to exiting the mirror
group at the mirror group exit; the mirror group entry positioned in a region where
radiation exiting the front lens group has an entry chief ray height; the second
reflecting area is positioned in a region where radiation impinging on the second
mirror has a second chief ray height deviating from the entry chief ray height in a
first direction; and the fourth reflecting area is positioned in a region where
radiation impinging on the fourth mirror has a fourth chief ray height deviating
from the entry chief ray height in a second direction opposite to the first direction.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
196201
‫ מבנה מיגון ושיטה לייצורם‬,‫קיר מיגון‬
]54[
PROTECTIVE WALL AND
STRUCTURE AND A METHOD
FOR MANUFACTURING SAME
]22[
]51[
]71[
]74[
25.12.2008
Int. Cl.(2009.01) E04C 02/34, E04H 09/00, F41H 05/04
ISKOOR SHELTERS LTD.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]57[
308
‫ רמלה‬,‫איסכור מיגון בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬26 ‫רחוב הברזל‬
‫רמת החייל‬
A protective wall (12) comprising an inside panel (50) and an outside panel (52)
maintained in a spaced apart relation forming therebetween a space occupied by a
filler material (88) and a plurality of support links (54, 56), altermatingly
extending from an inside surface (58, 160) of one the inside panel and the outside
panel to another of the inside panel and outside panel, wherein the support links
are Z or S like shaped, and the support links are fixedly attached at one end only
to the inside surface of either the inside panel or the outside panel and further
wherein the support links have a height h greater than a length 1.
October 31, 2010-‫כ"ג בחשון התשע"א‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
__________________
]11[]21[
196873
‫שיטה לזיהוי גואנילט ציקלז מסיס באמצעות‬
‫פליטת אור‬
]54[
LUMINESCENT NETHOD OF
DETECTING SOLUBLE
GUANYLATE CYCLASE
]22[
]31[
]51[
]62[
]71[
19.08.2000
19944226.6
]32[ 15.09.1999
]33[ DE
Int. Cl.(2009.01) C12Q 01/25, 01/527, 01/66, G01N 33/50
DIVISION FROM 148600
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2001/020023
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬12704 .‫ד‬.‫ ת‬,
HERZLIYA 46733
]87[
]74[
]57[
309
The invention relates to a method for the detection of a soluble guanylate cyclase,
whose haem iron is present in a trivalent oxidation state and a method for detecting
chemical substances which stimulate the activity of soluble guanylate cyclase when
said haem iron present in soluble guanylate cyclase is at least in part trivalently
oxidized. Said invention also relates to a diagnostic agent for detecting a soluble
guanylate cyclase containing trivalent haem iron.
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
197280
]54[
N1-(2-AMINO)CYCLOHEXYL- N2(ARYL)ETHANEDIAMIDE
DERIVATIVES
]22[
]31[
20.06.2002
2001-187105
]32[ 20.06.2001
]33[ JP
2001-243046
09.08.2001
JP
2001-311808
09.10.2001
JP
2001-398708
28.12.2001
JP
PCT/JP02/02683
20.03.2002
WO
Int. Cl.(2009.01) A61K 31/381, 31/426, 31/44, 31/4965, 31/505, A61P 07/02, C07C
237/24, C07D 213/75, 237/20, 239/42, 241/20, 277/46, 333/36
DIVISION FROM 159438
DAIICHI SANKYO COMPANY,
LIMITED, JAPAN
WO/2003/000680
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
]51[
]62[
]71[
]87[
]74[
]57[
310
N2 – ‫ – אמינו) ציקלוהקסיל‬N – (21 ‫ניגזרות‬
‫– (אריל) את'אנאדימיד‬
Compounds represented by the following general formula (1), salts thereof, solvates of
the same or N−oxides of the same: Q1−Q2−T0−N(R1)−Q3−N(R2)−T1−Q4 (1)
wherein R1 and R2 represent each hydrogen, etc.; Q1 represents optionally
substituted, saturated or unsaturated 5− or 6−membered hydrocarbyl, etc.; Q 2
represents a single bond, etc.; Q3 represents the following group;
(wherein Q5 represents C1−8 alkylene, etc.); and T0 and T1 represent each
carbonyl, etc. These compounds are useful as preventives and/or remedies for
brain infarction, cerebral embolism, myocardial infarction, angina, pulmonary
infarction, pulmonary embolism, Buerger’s disease, bottom venous thrombosis,
disseminated intravascular coagulation, thrombosis following artificial valve/joint
replacement, thrombosis and reocclusion following circulation reconstruction, systemic
inflammatory responsive syndrome (SIRS), multiple organ dysfunction (MODS),
thrombosis in extracorporeal circulation or blood coagulation in collecting blood.
October 31, 2010-‫כ"ג בחשון התשע"א‬
The parent application from which this
application has been divided has not yet
been published
159438
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
__________________
]11[]21[
197281
]54[
N - (2 - AMINO)CYCLOHEXYL)(BICYCLICHETROCYCLYL)CARBOXAMIDE
DERIVATIVES
]22[
]31[
20.06.2002
2001-187105
]32[
20.06.2001
]33[ JP
2001-243046
09.08.2001
JP
2001-311808
09.10.2001
JP
2001-398708
28.12.2001
JP
PCT/JP02/02683
20.03.2002
WO
Int. Cl.(2009.01) A61K 31/428, 31/429, 31/4355, 31/4365, 31/437, 31/4436, 31/4439,
31/498, 31/5025, A61P 07/02, C07D 277/68, 471/04, 495/04, 498/04, 513/04
DIVISION FROM 159438
DAIICHI SANKYO COMPANY, LIMITED, JAPAN
WO/2003/000680
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
279 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬6451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
]51[
]62[
]71[
]87[
]74[
]57[
311
–N – (2 ‫נגזרות‬
– )‫אמינו)ציקלוהקסיל‬
)‫(ביציקליקהטרוציקליל‬
‫קארבוקסאמיד‬
Compounds represented by the following general formula (1), salts thereof, solvates of
the same or N−oxides of the same: Q1−Q2−T0−N(R1)−Q3−N(R2)−T1−Q4 (1)
wherein R1 and R2 represent each hydrogen, etc.; Q1 represents optionally
substituted, saturated or unsaturated 5− or 6−membered hydrocarbyl, etc.; Q 2
represents a single bond, etc.; Q3 represents the following group; (wherein
Q5 represents C1−8 alkylene, etc.); and T0 and T1 represent each carbonyl, etc.
These compounds are useful as preventives and/or remedies for brain infarction,
cerebral embolism, myocardial infarction, angina, pulmonary infarction, pulmonary
October 31, 2010-‫כ"ג בחשון התשע"א‬
embolism, Buerger’s disease, bottom venous thrombosis, disseminated intravascular
coagulation, thrombosis following artificial valve/joint replacement, thrombosis
and reocclusion following circulation reconstruction, systemic inflammatory responsive
syndrome (SIRS), multiple organ dysfunction (MODS), thrombosis in extracorporeal
circulation or blood coagulation in collecting blood.
159438
The parent application from which this application has
been divided has not yet been published
‫בקשת הורה לבקשה זו‬
‫שטרם פורסמה‬
__________________
]11[]21[
198562
‫פפטידים חדשים‬
]54[
NOVEL PEPTIDES
]22[
]31[
24.07.2000
210002/1999
]32[ 23.07.1999
]33[ JP
1338841/1999
29.11.1999
JP
126623/2000
26.04.2000
JP
Int. Cl.(2009.01) A61K 38/27, 48/00, A61P 05/06, C07K 14/61, C12N 15/11, 15/12
DIVISION FROM 147652
KENJI KANGAWA, JAPAN
WO/2001/007475
DANIEL FREIMANN & CO.,
,'‫דניאל פריימן ושות‬
5 DROYANOV ST., 10TH FLOOR ,
10 ‫ בית כלל קומה‬5 ‫דרויאנוב‬
TEL AVIV 63143
‫תל אביב‬
A peptide-type compound,
(a) which comprises one amino acid sequence selected from the group consisting
of amino acid sequences set forth in SEQ ID NOS: 1, 2, 3, 8, 9, 10, 11, 16, 17, 22,
25, 26, 27, 28, 29, 30 and 31, or an amino acid sequence thereof wherein one to
several amino acids may be deleted, replaced and/or added, with the proviso that
the amino acid sequence shown by SEQ ID NO: 5 and SEQ ID NO: 40 is
excluded; and
(b) which has an activity of increasing the intracellular calcium ion concentration,
or a pharmaceutically acceptable salt thereof.
]51[
]62[
]71[
]87[
]74[
]57[
312
October 31, 2010-‫כ"ג בחשון התשע"א‬
__________________
]11[]21[
201372
‫התקן ושיטה לייצור אות רב – ערוצי או קבוצת‬
‫נתוני פרמטר‬
]54[
DEVICE AND METHOD FOR
GENERATING A MULTI-CHANNEL
SIGNAL OR A PARAMETER DATA
SET
]22[
]31[
]51[
]62[
]71[
10.08.2005
102004043521.9 ]32[ 08.09.2004
]33[ DE
Int. Cl.(2009.01) G10L 19/00
DIVISION FROM 181743
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V., GERMANY
WO/2006/027079
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
31 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1426 .‫ד‬.‫ ת‬,
TEL AVIV 61013
Device for generating a parameter data output which, together with transmission
channel data including M transmission channels, represent N original channels,
wherein M is less than N and is equal to or larger than 1, using input data, wherein
the input data comprise a parameter configuration cue which has a first meaning
that configuration information for a multi-channel reconstruction means is
contained in the input data, or has a second meaning that the multi-channel
reconstruction means is to use configuration information depending on a coding
algorithm with which the transmission channel data have been decoded from a
coded version thereof, comprising:
writing means for writing configuration data, wherein the writng means is
designed to
read the input data to interpret the parameter configuration cue, and
when the parameter configuration cue has the second meaning, retrieve and output
as the configuration data information on a coding algorithm with which the
transmission channel data have been decoded from a coded version thereof .
]87[
]74[
]57[
__________________
313
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫פטנטים‬
PATENTS
‫פטנטים שניתנו‬
PATENTS GRANTED
124636
151705
152645
154334
155545
176518
156227
156871
157588
157902
158502
159534
160367
160981
140793
145381
161654
162513
163048
164037
164961
165782
166769
146887
150636
168014
169351
171104
171955
126626
151772
152770
154495
155801
176731
156254
156999
157591
158060
158634
159859
160522
161165
141061
145759
161872
162522
163287
164066
164972
165925
166897
147214
150972
168041
169463
171165
172437
126728
151858
152786
154538
155901
179865
156277
157015
157592
158127
158932
159947
160575
184004
142025
145982
161876
162562
163288
164199
165027
165965
167005
147963
151139
168245
169515
171508
172670
127581
152328
153100
154581
156049
180304
156330
157048
157678
158155
158933
159950
160580
187551
142905
161401
161898
162567
163376
164271
165162
166014
135999
148505
167081
168608
169612
171576
172839
127833
152372
153257
154663
175109
129966
156579
157097
157721
158161
158935
160049
160640
188086
143015
161402
161984
162592
163450
164696
165439
166354
136219
149108
167337
168700
170010
171585
173158
151216
152528
153719
154897
175191
131197
156626
157106
157818
158162
158968
160053
160660
138380
143351
161559
162035
162676
163734
164709
165520
166439
137123
149325
167624
168770
170046
171598
173505
151240
152561
153804
155183
175454
132251
156764
157117
157878
158228
159017
160330
160680
139674
144043
161587
162092
162721
163738
164823
165694
166557
137462
149496
167673
168793
170324
171860
173681
151372
152625
154130
155507
175846
156115
156858
157477
157895
158285
159218
160338
160769
140625
145145
161643
162492
162824
163921
164944
165715
166746
146679
150153
167935
168977
170728
171947
101598
101661
117647
117852
117925
101600
101680
117722
117863
117942
‫פטנטים שחודשו‬
PATENTS RENEWED
101445
101613
101696
117756
117864
314
101531
101616
101702
117765
117871
101537
101636
101715
117783
117885
101547
101649
101728
117791
117888
101571
101658
101769
117839
117916
101577
101660
116714
117842
117918
October 31, 2010-‫כ"ג בחשון התשע"א‬
117987
118036
118073
118158
132262
135547
135869
140625
143855
145234
145470
145585
145755
145818
145893
145937
145974
146032
146152
146276
149040
154301
156150
159412
160638
161243
161577
162024
163617
164972
166369
168002
169950
173325
186305
117998
118045
118078
118171
133540
135615
135931
140692
143866
145269
145483
145609
145765
145831
145897
145941
145975
146033
146163
146343
149085
154751
156253
159548
160895
161273
161618
162082
163917
165058
166405
168331
170095
175508
193076
118001
118046
118089
118179
134123
135736
135936
141306
144029
145286
145518
145613
145766
145842
145898
145942
145993
146034
146167
146372
149108
154871
156755
159785
160934
161283
161638
162549
163918
165155
166452
168657
170562
175537
193875
118004
118047
118095
118203
135191
135744
140348
142014
144565
145305
145546
145652
145770
145849
145904
145948
146002
146048
146192
146387
149496
155129
157755
160097
160935
161373
161647
162592
164033
165208
166675
168766
171287
175786
118022
118052
118102
118216
135261
135773
140379
142709
144733
145371
145548
145668
145783
145852
145908
145957
146005
146055
146220
146429
149850
155344
158060
160282
161082
161464
161766
162734
164128
165385
166890
169531
171439
178768
118024
118056
118106
118903
135371
135802
140458
143002
144916
145377
145553
145671
145784
145874
145922
145970
146014
146069
146222
147153
152343
155636
158151
160287
161087
161510
161827
163071
164176
165602
167336
169595
171571
178769
118027
118062
118142
125627
135524
135804
140510
143123
145029
145436
145554
145672
145787
145880
145923
145972
146029
146089
146224
147641
152379
155647
158502
160367
161227
161526
161888
163107
164627
165922
167356
169823
171633
178782
118033
118069
118150
132173
135533
135821
140511
143649
145076
145443
145580
145694
145812
145892
145934
145973
146031
146134
146232
148071
154096
155650
158796
160451
161242
161548
161979
163595
164723
165945
167612
169924
171935
182059
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
112083
113799
113902
114033
114127
114197
315
112167
113809
113913
114035
114140
114201
113011
113819
113977
114043
114141
114220
113750
113829
113982
114064
114142
114224
113762
113844
113990
114086
114180
114231
113771
113861
114004
114089
114186
114256
113778
113872
114011
114097
114193
114285
113798
113891
114032
114099
114196
114302
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫‪114374‬‬
‫‪114438‬‬
‫‪114514‬‬
‫‪114633‬‬
‫‪114808‬‬
‫‪134687‬‬
‫‪151360‬‬
‫‪153118‬‬
‫‪154278‬‬
‫‪155502‬‬
‫‪98180‬‬
‫‪98315‬‬
‫‪98525‬‬
‫‪98608‬‬
‫‪98775‬‬
‫‪98902‬‬
‫‪99005‬‬
‫‪99138‬‬
‫‪99225‬‬
‫‪99356‬‬
‫‪123934‬‬
‫‪138798‬‬
‫‪139697‬‬
‫‪139807‬‬
‫‪139963‬‬
‫‪140094‬‬
‫‪140165‬‬
‫‪140299‬‬
‫‪140476‬‬
‫‪140611‬‬
‫‪140727‬‬
‫‪140851‬‬
‫‪140973‬‬
‫‪141075‬‬
‫‪141229‬‬
‫‪141329‬‬
‫‪141422‬‬
‫‪141563‬‬
‫‪141755‬‬
‫‪142052‬‬
‫‪156260‬‬
‫‪156914‬‬
‫‪157622‬‬
‫‪158797‬‬
‫‪161038‬‬
‫‪114903‬‬
‫‪115010‬‬
‫‪114365‬‬
‫‪114433‬‬
‫‪114505‬‬
‫‪114631‬‬
‫‪114804‬‬
‫‪134665‬‬
‫‪151350‬‬
‫‪152857‬‬
‫‪154275‬‬
‫‪155356‬‬
‫‪180472‬‬
‫‪98304‬‬
‫‪98510‬‬
‫‪98605‬‬
‫‪98750‬‬
‫‪98895‬‬
‫‪99002‬‬
‫‪99130‬‬
‫‪99216‬‬
‫‪99354‬‬
‫‪123933‬‬
‫‪138632‬‬
‫‪139693‬‬
‫‪139795‬‬
‫‪139954‬‬
‫‪140070‬‬
‫‪140161‬‬
‫‪140284‬‬
‫‪140475‬‬
‫‪140603‬‬
‫‪140722‬‬
‫‪140843‬‬
‫‪140947‬‬
‫‪141072‬‬
‫‪141169‬‬
‫‪141324‬‬
‫‪141408‬‬
‫‪141540‬‬
‫‪141701‬‬
‫‪141953‬‬
‫‪156231‬‬
‫‪156886‬‬
‫‪157559‬‬
‫‪158678‬‬
‫‪160583‬‬
‫‪114902‬‬
‫‪114989‬‬
‫‪114363‬‬
‫‪114431‬‬
‫‪114479‬‬
‫‪114603‬‬
‫‪114790‬‬
‫‪134540‬‬
‫‪137899‬‬
‫‪152855‬‬
‫‪154062‬‬
‫‪155181‬‬
‫‪174385‬‬
‫‪98274‬‬
‫‪98479‬‬
‫‪98597‬‬
‫‪98729‬‬
‫‪98882‬‬
‫‪98977‬‬
‫‪99112‬‬
‫‪99203‬‬
‫‪99345‬‬
‫‪123932‬‬
‫‪138592‬‬
‫‪139689‬‬
‫‪139764‬‬
‫‪139953‬‬
‫‪140053‬‬
‫‪140145‬‬
‫‪140272‬‬
‫‪140468‬‬
‫‪140586‬‬
‫‪140691‬‬
‫‪140835‬‬
‫‪140902‬‬
‫‪141063‬‬
‫‪141158‬‬
‫‪141322‬‬
‫‪141404‬‬
‫‪141503‬‬
‫‪141688‬‬
‫‪141914‬‬
‫‪156212‬‬
‫‪156756‬‬
‫‪157548‬‬
‫‪158446‬‬
‫‪160393‬‬
‫‪114887‬‬
‫‪114988‬‬
‫כ"ג בחשון התשע"א‪October 31, 2010-‬‬
‫‪114351‬‬
‫‪114430‬‬
‫‪114473‬‬
‫‪114571‬‬
‫‪114785‬‬
‫‪134465‬‬
‫‪136358‬‬
‫‪152578‬‬
‫‪153947‬‬
‫‪155120‬‬
‫‪156107‬‬
‫‪98271‬‬
‫‪98469‬‬
‫‪98578‬‬
‫‪98709‬‬
‫‪98828‬‬
‫‪98971‬‬
‫‪99111‬‬
‫‪99202‬‬
‫‪99276‬‬
‫‪121415‬‬
‫‪138237‬‬
‫‪139687‬‬
‫‪139757‬‬
‫‪139928‬‬
‫‪140037‬‬
‫‪140144‬‬
‫‪140266‬‬
‫‪140452‬‬
‫‪140585‬‬
‫‪140684‬‬
‫‪140826‬‬
‫‪140899‬‬
‫‪141042‬‬
‫‪141144‬‬
‫‪141311‬‬
‫‪141393‬‬
‫‪141501‬‬
‫‪141684‬‬
‫‪141909‬‬
‫‪156186‬‬
‫‪156535‬‬
‫‪157524‬‬
‫‪158441‬‬
‫‪160070‬‬
‫‪114876‬‬
‫‪114972‬‬
‫‪114349‬‬
‫‪114416‬‬
‫‪114470‬‬
‫‪114563‬‬
‫‪114700‬‬
‫‪134357‬‬
‫‪135837‬‬
‫‪151573‬‬
‫‪153648‬‬
‫‪155047‬‬
‫‪156099‬‬
‫‪98256‬‬
‫‪98442‬‬
‫‪98574‬‬
‫‪98708‬‬
‫‪98826‬‬
‫‪98954‬‬
‫‪99102‬‬
‫‪99184‬‬
‫‪99261‬‬
‫‪120424‬‬
‫‪138212‬‬
‫‪139636‬‬
‫‪139736‬‬
‫‪139917‬‬
‫‪140031‬‬
‫‪140132‬‬
‫‪140265‬‬
‫‪140444‬‬
‫‪140581‬‬
‫‪140657‬‬
‫‪140810‬‬
‫‪140897‬‬
‫‪141000‬‬
‫‪141134‬‬
‫‪141304‬‬
‫‪141388‬‬
‫‪141466‬‬
‫‪141679‬‬
‫‪141902‬‬
‫‪156185‬‬
‫‪156525‬‬
‫‪157521‬‬
‫‪158305‬‬
‫‪159660‬‬
‫‪114840‬‬
‫‪114957‬‬
‫‪114346‬‬
‫‪114406‬‬
‫‪114467‬‬
‫‪114560‬‬
‫‪114679‬‬
‫‪134102‬‬
‫‪135814‬‬
‫‪151564‬‬
‫‪153534‬‬
‫‪154543‬‬
‫‪156066‬‬
‫‪98240‬‬
‫‪98430‬‬
‫‪98545‬‬
‫‪98660‬‬
‫‪98815‬‬
‫‪98940‬‬
‫‪99098‬‬
‫‪99165‬‬
‫‪99240‬‬
‫‪99442‬‬
‫‪138110‬‬
‫‪139635‬‬
‫‪139726‬‬
‫‪139874‬‬
‫‪140001‬‬
‫‪140116‬‬
‫‪140201‬‬
‫‪140416‬‬
‫‪140525‬‬
‫‪140650‬‬
‫‪140786‬‬
‫‪140890‬‬
‫‪140998‬‬
‫‪141133‬‬
‫‪141292‬‬
‫‪141370‬‬
‫‪141451‬‬
‫‪141659‬‬
‫‪141833‬‬
‫‪142179‬‬
‫‪156436‬‬
‫‪157254‬‬
‫‪157993‬‬
‫‪159596‬‬
‫‪114833‬‬
‫‪114951‬‬
‫‪114340‬‬
‫‪114391‬‬
‫‪114456‬‬
‫‪114522‬‬
‫‪114651‬‬
‫‪134010‬‬
‫‪135422‬‬
‫‪151518‬‬
‫‪153369‬‬
‫‪154461‬‬
‫‪155567‬‬
‫‪98214‬‬
‫‪98424‬‬
‫‪98543‬‬
‫‪98657‬‬
‫‪98790‬‬
‫‪98939‬‬
‫‪99079‬‬
‫‪99157‬‬
‫‪99234‬‬
‫‪99428‬‬
‫‪123944‬‬
‫‪139555‬‬
‫‪139716‬‬
‫‪139873‬‬
‫‪139973‬‬
‫‪140102‬‬
‫‪140187‬‬
‫‪140401‬‬
‫‪140503‬‬
‫‪140641‬‬
‫‪140767‬‬
‫‪140884‬‬
‫‪140992‬‬
‫‪141113‬‬
‫‪141291‬‬
‫‪141343‬‬
‫‪141449‬‬
‫‪141625‬‬
‫‪141824‬‬
‫‪142149‬‬
‫‪156347‬‬
‫‪157069‬‬
‫‪157827‬‬
‫‪158925‬‬
‫‪105379‬‬
‫‪114939‬‬
‫‪114336‬‬
‫‪114383‬‬
‫‪114446‬‬
‫‪114515‬‬
‫‪114646‬‬
‫‪114810‬‬
‫‪134836‬‬
‫‪151382‬‬
‫‪153339‬‬
‫‪154417‬‬
‫‪155515‬‬
‫‪98195‬‬
‫‪98369‬‬
‫‪98536‬‬
‫‪98647‬‬
‫‪98777‬‬
‫‪98935‬‬
‫‪99048‬‬
‫‪99148‬‬
‫‪99226‬‬
‫‪99401‬‬
‫‪123935‬‬
‫‪139301‬‬
‫‪139702‬‬
‫‪139862‬‬
‫‪139967‬‬
‫‪140095‬‬
‫‪140175‬‬
‫‪140339‬‬
‫‪140487‬‬
‫‪140640‬‬
‫‪140748‬‬
‫‪140873‬‬
‫‪140985‬‬
‫‪141079‬‬
‫‪141287‬‬
‫‪141337‬‬
‫‪141423‬‬
‫‪141588‬‬
‫‪141756‬‬
‫‪142140‬‬
‫‪156326‬‬
‫‪156952‬‬
‫‪157700‬‬
‫‪158862‬‬
‫‪182156‬‬
‫‪114912‬‬
‫‪316‬‬
‫‪115096‬‬
‫‪115184‬‬
‫‪130032‬‬
‫‪130312‬‬
‫‪130531‬‬
‫‪130870‬‬
‫‪130988‬‬
‫‪131137‬‬
‫‪131324‬‬
‫‪131564‬‬
‫‪131710‬‬
‫‪132133‬‬
‫‪148275‬‬
‫‪150366‬‬
‫‪167539‬‬
‫‪142522‬‬
‫‪145507‬‬
‫‪162081‬‬
‫‪165854‬‬
‫‪166865‬‬
‫‪115083‬‬
‫‪115175‬‬
‫‪130031‬‬
‫‪130303‬‬
‫‪130527‬‬
‫‪130841‬‬
‫‪130987‬‬
‫‪131096‬‬
‫‪131317‬‬
‫‪131562‬‬
‫‪131708‬‬
‫‪131842‬‬
‫‪148246‬‬
‫‪150302‬‬
‫‪167226‬‬
‫‪142366‬‬
‫‪144769‬‬
‫‪161793‬‬
‫‪163897‬‬
‫‪166704‬‬
‫‪115079‬‬
‫‪115162‬‬
‫‪130029‬‬
‫‪130275‬‬
‫‪130495‬‬
‫‪130799‬‬
‫‪130986‬‬
‫‪131074‬‬
‫‪131314‬‬
‫‪131518‬‬
‫‪131683‬‬
‫‪131830‬‬
‫‪147804‬‬
‫‪149836‬‬
‫‪167181‬‬
‫‪128717‬‬
‫‪144614‬‬
‫‪161720‬‬
‫‪163427‬‬
‫‪166357‬‬
‫‪115075‬‬
‫‪115161‬‬
‫‪130021‬‬
‫‪130185‬‬
‫‪130458‬‬
‫‪130776‬‬
‫‪130975‬‬
‫‪131057‬‬
‫‪131269‬‬
‫‪131403‬‬
‫‪131650‬‬
‫‪131802‬‬
‫‪147416‬‬
‫‪149767‬‬
‫‪150934‬‬
‫‪125959‬‬
‫‪143465‬‬
‫‪161678‬‬
‫‪163193‬‬
‫‪166300‬‬
‫‪115060‬‬
‫‪115122‬‬
‫‪129989‬‬
‫‪130175‬‬
‫‪130448‬‬
‫‪130771‬‬
‫‪130941‬‬
‫‪131052‬‬
‫‪131238‬‬
‫‪131401‬‬
‫‪131620‬‬
‫‪131800‬‬
‫‪147399‬‬
‫‪149592‬‬
‫‪150921‬‬
‫‪171405‬‬
‫‪143403‬‬
‫‪161292‬‬
‫‪162826‬‬
‫‪166215‬‬
‫‪115047‬‬
‫‪115118‬‬
‫‪129954‬‬
‫‪130119‬‬
‫‪130447‬‬
‫‪130770‬‬
‫‪130930‬‬
‫‪131031‬‬
‫‪131222‬‬
‫‪131396‬‬
‫‪131613‬‬
‫‪131775‬‬
‫‪146789‬‬
‫‪149526‬‬
‫‪150671‬‬
‫‪169455‬‬
‫‪143160‬‬
‫‪145602‬‬
‫‪162753‬‬
‫‪166081‬‬
‫‪115039‬‬
‫‪115110‬‬
‫‪118817‬‬
‫‪130110‬‬
‫‪130434‬‬
‫‪130650‬‬
‫‪130905‬‬
‫‪131018‬‬
‫‪131184‬‬
‫‪131375‬‬
‫‪131568‬‬
‫‪131768‬‬
‫‪146421‬‬
‫‪148678‬‬
‫‪150461‬‬
‫‪168849‬‬
‫‪143135‬‬
‫‪145582‬‬
‫‪162583‬‬
‫‪166077‬‬
‫‪115035‬‬
‫‪115099‬‬
‫‪115201‬‬
‫‪130084‬‬
‫‪130387‬‬
‫‪130541‬‬
‫‪130895‬‬
‫‪131017‬‬
‫‪131183‬‬
‫‪131329‬‬
‫‪131566‬‬
‫‪131712‬‬
‫‪133137‬‬
‫‪148371‬‬
‫‪150457‬‬
‫‪168788‬‬
‫‪142743‬‬
‫‪145559‬‬
‫‪162552‬‬
‫‪166020‬‬
‫פטנטים שחודשו לעשרים שנה‬
‫‪PATENTS RENEWED FOR 20 YEARS‬‬
‫‪146161‬‬
‫כ"ג בחשון התשע"א‪October 31, 2010-‬‬
‫‪317‬‬
‫הודעה‬
NOTICE
‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
132813
8/2006
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
‫אורמת תעשיות בע"מ‬
ORMAT TECHNOLOGIES INC.
:‫שם האמצאה‬
‫תחנת כוח במעגל משולב‬
COMBINED CYCLE POWER PLANT
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
the law and by regulation 92
-‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1968
Title of invention:
318
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
319
154720
9/2007
,‫ לחוק הפטנטים‬66 ‫לפי סעיף‬
1967-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬67 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬99
.1968
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
320
158502
6/2008
,‫ לחוק הפטנטים‬66 ‫לפי סעיף‬
1967-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬67 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬99
.1968
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫תיקונים ביומן‬
Gournal Corrections
Patent application No
No. of Patent:
CORRECT DATE OF
APPLICATION
18.6.2002
321
150295
72009
'‫בקשת פטנט מס‬
:‫מספר יומן בו נפלה טעות‬
‫תקן את תאריך הבקשה‬
18.06.2002
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
45548
9)01(
20.02.2008
.GUERLAIN
Bottle
Convention date (OHIM)
Class
06.09.2007
45584
6)06(
28.02.2008
‫סוג פרסום‬
S.A
‫בקבוק‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
‫הרדור ייצור מנגנונים בע"מ‬
HARDOOR MECHANISMS
PRODUCTION LTD.
‫פרופיל‬
Profile
Class
46484
4)02(
12.08.2008
‫סוג פרסום‬
COLGATE-PALMOLIVE COMPANY
Toothbrush
Convention date (U.S.A.)
Class
EXTAL LTD.
322
15.02.2008
46573
8)09(
01.09.2008
‫מברשת שיניים‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
‫אקסטל בע"מ‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫אטם שליבה‬
Linkage gasket
46729 ,46728 ,46727
46732 ,46731 ,46730
46734 ,46733
25)01(
12.10.2008
Class
‫סוג פרסום‬
‫סט אל סיטון בע"מ‬
‫פרופיל‬
SET AL SETTON LTD.
Profile
46797
25)01(
29.10.2008
Class
ALUMA ALUMINUM SOLUTIONS
LTD.
‫סוג פרסום‬
‫אלומה פתרונות באלומיניום בע"מ‬
‫פרופיל‬
Profile
46850
24)02(
18.11.2008
Class
.OTSUKA
Inhaler
Convention date (JAPAN)
‫סוג פרסום‬
PHARMACEUTICAL CO.LTD
Class
‫משאף‬
)‫תאריך האמנה (יפן‬
23.05.2008
46880
9)03(
25.11.2008
‫סוג פרסום‬
‫) בע"מ‬1990( ‫ווק‬-‫פלסטו‬
‫מיכל‬
PLASTO-VACK (1990) LTD.
Container
46932
323
October 31, 2010-‫כ"ג בחשון התשע"א‬
9)01(
02.07.2008
Class
.SOCIETE DES PRODUITS
Jar
Convention date (Switzerland)
28.01.2008
46988
9)03(
14.12.2008
Class
‫סוג פרסום‬
NESTLE S.A
‫צנצנת‬
)‫תאריך האמנה (שוויץ‬
‫סוג פרסום‬
‫דרפלסט בע"מ‬
‫קופסא‬
DARPLAST LTD.
Box
46574
8)09(
01.09.2008
Class
‫סוג פרסום‬
‫אקסטל בע"מ‬
‫פקק לזקף‬
EXTAL LTD.
Upright cover
46908
3)01(
03.12.2008
Class
ZALI AND NOAM LASER ART
LTD.
‫סוג פרסום‬
‫צלי ונעם לייזר ארט בע"מ‬
‫מחזיק מפתחות‬
Key chain
Class
46910 ,46909
11)02(
03.12.2008
ZALI AND NOAM LASER ART
LTD.
Magnet ornament
324
‫סוג פרסום‬
‫צלי ונעם לייזר ארט בע"מ‬
‫מגנט לקישוט‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
Class
47015
8)08(
22.12.2008
‫סוג פרסום‬
‫ספיראל סאפורטס בע"מ‬
‫תומך למדף‬
SPIRAL SUPPORTS LTD.
Shelf support
Class
47030
2)04(
24.12.2008
‫סוג פרסום‬
‫יעל ברומברג‬
‫כסות רגל‬
YAEL BROMBERG
Leg wrapper
Class
47082
25)02(
04.01.2009
‫סוג פרסום‬
‫אריכא ובניו בע"מ‬.‫שחם י‬
SHAHAM Y. ARICHA AND SONS
LTD.
‫מחסום‬
Bolard
Class
47094
3)01(
08.01.2009
.GRIPPING EYEWEAR,
Eyeglass case
Convention date (U.S.A.)
08.07.2008
Class
.OMS
Spray bottle
Convention date (U.S.A.)
325
47097
9)07(
11.01.2009
‫סוג פרסום‬
INC
‫נרתיק משקפיים‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
INVESTMENTS, INC
10.07.2008
‫בקבוק התזה‬
)‫תאריך האמנה (ארצות הברית‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
Class
47157
9)03(
22.01.2009
‫סוג פרסום‬
‫קוסמופארם בע"מ‬
‫מיכל‬
COSMOPHARM LTD.
Container
Class
47254
11)02(
15.02.2009
‫סוג פרסום‬
‫דתיה לנדאו‬
‫פסל אדם‬
DATYA LANDAU
Men statue
Class
47368
6)01(
09.03.2009
SHAHAM Y. ARICHA AND SONS
LTD.
‫סוג פרסום‬
‫אריכא ובניו בע"מ‬.‫שחם י‬
‫ספסל‬
Bench
Class
47475
21)02(
23.03.2009
‫איל מונטאנו‬
‫ריבוע לתלייה למופעים‬
EYAL MUNTEANU
Hangable square for performance
Class
47631
25)02(
04.05.2009
SHAHAM Y. ARICHA AND SONS
LTD.
326
‫סוג פרסום‬
‫סוג פרסום‬
‫אריכא ובניו בע"מ‬.‫שחם י‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫מחסום‬
Bolard
Class
47729
23)01(
26.05.2009
‫סוג פרסום‬
VICTAULIC COMPANY
Rigid pipe coupling
Convention date (U.S.A.)
Class
03.12.2008
47512
26)01(
07.04.2009
‫מחבר לצינור קשיח‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
‫נר לחיים בע"מ‬
‫בית נרות זיכרון‬
LIFECANDLE LTD.
Memorial candles casing
Class
47714
6)01(
24.05.2009
‫עופר לוי‬
‫אריק כהן‬
‫תומך גב למושב הרכב‬
OFER LEVI
ARIK COHEN
Vehicle seat back support
Class
‫סוג פרסום‬
47815
2)03(
04.06.2009
‫סוג פרסום‬
‫שחר קליין‬
‫מתקן להגבהת כובע‬
SHAHAR KLEIN
Device for elevation hat
Class
327
47862
2)02(
18.06.2009
‫סוג פרסום‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫תור‬-‫יצחק קן‬
‫חולצה‬
ISAAC KEN-TOR
Shirt
47864
24)04(
14.08.2008
Class
‫סוג פרסום‬
GLAXO GROUP LIMITED
Inhaler
Convention date (Great Britain)
Class
‫משאף‬
‫תאריך האמנה (הממלכה‬
)‫המאוחדת‬
18.02.2008
47873
21)02(
23.06.2009
‫סוג פרסום‬
‫אריאל טמיר‬
‫מתקן ספורט‬
ARIEL TAMIR
Sport device
Class
47876
24)01(
24.06.2009
‫סוג פרסום‬
UNI-CHARM CORPORATION
‫מסיכה סניטארית‬
Sanitary mask
Class
47978
6)09(
13.07.2009
HAGAI KARP
LIOR TEXTILE INDUSTRIES LTD.
Mattress
‫סוג פרסום‬
‫חגי קרפ‬
‫מתפרות ליאור בע"מ‬
‫מזרון‬
48030
328
October 31, 2010-‫כ"ג בחשון התשע"א‬
Class
23)01(
20.07.2009
‫סוג פרסום‬
VICTAULIC COMPANY
Gasket
Convention date (U.S.A.)
23.01.2009
Class
48032
24)02(
20.07.2009
.FLUORINEX
‫אטם‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
ACTIVE LTD
‫מכשיר דנטלי‬
Dental instrument
Class
48107
25)01(
02.08.2009
‫סוג פרסום‬
‫יגאל בלכר‬
‫פרופיל‬
IGAL BLECHER
Profile
Class
48110 ,48109
8)05(
02.08.2009
‫סוג פרסום‬
.SUMITOMO ELECTRIC HARDMETAL CORP
Indexable insert for a grooving tool
‫מפתוח לכלי חריצה‬-‫התקן בר‬
Convention date (JAPAN)
02.02.2009
)‫תאריך האמנה (יפן‬
Class
BENZION GOLDSTEIN
Pants
329
48124
2)02(
05.08.2009
‫סוג פרסום‬
‫בן ציון גולדשטיין‬
‫מכנסיים‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
Class
48150 ,48149 ,48148
48151
2)02(
09.08.2009
‫סוג פרסום‬
‫רחל ליפשיץ‬
‫חולצה‬
RACHEL LIFSHITZ
Shirt
Class
48152
2)07(
09.08.2009
‫סוג פרסום‬
‫רחל ליפשיץ‬
‫חולצה‬
RACHEL LIFSHITZ
Shirt
Class
48154
26)05(
09.08.2009
‫גלובל אל סי אס בע"מ‬
‫פרופיל לתאורה‬
GLOBAL LCS LTD.
Profile for lighting
Class
.H.
‫סוג פרסום‬
48194 ,48192 ,48185
11)01(
16.08.2009
‫סוג פרסום‬
STERN COMERCIO E INDUSTRIA S.A
‫תכשיט‬
Jewel
Class
KLIL INDUSTRIES LTD.
Profile
330
48219 ,48218 ,48216
48220
25)01(
20.08.2009
‫סוג פרסום‬
‫קליל תעשיות בע"מ‬
‫פרופיל‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
Class
.SONY
Supporting base
Convention date (JAPAN)
‫מתקן תמיכה‬
)‫תאריך האמנה (יפן‬
22.06.2009
48290
14)02(
07.09.2009
‫סוג פרסום‬
COMPUTER ENTERTAINMENT, INC
‫יחידת חשבון ובקרה‬
)‫תאריך האמנה (יפן‬
02.06.2009
Class
.SONY
Camera
Convention date (JAPAN)
‫סוג פרסום‬
COMPUTER ENTERTAINMENT, INC
Class
.SONY
Arithmetic and control unit
Convention date (JAPAN)
48289
14)02(
07.09.2009
48292
16)01(
07.09.2009
‫סוג פרסום‬
COMPUTER ENTERTAINMENT, INC
Class
‫מצלמה‬
)‫תאריך האמנה (יפן‬
30.04.2009
48298
12)16(
09.09.2009
‫סוג פרסום‬
‫הדר רוזן בע"מ‬
‫כיסוי למושב הרכב‬
HADAR ROSEN LTD.
Car seat cover
Class
ERGO4U LTD.
Arm support
331
48302
6)06(
10.09.2009
‫סוג פרסום‬
‫ארגו פור יו בע"מ‬
‫מתקן תמיכה לאמות הידיים‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
Class
48352
14)03(
24.09.2009
.MODU
‫סוג פרסום‬
LTD
‫טלפון סלולרי‬
Cell phone
Class
48566 ,48565
23)01(
04.06.2009
‫סוג פרסום‬
VICTAULIC COMPANY
Pipe coupling
Convention date (U.S.A.)
Class
13.12.2008
47323
9)05(
25.02.2009
‫מצמד לצינור‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
UNILEVER PLC
Tube
Convention date (India)
332
25.08.2008
‫שפופרת‬
)‫תאריך האמנה (הודו‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫מדגמים שחודשו‬
‫‪DESIGNS RENEWED‬‬
‫‪33307‬‬
‫‪33489‬‬
‫‪40506‬‬
‫‪40555‬‬
‫‪42958‬‬
‫‪42966‬‬
‫‪42974‬‬
‫‪43078‬‬
‫‪33306‬‬
‫‪33375‬‬
‫‪40505‬‬
‫‪40532‬‬
‫‪42957‬‬
‫‪42965‬‬
‫‪42973‬‬
‫‪42981‬‬
‫‪33305‬‬
‫‪33374‬‬
‫‪40472‬‬
‫‪40531‬‬
‫‪40867‬‬
‫‪42964‬‬
‫‪42972‬‬
‫‪42980‬‬
‫כ"ג בחשון התשע"א‪October 31, 2010-‬‬
‫‪33304‬‬
‫‪33312‬‬
‫‪40471‬‬
‫‪40530‬‬
‫‪40864‬‬
‫‪42963‬‬
‫‪42971‬‬
‫‪42979‬‬
‫‪33285‬‬
‫‪33311‬‬
‫‪40470‬‬
‫‪40529‬‬
‫‪40863‬‬
‫‪42962‬‬
‫‪42970‬‬
‫‪42978‬‬
‫‪33274‬‬
‫‪33310‬‬
‫‪40445‬‬
‫‪40528‬‬
‫‪40775‬‬
‫‪42961‬‬
‫‪42969‬‬
‫‪42977‬‬
‫‪43265‬‬
‫‪33273‬‬
‫‪33309‬‬
‫‪40442‬‬
‫‪40526‬‬
‫‪40737‬‬
‫‪42960‬‬
‫‪42968‬‬
‫‪42976‬‬
‫‪43080‬‬
‫‪33258‬‬
‫‪33308‬‬
‫‪33634‬‬
‫‪40507‬‬
‫‪40592‬‬
‫‪42959‬‬
‫‪42967‬‬
‫‪42975‬‬
‫‪43079‬‬
‫‪333‬‬
‫מדגמים שבוטלו‬
‫‪DESIGNS VOID‬‬
‫‪32216‬‬
‫‪32302‬‬
‫‪39634‬‬
‫‪32215‬‬
‫‪32300‬‬
‫‪39629‬‬
‫‪32214‬‬
‫‪32290‬‬
‫‪39628‬‬
‫כ"ג בחשון התשע"א‪October 31, 2010-‬‬
‫‪32214‬‬
‫‪32267‬‬
‫‪39627‬‬
‫‪40950‬‬
‫‪24178‬‬
‫‪32266‬‬
‫‪39626‬‬
‫‪39647‬‬
‫‪24081‬‬
‫‪32255‬‬
‫‪39622‬‬
‫‪39644‬‬
‫‪24073‬‬
‫‪32254‬‬
‫‪39621‬‬
‫‪39642‬‬
‫‪24043‬‬
‫‪32252‬‬
‫‪39620‬‬
‫‪39640‬‬
‫‪334‬‬
‫מדגמים שהוזנחו‬
WITHDRAWN DESIGNS
46122
46165
46244
46306
46342
46395
46403
46475
46535
47005
46123
46172
46245
46318
46362
46396
46404
46498
46536
47007
Dr. Meir Noam
Commissioner of Patents,
Designs and Trade Marks
335
46125
46226
46246
46319
46365
46397
46426
46499
46537
47031
46126
46230
46248
46320
46390
46398
46427
46506
46540
47868
46127
46236
46258
46331
46391
46399
46443
46510
46541
48184
46128
46237
46271
46335
46392
46400
46470
46511
46542
48187
46129
46240
46272
46340
46393
46401
46471
46517
46685
48427
46137
46243
46305
46341
46394
46402
46472
46518
46856
48955
‫ד"ר מאיר נועם‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫‪177247 - EARLYSENSE LTD‬‬
‫‪NAME INDEX‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ ‪-‬‬
‫‪150935‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ ‪-‬‬
‫‪183335‬‬
‫אבנר הלפרין ‪177247 -‬‬
‫אדורם לשם ‪187447 -‬‬
‫אדריאן ישראלסון ‪160492 -‬‬
‫אוניברסיטת בן‪-‬גוריון בנגב‪ ,‬הרשות למחקר‬
‫ופיתוח ‪160492 -‬‬
‫אי‪ .‬סי‪ .‬איי‪ .‬טלקום בע"מ ‪172301 , 169416 -‬‬
‫איסכור מיגון בע"מ ‪196201 -‬‬
‫אלביט מערכות בע"מ ‪162025 -‬‬
‫אלי תייר ‪148847 -‬‬
‫אלכסנדר דברין ‪171141 -‬‬
‫מוסד הטכניון למחקר ופיתוח בע"מ ‪-‬‬
‫‪151860‬‬
‫מיכאל נאומוב ‪176167 -‬‬
‫מנשה שורץ ‪180908 -‬‬
‫בי‪.‬בי‪.‬אם‪.‬אס‪ .‬בע"מ ‪158243 -‬‬
‫נובה מכשירי מדידה בע"מ ‪150438 -‬‬
‫גאורגי נאומוב ‪176167 -‬‬
‫גרגורי פרלוב ‪195629 -‬‬
‫קדנט בע"מ ‪166053 -‬‬
‫קופרגייט תקשורת בע"מ ‪167973 -‬‬
‫קורפלו פתרונות מדעיים בע"מ ‪178342 -‬‬
‫קראל (טכנולוגיות קרמיקה) בע"מ ‪170659 -‬‬
‫דבלוגן ישראל בע"מ ‪163270 -‬‬
‫דוד דיילי ‪160891 -‬‬
‫דניאל לאנג ‪177247 -‬‬
‫הדסית שרותי מחקר רפואי ופתוח בע"מ ‪-‬‬
‫‪143485‬‬
‫הרדור ייצור מנגנונים בע"מ ‪181093 -‬‬
‫ורדה שושן‪-‬ברמץ ‪160492 -‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪148445 -‬‬
‫יוסף גרוס ‪177247 -‬‬
‫יוריזן בע"מ ‪120449 -‬‬
‫‪ADORAM LESHEM - 187447‬‬
‫‪ADRIAN ISRAELSON - 160492‬‬
‫ ‪AEOLUS PHARMACEUTICALS,INC.‬‬‫‪164048‬‬
‫כ"ג בחשון התשע"א‪October 31, 2010-‬‬
‫ליאור רדאי ‪160891 -‬‬
‫רפא"ל רשות לפיתוח אמצעי לחימה בע"מ ‪-‬‬
‫‪149431‬‬
‫שמואל קפלן ‪174105 -‬‬
‫תעשיות מתכת כפר סבא האחים שהרבני‬
‫(‪ )1980‬בע"מ ‪145361 -‬‬
‫‪3M COMPANY - 166053‬‬
‫‪3M COMPANY - 166053‬‬
‫‪336‬‬
AKZO NOBEL N.V. - 152957
ALEXANDER DVERIN - 171141
ALI HASAN HAMBAN ABDELQADER 171425
AMGEN INC. - 193813
AMGEN, INC. - 142023
AMIR BELSON - 160137
ANDROMEDA BIOTECH LTD. - 163270
ANGELANTONI INDUSTRIE SPA 181959
ARIZONA BOARD OF REGENTS ON
BEHALF OF THE UNIVERSITY OF
ARIZONA - 164560
ARM LIMITED - 172114
ASBJORN DRENGSTIG - 167510
ASHER BARTOV - 166573
ASTRAZENECA AB - 156096 , 160219
ATHEROS COMMUNICATIONS, INC. 166907
AVENTIS PHARMA S.A. - 164247 ,
173112
AVNER HALPERIN - 177247
AVOCENT CORPORATION - 180028
AVOCENT HUNTSVILLE
CORPORATION - 169215
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.p.A. - 172156 , 175827
BAE SYSTEMS LAND AND
ARMAMENTS L.P. - 167926
BAXTER INTERNATIONAL INC. 143485
BAYER
BETEILIGUNGSVERWALTUNG
GOSLAR GMBH - 176766
BAYER CROPSCIENCE AG - 154304
BAYER MATERIALSCIENCE AG 163326 , 169887
BBMS LTD. - 158243
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY - 160492
BERRY PLASTICS CORPORATION 176573
BHARAT SERUMS AND VACCINES
LTD. - 167228
337
BIOCYBERNETICS INTERNATIONAL 174851
BIOLEX THERAPEUTICS, INC. - 158984
BIOSYNERGETICS, INC. - 149240
BOEHRINGER INGELHEIM (CANADA)
LTD. - 156058
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH - 166404
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG - 163696
BONE CARE INTERNATIONAL, INC. 159067
BURY SP. Z.O.O. - 183098
CABOT MICROELECTRONICS
CORPORATION - 179112
CADENT LTD. - 166053
CEREL (CERAMIC TECHNOLOGIES)
LTD. - 170659
COMVERSE, INC. - 151957
COPPERGATE COMMUNICATIONS
LTD. - 167973
CORE-FLOW SCIENTIFIC SOLUTIONS
LTD. - 178342
CREANOVA UNIVERSAL CLOSURES
LTD. - 181627
CURTIS SWORD - 182916
DAIICHI SANKYO COMPANY LIMITED
- 166196
DAIICHI SANKYO COMPANY,
LIMITED - 197280 , 197281
DANIEL H. LANGE - 177247
DAVID DAILY - 160891
DEKA PRODUCTS LIMITED
PARTNERSHIP - 155390
DEUTSCHE POST AG - 166913 , 178449
DEVELOGEN ISRAEL LTD. - 163270
DIATOS - 190542
DIEHL BGT DEFENCE GMBH & CO. KG
- 172373 , 180215
DSM FINE CHEMICALS AUSTRIA NFG
GMBH & CO. KG - 188710
DTS, INC. - 178244 , 181449
EARLYSENSE LTD. - 177247
ECI TELECOM LTD. - 169416 , 172301
October 31, 2010-‫כ"ג בחשון התשע"א‬
ECLIPSE AVIATION CORPORATION 166643
ELBIT SYSTEMS LTD. - 162025
ELI TIAR - 148847
EMBREX, INC. - 156275
EORIGINAL, INC. - 166311
ETHICON ENDO-SURGERY, INC. 176359
EVENING STAR INVESTMENTS, L.L.C.
- 170941
EVERGREEN PACKAGING
INTERNATIONAL B.V. - 173899
EXONHIT THERAPEUTICS S.A. 148613
FERROTEC (USA) CORPORATION 159707
FIDELINE - 165754
FLAMEL TECHNOLOGIES - 166383
FOURNIER LABORATORIES IRELAND
LIMITED - 168737
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V. - 176857 , 181743 ,
201372
FUJIKIN INCORPORATED - 177350
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC 165847
GENELUX CORPORATION - 171859
GENERAL ELECTRIC COMPANY 169704
GENMAB A/S - 170373
GEORGE NAUMOV - 176167
GILEAD PALO ALTO, INC. - 163535
GLAXO GROUP LIMITED - 165330
GLAXOSMITHKLINE LLC - 143088
GRIGORI PERLOV - 195629
GW PHARMA LIMITED - 157130
H. LUNDBECK A/S - 160655 , 187143
HADASIT MEDICAL RESEARCH
SERVICES AND DEVELOPMENT LTD. 143485
HAMAMATSU PHOTONICS K.K. 172123 , 179130
338
HANMI PHARM. CO., LTD. - 177805
HARDOOR MECHANISMS
PRODUCTION LTD. - 181093
HAYGROVE LIMITED - 169566
HEMOTEQ AG - 164948
HF ARZNEIMITTELFORSCHUNG
GMBH - 158383
HUCK INTERNATIONAL, INC. - 162521
HYDROBALL TECHNICS HOLDINGS
PTE LTD. - 164943
ICX RADIATION GMBH - 179147
IMBERA ELECTRONICS OY - 171212
IMMUNOMEDICS, INC. - 163477 ,
163852
INDENA S.P.A. - 166554
INSTITUT NATIONALE DE LA
RECHERCHE AGRONOMIQUE - 183335
INTER IKEA SYSTEMS B.V. - 167481
INTERDIGITAL TECHNOLOGY
CORPORATION - 189157
INTERNATIONAL PAPER COMPANY 173899
IPSEN PHARMA S.A.S. - 143346
ISHIHARA SANGYO KAISHA LTD. 153779
ISKOOR SHELTERS LTD. - 196201
IVAR KOLLSGARD - 167510
JOHNS HOPKINS UNIVERSITY - 158618
KENJI KANGAWA - 198562
KERR GROUP, INC. - 176573
KIRIN-AMGEN INC. - 142023
L-3 COMMUNICATIONS SECURITY &
DETECTION SYSTEMS - 158189
LES LABORATOIRES SERVIER 173958 , 173960
LIOR RADAY - 160891
LOCKHEED MARTIN CORPORATION 163518
LONG LIFE S.R.L. - 182040
LTS-LOHMANN THERAPIE-SYSTEME
AG - 187582
MASTERCARD INTERNATIONAL
October 31, 2010-‫כ"ג בחשון התשע"א‬
INCORPORATED - 176961 , 176962
MATECHET KFAR-SABA
SHAHARBANI BROS. (1980) LTD. 145361
MENASHE SCHWARTZ - 180908
MERIDIAN MEDICAL
TECHNOLOGIES, INC. - 161681
MICHAEL NAUMOV - 176167
MICROSOFT CORPORATION - 160571 ,
166813
MILKHAUS LABORATORY, INC. 157164
MOTOROLA, INC. - 172550
MYELOS CORPORATION - 141586
N.V. BEKAERT S.A. - 169785
N.V. ORGANON - 152957 , 181334
NAGRAVISION S.A. - 181495
NELSON IRRIGATION CORPORATION
- 182720
NIKON CORPORATION - 196081
NOVA MEASURING INSTRUMENTS
LTD. - 150438
NOVARTIS AG - 157333 , 157335 ,
160382
NOVEN PHARMACEUTICALS, INC. 136760
NOVO NORDISK A/S - 161709
NTT DOCOMO, INC. - 144424
OBRIST CLOSURES SWITZERLAND
GMBH - 182927
ONCOLYTICS BIOTECH INC. - 154881 ,
182562
ONERA (OFFICE NATIONAL D'ETUDES
ET DE RECHERCHES
AEROSPATIALES) - 179045
ONO PHARMACEUTICAL CO., LTD. 159996
ORTHOFIX S.R.L. - 178285
ORTHOVITA, INC. - 157486
PARATEK PHARMACEUTICALS, INC. 157860
PATIENT ON LINE - 164863 , 165607
PFIZER ITALIA S.R.L. - 159570
PFIZER PRODUCTS, INC. - 139586 ,
339
158588
PHARMADESIGN INC. - 174018
PLANT BIOSCIENCE LIMITED - 149388
PYNG MEDICAL CORP. - 174851
QINETIQ LIMITED - 181491
QUALCOMM INCORPORATED - 167438
, 167442
QUALCOMM INCORPORATED - 179708
QX CORPORATION PTY LTD. - 188515
, 188516
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 149431
RAYTHEON COMPANY - 157861
RAYTHEON COMPANY - 168120 ,
172284 , 176188
SAES GETTERS S.P.A. - 162066
SAFRAN - 168406
SAGEM DEFENSE SECURITE - 168406 ,
173496
SAGEM SECURITE - 168406
SAINT GOBAIN ABRASIVES, INC. 178169
SANOFI-AVENTIS - 165434 , 176710
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 196873
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 157414 , 157415
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 162973 , 166058
SCHERING CORPORATION - 157551 ,
160918
SEALY TECHNOLOGY LLC - 174889
SHERWOOD SERVICES AG - 168913
SHMUEL KAPLAN - 174105
SICPA HOLDING S.A. - 171335
SILVERBROOK RESEARCH PTY. LTD.
- 146621 , 163498
SONIC MOBILITY INC. - 169215
STELLIFERI & ITAVEX SPA - 182040
SUMITOMO CHEMICAL COMPANY,
LIMITED. - 179703
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD. October 31, 2010-‫כ"ג בחשון התשע"א‬
151860
TEENESS ASA - 174423
THALES - 176241
THE DIRECTV GROUP, INC. - 168223
THE DIRECTV GROUP, INC. - 168222 ,
168226 , 168230
THE QUIGLEY CORPORATION - 162505
THE ROGOSIN INSTITUTE - 182853
THOMSON LICENSING S.A. - 160080
TIKOMED AB - 174488
TORMOD DRENGSTIG - 167510
TRUEPOSITION, INC. - 187185
UCB, S.A. - 179650
UHDE GMBH - 165640
UNILEVER PLC - 177738
UNISENSOR S.A. - 186636
UNITED RESOURCE RECOVERY
CORPORATION - 173617
UNITED STATES POSTAL SERVICE 148918
UNIVERSITE PIERRE ET MARIE CURIE
( PARIS 6 ) - 183335
UNIVERSITY OF NORTH CAROLINA
AT CHAPEL HILL - 164048
UNIVERSITY OF ROCHESTER - 170916
URIZEN NETWORK SYSTEMS LTD. 120449
VARDA SHOSHAN-BARMATZ - 160492
VESTA THERAPEUTICS, INC. - 164048
VTOL TECHNOLOGIES LIMITED 165968
WARNER-LAMBERT COMPANY LLC 177377
WILLIAM P. PANTOS - 182916
WYETH HOLDINGS CORPORATION 153133 , 153290
YEDA RESEARCH AND
DEVELOPMENT CO. LTD. - 148445
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD. 150935
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD 183335
YOSEF GROSS - 177247
ZAMBON GROUP S.P.A. - 161734
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01G - 169566
A01H - 158984
A01K - 167510
A01N - 153779,
A47K - 182916
A61B - 157486,
174851,
A61C - 166053
A61F - 174488
A61K - 136760,
148445,
340
154304
158243, 162025,
177247, 178285
143088, 143485,
150935, 153133,
154881, 157130,
157333, 158383,
160382, 162505,
164048, 164560,
166383, 167228,
172156, 173112,
181334, 198562
A61L - 149240, 163535
A61M - 160137, 160891,
161709, 176359,
A63F - 180908
157164,
159067,
163696,
165754,
168737,
175827,
161681,
187582
October 31, 2010-‫כ"ג בחשון התשע"א‬
E06B - 145361
B01D - 171425
B01J - 165640
B02C - 173617
B05B - 182720
B23B - 174423
B23K - 166643
B24D - 178169
B29C - 174889,
B32B - 173899
B60R - 183098
B62D - 181491
B62K - 155390
B63B - 172373
B64D - 166573
B65D - 167481,
176573,
182040,
B65G - 178342,
B66B - 169785
C07C - 157860,
179703
C07D - 139586,
158588,
160219,
161734,
166404,
176710,
179650,
197280,
C07H - 158618,
C07J - 152957
C07K - 141586,
163270,
183335,
C08B - 166554
C08K - 163326
C12N - 142023,
156058,
157415,
182562,
C12Q - 148613,
C23C - 162066
E02D - 148847
E04H - 196201
341
F02K - 165968
F16B - 162521, 170941
F16H - 195629
F16K - 177350
F24J - 169887
F25D - 173496
F28G - 164943
F42B - 157861, 167926, 172284
181093
171141, 174018,
177738, 181627,
182927, 187447
181959
164247, 166196,
156096,
159570,
160655,
165330,
173958,
177377,
187143,
197281
164948,
157551,
159996,
160918,
165434,
173960,
177805,
193813,
160492, 162973,
179045
167438, 176241,
188515, 188516
179147
196081
164863, 165607,
166913, 172114
171335, 176961,
178244, 181743,
166058
143346, 151860,
163852, 170373,
190542
149388,
157335,
163477,
188710
182853,
G01B - 150438
G01C - 178449
G01J - 179130
G01K - 168913
G01N - 156275,
186636
G01P - 176167,
G01S - 163518,
187185,
G01T - 165847,
G01V - 158189
G02B - 176188,
G06F - 146621,
166813,
G06K - 168406,
176962
G06Q - 166311
G08B - 174105
G10L - 176857,
201372
153290,
157414,
171859,
196873
H01G - 170659, 176766
H01J - 179112, 180215
H01L - 159707, 166907,
171212, 172123
H01Q - 149431, 172550
H03F - 168223
H04B - 168226, 168230,
172301, 189157
H04J - 167973, 169416
H04L - 120449
H04L - 148918, 160571,
168222, 169215
H04M - 151957
H04N - 160080, 163498,
181495
168120,
170916,
167442,
180028,
October 31, 2010-‫כ"ג בחשון התשע"א‬
H04R - 181449
H04W - 144424, 179708
H05K - 169704
342
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV
343
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Code
MX
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Country or Organization
Mexico
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property
Organization (W.I.P.O.)
South Africa
October 31, 2010-‫כ"ג בחשון התשע"א‬
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
‫ ירושלים‬,‫הופק והודפס במדפיס הממשלתי‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER
344
October 31, 2010-‫כ"ג בחשון התשע"א‬